20086 & 23035_VI Install Rpt_Occ Sampling 20221101_DEQ Con Letter

Via Email November 1, 2022
NCDEQ – Division of Waste Management Brownfields Program
1646 Mail Service Center Raleigh, North Carolina 27699-1646 Attn: Ms. Carolyn Minnich Re: Vapor Intrusion Mitigation System (VIMS) Installation Report – West Building Chadbourn Mill East and Theron Properties
500 & 508 Charles Avenue Charlotte, North Carolina Brownfields Project Nos. 20086-16-060 and 23035-19-060
H&H Project No. CAM-010
Dear Carolyn: On behalf of CUSA NC Holdings, LP, enclosed please find a copy of the VIMS Installation Report – West
Building – Revision 1, dated November 1, 2022 prepared for the West Building and a portion of the East Building at the Chadbourn Mill and Theron Properties Brownfield properties located in Charlotte, Mecklenburg County.
Should you have any questions or need additional information, please do not hesitate to contact us at [phone]. Sincerely,
Hart & Hickman, PC

Trinh DeSa, PE
Engineering Manager Enclosure:
cc: Mr. Will Smith, Camden USA (via email) Mr. Duane Canter, Camden USA (via email)
Mr. Ralph McGee, H&H (via email) Mr. Andrew Besu, H&H (via email) Ms. Shannon Switch, H&H (via email)
VIMS Installation Report - West Building
– Revision 1
Camden NoDa
500 and 508 Charles Avenue
Charlotte, North Carolina
Brownfields Project Nos.
Chadbourn Mill: 20086-16-060
Theron Properties: 23035-19-060
November 1, 2022
H&H Job No. CAM-010
#C-1269 Engineering #C-245 Geology
i
https://harthick.sharepoint.com/sites/masterfiles-1/shared documents/aaa-master projects/camden - cam/cam-010 camden noda redevelopment/vimp/vims install report - west bldg/rev 1/vims installation report - west building - rev 1.docx
VIMS Installation Report – West Building – Rev. 1 500 and 508 Charles Avenue Charlotte, North Carolina Brownfields Project Numbers: 20086-16-060 & 23035-19-060 H&H Job No. CAM-010 Table of Contents

1.0 Introduction ................................................................................................................ 1
2.0 VIMS Installation Inspections and Influence Testing ............................................ 4
2.1 VIMS Installation......................................................................................................4
2.2 VIMS Pilot Influence Testing ...................................................................................7
3.0 VIMS Effectiveness Sampling Activities .................................................................. 9
3.1 Sub-Slab Soil Vapor Sampling .................................................................................9
3.2 Sub-Slab Soil Vapor Sampling Results ..................................................................10
3.3 Vapor Intrusion Evaluation .....................................................................................11
4.0 Summary and Conclusions ..................................................................................... 13

List of Tables

Table 1 Summary of Sub-Slab Soil Vapor Analytical Data
List of Figures

Figure 1 Site Location Map
Figure 2 Site and Surrounding Area Map
Figure 3 Site Development Layout

ii
https://harthick.sharepoint.com/sites/masterfiles-1/shared documents/aaa-master projects/camden - cam/cam-010 camden noda redevelopment/vimp/vims install report - west bldg/rev 1/vims installation report - west building - rev 1.docx
List of Appendices

Appendix A VIMS As-Built Drawings (VM-1, VM-2, VM-3, and VM-3A)
Appendix B Product Specifications
Appendix C Photographic Log
Appendix D VIMS Influence Testing Forms and Sampling Field Forms
Appendix E Laboratory Analytical Reports
Appendix F PVC Primer and PVC Glue Material Safety Data Sheets
Appendix G DEQ Risk Calculators (July 2022)

1

https://harthick.sharepoint.com/sites/masterfiles-1/shared documents/aaa-master projects/camden - cam/cam-010 camden noda redevelopment/vimp/vims install report - west bldg/rev 1/vims installation report - west building - rev 1.docx
VIMS Installation Report – West Building – Rev. 1
500 and 508 Charles Avenue Charlotte, North Carolina Brownfields Project Numbers: 20086-16-060 & 23035-19-060 H&H Job No. CAM-010
1.0 Introduction

On behalf of CUSA N.C. Holdings, L.P. (Prospective Developer or PD), Hart & Hickman, PC
(H&H) has prepared this report to document vapor intrusion mitigation system (VIMS) installation
inspections, VIMS influence testing, and VIMS efficacy sampling activities completed for the
western portion of the apartment building on the Chadbourn Mill Brownfields property
(Brownfields Project No. 20086-16-060) and the Theron Properties Brownfields property
(Brownfields Project No. 23035-19-060) located at 500 and 508 Charles Avenue in Charlotte,
Mecklenburg, North Carolina (Site). A Site location map is included as Figure 1, and a Site and
surrounding area map is included as Figure 2.

Redevelopment of the Site is nearing completion and includes construction of a high-density
residential apartment building. The apartment building is one interconnected building, but it is
being completed in stages. For simplicity, the western portion of the building is referred to as the
West Building, and the eastern portion of the building is referred to as the East Building. The
West Building contains residential units on the ground floor, and the East Building contains mixed-
use residential and commercial spaces. The remainder of the Site will consist of a parking deck,
driveways, and outdoor amenity and urban spaces. This report only applies to the West Building
and a small portion of the East Building where the riser F-13 is located, referred to herein as East
Building – F-13 Area. The remainder of the East Building is still currently under construction and
a VIMS installation report for this remaining portion the East Building will be submitted under
separate cover. A layout of the development is depicted on Figure 3 and Sheets VM-1 and VM-2
provided in Appendix A.

The ground floor of the West Building (Level 1) is approximately 25,000 square foot (sq-ft) in
area and contains residential tenant spaces, amenity spaces, and office/lobby space. The West
2

https://harthick.sharepoint.com/sites/masterfiles-1/shared documents/aaa-master projects/camden - cam/cam-010 camden noda redevelopment/vimp/vims install report - west bldg/rev 1/vims installation report - west building - rev 1.docx
Building was constructed with a slab-on-grade foundations supported by columns. An
approximate 2,000-sq ft area in the southwestern portion of the West Building was constructed
partially below Level 1 as for-rent residential townhouse style apartments. This area is referred to
as Basement Level and consists of slab-on-grade construction with interior columns. A retaining
wall separates the Basement Level from the adjoining Level 1 spaces.

To address potential environmental concerns in connection with the Site, a Brownfields Agreement
between the North Carolina Department of Environmental Quality (DEQ) and the original PD was
recorded for Chadbourn Mill on September 1, 2017. On April 3, 2019, the PD purchased the
eastern portion of the Chadbourn Mill Brownfields Property. DEQ issued a Brownfields eligibility
letter for the Theron Properties on July 5, 2019. Land Use Restriction (LUR) No. 11 included in
the Brownfields Agreement generally states that no enclosed building may be constructed on the
property until DEQ determines in writing that the building would be protective of users from risks
of potential vapor intrusion. In accordance with LUR No. 11 in the Brownfields Agreement for
the Site, H&H prepared a Vapor Intrusion Mitigation Plan (VIMP) – Revision 1 dated May 4,
2020, which was subsequently approved by the DEQ Brownfields Program on June 11, 2020.

The DEQ-approved VIMP includes installation of a VIMS during construction of the building to
minimize the potential for vapor intrusion into the building using a passive sub-slab vapor
extraction system. The VIMS consists of a network of sub-slab horizontal collection piping,
vertical exhaust risers connected to wind-driven turbine ventilators on the building roof, and vapor
barrier below the concrete slabs and long retaining walls. The VIMS as-built drawings depicted
the installed VIMS components are included as Appendix A.

H&H completed VIMS inspections, VIMS influence testing, and VIMS efficacy testing for the
West Building and the East Building – F-13 Area (Figure 3) in accordance with the DEQ-approved
VIMP. A summary of the VIMS installation and influence testing activities is provided in Section
2.0. The VIMS efficacy sampling activities and results are detailed in Section 3.0, and summary
and conclusions based on the installation activities, influence testing, and efficacy sampling are
provided in Section 4.0.

3

https://harthick.sharepoint.com/sites/masterfiles-1/shared documents/aaa-master projects/camden - cam/cam-010 camden noda redevelopment/vimp/vims install report - west bldg/rev 1/vims installation report - west building - rev 1.docx
Engineer’s Certification
According to the DWM Vapor Intrusion Guidance: “Risk-based screening is used to identify sites
or buildings likely to pose a health concern, to identify buildings that may warrant immediate
action, to help focus site-specific investigation activities or to provide support for building
mitigation and other risk management options including remediation.” In addition, this VIMP was
prepared to satisfy the standard vapor intrusion mitigation provisions anticipated to be included in
the Brownfields Agreement. Per the North Carolina Brownfields Property Reuse Act 130A-
310.32, a prospective developer, with the assistance of H&H for this project, is to provide DEQ
with “information necessary to demonstrate that as a result of the implementation of the
brownfields agreement, the brownfields property will be suitable for the uses specified in the
agreement while fully protecting public health and the environment instead of being remediated to
unrestricted use standards.” It is in the context of these risk-based concepts that the H&H
professional engineer makes the following statement:

“The Vapor Intrusion Mitigation System (VIMS) detailed herein is designed to mitigate intrusion
of subsurface vapors into the subject building from known Brownfields Property contaminants in
a manner that is in accordance with the most recent and applicable guidelines including, but not
limited to, DWM Vapor Intrusion Guidance, Interstate Technology & Regulatory Council (ITRC)
guidance, and American National Standards Institute (ANSI)/American Association of Radon
Scientists and Technologists (AARST) standards. The sealing professional engineer below is
satisfied that the design and its installation are fully protective of public health from known
Brownfields Property contaminants.

[SEAL]

Trinh DeSa North Carolina PE (#044470)
Hart & Hickman, PC (#C-1269)
4

https://harthick.sharepoint.com/sites/masterfiles-1/shared documents/aaa-master projects/camden - cam/cam-010 camden noda redevelopment/vimp/vims install report - west bldg/rev 1/vims installation report - west building - rev 1.docx

2.0 VIMS Installation Inspections and Influence Testing
The Basement Level and Level 1 systems operate as independent sub-slab vapor extraction
systems, which include a permeable gravel layer, sub-slab vapor collection piping, a vapor barrier
(vapor liner), riser piping, and passive turbine ventilators. As-built drawings depicting the layout
of the VIMS (VM-1 and VM-2) and the system specifications and details (VM-3 and VM-3A) are
provided in Appendix A. Product specifications for the VIMS components are included in
Appendix B.

2.1 VIMS Installation

Between January 2021 and August 2022, H&H conducted inspections under direction of a North
Carolina (NC) Professional Engineer (PE) during various phases of construction to verify that the
VIMS was installed in accordance with the DEQ-approved VIMP. Inspections were completed
for the VIMS during the following phases of installation:

(1) Inspection of the base course gravel layer, sub-slab piping layout, and monitoring points
prior to installing the vapor liner;
(2) Inspection of the vapor liner prior to pouring concrete;
(3) Inspection of above-grade vertical riser piping; and
(4) Inspection of turbine ventilators and riser pipe connections.

A representative photographic log of installed VIMS components along with inspection checklists
are provided in Appendix C. Based on observations made during the VIMS inspections, the VIMS
was installed in general accordance with the DEQ-approved VIMP. A brief summary of the main
VIMS components and slight modifications to the VIMP are provided in the following paragraphs.

Passive sub-slab vapor extraction is achieved through an interconnected system of 3-inch Schedule
(SCH) 40 PVC vapor collection/conveyance piping installed in a 4-inch permeable gravel layer
beneath the building. The permeable gravel layer (clean #57) was installed beneath the entirety of
the building to enhance sub-slab vapor transmission and allow for air movement beneath the slab.
5

https://harthick.sharepoint.com/sites/masterfiles-1/shared documents/aaa-master projects/camden - cam/cam-010 camden noda redevelopment/vimp/vims install report - west bldg/rev 1/vims installation report - west building - rev 1.docx
The sub-slab vapor collection piping is connected to riser piping which extends vertically through
the building and discharges vapors through exhaust stacks installed above the building roof.
Empire Model TV04SS (stainless steel) turbine ventilators were installed on the discharge end of
the exhaust stacks on the roof.

Two types of vapor barriers approved for use in the VIMP were used in the West Building.
Vaporblock® Plus 20 (VBP20), a vapor barrier manufactured by Raven Industries (Raven), was
installed above the gravel layer and beneath the concrete slab for a significant portion of the Level
1 building footprint. The remaining portion of Level 1 utilized Drago® Wrap Vapor Intrusion
Barrier (Drago Wrap), manufactured by Stego® Industries (Stego), installed above the gravel layer
and below the concrete slab. Drago Wrap was also installed above the gravel layer and beneath
the concrete slab of the Basement Level and along the retaining walls between the basement area
Level 1. VBP20 and Drago Wrap are both ASTM-certified 20-mil, multi-layer, chemically-
resistant vapor barrier, designed to prevent structural vapor intrusion of volatile organic
compounds (VOCs). In accordance with manufacturer instructions, the exterior edges of the vapor
liners were laid underneath the footings and attached and sealed to existing concrete utilizing the
proper sealant for the respective vapor liners. Generally, the VBP20 vapor barrier were sealed
with VaporSeal™ tape and Butyl Seal double-sided tape along the exterior, and the seams within
the building footprint have a minimum 12-inch overlap and were sealed with VaporSeal™ tape.
The Drago Wrap barrier was sealed with Dragotack Tape along the exterior, and seams within the
building footprint have a minimum 12-inch overlap and were sealed with Drago Tape. The extent
of the Drago Wrap compared to the VBP20 liner is shown on VM-1, in Appendix A.

For the East Building – F-13 Area, in accordance with the VIMP, Raven VaporBlock-15 (VB-15)
was the vapor barrier installed below the concrete slab. The penetrations and seams were sealed
using the same Raven tapes listed above in accordance with manufacturer instructions. Product
specifications the both vapor barriers are provided in Appendix B.

The VIMS includes ten vacuum monitoring points (labeled MP-1 through MP-10) installed within
the West Building footprint, and two monitoring points (MP-29 and MP-30) installed within the
East Building - F-13 Area. Additional monitoring points are installed within the remaining
6

https://harthick.sharepoint.com/sites/masterfiles-1/shared documents/aaa-master projects/camden - cam/cam-010 camden noda redevelopment/vimp/vims install report - west bldg/rev 1/vims installation report - west building - rev 1.docx
portions of the East Building that will be reported under separate cover. Each monitoring point is
constructed with 2-inch diameter SCH 40 PVC to conduct effectiveness testing including vacuum
influence measurements and for collection of sub-slab vapor samples for laboratory analysis. The
monitoring points were installed in general accordance with the VIMP with slight modifications.
During construction, some of the monitoring point access ports were moved to be within utility
rooms or mechanical rooms to ensure ports could be properly secured and away from public access.
While the access ports moved in some locations, the monitoring point intake screens remained in
the same VIMS treatment area as depicted in the DEQ-approved VIMP. Monitoring point MP-8
was shifted slightly due to the inaccessibility of the initial location from conflicts with the
bathroom construction, but the re-located point was installed within the same area and same stone
layer connection as the proposed location. The final monitoring point locations and access ports
were approved by the design engineer-of-record.

VIMS at Elevator Installation
There are two elevators within the area of the West Building (Elevator 1) and the East Building –
F-13 Area (Elevator 2). The VIMS at Elevator 2 was installed with vapor barrier below the base
of the pit and along the vertical walls in accordance with the VIMP. For Elevator 1, which is
located within the parking garage adjacent to the West Building, the builder was unable to install
vapor barrier along the base of the elevator prior to the concrete pour, but vapor barrier is installed
along the sides of the elevator and under the adjacent slabs that are part of the elevator lobby
located within the parking deck.

While the concrete base for the elevator pit is approximately 2-feet to 3-feet thick with substantial
rebar which is designed to prevent cracks in the concrete base, as an additional precaution, the
builder also installed the W.R. Meadows MEL-ROL 60-mil thick waterproofing membrane along
the interior base of the elevator pit. The MEL-ROL waterproofing membrane is an asphalt-based
membrane made with similar materials and the same thickness as some commonly used VOC-
rated vapor barriers, such as Cetco Liquid-Boot™ and EPRO Geo-Seal®. While MEL-ROL
hasn’t been specifically tested for VOC transmission, it has a lower water vapor permeance than
the aforementioned vapor barriers and is rated as the highest class of vapor retarders (Class A) by
7

https://harthick.sharepoint.com/sites/masterfiles-1/shared documents/aaa-master projects/camden - cam/cam-010 camden noda redevelopment/vimp/vims install report - west bldg/rev 1/vims installation report - west building - rev 1.docx
ASTM Method E1745. A specification sheet for the MEL-ROL waterproofing membrane is
included in Appendix B and elevator details are included in the as-built drawings (Appendix A).

Furthermore, as described in Section 3.0, the effectiveness testing indicated that the sub-slab vapor
sample (MP-7) collected in the vicinity of Elevator 1 indicated only low-level detections of several
compounds were detected in this area. In addition, Elevator 1 has elevator doors that open to the
elevator lobbies within the open-air parking deck in addition to the elevator door that opens to the
living spaces, which allows for some air transfer from the elevator pit to the parking deck open-air
areas. The ground floor elevator lobbies also contain vapor barrier installed below these concrete
slabs. Based on the application of the MEL-ROL waterproofing above the thick concrete base in
the elevator pit, the sampling data, and the location of the elevator within the parking deck, the
installed components are considered sufficient to mitigate vapor intrusion in the area of Elevator
1.

2.2 VIMS Pilot Influence Testing
In accordance with the DEQ-approved VIMP, on May 27, 2021 and December 14, 2021, post-
installation VIMS pilot influence testing was conducted at the West Building and East Building –
F-13 Area to evaluate sub-slab vacuum communication across mitigated areas and verify that
sufficient depressurization can be achieved should electric fans be needed in the future. H&H
completed the pilot influence testing for the building after the concrete slabs had been poured.

H&H connected electric fans to the vertical riser piping to model an active sub-slab
depressurization system. Differential pressure measurements were collected at corresponding
vacuum monitoring points using a Dwyer series 475 Mark III digital manometer (capable of
measuring to 0.001 inches of water column [in-WC] or 0.25 Pa) to establish baseline conditions
prior to use of the electric fans. Following collection of baseline differential pressure
measurements, the electric fans were turned on and differential pressure measurements were
collected at each monitoring point and fan. A pressure differential resulting in depressurization
below the slab of at least 4 pascals (approximately 0.016 in-WC) at remote distances from riser
location in each VIMS treatment area is generally considered sufficient evidence for adequate sub-
slab depressurization.
8

https://harthick.sharepoint.com/sites/masterfiles-1/shared documents/aaa-master projects/camden - cam/cam-010 camden noda redevelopment/vimp/vims install report - west bldg/rev 1/vims installation report - west building - rev 1.docx

Due to structural features of the building, the VIMS sub-slab communication potential was
separated into four areas (Area 1 through 4). Each area was tested separately at corresponding fan
and monitoring point locations. A summary of the monitoring point differential pressure range is
provided in the table below. Fan and monitoring point locations are depicted on VM-1 in
Appendix A and the results of pilot influence testing is included in Appendix D.

Test Area Associated Fan Locations Associated Monitoring Points
Differential Pressure Range (in-WC)
Area 1 F-1 MP-1 -1.197 to -1.199
Area 2 F-2, F-3, F-4, F-5,
and F-6
MP-2, MP-3, MP-4,
MP-5, MP-6, and
MP-7
-0.560 to -0.707
Area 3 F-7, F-8, and F-9 MP-8, MP-9,
and MP-10 -0.560 to -0.651
Area 4 F-13 MP-29 and MP-30 -0.072 to -0.079

The influence test results indicate that adequate connection from the risers to each corresponding
area of the sub-slab annular space is present and that adequate sub-slab communication with
vacuum influence greater 0.016 in-WC (4 pascals) is achievable in each area should active sub-
slab depressurization be warranted in the future.
9

https://harthick.sharepoint.com/sites/masterfiles-1/shared documents/aaa-master projects/camden - cam/cam-010 camden noda redevelopment/vimp/vims install report - west bldg/rev 1/vims installation report - west building - rev 1.docx
3.0 VIMS Effectiveness Sampling Activities

Following successful installation of the VIMS, H&H collected sub-slab soil vapor samples from
monitoring points installed within the footprint of the Basement Level and Level 1 to evaluate risk
to future occupants of the building. The sub-slab soil vapor samples were collected in general
accordance with the DEQ-approved VIMP and the DEQ DWM Vapor Intrusion Guidance
(Guidance) dated March 2018. Details of the sub-slab soil vapor sampling activities and results
are provided in the following sections.

3.1 Sub-Slab Soil Vapor Sampling

On July 21, 2022, H&H collected eight sub-slab soil vapor samples from select monitoring points
in accordance with the DEQ-approved VIMP. One sub-slab soil vapor sample was collected from
monitoring point MP-1 on the Basement Level, and the remaining sub-slab soil vapor samples
were collected from monitoring points MP-3, MP-5, MP-7, MP-8, MP, 9, MP-10, and MP-29 on
Level 1. The sub-slab soil vapor sample locations are shown on Sheets VM-1 and VM-2.
In addition to the sub-slab soil vapor samples described above, one duplicate sub-slab soil vapor
sample (MP-DUP) was collected during the sampling event for quality assurance/quality control
(QA/QC) purposes from parent sample location MP-5. The duplicate sub-slab soil vapor sample
was collected utilizing a laboratory supplied stainless-steel sampling “T” which allows for the
simultaneous collection of two sub-slab soil vapor samples from a monitoring point.

At each sample location, a temporary expandable plug with a quick connect sampling port was
placed within the monitoring point to create an air-tight seal. Teflon sample tubing was then
secured to the sampling port and connected to an airflow regulator and laboratory-supplied
batch-certified 1.4-liter stainless steel Summa canister. The air flow regulator was preset by the
laboratory to collect a sub-slab soil vapor sample at a flow rate no greater than approximately 140
milliliters per minute.

Prior to sample collection, H&H conducted a leak test at each monitoring point by placing a shroud
around the monitoring point and sampling train including the Summa canister. The air within the
10

https://harthick.sharepoint.com/sites/masterfiles-1/shared documents/aaa-master projects/camden - cam/cam-010 camden noda redevelopment/vimp/vims install report - west bldg/rev 1/vims installation report - west building - rev 1.docx
shroud was flooded with helium vapor and concentrations were measured with a calibrated helium
detector. Helium concentrations within the shroud were maintained between approximately 10%
and 15%. A small air pump was connected to the sample tubing outside of the shroud and used to
purge a minimum of three sample train volumes into a Tedlar® bag at each sampling point. The
helium detector was used to measure helium concentrations within the Tedlar® bag sample to
confirm helium concentrations in the sample were less than 10% of that measured within the
shroud. Results of the helium leak checks indicate that unacceptable short-circuiting at the
monitoring points or within the sampling train was not present. Sub-slab soil vapor sample field
forms completed by sampling personnel are included in Appendix D.

Following a successful leak check, the air flow regulators were opened to allow collection of the
sub-slab soil vapor samples. Vacuum in the Summa canisters was monitored during the sampling
event to confirm adequate sample volume was collected at each monitoring point. Upon
completion of sample collection, the air flow regulator was closed to the Summa canister. The
canisters were labeled with the sample identification, the beginning and ending times, the pressure
measurements, and the requested analysis. The canisters were then placed in laboratory supplied
shipping containers and delivered to Eurofins Scientific (Eurofins) under standard chain of custody
protocols for analysis of VOCs by EPA Method TO-15.

3.2 Sub-Slab Soil Vapor Sampling Results

A tabular summary of the sub-slab soil vapor sample analytical results is provided in Table 1, and
a copy of the laboratory analytical report with chain of custody record is provided as Appendix E.
The sub-slab soil vapor sample laboratory analytical results were compared to the DEQ DWM
Residential Vapor Intrusion Sub-Slab and Exterior Soil Vapor Screening Levels (SGSLs) dated
July 2022.

The analytical results for the sub-slab soil vapor samples indicate that VOCs were detected in each
sample at concentrations above laboratory method detection limits (MDLs), but below the
Residential SGSLs. Tetrachloroethene (PCE) was detected above the MDL, but below the
Residential SGSL, in samples MP-1 and MP-29. Trichloroethene (TCE) was detected at a
11

https://harthick.sharepoint.com/sites/masterfiles-1/shared documents/aaa-master projects/camden - cam/cam-010 camden noda redevelopment/vimp/vims install report - west bldg/rev 1/vims installation report - west building - rev 1.docx
concentration of 15 µg/m3 slightly above its SGSL of 14 µg/m3 in sample MP-1. In addition,
chloroform was detected at a concentration (19 µg/m3) above its Residential SGSL of 4.1 µg/m3
in sample MP-1. TCE was also detected at a concentration of 6.1µg/m3 below is SGSL in sample
MP-29. No other compounds were detected above Residential SGSLs. In addition, for sample
MP-7 collected near Elevator 1 (see Section 2.1), the sampling data indicated TCE was not
detected in this sample and no compounds were detected above their SGSLs in this sample.

Some other compounds were detected at slightly elevated levels including acetone, 2 butanone,
and tetrahydrofuran. Note, acetone and 2-butanone are two of the main components in PVC primer,
and tetrahydrofuran is one of the main components in PVC glue. PVC primer and glue are
common construction materials used throughout construction of the townhome units. Material
safety data sheets for PVC glue and primer used during construction are included as Appendix F.

At sample location MP-8 located with the bathrooms for the club/fitness area in the West Building,
the laboratory MDLs for several compounds, including TCE, were elevated over the SGSLs due
to an elevated concentration of tetrahydrofuran (Table 1). This detection was likely attributed to
use of PVC glues and primers for the increased amount of plumbing pipes located within the
bathroom. Based on the elevated MDLs, per DEQ request, an additional sub-slab vapor sample
will be collected from monitoring point MP-8 along with a duplicate sample using the same
methods described in Section 3.1. Based on the results of the sampling, a revised worst-case risk
calculator will be developed and the sample results and risk calculations will be submitted to DEQ.
If additional investigation or measures are warranted based on the sample results, then the
proposed next steps will be discussed with DEQ after submittal of the data.

3.3 Vapor Intrusion Evaluation

The DEQ DWM Vapor Intrusion SGSLs are conservative and based on a target carcinogenic risk
(TCR) of 1 x 10-6 and a non-carcinogenic target hazard quotient (THQ) of 0.2 for potential non-
carcinogenic risks. The DEQ acceptable risk level for potential carcinogenic risks is a cumulative
lifetime incremental cancer risk (LICR) of 1 x 10-4 or less and the acceptable risk level for non-
carcinogenic risks is a cumulative hazard index (HI) of 1 or less.
12

https://harthick.sharepoint.com/sites/masterfiles-1/shared documents/aaa-master projects/camden - cam/cam-010 camden noda redevelopment/vimp/vims install report - west bldg/rev 1/vims installation report - west building - rev 1.docx

H&H utilized the DEQ Risk Calculator (July 2022) to further evaluate potential vapor intrusion
risks at the Site. Because the proposed building use includes residential, H&H modeled a “worst-
case” scenario by using the highest concentrations of any compound detected in sub-slab vapor
samples based on a residential use scenario to conservatively evaluate potential vapor intrusion
risks. The calculated worst-case cumulative LICR and HI values for the building are provided in
Table 1, and a copy of the completed DEQ Risk Calculator is provided in Appendix G.

As shown in Table 1, results of the worst-case risk calculations for a residential use scenario
indicate a calculated cumulative LICR of 6.0 x10-6 and a HI value of 0.48. The calculated worst-
case cumulative residential use LICR and HI values are within the DEQ acceptable levels. These
worst-case risk calculator results confirm that compound concentrations detected below the slab
do not pose vapor intrusion risks at unacceptable levels within the West Building and East Building
- F-13 Area. Note, as indicated above, the worst-case risk calculations will be re-calculated, if
warranted, based on the sample results from monitoring point MP-8.

13

https://harthick.sharepoint.com/sites/masterfiles-1/shared documents/aaa-master projects/camden - cam/cam-010 camden noda redevelopment/vimp/vims install report - west bldg/rev 1/vims installation report - west building - rev 1.docx
4.0 Summary and Conclusions

Installation of the VIMS has been completed at the West Building and East Building - F-13 Area
on the Chadbourn Mill and Theron Properties Brownfields Properties. Results of installation
inspections, influence testing, and effectiveness sampling activities indicate that the VIMS has
been successfully installed in general accordance with the DEQ-approved VIMP. The remainder
of the East Building is still currently under construction and a summary of the VIMS installation
will be reported under separate cover.

During construction of the West Building, H&H conducted VIMS installation inspections to
confirm the system was installed as designed and completed post-installation influence testing and
sub-slab soil vapor sampling activities to evaluate the efficacy of the system. The VIMS
installation inspections and post-installation testing activities were completed in general
accordance with the DEQ-approved VIMP with minor modifications noted herein. A brief
summary of the VIMS installation and post-installation efficacy assessment activities is provided
below.

VIMS Installation
VIMS installation has been completed for the West Building and the East Building F-13 Area
which consist of a passive sub-slab depressurization system with vertical extraction piping to the
roof connected to wind-driven turbine ventilators. During installation of the VIMS, H&H
personnel, under the direction of a North Carolina licensed Professional Engineer, conducted
inspections during each stage of installation. Results of the installation inspections indicate that
the VIMS was successfully installed in general accordance with the DEQ-approved VIMP. Minor
modifications were made to adjust final locations of the monitoring points with approval from the
engineer-of-record.

Sub-Slab Vacuum
H&H completed vacuum influence pilot testing in May 2021 and December 2021. Differential
pressure measurements collected during the pilot test activities (ranged from 0.072 in-WC to 1.199
in-WC) indicated that adequate vacuum communication beneath the slab was achieved. In
14

https://harthick.sharepoint.com/sites/masterfiles-1/shared documents/aaa-master projects/camden - cam/cam-010 camden noda redevelopment/vimp/vims install report - west bldg/rev 1/vims installation report - west building - rev 1.docx
addition, sufficient vacuum (greater than 0.016 in-WC differential pressure) can be achieved by
vacuum fans if an active system is needed in the future.

Sub-Slab Soil Vapor Assessment
Following the installation of the VIMS, H&H collected eight sub-slab soil vapor samples, plus a
duplicate, from the West Building to evaluate potential vapor intrusion risks. Laboratory analytical
results of the sub-slab soil vapor samples indicate that chloroform and TCE were the only
compounds that were detected at concentrations above the DEQ DWM Residential Vapor
Intrusion SGSLs. TCE was also detected in another sample but at concentrations below the
Residential SGSL. PCE was detected above the MDL, but below the Residential SGSL, in two
samples. H&H utilized the DEQ Risk Calculator (July 2022) to calculate the cumulative
carcinogenic and non-carcinogenic risks under a hypothetical worst-case residential-use scenario
by utilizing the highest concentration of each compound detected in the West Building sub-slab
soil vapor samples. The hypothetical worst-case residential use risk calculator results indicate a
cumulative LICR of 6.0 x 10-6 and a HI value of 0.48 which are within the DEQ and EPA
acceptable risk levels.

Based on the VIMS installation inspections, influence testing, and post-installation sub-slab soil
vapor sampling results, the VIMS is effectively mitigating potential vapor intrusion risks within
the West Building and the East Building F-13 location and is operating as designed. The sub-slab
soil vapor to indoor air risk calculator results confirm that worst-case sub-slab vapor risks are
within acceptable levels.

In accordance with the DEQ-approved VIMP, further pre-occupancy sampling isn’t required
where the sub-slab vapor risks are within acceptable risk levels. Post-construction sampling
consisting of sub-slab vapor sampling from the locations for the pre-occupancy sampling (Section
3.0) will be completed in early Fall 2023, approximately 1 year after the pre-occupancy sampling
event. The post-construction sampling events will be performed in accordance with the
procedures outlined in the VIMP and the results will be reported to DEQ.

Table 1
Summary of Sub-Slab Soil Gas Analytical Data - West Building
Chadbourn Mill/Theron Properties
Charlotte, North Carolina
Brownfields Project No. 20086-16-060 & 23035-19-060
H&H Job No. Project CAM-010
Location East Building
Sample ID MP-1 MP-3 MP-7 MP-8 MP-9 MP-10 MP-29
Date
Units µg/m3
VOCs (TO-15)
Acetone 120 120 35 42 40 800 210 47 240 NE
Benzene <1.2 <1.2 <1.2 <1.2 <1.3 <13 <1.2 1.3 J <1.2 12
Carbon Disulfide <4.9 <4.9 <4.8 43 <5.0 <53 <4.9 <4.7 6.5 J 4,900
Chloroform 19 <2.0 <2.0 <2.0 <2.1 <22 <2.0 <1.9 <2.0 4.1
Cyclohexane 2.5 J 1.4 J 4.4 1.4 J 3.3 J <7.1 4.7 12 1.5 J 42,000
Dichlorodifluoromethane 2.5 J 2.4 J 2.4 J 2.6 J 2.4 J <23 2.7 J 2.4 J 2.8 J 700
Ethanol 20 12 J 26 28 23 120 J 21 43 46 NE
Ethylbenzene <1.3 <1.3 <1.3 <1.3 <1.4 <14 1.6 J 1.3 J <1.3 37
1,1,2-Trichloro-1,2,2-trifluoroethane <1.9 <1.9 <1.9 <1.9 <2.0 <20 <1.9 <1.8 2.1 J 35,000
n-Hexane <1.1 <1.1 <1.1 <1.1 <1.1 <12 <1.1 1.4 J <1.1 4,900
Isopropyl Alchohol (Isopropanol)9.3 J 13 6.8 J 14 8.7 J <40 13 18 46 1,400
Methyl Ethyl Ketone (MEK)35 <4.2 <4.1 <4.1 4.6 J 1,400 210 9.0 J 5.0 J 35,000
4-Methyl-2-Pentanone <1.3 <1.3 <1.3 <1.3 <1.4 <14 1.7 J <1.3 <1.3 21,000
Methylene Chloride <5.7 <5.8 <5.6 <5.6 <5.9 <62 <5.7 6.9 J <5.7 3,400
Tetrachloroethene 68 <1.9 <1.8 <1.8 <1.9 <20 <1.9 <1.8 2.0 J 280
Tetrahydrofuran 34 4.4 10 11 12 13,000 1,500 E 6.5 <1.3 14,000
Toluene 10 3.2 J 4.9 4.0 5.4 44 8.5 39 1.4 J 35,000
Trichloroethene 15 <2.6 <2.5 <2.5 <2.6 <27 <2.5 <2.4 6.1 14
Trichlorofluoromethane 2.3 J <1.8 <1.8 <1.8 <1.8 <19 <1.8 <1.7 <1.8 NE
2,2,4-Trimethylpentane <1.2 <1.2 <1.2 <1.2 <1.2 <13 <1.2 1.6 J <1.2 NE
Vinyl Chloride <2.0 <2.0 <2.0 <2.0 <2.1 <22 <2.0 <1.9 <2.0 5.6
o-Xylene <1.5 <1.5 <1.4 <1.4 <1.5 <16 2.9 J 1.9 J <1.5 700
mp-Xylene 1.6 J <1.4 <1.4 <1.4 <1.4 20 J 7.0 5.0 2.3 J 700
DEQ Cumulative Risk Calculator(2)Acceptable Risk Levels
Carcinogenic Risk (LICR)<1 x 10-4
Non-Carcinogenic Hazard Index (HI)<1.0
Notes:
1)NC Department of Environmental Quality (DEQ) Division of Waste Management (DWM) Vapor Intrusion Sub-slab and Exterior Soil Gas Screening Levels (SGSLs) dated July 2022 and based upon TCR = 1 x 10-6 and THQ = 0.2.
2)NC DEQ DWM Cumulative Risk Calculator dated July 2022.
Compound concentrations are reported in micrograms per cubic meter (μg/m3).
Compound concentrations are reported to the laboratory method detection limits.
Only those compounds detected in at least one sample, and select chlorinated solvents, are shown in the table above.
Laboratory analytical method shown in parentheses.
Bold indicates compound concentration exceeds Residential SGSLs.
Underline indicates the compound was detected below the MDL, but the MDL is greater that the Residential SGSL.
VOCs = Volatile Organic Compounds; NE = Not Established
TCR = Target Cancer Risk; THQ = Target Hazard Quotient
LICR = Lifetime Incremental Cancer Risk; HI = Hazard Index
Cumulative LICR and HI calculated using the residential worst-case scenario for each building and compared to DEQ and EPA acceptable risk levels for carcinogenic and non carcinogenic risks.
J = Compound was detected above the laboratory method detection limit, but below the laboratory reporting limit resulting in a laboratory estimated concentration.
E = Exceeds instrument calibration range.
0.48
Residential
SGSLs (1)
7/21/2022
Residential Worst Case
6.0 x 10-6
MP-5 / MP-DUP
West Building
µg/m3
https://harthick.sharepoint.com/sites/MasterFiles-1/Shared Documents/AAA-Master Projects/Camden - CAM/CAM-010 Camden NoDa Redevelopment/VIMP/VIMS Install Report - West Bldg/Tables/Data Table (with MDLs)
8/18/2022
Table 1 (Page 1 of 1)
Hart & Hickman, PC
TITLE
PROJECT
SITE LOCATION MAP
CHADBOURN MILL/THERON PROPERTIES
500 & 508 CHARLES AVENUE
CHARLOTTE, NORTH CAROLINA
DATE:
JOB NO:
REVISION NO:
FIGURE:
10-17-2019 0
1CAM-010
SITE
0 2000 4000
APPROXIMATE
SCALE IN FEET
N
U.S.G.S. QUADRANGLE MAP
QUADRANGLE
7.5 MINUTE SERIES (TOPOGRAPHIC)
CHARLOTTE EAST, NC, 1991
REVISION NO. 0
JOB NO. CAM-010
DATE: 3-10-20
FIGURE NO. 2
CHADBOURN MILL/THERON PROPERTIES
500 & 508 CHARLES AVENUE
CHARLOTTE, NORTH CAROLINA
SITE AND SURROUNDING AREA MAP
LEGEND
SITE BOUNDARY
UNNAMED CREEK
LYNX BLUE LINE LIGHT RAIL
2923 South Tryon Street-Suite 100
Charlotte, North Carolina 28203
704-586-0007(p) 704-586-0373(f)
License # C-1269 / #C-245 Geology
N. B
R
E
V
A
R
D

S
T
R
E
E
T
RESIDENTIAL
DUKE POWER
SUBSTATION
NEESE SAUSAGE COMPANY
(2604 N. DAVIDSON STREET)
JORD
A
N

P
L
A
C
E
CHARL
E
S

A
V
E
N
U
E
N. D
A
V
I
D
S
O
N

S
T
R
E
E
T
M
A
T
H
E
S
O
N

A
V
E
N
U
E
NOTES:
AERIAL IMAGERY OBTAINED FROM MECKLENBERG COUNTY GIS.
CHARL
E
S

A
V
E
N
U
E
FILLING STATION / AUTO REPAIR
(1950s TO PRESENT)
FORMER BOILER
BUILDING
FORMER CHADBOURN
MILL FACILITY
(PARTIALLY DEMOLISHED)
RESIDENTIAL
REDEVELOPMENT
(UNDER
CONSTRUCTION)
S:
\
A
A
A
-
M
a
s
t
e
r

P
r
o
j
e
c
t
s
\
C
a
m
d
e
n

-

C
A
M
\
C
A
M
-
0
1
0

C
a
m
d
e
n

N
o
D
a

R
e
d
e
v
e
l
o
p
m
e
n
t
\
V
I
M
P
\
F
i
g
u
r
e
s
\
F
i
g
u
r
e

2

-

S
i
t
e

M
a
p
.
d
w
g
,

F
I
G

2
,

3
/
1
0
/
2
0
2
0

2
:
5
9
:
4
2

P
M
,

s
p
e
r
r
y
C
C
C
C
C
C
C
IDF
.
REVISION NO. 1
JOB NO. CAM-010
DATE: 10-31-22
FIGURE NO. 3
CHADBOURN MILL/THERON PROPERTIES
500 & 508 CHARLES AVENUE
CHARLOTTE, NORTH CAROLINA
SITE DEVELOPMENT LAYOUT
LEGEND
SITE BOUNDARY
UNNAMED CREEK
LYNX BLUE LINE LIGHT RAIL
BUILDINGS FOOTPRINT
PARCEL LINE
BUILDING AREA INCLUDED IN VIMS
INSTALLATION REPORT - WEST BUILDING
2923 South Tryon Street-Suite 100
Charlotte, North Carolina 28203
704-586-0007(p) 704-586-0373(f)
License # C-1269 / #C-245 Geology
N. B
R
E
V
A
R
D

S
T
R
E
E
T
RESIDENTIAL
DUKE POWER
SUBSTATION
NEESE SAUSAGE COMPANY
(2604 N. DAVIDSON STREET)
JORD
A
N

P
L
A
C
E
CHARL
E
S

A
V
E
N
U
E
N. D
A
V
I
D
S
O
N

S
T
R
E
E
T
M
A
T
H
E
S
O
N

A
V
E
N
U
E
CHARL
E
S

A
V
E
N
U
E
FILLING STATION / AUTO REPAIR
(1950s TO PRESENT)
FORMER CHADBOURN
MILL FACILITY
(PARTIALLY DEMOLISHED)
FORMER BOILER
BUILDING
RESIDENTIAL
REDEVELOPMENT
(UNDER
CONSTRUCTION)
WEST BUILDING
FOOTPRINT
EAST BUILDING
FOOTPRINT
NOTES
1.REFER TO VAPOR INTRUSION MITIGATION SYSTEM
(VIMS) INSTALLATION REPORT - WEST BUILDING
FOR MORE DETAILS.
2.INFORMATION FOR THE VIMS IN THE REMAINING
PORTION OF BUILDING (EAST BUILDING) WILL BE
INCLUDED UNDER SEPARATE COVER.
OPEN AIR SPACES
(REFER TO SHEET VM-1)
OPEN AIR SPACES/COURTYARD
(REFER TO SHEET VM-2)
OPEN AIR SPACES
(REFER TO SHEET VM-2)
ELECTRICAL TRANSFORMER
ELECTRICAL TRANSFORMERS
MULTI-LEVEL PARKING
GARAGE FOOTPRINT
EAST BUILDING
F-13 AREA
S:\
A
A
A
-
M
a
s
t
e
r

P
r
o
j
e
c
t
s
\
C
a
m
d
e
n

-

C
A
M
\
C
A
M
-
0
1
0

C
a
m
d
e
n

N
o
D
a

R
e
d
e
v
e
l
o
p
m
e
n
t
\
V
I
M
P
\
V
I
M
S

I
n
s
t
a
l
l

R
e
p
o
r
t

-

W
e
s
t

B
l
d
g
\
A
s
-
b
u
i
l
t
s
\
F
i
g
u
r
e

3

-

B
L
D
G
.
L
a
y
o
u
t

M
a
p
.
d
w
g

Appendix A
VIMS As-Built Drawings (VM-1, VM-2, VM-3 and VM-3A) West Building and East Building – F-13 Area
SL
A
B

O
N

G
R
A
D
E
4" THK.7" THK. MIN.
#3
#3
F-8 F-10
F-10
F-7
F-7F-9 F-9
F-9
F-7
F-7
F-9
F-9.5
F-8
F-8
F-9.5F-10.5
F-11 F-12 F-10 F-9.5
F-8.5
F-10.5 F-10
F-9.5
F-11
F-12
F-12
F-11
F-10
F-11.5
F-12.5
F-11
F-10
F-11 F-12
F-A
F-B
F-C
Col
.
Col.
Col.
Col.
Co
l
.
Col
.
Col.
Col
.
C-10 C-10 C-10
C-8 C-8
C-8
C-8
C-8
C-6 C-5
C-6
C-6
C-5
C-6 C-5
C-5 C-6
C-6 C-5
C-6 C-5
C-6 C-5
C-5 C-6
C-5 C-6
C-5 C-6
C-2 C-1
C-1 C-2
C-2 C-1
C-2 C-2
C-2
C-2
C-2
C-2
C-1
C-1
C-2
C-1
C-2
C-2
C-2
C-2
C-2
Col.F-5 F-5
SLP.
SLP.
SLP.
SLP.
SL
P
.
SLP.
T.O.C.= 703' - 6"
T.O.C.= 701' - 6"
T.O.C.= 692' - 6"
4" THK.7" THK. MIN.
4" THK.7" THK. MIN.
PRECAST GARAGE STRUCTUREBY OTHERS BEARING ONTO
CAST-IN-PLACE FOUNDATIONS
15" O.C.#34"
#3
SLOPE DOWN 8.00%
F-7
F-7
F-9
F-8
F-8
F-8
F-9 F-10
F-9.5
F-11
F-6
F-8
F-8.5
F-9
F-7
F-8X12 F-8X12 F-8X12
F-8.5
F-9
F-8.5
F-9
F-9
F-8
F-8X12 F-8 F-8X16.5
F-7
F-8F-10
F-11F-12
F-9.5F-10.5
F-11.5
F-11 F-12 F-10 F-9.5
F-8.5
F-11 F-12
F-E
F-B
F-C
Col
.
F-D
F-F
Col.Col.
Col.
Col.
Col.
Col.
Col
.
Col
.
Co
l
.
Col
.
Col
.
Col.
C-6 C-5
C-6 C-5
C-5 C-6
C-5 C-6
C-5 C-6
C-5 C-5
C-6 C-5
C-6 C-5
C-6 C-5
C-6 C-6
C-5
C-5
C-5
C-5
C-5
C-5
C-5
C-5
C-5
C-5
C-5
C-5
C-5
C-9 C-9
C-9 C-9
C-5 C-5
C-5 C-5 C-7
C-7
C-2 C-1
C-1 C-2
C-2 C-1
C-2 C-2
C-2
C-2
Col.
Col.
Co
l
.
F-5 F-5
SLP.
S
L
P
.
SLP.
SLP.
SL
P
.
SL
P
.
SLOPE DOWN 2.50%
SLP.
T.O.C.= 703' - 6"
T.O.C.= 701' - 6"
T.O.C.= 701' - 6"
T.O.C.= 702' - 0"
T.O.C.= 697' - 6 1/2"
STAIR 2
BASEMENT/GROUND
LEVEL 1
STAIR 1
F-1
F-2
F-3
F-4
F-5
F-6
F-7
F-8
F-9
LEVEL 1
LEVEL 1
STAIR 8
SUB-SLAB SAMPLE
SUB-SLAB SAMPLE
SUB-SLAB SAMPLE
SUB-SLAB SAMPLE
SUB-SLAB SAMPLE
SUB-SLAB SAMPLE
SUB-SLAB SAMPLE
MP-1
MP-2
MP-3
MP-4
MP-5
MP-6 MP-7
MP-8
MP-9
MP-10
ELEV. 1
3" SCH 40 PVC
22.5-DEGREE ELBOW
SEE DETAIL 3/VM-3 & 29/VM-3A
SEE DETAIL 23/VM-3A
SEE DETAIL 21/VM-3A
RETAINING WALL
SEE DETAIL 22/VM-3A
SEE DETAIL 1/VM-3
SEE DETAIL 19/VM-3A
SEE DETAIL 20/VM-3A
SEE DETAIL 10/VM-3
SEE DETAIL 11/VM-3
SEE DETAIL 12/VM-3 & 29/VM-3A
SEE DETAIL 24 & 26/VM-3A
SEE DETAIL 14/VM-3
SEE DETAIL 4/VM-3
SEE DETAIL 27/VM-3A
SEE DETAIL 32/VM-3A
SEE DETAIL 28/VM-3A
SEE DETAIL 31/VM-3A
ELEVATOR AND LOBBIESSEE DETAIL 28/VM-3A
SEE DETAIL 1/VM-3
LEGEND
SLAB GRADE CHANGE
BUILDING FOOTER
INTERIOR COLUMN
OPEN AIR SPACE (PATIO/CORRIDOR)
THICKENED SLAB
EXTENT OF VAPOR LINER - RAVEN VAPORBLOCK-20
EXTENT OF VAPOR LINER - DRAGO WRAP
3" DIA SCH 40 SLOTTED PVC PIPE
3" DIA SCH 40 SOLID PIPE
2" DIA SCH 40 SLOTTED PVC PIPE
3" DIA SCH 40 SOLID PVC VERTICAL RISER WITH FAN
IDENTIFICATION NUMBER (REFER TO DETAIL NUMBER 27 ON
SHEET VM-3A)
2" DIA SOLID PVC PRESSURE MONITORING POINT WITH
FLUSH-MOUNTED COVER
INDICATES LOCATION OF SUB-SLAB SOIL-GAS ANALYTICAL
SAMPLE. REFER TO SECTION 4.2 OF THE VAPOR INTRUSION
MITIGATION PLAN.
NOTES:
1.FIRST FLOOR LEVEL OF BUILDING SHOWN. REFER TO STRUCTURAL
AND ARCHITECTURAL DRAWINGS FOR FINAL BUILDING LAYOUT.
2.DIA = DIAMETER
SCH = SCHEDULE
T.O.C. = TOP OF CONCRETE
ELEV. = ELEVATOR
TYP = TYPICAL
H&H NO. CAM-010
VIMS LAYOUT -
WEST BUILDING
NOVEMBER 1, 2022
VM-1
VAPOR MITIGATION PLAN PREPARED BY:
2923 South Tryon Street-Suite 100
Charlotte, North Carolina 28203
704-586-0007(p) 704-586-0373(f)
License # C-1269 / #C-245 Geology
PROFESSIONAL
APPROVAL
3" TO 2" SCH 40 PVC
REDUCER (TYP)
45-DEGREE SCH 40
PVC ELBOW (TYP)
TRUEWYE PVC FITTING OR OTHERWISE
FIELD FABRICATED WITH PVC FITTINGS (TYP)
SCH 40 PVC TEE
(TYP)
SCH 40 PVC CROSS
(TYP)
3" VENT CAP AT ENDS
OF SLOTTED PIPE(TYP)
45-DEGREE SCH 40
PVC ELBOW (TYP)
3" VENT CAP AT ENDS
OF SLOTTED PIPE(TYP)
SCH 40 PVC TEE
(TYP)
45-DEGREE SCH 40
PVC ELBOW (TYP)
F-7
AS-BUILT
WEST BUILDING
REVISION 1
11/01/22
SUB-SLAB SAMPLE
OPEN AIR
SPACE CA
M
D
E
N

N
O
D
A
CH
A
D
B
O
U
R
N

M
I
L
L

A
N
D

T
H
E
R
O
N

P
R
O
P
E
R
T
I
E
S
#2
0
0
8
6
-
1
6
-
0
6
0

A
N
D

2
3
0
3
5
-
1
9
-
0
6
0
50
0

&

5
0
8

C
H
A
R
L
E
S

A
V
E
CH
A
R
L
O
T
T
E
,

N
O
R
T
H

C
A
R
O
L
I
N
A
S:\
A
A
A
-
M
a
s
t
e
r

P
r
o
j
e
c
t
s
\
C
a
m
d
e
n

-

C
A
M
\
C
A
M
-
0
1
0

C
a
m
d
e
n

N
o
D
a

R
e
d
e
v
e
l
o
p
m
e
n
t
\
V
I
M
P
\
V
I
M
S

I
n
s
t
a
l
l

R
e
p
o
r
t

-

W
e
s
t

B
l
d
g
\
A
s
-
b
u
i
l
t
s
\
V
M
P

L
a
y
o
u
t
_
D
e
c
_
A
s
-
b
u
i
l
t
_
W
e
s
t

B
l
d
g
.
d
w
g
SL
O
P
E

D
O
W
N

8
.
4
3
%
SLOPE DOWN 8.13%
SLOP
E

D
O
W
N

7
.
6
9
%
SLOPE

D
O
W
N

7
.
6
9
%
SL
O
P
E

D
O
W
N

8
.
3
3
%
SL
O
P
E

D
O
W
N

5
.
7
7
%
F-8X16.5 F-7X9.5
F-7 F-10
F-13
F-13
F-14
F-14
F-14
F-14
F-15
F-13
F-13
F-14
F-14
F-13
F-12
F-12
F-11
F-13
F-15
F-6
F-6
F-9
F-12.5
F-7
F-8
F-G
F-H
Col.
Col.
Col.
Col.
Col
.
Col.
C-7 C-7
C-7 C-7
C-6 C-6
C-6
C-7
C-7
C-4
C-4
C-4
C-3
C-3
C-3
C-3
C-3
C-3
C-3
C-3
C-3
C-4
C-4
C-4
C-4
C-4
C-4
C-3
C-4
C-4
C-4
C-6
C-7
Col.Col.
SLAB ON GRADE BY OTHERS.
RE: LANDSCAPE
SLP.
SLP.SLP.
SL
P
.
SL
P
.
SL
P
.
SLP.
STAIR 3
ELEV. 2
C-7
C-6
T.O.C.= 702' - 0"T.O.C.= 703' - 0"
T.O.C.= 704' - 0"
T.O.C.= 702' - 0"
T.O.C.= 702' - 0"
T.O.C.= 703' - 2"
T.O.C.= 703' - 2"
CONFIRM FOOTINGELEVATION W/ELEV. MFG.
F-I
T.O.C.= 702' - 0"
T.O.C.= 701' - 6"
T.O.C.= 702' - 0"
SL
O
P
E

D
O
W
N

2
.
5
5
%
SLO
P
E

D
O
W
N

2
.
5
5
%
SLOPE DOWN 7.89%
SLO
P
E

D
O
W
N

8
.
0
0
%
T.O.C.= 703' - 11 3/4"
SL
P
.
SLP
.
SLP.
SLP.
SL
P
.
SLP.
SLP.
SLP.
SLP
.
SL
P
.
SLP
.
SLP
.
SLP
.
SLP
.
SLP.
SLP.
ELEV. 3
T.O.C.= 704' - 0"T.O.C.= 704' - 0"T.O.C.= 702' - 6"
T.O.C.= 704' - 0"
T.O.C.= 703' - 2"
T.O.C.= 703' - 6"
F-10 F-10
F-11
F-10
F-9
F-10
F-9
F-J
C-1
C-1
C-1
C-1
C-1
C-1 C-1
C-1 C-1
CONFIRM FOOTINGELEVATION W/ELEV. MFG.
SLP
.
SLP.
SL
P
.
SL
P
.
SLP.
SLP.
SLP.
T.O.C.= 702' - 6"
T.O.C.= 704' - 0"
T.O.C.= 700' - 0"
T.O.C.= 697' - 3 5/8"
T.O.C.= 698' - 11 3/4"
FUTURE
TENANT
SLAB
STAIR 4
ELEV. 3
ELEV. 4
STAIR 5
STAIR 3
ELEV. 2
FUTURE
TENANT
SLAB
F-1
F-2 F-3
F-4
F-6
F-7
F-8
F-5
F-10
F-9
F-11
F-12
F-13
F-14
F-15
F-16
STAIR 7
PRECAST GARAGE STRUCTURE
BY OTHERS BEARING ONTOCAST-IN-PLACE FOUNDATIONS
SUB-SLAB SAMPLE
SUB-SLAB SAMPLE
SUB-SLAB SAMPLE
SUB-SLAB SAMPLE
SUB-SLAB SAMPLE
SUB-SLAB SAMPLE
SUB-SLAB SAMPLE
MP-11
MP-12
MP-13
MP-14 MP-15
MP-16
MP-17
MP-18
MP-19
MP-20
MP-21
MP-22
MP-23
MP-24
MP-25
MP-26
MP-27
MP-28
MP-30
MP-31
MP-29
SUB-SLAB
SAMPLE
OPEN AIR
CORRIDOR
OPEN AIR
PATIO SPACE
ELECTRICAL ROOM
SPRINKLER ROOM
LOADING / MOVE-IN
STORAGE
BIKE STORAGE
TRASH / RECYCLING
ROOMS
STORAGE
EXHAUST
LEGEND
SLAB GRADE CHANGE
FOOTING
INTERIOR COLUMN
AREA NOT PLANNED TO BE OCCUPIED WITH WEST BUILDING
FUTURE TENANT SLAB
THICKENED SLAB
EXTENT OF VAPOR LINER (RAVEN VAPORBLOCK-15)
3" DIA SCH 40 SLOTTED PVC PIPE
3" DIA SCH 40 SOLID PIPE
2" DIA SCH 40 SLOTTED PVC PIPE
3" DIA SCH 40 SOLID PVC VERTICAL RISER LOCATION WITH
FAN IDENTIFICATION NUMBER
(REFER TO DETAIL NUMBER 27 ON SHEET VM-3A)
2" DIA SOLID PVC PRESSURE MONITORING POINT WITH
FLUSH-MOUNTED COVER
INDICATES LOCATION OF SUB-SLAB SOIL-GAS ANALYTICAL
SAMPLE. REFER TO SECTION 4.2 OF THE VAPOR INTRUSION
MITIGATION PLAN.
NOTES:
1.FIRST FLOOR LEVEL OF BUILDING SHOWN. REFER TO
STRUCTURAL AND ARCHITECTURAL DRAWINGS FOR FINAL
BUILDING LAYOUT.
2.DIA = DIAMETER
SCH = SCHEDULE
T.O.C. = TOP OF CONCRETE
ELEV. = ELEVATOR
TYP. = TYPICAL
3.SECTION OF EAST BUILDING NEAR F-13 AND MP-30 WILL BE
TURNED OVER TO OCCUPANTS WITH THE WEST BUILDING (VM-1).
REFER TO VIMS INSTALLATION REPORT - WEST BUILDING.
H&H NO. CAM-010
VIMS LAYOUT -
EAST BUILDING
F-13 AREA
NOVEMBER 1, 2022
VM-2
VAPOR MITIGATION PLAN PREPARED BY:
2923 South Tryon Street-Suite 100
Charlotte, North Carolina 28203
704-586-0007(p) 704-586-0373(f)
License # C-1269 / #C-245 Geology
PROFESSIONAL
APPROVAL
SEE DETAIL 24 & 26/VM-3A
SEE DETAIL 21/VM-3A
SEE DETAIL 1/VM-3
SEE DETAIL 30/VM-3A
SEE DETAIL 6/VM-3
SEE DETAIL 19/VM-3A
SEE DETAIL 20/VM-3A
SEE DETAIL 5/VM-3
SEE DETAIL 7/VM-3
SEE DETAIL 25 & 26/VM-3A
SEE DETAIL 2/VM-3
SEE DETAIL 10/VM-3
SEE DETAIL 17/VM-3
SEE DETAIL 18/VM-3
SEE DETAIL 12/VM-3 & 29/VM-3A
SEE DETAIL 13/VM-3
SEE DETAIL 8/VM-3
SEE DETAIL 9/VM-3
SEE DETAIL 11/VM-3
SEE DETAIL 18/VM-3 & 29/VM-3A
3" TO 2" SCH 40
PVC REDUCER
3" TO 2" SCH 40 PVC
REDUCER (TYP)
45-DEGREE SCH 40
PVC ELBOW (TYP)
45-DEGREE SCH 40
PVC ELBOW (TYP)
SCH 40 PVC TEE
(TYP)
SEE DETAIL 4/VM-3
SCH 40 PVC CROSS
(TYP)
SEE DETAIL 16/VM-3
SEE DETAIL 16/VM-3
DEEP SLAB STEP
SEE DETAIL 15/VM-3
SEE DETAIL 4/VM-3
TRUEWYE PVC FITTING OR
OTHERWISE FIELD FABRICATED
WITH PVC FITTINGS (TYP)
3" SCH 40 PVC TEE
(TYP)
3" VENT CAP AT ENDS
OF SLOTTED PIPE(TYP)
3" VENT CAP AT ENDS
OF SLOTTED PIPE(TYP)
3" SCH 40 PVC WYE
(TYP)
F-8
45-DEGREE SCH 40
PVC ELBOW (TYP)
90-DEGREE SCH 40
PVC ELBOW (TYP)
SEE DETAIL 1/VM-3
AS-BUILT
SUB-SLAB SAMPLE
OPEN AIR
COURTYARD
OPEN AIR
SPACE
SEE DETAIL 27/VM-3A SEE DETAIL 27/VM-3A
CA
M
D
E
N

N
O
D
A
CH
A
D
B
O
U
R
N

M
I
L
L

A
N
D

T
H
E
R
O
N

P
R
O
P
E
R
T
I
E
S
#2
0
0
8
6
-
1
6
-
0
6
0

A
N
D

2
3
0
3
5
-
1
9
-
0
6
0
50
0

&

5
0
8

C
H
A
R
L
E
S

A
V
E
CH
A
R
L
O
T
T
E
,

N
O
R
T
H

C
A
R
O
L
I
N
A
11/01/22
EAST BUILDING - F-13 AREA
S:\
A
A
A
-
M
a
s
t
e
r

P
r
o
j
e
c
t
s
\
C
a
m
d
e
n

-

C
A
M
\
C
A
M
-
0
1
0

C
a
m
d
e
n

N
o
D
a

R
e
d
e
v
e
l
o
p
m
e
n
t
\
V
I
M
P
\
V
I
M
S

I
n
s
t
a
l
l

R
e
p
o
r
t

-

W
e
s
t

B
l
d
g
\
A
s
-
b
u
i
l
t
s
\
V
M
P

L
a
y
o
u
t
_
D
e
c
_
A
s
-
b
u
i
l
t
_
W
e
s
t

B
l
d
g
.
d
w
g
VIMS VAPOR LINER AND BASE COURSE (TYP)1
VAPOR LINER (SEE SPECIFICATION #1)
CONCRETE FLOOR SLAB
SUB-BASE
NTSVM-3
VIMS SLOTTED COLLECTION PIPING (TYP)2
3" SCH 40 THREADED FLUSH JOINT
SLOTTED PVC PIPE (0.020" SLOT WIDTH,
1/8" SLOT SPACING)
SET WITHIN MIN 5" BASE COURSE
(SEE SPECIFICATION #2)
VAPOR LINER (SEE SPECIFICATION #1)
SUB-BASE
NTS
CONCRETE FLOOR SLAB
VM-3
BASE COURSE - CLEAN # 57 STONE (WASHED
WITH NO FINES), MIN 5" THICK BENEATH VIMS
VAPOR LINER
VAPOR LINER
(SEE SPECIFICATION #1)
CMU WALL (NOT PRESENT
IN ALL LOCATIONS)
VIMS AT CMU WALL FOUNDATION (TYP)
NTS
8
VM-3
BASE COURSE
(SEE SPECIFICATION #1)
SUB-BASE
CONCRETE FLOOR SLAB
DIS
T
A
N
C
E

V
A
R
I
E
S
VIMS AT DEEP SLAB STEP (TYP)15
VM-3
SUB-BASE
VAPOR LINER
(SEE SPECIFICATION #1)
BASE COURSE
(SEE SPECIFICATION #1)
VAPOR LINER SEALED TO
CONCRETE PER MANUFACTURER
INSTRUCTIONS. IF WATERPROOFING
IS PRESENT, INSTALL VAPOR LINER
ON OUTSIDE OF WATERPROOFING
SO VAPOR LINER IS BETWEEN
WATERPROOFING AND BACKFILLED
SOIL
WATERPROOFING
T.O.C.
T.O.C.
T.O.C.
CONCRETE
FLOOR SLAB
BASE COURSE
(SEE SPECIFICATION #1)
VAPOR LINER
(SEE SPECIFICATION #1)
SUB-BASE
VIMS AT INTERIOR GRADE BEAM (TYP)
NTS
4
VM-3
COLUMN BLOCKOUT
VIMS AT EXTERIOR COLUMN (TYP)
NTS
13
VM-3
T.O.C.
SUB-BASE
CONCRETE
FLOOR SLAB
BASE COURSE
(SEE SPECIFICATION #1)
VAPOR LINER
(SEE SPECIFICATION #1)
CIP CONCRETE COLUMN
EXTERIOR GRADE
T.O.F.
VAPOR LINER SEALED
TO CONCRETE PER
MANUFACTURERS
INSTRUCTIONS
(VARIES)
COLUMN BLOCKOUT
VIMS AT INTERIOR COLUMN (TYP)
NTS
11
VM-3
SUB-BASE
CONCRETE FLOOR SLAB
BASE COURSE
(SEE SPECIFICATION #1)
VAPOR LINER
(SEE SPECIFICATION #1)
T.O.F.
CIP CONCRETE COLUMN
CONCRETE FOOTING
T.O.C.
VAPOR LINER SEALED OUTSIDE OF
CONCRETE COLUMN PER
MANUFACTURER INSTRUCTIONS
VIMS AT EXTERIOR GRADE BEAM (TYP)
NTSVM-3
10
CONCRETE FLOOR SLAB
VAPOR LINER SEALED TO CONCRETE
PER MANUFACTURERS INSTRUCTIONS
VAPOR LINER
(SEE SPECIFICATION #1)
BASE COURSE
(SEE SPECIFICATION #1)
SUB-BASE
EXTERIOR GRADE
(VARIES)
EXTERIOR WALL / FINISH
(NOT PRESENT IN ALL LOCATIONS)
VIMS AT SLAB DROP (TYP)
NTS
16
VM-3
SUB-BASE
CONCRETE FLOOR SLAB
BASE COURSE
(SEE SPECIFICATION #1)
VAPOR LINER
(SEE SPECIFICATION #1)T.O.C.
T.O.C.
T.O.C.
CONCRETE
FLOOR SLAB
BASE COURSE
(SEE SPECIFICATION #1)
SUB-BASE
VIMS PIPING THROUGH INTERIOR GRADE BEAM WITH RISER DUCT PIPING (TYP)
NTS
6
VM-3
SOLID 3"
SCH 40 PVC
VAPOR LINER SEALED TO PIPE PER
MANUFACTURER INSTRUCTIONS
SINGLE OR DOUBLE STUD
SEPARATION WALL
PROVIDE PIPE SUPPORT TO PREVENT
LOW POINT IN SOLID PIPE. MAINTAIN 1%
SLOPE TOWARD SLOTTED SECTION OF
PIPE (SEE SPECIFICATION #2)
VAPOR LINER
(SEE SPECIFICATION #1)
SOLID TO SLOTTED 3" SCH 40
PVC PIPE TRANSITION (SLIP
COUPLING OR THREADED JOINT)
VAPOR LINER BENEATH
GRADE BEAM
3" SCH 40 PVC RISER DUCT PIPE
(SEE SPECIFICATION #3 & #4)
3" SCH 40 PVC TEE
T.O.C.
CONCRETE
FLOOR SLAB
BASE COURSE
(SEE SPECIFICATION #1)
SUB-BASE
VIMS PIPING THROUGH INTERIOR GRADE BEAM (TYP)
NTS
5
VM-3
SOLID 3"
SCH 40 PVC
VAPOR LINER SEALED TO PIPE PER
MANUFACTURER INSTRUCTIONS
PROVIDE PIPE SUPPORT TO PREVENT
LOW POINT IN SOLID PIPE. MAINTAIN 1%
SLOPE TOWARD SLOTTED SECTION OF
PIPE (SEE SPECIFICATION #2)
VAPOR LINER
(SEE SPECIFICATION #1)
SOLID TO SLOTTED 3" SCH 40
PVC PIPE TRANSITION (SLIP
COUPLING OR THREADED JOINT)
VAPOR LINER BENEATH
GRADE BEAM
SINGLE OR DOUBLE STUD
SEPARATION WALL
FOAM PIPE SLEEVE (SEE
SPECIFICATION #11)
T.O.C.
BASE COURSE
(SEE SPECIFICATION #1)SUB-BASE
VIMS AT SLAB ON GRADE WITH RISER DUCT PIPING (TYP)
NTS
3
VM-3
SOLID 3" SCH 40 PVC
VAPOR LINER SEALED TO PIPE PER
MANUFACTURER INSTRUCTIONS
VAPOR LINER
(SEE SPECIFICATION #1)
SOLID TO SLOTTED 3" SCH 40
PVC PIPE TRANSITION (SLIP
COUPLING OR THREADED JOINT)
3" SCH 40 PVC RISER DUCT PIPE
(SEE SPECIFICATION #3 & #4)DOUBLE STUD TENANT
SEPARATION WALLS
3" SCH 40 PVC TEE
VAPOR LINER
(SEE SPECIFICATION #1)
CMU WALL
VIMS PIPING THROUGH CMU WALL FOUNDATION (TYP)
NTS
9
VM-3
BASE COURSE
(SEE SPECIFICATION #1)
SUB-BASE
CONCRETE FLOOR SLAB
SOLID 3"
SCH 40 PVC
PROVIDE PIPE SUPPORT TO PREVENT LOW POINT IN SOLID
PIPE. MAINTAIN 1% SLOPE TOWARD SLOTTED SECTION OF
PIPE (SEE SPECIFICATION #2)
VAPOR LINER SEALED TO PIPE PER
MANUFACTURER INSTRUCTIONS
SOLID TO SLOTTED 3" SCH 40 PVC
PIPE TRANSITION (SLIP COUPLING
OR THREADED JOINT)
FOAM PIPE SLEEVE (SEE
SPECIFICATION #11)
COLUMN BLOCKOUT
VIMS PIPING AT INTERIOR COLUMN WITH RISER DUCT PIPING (TYP)
NTS
12
VM-3
SUB-BASE
CONCRETE FLOOR SLAB
BASE COURSE
(SEE SPECIFICATION #1)
VAPOR LINER
(SEE SPECIFICATION #1)
CIP CONCRETE COLUMN
CONCRETE FOOTING
VAPOR LINER SEALED
TO PIPE PER
MANUFACTURER
INSTRUCTIONS
SOLID TO SLOTTED 3" SCH
40 PVC PIPE TRANSITION
(SLIP COUPLING OR
THREADED JOINT)
3" SCH 40 PVC
90-DEGREE ELBOW
3" SCH 40 PVC RISER DUCT PIPE.
POSITION RISER PIPE WITHIN
STUD WALLS OR ALONG
INTERIOR WALLS IN VAULTED
AREAS ON UPPER FLOORS (SEE
SPECIFICATIONS #3 & #4)
T.O.C.
VAPOR LINER SEALED OUTSIDE OF
CONCRETE COLUMN PER
MANUFACTURER INSTRUCTIONS
FOAM PIPE SLEEVE (SEE
SPECIFICATION #11)
VIMS AT SLAB STEP (TYP)
NTS
14
VM-3
SUB-BASE
CONCRETE FLOOR SLAB
BASE COURSE
(SEE SPECIFICATION #1)
VAPOR LINER
(SEE SPECIFICATION #1)
T.O.C.
T.O.C.
NOTE: SLAB HEIGHT VARIES
VIMS PIPING THROUGH SLAB DROP (TYP)
NTS
17
VM-3
SUB-BASE
CONCRETE FLOOR SLAB
VAPOR LINER
(SEE SPECIFICATION #1)
T.O.C.
T.O.C.
BASE COURSE
(SEE SPECIFICATION #1)
SOLID TO SLOTTED 3" SCH 40 PVC
PIPE TRANSITION (SLIP COUPLING OR
THREADED JOINT)
3" SCH 40 PVC
90-DEGREE ELBOW
VAPOR LINER SEALED
TO PIPE PER
MANUFACTURER
INSTRUCTIONS
SOLID 3" SCH 40 PVC
(SEE SPECIFICATION #5)
FOAM PIPE SLEEVE (SEE
SPECIFICATION #11)
VIMS PIPING THROUGH SLAB DROP WITH RISER DUCT PIPING (TYP)
NTS
18
VM-3
SUB-BASE
VAPOR LINER
(SEE SPECIFICATION #1)
T.O.C.
T.O.C.
BASE COURSE
(SEE SPECIFICATION #1)
SOLID TO SLOTTED 3" SCH 40 PVC
PIPE TRANSITION (SLIP COUPLING
OR THREADED JOINT)
3" SCH 40 PVC
90-DEGREE ELBOW
VAPOR LINER SEALED TO PIPE
PER MANUFACTURER
INSTRUCTIONS
SOLID 3" SCH 40 PVC
(SEE SPECIFICATION #2)STUD WALLS
SOLID 3" SCH 40 PVC
RISER DUCT PIPE
(SEE SPECIFICATION #2)
3" SCH 40 PVC
90-DEGREE TEE
FOAM PIPE SLEEVE (SEE
SPECIFICATION #11)
T.O.C.
CONCRETE
FLOOR SLAB
BASE COURSE
(SEE SPECIFICATION #1)
SUB-BASE
SOLID PIPE CONNECTOR THROUGH INTERIOR GRADE BEAM (TYP)
NTS
7
VM-3
SOLID 3"
SCH 40 PVC
VAPOR LINER SEALED TO PIPE PER
MANUFACTURER INSTRUCTIONS
SINGLE OR DOUBLE STUD
SEPARATION WALL
VENT PIPE
PROTECTION SCREEN
PROVIDE PIPE SUPPORT TO PREVENT
LOW POINT IN SOLID PIPE. MAINTAIN 1%
SLOPE TOWARD SLOTTED SECTION OF
PIPE (SEE SPECIFICATION #2)
VAPOR LINER
(SEE SPECIFICATION #1)
VAPOR LINER BENEATH
GRADE BEAM
FOAM PIPE SLEEVE (SEE
SPECIFICATION #11)
NOTES:
VIMS = VAPOR INTRUSION MITIGATION SYSTEM
T.O.C. = TOP OF CONCRETE
T.O.F. = TOP OF FOOTING
TYP = TYPICAL
SCH = SCHEDULE
PVC = POLYVINYL CHLORIDE
CMU = CONCRETE MASONRY UNIT
ALL PIPE MEASUREMENTS ARE BY DIAMETER
H&H NO. CAM-010
VIMS LAYOUT
SECTION DETAILS
VM-3
VAPOR MITIGATION PLAN PREPARED BY:
2923 South Tryon Street-Suite 100
Charlotte, North Carolina 28203
704-586-0007(p) 704-586-0373(f)
License # C-1269 / #C-245 Geology
CA
M
D
E
N

N
O
D
A
CH
A
D
B
O
U
R
N

M
I
L
L

A
N
D

T
H
E
R
O
N

P
R
O
P
E
R
T
I
E
S
#2
0
0
8
6
-
1
6
-
0
6
0

A
N
D

2
3
0
3
5
-
1
9
-
0
6
0
50
0

&

5
0
8

C
H
A
R
L
E
S

A
V
E
CH
A
R
L
O
T
T
E
,

N
O
R
T
H

C
A
R
O
L
I
N
A
PROFESSIONAL
APPROVAL
FOAM PIPE SLEEVE (SEE
SPECIFICATION #11)
AS-BUILT
WEST BUILDING
NOVEMBER 1, 2022
11/01/22
S:\
A
A
A
-
M
a
s
t
e
r

P
r
o
j
e
c
t
s
\
C
a
m
d
e
n

-

C
A
M
\
C
A
M
-
0
1
0

C
a
m
d
e
n

N
o
D
a

R
e
d
e
v
e
l
o
p
m
e
n
t
\
V
I
M
P
\
V
I
M
S

I
n
s
t
a
l
l

R
e
p
o
r
t

-

W
e
s
t

B
l
d
g
\
A
s
-
b
u
i
l
t
s
\
V
M
P

D
e
t
a
i
l
s
_
A
s
-
B
u
i
l
t
_
W
e
s
t

B
l
d
g
.
d
w
g
SLP.
VIMS AT RAMP UP (TYP)
NTS
19
VM-3A
VAPOR LINER
(SEE SPECIFICATION #1)CONCRETE FLOOR SLAB
SUB-BASE
SLOTTED 3-INCH
SCH 40 PIPEBASE COURSE
(SEE SPECIFICATION #1)
VAPOR LINER
T.O.C.
VIMS AT RETAINING WALL STAIRWELL (WESTERN BUILDING - STAIR 1)
NTS
23
VM-3A
BASE COURSE
(SEE SPECIFICATION #1)
VAPOR LINER
(SEE SPECIFICATION #1)
CMU WALL
STUD WALL
T.O.C.
T.O.F.
T.O.C.
VAPOR LINER SEALED TO OUTSIDE OF CONCRETE
AND WATERPROOFING/INSULATION (WHERE
PRESENT) PER MANUFACTURER INSTRUCTIONS
WATERPROOFNG AND
RIGID INSULATION
LEVEL 1
INTERIOR SPACE
3" SCH 40 PVC
90-DEGREE ELBOW
SOLID TO SLOTTED 3" SCH
40 PVC PIPE TRANSITION
(SLIP COUPLING OR
THREADED JOINT)
VAPOR LINER SEALED TO PIPE PER
MANUFACTURER INSTRUCTIONS
3" SCH 40 PVC
90-DEGREE ELBOW
SUB-BASE
SOLID 3" SCH 40 PVC
(SEE SPECIFICATION #2)
STAIRWELL
FOAM PIPE SLEEVE, OR SIMILAR,
INSTALLED AROUND PIPE PENETRATION.
(SEE SPECIFICATION #11)
VIMS AT RETAINING WALL (WESTERN BUILDING - GROUND FLOOR TO LEVEL 1)
NTS
22
VM-3A
SUB-BASE
CONCRETE
FLOOR SLAB
BASE COURSE
(SEE SPECIFICATION #1)
VAPOR LINER
(SEE SPECIFICATION #1)
STUD WALLS
T.O.C.
T.O.F.
T.O.C.
LEVEL 1
INTERIOR SPACE
VAPOR LINER SEALED TO OUTSIDE OF CONCRETE
AND WATERPROOFING/INSULATION (WHERE
PRESENT) PER MANUFACTURER INSTRUCTIONS
WATERPROOFING AND
RIGID INSULATION GROUND FLOOR
INTERIOR SPACE
24
NTS
VAPOR LINER PENETRATION SEALED TO
PIPE PER MANUFACTURER INSTRUCTIONS
2" SCH 40 PVC 90 DEGREE ELBOW
2" VENT PIPE PROTECTION
SCREEN OR OPEN PIPE
BASE COURSE
(SEE SPECIFICATION #1)
VIMS MONITORING POINT (TYP)
2" SOLID SCH 40 PVC
VM-3A
VAPOR LINER
(SEE SPECIFICATION #1)
FLOOR CLEANOUT, ADJUSTABLE,
4" DIA ZURN INDUSTRIES
MODEL #CO2450-PV4 (OR ENGINEER
APPROVED EQUIVALENT)
SEE DETAIL 26/VM-3
TOP OF THICKENED
SLAB TURNDOWN
VENT PIPE
PROTECTION SCREEN
BASE COURSE
(SEE SPECIFICATION #1)
FLOOR CLEANOUT, ADJUSTABLE,
4" DIA ZURN INDUSTRIES
MODEL #CO2450-PV4 (OR ENGINEER
APPROVED EQUIVALENT)
SEE DETAIL 26/VM-3
VAPOR LINER PENETRATION SEALED TO
PIPE PER MANUFACTURER
INSTRUCTIONS
2" SOLID SCH 40
PVC (APPROXIMATE 5 FT LENGTH)
2" SCH 40
PVC 90 DEGREE ELBOW
FLUSH WITH
FINISHED FLOOR
PROVIDE PIPE SUPPORT TO PREVENT LOW POINT
IN SOLID SECTION OF PIPE. MAINTAIN MINIMUM
1% SLOPE TOWARD SLOTTED SECTIONS OF PIPE.
(SEE SPECIFICATION #2)
25
NTSVM-3A
VIMS MONITORING POINT AT GRADE BEAM / THICKENED SLAB WITH EXTENDED INTAKE PIPE
FOAM PIPE SLEEVE (SEE
SPECIFICATION #11)
FINISHED FLOOR SLAB
2" SCH 40 PVC SET WITHIN GRAVEL LAYER
(SEE DETAIL 12 & 13/VM3)
2" DRAIN EXPANSION TEST PLUG
BASE COURSE
(SEE SPECIFICATION #1)
FLOOR CLEANOUT, ADJUSTABLE, 4" DIA ZURN
INDUSTRIES MODEL #CO2450-PV4 (OR
ENGINEER APPROVED EQUIVALENT) FLUSH
WITH FINISHED FLOOR
VIMS MONITORING POINT - TYPICAL DETAIL VIEW
NTS
26
VM-3A
4" x 2" FLUSH REDUCER
BUSHING
VAPOR BARRIER PENETRATION SEALED TO
PIPE PER MANUFACTURER INSTRUCTIONS
2" SCH 40 PVC 90 DEGREE STREET ELBOW
2" VENT PIPE PROTECTION
SCREEN OR OPEN PIPE
VIMS TURBINE VENTILATOR FAN & EXHAUST (TYPICAL)29
NTS
TURBINE VENTILATOR FAN
(EMPIRE MODEL TV04SS)
ELECTRICAL JUNCTION BOX FOR POTENTIAL FUTURE
VACUUM FAN (REFER TO SPECIFICATION #4)
4" X 3" PVC COUPLING
RISER DUCT PIPE THROUGH ROOF
FLASHING
ROOFTOP
VM-3A
STAIR STRINGER
SUB-BASE
BASE COURSE
(SEE SPECIFICATION #1)
CONCRETE FLOOR
SLAB
21
NTSVM-3A
VIMS AT STAIR TURNDOWN (TYP)
VAPOR LINER BENEATH
STAIR TURNDOWN
VAPOR LINER
(SEE SPECIFICATION #1)
30
NTSVM-3A
VIMS AT ELEVATOR PIT (TYP)
2-FT TO 3-FT THICK CONCRETE
FOOTER WITH REBAR
REINFORCEMENT
VAPOR LINER SEALED TO OUTSIDE
OF WATERPROOFING PER
MANUFACTURER INSTRUCTIONS
WATERPROOFING MEMBRANE
WITH DRAINAGE MAT
SUB-BASE
BASE COURSE
(SEE SPECIFICATION #1)
VAPOR LINER
(SEE SPECIFICATION #1)
T.O.C.
8" CONCRETE WALLS WITH
REBAR REINFORCEMENT
SLP.
VIMS AT RAMP DOWN (TYP)
NTS
20
VM-3A
SUB-BASE
SLOTTED 3-INCH
SCH 40 PIPE
VAPOR LINER
(SEE SPECIFICATION #1)CONCRETE FLOOR SLAB
BASE COURSE
(SEE SPECIFICATION #1)
T.O.C.
TOP OF THICKENED
SLAB TURNDOWN
VENT PIPE
PROTECTION SCREEN
BASE COURSE
(SEE SPECIFICATION #1)
VAPOR LINER PENETRATION SEALED TO
PIPE PER MANUFACTURER
INSTRUCTIONS
2" SOLID SCH 40
PVC (APPROXIMATE 5 FT LENGTH)
2" SCH 40
PVC 90 DEGREE ELBOWPROVIDE PIPE SUPPORT TO PREVENT LOW POINT
IN SOLID SECTION OF PIPE. MAINTAIN MINIMUM
1% SLOPE TOWARD SLOTTED SECTIONS OF PIPE.
(SEE SPECIFICATION #2)
27
NTSVM-3A
VIMS MONITORING POINT AT WALL CONNECTION
12" X 12" WALL
ACCESS PANEL
INTERIOR 6" STUD WALL
2" DRAIN EXPANSION TEST PLUG
POSITION TOP OF 2" PIPE MINIMUM 8"
FROM TOP OF ACCESS PANEL DOOR
28
NTS
VAPOR LINER PENETRATION SEALED TO
PIPE PER MANUFACTURER INSTRUCTIONS
2" SCH 40 PVC 90 DEGREE ELBOW
2" VENT PIPE PROTECTION
SCREEN OR OPEN PIPE
BASE COURSE
(SEE SPECIFICATION #1)
VIMS MONITORING POINT WITHIN UTILITY ROOM (TYP)
2" SOLID SCH 40 PVC
VM-3A
VAPOR LINER
(SEE SPECIFICATION #1)
2" DRAIN EXPANSION TEST PLUG
31
NTSVM-3A
VIMS AT ELEVATOR PIT WITH WATERPROOFING (ELEVATOR 1)
2-FT TO 3-FT THICK CONCRETE
FOOTER WITH REBAR
REINFORCEMENT
VAPOR LINER SEALED TO OUTSIDE
OF WATERPROOFING PER
MANUFACTURER INSTRUCTIONS
WATERPROOFING MEMBRANE
WITH DRAINAGE MAT
SUB-BASE
BASE COURSE
(SEE SPECIFICATION #1)
VAPOR LINER
(SEE SPECIFICATION #1)
T.O.C.
8" CONCRETE WALLS WITH
REBAR REINFORCEMENT
WATERPROOFING MEMBRANE
WITH DRAINAGE MAT
60-MIL WATERPROOFING
MEMBRANE (W.R. MEADOWS
MEL-ROL)
FINISHED FLOOR SLAB
2" DRAIN EXPANSION TEST PLUG
FLOOR CLEANOUT, ADJUSTABLE, 4" DIA ZURN
INDUSTRIES MODEL #CO2450-PV4 (OR
ENGINEER APPROVED EQUIVALENT) FLUSH
WITH FINISHED FLOOR
VIMS MONITORING POINT (MP-8)
NTS
32
VM-3A
4" x 2" FLUSH REDUCER
BUSHING
VAPOR BARRIER PENETRATION SEALED TO
PIPE PER MANUFACTURER INSTRUCTIONS
BASE COURSE
(SEE SPECIFICATION #1)
2" SOLID SCH 40 PVC
2" PERFORATED SCH 40 PVC
2" SOLID PVC CAP
VIMS SPECIFICATIONS
1.WEST BUILDING ONLY: VIMS VAPOR LINER IS VAPORBLOCK PLUS 20 (VBP20) 20-MIL VAPOR LINER
MANUFACTURED BY RAVEN INDUSTRIES (RAVEN) AND DRAGO WRAP 20-MIL VAPOR LINER
MANUFACTURED BY STEGO INDUSTRIES, LLC (STEGO).
EAST BUILDING ONLY: VIMS VAPOR LINER IS VAPORBLOCK (VB15) 15-MIL VAPOR LINER
MANUFACTURED BY RAVEN.
2.HORIZONTAL COLLECTION PIPE CONSISTS OF 3" SCH 40 PVC (OR OTHERWISE NOTED IN THE
DRAWINGS). PVC PIPE JOINTS WERE CONNECTED USING PVC SOCKET COUPLINGS AND PVC GLUE.
SUB-SLAB SLOTTED VAPOR COLLECTION PIPE ARE THREADED FLUSH JOINT 3" SCH 40 PVC PIPE WITH
0.020" SLOT WIDTH AND 1/8" SLOT SPACING. SLOTTED COLLECTION PIPING WAS SET WITHIN A
MINIMUM 5” BASE COURSE LAYER, WITH APPROXIMATELY 1” OF BASE COURSE MATERIAL ABOVE
AND BELOW THE PIPING. VIMS BELOW AND ABOVE GRADE SOLID PIPING IS NOT TRAPPED AND IS
SLOPED A MINIMUM OF 1/8 UNIT VERTICAL IN 12 UNITS HORIZONTAL (1% SLOPE) TO GRAVITY DRAIN.
SOLID SECTIONS OF HORIZONTAL COLLECTION PIPE ARE SUPPORTED TO PREVENT PIPE SAG OR LOW
POINTS AND MAINTAIN 1% SLOPE TOWARD SLOTTED OR OPEN SECTIONS TO DRAIN CONDENSATION.
3.3" SCH 40 PVC RISER DUCT PIPING WAS INSTALLED TO CONNECT EACH SLAB PENETRATION LOCATION
TO A ROOFTOP EXHAUST DISCHARGE POINT WITH TURBINE VENTILATOR (SEE SPECIFICATION #4).
ABOVE-SLAB RISER DUCT PIPE RUNS BETWEEN THE SLAB PENETRATION AND THE ROOFTOP EXHAUST
DISCHARGE WAS INSTALLED PER APPLICABLE BUILDING CODE AND AS SPECIFIED IN THE
CONSTRUCTION DOCUMENTS AND DRAWINGS. VERTICAL RISER PIPING WERE INSTALLED PER 2018
NORTH CAROLINA STATE PLUMBING CODE.
4.3” SCH 40 PVC RISER DUCT PIPING EXTENDS IN A VERTICAL ORIENTATION THROUGH THE BUILDING
ROOF AND TERMINATES A MINIMUM OF 2 FT ABOVE THE BUILDING ROOF LINE. EMPIRE MODEL
TV04SS STAINLESS STEEL TURBINE VENTILATOR WERE INSTALLED ON THE EXHAUST DISCHARGE END
OF EACH RISER DUCT PIPE. A 4" X 3" PVC ADAPTOR COUPLING WAS INSTALLED AT THE DISCHARGE
END OF THE 3" RISER DUCT PIPE AND THE VENTILATOR IS SECURED TO THE PVC RISER IN A VERTICAL
ORIENTATION. EXHAUST DISCHARGE LOCATIONS ARE A MINIMUM OF 10 FT FROM ANY OPERABLE
OPENING OR AIR INTAKE INTO THE BUILDING. NOTE THAT DISCHARGE LOCATIONS ON THE ROOFTOP
DEPICTED IN THE VAPOR MITIGATION PLAN MAY HAVE BEEN REPOSITIONED AS LONG AS THE NEW
POSITION MET THE REQUIREMENTS PRESENTED ABOVE, WITH ENGINEER APPROVAL. AN ELECTRICAL
JUNCTION BOX (120V, 60HZ AC REQUIRED) WAS INSTALLED NEAR THE DISCHARGE LOCATION ON THE
ROOFTOP FOR CONVERSION TO ELECTRIC FANS, IF REQUIRED. ALL WIRING AND ELECTRICAL WAS
INSTALLED PER APPLICABLE BUILDING AND ELECTRICAL CODES.
5.ABOVE-SLAB ACCESSIBLE RISER DUCT PIPING IS PERMANENTLY IDENTIFIED BY MEANS OF A TAG OR
STENCIL AT A MINIMUM OF ONCE EVERY 10-LINEAR FT WITH "VAPOR MITIGATION". LABELS ARE
ALSO FIXED TO THE TURBINE FANS IN AN ACCESSIBLE LOCATION ON THE ROOFTOP.
6.MONITORING POINTS CONSIST OF 2-INCH DIAMETER SCH 40 PVC PIPE WITH A 90-DEGREE ELBOW TO
FORM AN “L” SHAPE. A MINIMUM OF 6” SECTION OF PIPING IS SET WITHIN THE BASE COURSE LAYER
WITH A VENT PIPE PROTECTION SCREEN AT THE TERMINATION. THE PIPE TERMINATION IS ENCASED
WITHIN THE BASE COURSE LAYER. THE HORIZONTAL PIPING IS SLOPED A MINIMUM OF 1/8 UNIT
VERTICAL IN 12 UNITS HORIZONTAL (1% SLOPE) TO GRAVITY DRAIN TOWARDS THE PIPE TERMINATION
AND PREVENT MOISTURE FROM COLLECTING AT THE 90-DEGREE ELBOW. A 4-INCH DIAMETER
ADJUSTABLE FLOOR CLEAN-OUT (ZURN INDUSTRIES MODEL #CO2450-PV4, OR EQUIVALENT) IS
INSTALLED AT THE CONCRETE SLAB INTERFACE FOR FLOOR-MOUNTED MONITORING POINTS.
7.CONSTRUCTION CONTRACTORS AND SUB-CONTRACTORS USED "LOW OR NO VOC" PRODUCTS AND
MATERIALS, WHEN POSSIBLE.
8.CONSTRUCTION CONTRACTORS AND SUB-CONTRACTORS AVOIDED THE USE OF TEMPORARY FORM
BOARDS THAT PENETRATE THE VAPOR LINER WHERE POSSIBLE. IF TEMPORARY FORM BOARDS WERE
USED, THE SIZE AND NUMBER OF PENETRATIONS THROUGH THE VAPOR LINER WAS LIMITED AND
SMALL DIAMETER STAKES (I.E. SOLID METAL STAKES) WERE BE USED. AS FORM BOARDS WERE
REMOVED, THE CONTRACTOR OR SUB-CONTRACTORS SEALED ALL PENETRATIONS IN ACCORDANCE
WITH VAPOR LINER MANUFACTURER INSTALLATION INSTRUCTIONS.
9.INSPECTIONS: INSPECTIONS OF EACH COMPONENT OF THE VIMS WERE CONDUCTED BY THE
ENGINEER, OR ENGINEER'S DESIGNEE, TO CONFIRM VIMS COMPONENTS WERE INSTALLED PER THE
APPROVED DESIGN. THE REQUIRED INSPECTION COMPONENTS INCLUDED: (1) INSPECTION OF
SUB-SLAB PIPING LAYOUT, (2) GRAVEL PLACEMENT, AND (3) MONITORING POINT PLACEMENT PRIOR
TO INSTALLING VAPOR BARRIER; (4) INSPECTION OF VAPOR BARRIER PRIOR TO POURING CONCRETE;
(5) INSPECTION OF ABOVE-GRADE PIPING LAYOUT; AND (6) INSPECTION OF TURBINE VENTILATOR
AND RISER DUCT PIPE CONNECTIONS. INSPECTIONS WERE COMBINED WHEN POSSIBLE DEPENDING
ON THE CONSTRUCTION SEQUENCE/SCHEDULE. THE CONSTRUCTION CONTRACTOR(S) COORDINATED
WITH THE ENGINEER TO PERFORM THE REQUIRED INSPECTIONS. A MINIMUM 48-HOUR NOTICE WAS
GIVEN TO THE ENGINEER PRIOR TO THE REQUIRED INSPECTION(S).
10.THE VAPOR MITIGATION PLAN WAS INTENDED TO BE USED FOR DIRECTION OF VIMS COMPONENT
INSTALLATION ONLY AND WAS NOT INTENDED TO GUIDE CONSTRUCTION OF STRUCTURAL
COMPONENTS NOT RELATED TO THE VIMS. CONSTRUCTION CONTRACTOR VERIFIED CONSISTENCY OF
VIMS DETAILS WITH APPLICABLE STRUCTURAL, ARCHITECTURAL, MECHANICAL, & PLUMBING PLANS
AND RESOLVED ANY INCONSISTENCIES PRIOR TO VIMS INSTALLATION.
11.FOAM PIPE SLEEVES, OR SIMILAR, WERE INSTALLED AROUND PIPES THAT PENETRATE CONCRETE
FOOTERS AND WALLS PER APPLICABLE STRUCTURAL PLANS AND BUILDING CODES, OR OTHERWISE
DIRECTED BY THE APPLICABLE PLANS AND CONSTRUCTION ENGINEERS. THE PIPE SLEEVES, WHERE
PRESENT, WERE ONLY INSTALLED ON HORIZONTAL PORTIONS OF PIPING THROUGH FOOTERS AND
WERE NOT INSTALLED ON VERTICAL SECTIONS OF PIPING THAT ENTER THE BUILDING THROUGH THE
SLAB, OR WERE PROPERLY SEALED TO PREVENT A PREFERENTIAL AIR PATHWAY FROM BELOW THE
SLAB INTO THE BUILDING. PIPE SLEEVES THAT EXITED THROUGH AN EXTERIOR FOOTER OR RETAINING
WALL WERE PROPERLY SEALED TO PREVENT A PREFERENTIAL AIR PATHWAY ALONG THE PIPE AND
INTO THE GRAVEL LAYER BELOW THE BUILDING SLAB.
12.WATERPROOFING USED ALONG ELEVATOR PITS IN LIEU OF VAPOR LINER EXHIBITS THE
CHARACTERISTICS OF AN ASTM E1745 VAPOR RETARDER CLASS A MATERIAL, OR OTHERWISE
APPROVED BY THE DESIGN ENGINEER. THESE CHARACTERISTICS INCLUDE A MINIMUM 60-MIL
THICKNESS, PERMEANCE OF LESS THAN <0.1 PERMS, MINIMUM TENSILE STRENGTH OF 45 PSI, AND
MINIMUM PUNCTURE RESISTANCE OF 2,200 GRAMS.
NOTES:
VIMS = VAPOR INTRUSION MITIGATION SYSTEM
T.O.C. = TOP OF CONCRETE
T.O.F. = TOP OF FOOTING
TYP = TYPICAL
SCH = SCHEDULE
PVC = POLYVINYL CHLORIDE
CMU = CONCRETE MASONRY UNIT
ALL PIPE MEASUREMENTS ARE BY DIAMETER
H&H NO. CAM-010
VIMS LAYOUT
SECTION DETAILS
NOVEMBER 1, 2022
VM-3A
VAPOR MITIGATION PLAN PREPARED BY:
2923 South Tryon Street-Suite 100
Charlotte, North Carolina 28203
704-586-0007(p) 704-586-0373(f)
License # C-1269 / #C-245 Geology
PROFESSIONAL
APPROVAL
ISSUED FOR CONSTRUCTION
11/01/22
AS-BUILT
WEST BUILDING
CA
M
D
E
N

N
O
D
A
CH
A
D
B
O
U
R
N

M
I
L
L

A
N
D

T
H
E
R
O
N

P
R
O
P
E
R
T
I
E
S
#2
0
0
8
6
-
1
6
-
0
6
0

A
N
D

2
3
0
3
5
-
1
9
-
0
6
0
50
0

&

5
0
8

C
H
A
R
L
E
S

A
V
E
CH
A
R
L
O
T
T
E
,

N
O
R
T
H

C
A
R
O
L
I
N
A
S:\
A
A
A
-
M
a
s
t
e
r

P
r
o
j
e
c
t
s
\
C
a
m
d
e
n

-

C
A
M
\
C
A
M
-
0
1
0

C
a
m
d
e
n

N
o
D
a

R
e
d
e
v
e
l
o
p
m
e
n
t
\
V
I
M
P
\
V
I
M
S

I
n
s
t
a
l
l

R
e
p
o
r
t

-

W
e
s
t

B
l
d
g
\
A
s
-
b
u
i
l
t
s
\
V
M
P

D
e
t
a
i
l
s
_
A
s
-
B
u
i
l
t
_
W
e
s
t

B
l
d
g
.
d
w
g

Appendix B Product Specifications
PRODUCT PART #
VaporBlock® Plus™ 20 ................................................................ VBP20
UNDER-SLAB VAPOR / GAS BARRIER
Under-Slab Vapor/Gas Retarder
© 2018 RAVEN INDUSTRIES INC. All rights reserved.
VAPORBLOCK® PLUS™VBP20
PRODUCT DESCRIPTION
VaporBlock® Plus™ is a seven-layer co-extruded barrier
made using high quality virgin-grade polyethylene and
EVOH resins to provide unmatched impact strength as well
as superior resistance to gas and moisture transmission.
VaporBlock® Plus™ 20 is more than 100 times less permeable
than typical high-performance polyethylene vapor retarders
against Methane, Radon, and other harmful VOCs. Tested and
verified for unsurpassed protection against BTEX, HS, TCE, PCE,
methane, radon, other toxic chemicals and odors.
VaporBlock® Plus™ 20 multi-layer gas barrier is manufactured
with the latest EVOH barrier technology to mitigate hazardous
vapor intrusion from damaging indoor air quality, and the safety
and health of building occupants. VBP20 is one of the most
effective underslab gas barriers in the building industry today
far exceeding ASTM E-1745 (Plastic Water Vapor Retarders
Used in Contact with Soil or Granular Fill Under Concrete Slabs)
Class A, B and C requirements. Available in a 20 (Class A) mil
thicknesses designed to meet the most stringent requirements.
VaporBlock® Plus™ 20 is produced within the strict guidelines
of our ISO 9001 Certified Management System.
PRODUCT USE
VaporBlock® Plus™ 20 resists gas and moisture migration
into the building envelop when properly installed to provide
protection from toxic/harmful chemicals. It can be installed as
part of a passive or active control system extending across the
entire building including floors, walls and crawl spaces. When
installed as a passive system it is recommended to also include
a ventilated system with sump(s) that could be converted to an
active control system with properly designed ventilation fans.
VaporBlock® Plus™ 20 works to protect your flooring and
other moisture-sensitive furnishings in the building’s interior
from moisture and water vapor migration, greatly reducing
condensation, mold and degradation.
SIZE & PACKAGING
VaporBlock® Plus™ 20 is available in 10’ x 150’ rolls to
maximize coverage. All rolls are folded on heavy-duty cores
for ease in handling and installation. Other custom sizes
with factory welded seams are available based on minimum
volume requirements. Installation instructions and ASTM E-1745
classifications accompany each roll.
APPLICATIONS
Radon Barrier
Methane Barrier
VOC Barrier
Brownfields Barrier
Vapor Intrusion Barrier
Under-Slab Vapor Retarder
Foundation Wall Vapor Retarder
VaporBlock® Plus™ is a seven-layer co-extruded barrier made using high quality virgin-grade polyethylene and EVOH resins to provide unmatched impact strength as well as superior resistance to gas and moisture transmission.
VaporBlock® Plus™ Placement
All instructions on architectural or structural drawings should be reviewed and followed.
Detailed installation instructions accompany each roll of VaporBlock® Plus™ and can also be located at www.ravenefd.com.
ASTM E-1643 also provides general installation information for vapor retarders.
VAPORBLOCK® PLUS™ 20
PROPERTIES TEST METHOD IMPERIAL METRIC
AppeArAnce White/Gold
Thickness, nominAl 20 mil 0.51 mm
WeighT 102 lbs/MSF 498 g/m²
clAssificATion ASTM E 1745 CLASS A, B & C
³ Tensile sTrengTh
ASTM E 154Section 9(D-882)58 lbf 102 N
impAcT resisTAnce ASTM D 1709 2600 g
permeAnce (neW mATeriAl)
ASTM E 154Section 7ASTM E 96Procedure B
0.0098 Perms
grains/(ft²·hr·in·Hg)
0.0064 Perms
g/(24hr·m²·mm Hg)
permeAnce (AfTer condiTioning)
(sAme meAsuremenT As Above permeAnce)
ASTM E 154Section 8, E96Section 11, E96Section 12, E96Section 13, E96
0.00790.00790.00970.0113
0.00520.00520.00640.0074
WvTr ASTM E 96Procedure B 0.0040 grains/hr-ft²0.0028 gm/hr-m²
benzene permeAnce See Note ⁶1.13 x 10-¹⁰ m²/sec or 3.62 x 10-¹³ m/s
Toluene permeAnce See Note ⁶1.57 x 10-¹⁰ m²/sec or 1.46 x 10-¹³ m/s
eThylbenzene permeAnce See Note ⁶1.23 x 10-¹⁰ m²/sec or 3.34 x 10-¹⁴ m/s
m & p-Xylenes permeAnce See Note ⁶1.17 x 10-¹⁰ m²/sec or 3.81 x 10-¹⁴ m/s
o-Xylene permeAnce See Note ⁶1.10 x 10-¹⁰ m²/sec or 3.43 x 10-¹⁴ m/s
hydrogen sulfide See Note 9 1.92E-⁰⁹ m/s
TrichloroeThylene (Tce) See Note ⁶7.66 x 10-¹¹ m²/sec or 1.05 x 10-¹⁴ m/s
perchloroeThylene (pce)See Note ⁶7.22 x 10-¹¹ m²/sec or 1.04 x 10-¹⁴ m/s
rAdon diffusion coeffiecienT K124/02/95 < 1.1 x 10-13 m2/s
meThAne permeAnce ASTM D 1434 3.68E-¹² m/sGas Transmission Rate (GTR):0.32 mL/m²•day•atm
mAXimum sTATic use TemperATure 180° F 82° C
minimum sTATic use TemperATure - 70° F - 57° C
UNDER-SLAB VAPOR / GAS BARRIER
VAPORBLOCK® PLUS™VBP20
© 2018 RAVEN INDUSTRIES INC. All rights reserved.
Scan QR Code to download current technical data sheets via the Raven website.
Note: To the best of our knowledge, unless otherwise stated, these are typical property values and are intended as guides only, not as specification limits. Chemical resistance, odor transmission, longevity as well as other performance criteria is not implied or given and actual testing must be performed for applicability in specific applications and/or conditions. RAVEN INDUSTRIES MAKES NO WARRANTIES AS TO THE FITNESS FOR A SPECIFIC USE OR MERCHANTABILITY OF PRODUCTS REFERRED TO, no guarantee of satisfactory results from reliance upon contained information or recommendations and disclaims all liability for resulting loss or damage. Limited Warranty available at www.RavenEFD.com
061318 EFD 1125
RAVEN ENGINEERED FILMSP.O. Box 5107 Sioux Falls, SD 57117-5107Ph: [phone] • TF: [phone] [e-mail]
³ Tests are an average of machine and transverse directions.5 Raven Industries performs seam testing at 20” per minute.6 Aqueous Phase Film Permeance. Permeation of Volatile Organic Compounds through EVOH Thin Film Membranes and Coextruded LLDPE/EVOH/
LLDPE Geomembranes, McWatters and Rowe, Journal of Geotechnical and Geoenvironmental Engineering© ASCE/
September 2015. (Permeation is the Permeation Coefficient adjusted to actual film thickness - calculated at 1 kg/m³.)
The study used to determine PCE and TCE is titled: Evaluation of diffusion of PCE & TCE through high performance geomembranes by Di
Battista and Rowe, Queens University 8 Feb 2018.9 The study used to determine diffusion coefficients is titled: Hydrogen Sulfide (H₂S) Transport through Simulated Interim Covers with Conventional and Co-Extruded Ethylene-Vinyl Alcohol (EVOH) Geomembranes.
INSTALLATION GUIDELINES - With VaporSeal™ Tape
VaporSeal™
4” Tape
VaporSeal™ 4” Tape Optional Butyl Seal
2-Sided Tape
Gas Barrier Applications
Elements of a moisture/gas-resistant floor system. General illustration only.(Note: This example shows multiple options for waterstop placement.
VaporSeal™
4” Tape
VaporSeal™ 4” Tape Optional Butyl Seal
2-Sided Tape
Gas Barrier Applications
Fig. 2: VaporBlock® Plus™ Overlap Joint Sealing Methods
Fig. 1: VaporBlock® Plus™ Overlapping Roll-out Method
Please Note: Read these instructions thoroughly before installation to ensure proper use of VaporBlock® Plus™. ASTM E 1465, ASTM E 2121 and, ASTM E 1643 also provide valuable information regarding the installation of vapor / gas barriers. When installing this product, contractors shall conform to all applicable local, state and federal regulations and laws pertaining to residential and commercial building construction.
• When VaporBlock® Plus™ gas barrier is used as part of an active control system for radon or other gas, a ventilation system will be required.
• If designed as a passive system, it is recommended to install a ventilation system that could be converted to an active system if needed.
Materials List:VaporBlock® Plus™ Vapor / Gas BarrierVaporSeal™* 4” Seaming TapeVaporSeal™* 12” Seaming/Repair TapeButyl Seal 2-Sided TapeVaporBoot Plus Pipe Boots 12/Box (recommended)VaporBoot Tape (optional)POUR-N-SEAL™ (optional)1” Foam Weather Stripping (optional)Mako® Screed Supports (optional)
VAPORBLOCK® PLUS™ PLACEMENT
1.1. Level and tamp or roll granular base as specified. A base for a gas-reduction system may require a 4” to 6” gas permeable layer of clean coarse aggregate as specified by your architectural or structural drawings after installation of the recommended gas collection system. In this situation, a cushion layer consisting of a non-woven geotextile fabric placed directly under VaporBlock® Plus™ will help protect the barrier from damage due to possible sharp coarse aggregate.
1.2. Unroll VaporBlock® Plus™ running the longest dimension parallel with the direction of the pour and pull open all folds to full width. (Fig. 1)
1.3. Lap VaporBlock® Plus™ over the footings and seal with Raven Butyl Seal tape at the footing-wall connection. Prime concrete surfaces, when necessary, and assure they are dry and clean prior to applying Raven Butyl Seal Tape. Apply even and firm pressure with a rubber roller. Overlap joints a minimum of 6” and seal overlap with 4” VaporSeal™ Tape. When used as a gas barrier, overlap joints a minimum of 12” and seal in-between overlap with an optional 2-sided Raven Butyl Seal Tape. Then seal with 4” VaporSeal™ Tape centered on the overlap seam. (Fig. 2)
Page 1 of 4
To
p

o
r
i
g
i
n
a
l

d
i
a
g
r
a
m

a
n
d

f
i
g
u
r
e

#
1

w
e
r
e

r
e
p
r
i
n
t
e
d

w
i
t
h

p
e
r
m
i
s
s
i
o
n

b
y

t
h
e

P
o
r
t
l
a
n
d

C
e
m
e
n
t

A
s
s
o
c
i
a
t
i
o
n
.
Re
f
e
r
e
n
c
e
:

K
a
n
a
r
e
,

H
o
w
a
r
d

M
.
,

C
o
n
c
r
e
t
e

F
l
o
o
r
s

a
n
d

M
o
i
s
t
u
r
e
,

E
B
11
9
,

P
o
r
t
l
a
n
d

C
e
m
e
n
t

A
s
s
o
c
i
a
t
i
o
n
,

S
k
o
k
i
e
,

I
l
l
i
n
o
i
s
,

a
n
d

N
a
t
i
o
n
a
l

R
e
a
d
y

M
i
x
e
d

C
o
n
c
r
e
t
e

A
s
s
o
c
i
a
t
i
o
n
,

S
i
l
v
e
r

S
p
r
i
n
g
,

M
a
r
y
l
a
n
d
,

U
S
A
,

2
0
0
8
,

1
7
6

p
a
g
e
s
.
1.4. Seal around all plumbing, conduit, support columns or other penetrations that come through the VaporBlock® Plus™ membrane.
1.4a. Method 1: Pipes four inches or smaller can be sealed with Raven VaporBoot Plus preformed pipe boots. VaporBoot Plus preformed pipe boots are formed in steps for 1”, 2”, 3” and 4” PVC pipe or IPS size and are sold in units of 12 per box (Fig. 3 & 5).
Pipe boots may also be fabricated from excess VaporBlock® Plus™ membrane (Fig. 4 & 6) and sealed with VaporBoot Tape or VaporSeal™ Tape (sold separately).
1.4b. Method 2: To fabricate pipe boots from VaporBlock® Plus™ excess material (see Fig. 4 & 6 for A-F):
A) Cut a square large enough to overlap 12” in all directions.
B) Mark where to cut opening on the center of the square and cut four to eight slices about 3/8” less than the diameter of the pipe.
C) Force the square over the pipe leaving the tightly stretched cut area around the bottom of the pipe with approximately a 1/2” of the boot material running vertically up the pipe. (no more than a 1/2” of stretched boot material is recommended)
D) Once boot is positioned, seal the perimeter to the membrane by applying 2-sided Raven Butyl Seal Tape in between the two layers. Secure boot down firmly over the membrane taking care not to have any large folds or creases.
E) Use VaporBoot Tape or VaporSeal™ Tape to secure the boot to the
pipe.
VaporBoot Tape (option) – fold tape in half lengthwise, remove half of the release liner and wrap around the pipe allowing 1” extra for overlap sealing. Peel off the second half of the release liner and work the tape outward gradually forming a complete seal.
VaporSeal™ Tape (option) - Tape completely around pipe overlapping the VaporBlock® Plus™ square to create a tight seal against the pipe.
F) Complete the process by taping over the boot perimeter edge with VaporSeal™ Tape to create a monolithic membrane between the surface of the slab and gas/moisture sources below and at the slab perimeter. (Fig. 4 & 6)
Preformed Pipe Boot Square Material Pipe Boot
Fig. 3
SINGLE PENETRATION PIPE BOOT INSTALLATION
Fig. 5 Fig. 6
1. Cut a square of VaporBlock® Plus™ barrier to extend at least 12” from the pipe in all directions.
2. Cut four to eight slices about 3/8” less than the diameter of the pipe.
5. Use Raven VaporBoot or VaporSeal™ Tape and overlap 1” at the seam.
4. Tape over the boot perimeter edge with VaporSeal™ Tape.
1. Cut out one of the preformed boot steps (1” to 4”).
2. Tape the underside boot perimeter with 2-sided Butyl Seal Tape.
3. Force the boot over pipe and press tape firmly in place.
4. Use VaporSeal™ Tape
to secure boot to the pipe.
5. Tape around entire boot edge with VaporSeal™ Tape.
VaporBoot Flexible Tapeor VaporSeal™ 4” TapeVaporSeal™ 4” Tape
VaporBlock® Plus™Material
VaporSeal™ 4” Tape
Raven Butyl Seal2-Sided Tape Raven Butyl Seal2-Sided Tape
VaporBoot PlusPreformed Boot 12”(minimum)
3. Force over pipe and tape the underside boot perimeter to existing barrier with 2-sided Butyl Seal Tape.
Fig. 4
Page 2 of 4
Or
i
g
i
n
a
l

f
i
g
u
r
e

#
4

d
i
a
g
r
a
m

i
s

r
e
p
r
i
n
t
e
d

w
i
t
h

p
e
r
m
i
s
s
i
o
n

b
y

t
h
e

P
or
t
l
a
n
d

C
e
m
e
n
t

A
s
s
o
c
i
a
t
i
o
n
.
Re
f
e
r
e
n
c
e
:

K
a
n
a
r
e
,

H
o
w
a
r
d

M
.
,

C
o
n
c
r
e
t
e

F
l
o
o
r
s

a
n
d

M
o
i
s
t
u
r
e
,

E
B
11
9
,

P
o
r
t
l
a
n
d

C
e
m
e
n
t

A
s
s
o
c
i
a
t
i
o
n
,

S
k
o
k
i
e
,

I
l
l
i
n
o
i
s
,

a
n
d

N
a
t
i
o
n
a
l

R
e
a
d
y

M
i
x
e
d

C
o
n
c
r
e
t
e

A
s
s
o
c
i
a
t
i
o
n
,

S
i
l
v
e
r

S
p
r
i
n
g
,

M
a
r
y
l
a
n
d
,

U
S
A
,

2
0
0
8
,

1
7
6

p
a
g
e
s
.
Method 1
Method 2
VaporSeal™4” Tape VaporBoot PlusPerformed Boot
Raven Butyl Seal 2-sided Tape Raven Butyl Seal 2-sided Tape
1.5. Sealing side-by-side multiple penetrations (option 1);
A) Cut a patch large enough to overlap 12” in all directions (Fig. 7)
of penetrations.
B) Mark where to cut openings and cut four to eight slices about
3/8” less than the diameter of the penetration for each.
C) Force patch material over penetration to achieve a tight fit and
form a lip.
D) Once patch is positioned, seal the perimeter to the membrane
by applying 2-sided Raven Butyl Seal Tape in-between the two
layers. (Fig. 8)
E) After applying Raven Butyl Seal Tape between the patch and
membrane, tape around each of the penetrations and the patch
with VaporSeal™ 4” tape. (Fig. 9) For additional protection apply
POUR-N-SEAL™ or an acceptable polyurethane elastomeric
sealant around the penetrations. (Fig. 10)
Fig. 7 Fig. 8
Fig. 9 Fig. 10
MULTIPLE PENETRATION PIPE BOOT INSTALLATION
Fig. 6
Cut a patch large enough to overlap 12” in all directions and slide over penetrations (Make openings as tight as possible.)
Once the overlay patch is positioned, seal the perimeter to the membrane by applying 2-sided Raven Butyl Seal Tape in-between the two layers.
After applying Raven Butyl Seal Tapebetween the patch and membrane, tape around the perimeter of the penetration and the patch with VaporSeal™ 4” Tape.
For additional protection apply POUR-N-SEAL™ or an acceptable polyurethane elastomeric sealant around the penetrations.
VaporSeal™ 4” Tape VaporSeal™ 4” Tape
Page 3 of 4
Option 1
Raven Butyl Seal 2-sided Tape
1.6. POUR-N-SEAL™ method of sealing side-by-side multiple penetrations (option 2);
A) Install the vapor barrier as closely as possible to pipe penetrations to minimize the amount of POUR-N-SEAL™ necessary to seal around all penetrations.
B) Once barrier is in place, remove soil or other particles with a dry cloth or a fine broom to allow for improved adhesion to the POUR-N-SEAL™ liquid.
C) Create a dam around the penetration area approximately 2” away from the pipe or other vertical penetrations by removing the release liner from the back of a 1” weather stripping foam and adhere to the vapor barrier. Form a complete circle to contain the POUR-N-SEAL™ materials (Fig. 11).
D) Once mixed, pour contents around the pipe penetrations. If needed, a brush or a flat wooden stick can be used to direct the sealant completely around penetrations creating a complete seal (Fig. 12-13).
E) DO NOT leave excess POUR-N-SEAL™ in plastic container for longer than the time it takes to pour sealant.
Fig. 12 Fig. 13
Fig. 11
Option 2
VAPORBLOCK® PLUS™ REPAIR INSTRUCTIONS
1.7. Proper installation requires all holes and openings are repaired prior
to placing concrete. When patching small holes, simply cut a 12” long
piece of 12” wide VaporSeal™ tape. Remove release liner and center
over the opening. Apply pressure to create a seal (Fig. 14-15).
1.8. When installing VaporBlock® Plus™ around pipe penetrations,
vertical columns, electrical ducts and other obstructions, you will
find it necessary to cut it to the nearest outside edge. This cut can
be easily sealed with 12” wide VaporSeal™ tape, by simply centering
it over the cut, 6” on either side. Once the tape is placed correctly,
apply pressure to assure a complete seal (Fig. 16).
Reminder Note: All holes or penetrations through the membrane will need
to be patched with 12” VaporSeal™ Tape.
Fig. 14
Page 4 of 5
Fig. 15
2.1. When installing reinforcing steel and utilities, in addition to the
placement of concrete, take precaution to protect VaporBlock®
Plus™. Carelessness during installation can damage the most
puncture–resistant membrane. Sheets of plywood cushioned with
geotextile fabric temporarily placed on VaporBlock® Plus™ provide
for additional protection in high traffic areas including concrete
buggies.
2.2. Use only brick-type or chair-type reinforcing bar supports to protect
VaporBlock® Plus™ from puncture.
2.3. Avoid driving stakes through VaporBlock® Plus™. If this cannot be
avoided, each individual hole must be repaired per section 1.7.
2.4. To avoid penetrating VaporBlock® Plus™ when installing screed
supports, utilize non-penetrating support, such as the Mako®
Screed Support System (Fig. 17). Avoid driving stakes through
VaporBlock® Plus™. If this cannot be avoided, each individual hole
must be repaired per figures 14-15.
2.5. If a cushion or blotter layer is required in the design between
VaporBlock® Plus™ and the slab, additional care should be given if
sharp crushed rock is used. Washed rock will provide less chance of
damage during placement. Care must be taken to protect blotter layer
from precipitation before concrete is placed.
VaporBlock® Plus™ Gas & Moisture Barrier can be identified on site
as gold/white in color printed in black ink with following logo and
classification listing (Fig. 18)
Page 5 of 5
VaporBlock® Plus™
Gas & Moisture Barrier
Note: To the best of our knowledge, unless otherwise stated, these are typical property values and are intended as guides only, not as specification limits. Chemical resistance, odor transmission, longevity as well as other performance criteria is not implied or given and actual testing must be performed for applicability in specific applications and/or conditions. RAVEN INDUSTRIES MAKES NO WARRANTIES AS TO THE FITNESS FOR A SPECIFIC USE OR MERCHANTABILITY OF PRODUCTS REFERRED TO, no guarantee of satisfactory results from reliance upon contained information or recommendations and disclaims all liability for resulting loss or damage. Limited Warranty available at wwww.RavenEFD.com
ENGINEERED FILMSP.O. Box 5107 Sioux Falls, SD 57117-5107Ph: [phone] • TF: [phone]
[e-mail]
020316 EFD 1127
VAPORBLOCK® PLUS™ PROTECTION
Fig. 16
Fig. 18
Fig. 17
* Patent Pending
© Raven 2016. All Rights Reserved.
P1 OF 2
DRAGO® WRAPVAPOR INTRUSION BARRIER
A STEGO TECHNOLOGY, LLC INNOVATION | VAPOR RETARDERS 07 26 00, 03 30 00 | VERSION: 2/22/2019
1. PRODUCT NAME
DRAGO WRAP VAPOR INTRUSION BARRIER
2. MANUFACTURER
c/o Stego® Industries, LLC*
216 Avenida Fabricante, Suite 101
San Clemente, CA 92672
Sales, Technical Assistance
Ph: [phone]
Fx: [phone]
www.stegoindustries.com
3. PRODUCT DESCRIPTION
TABLE 4.1: PHYSICAL PROPERTIES OF DRAGO WRAP VAPOR INTRUSION BARRIER
PROPERTY TEST RESULTS
Under Slab Vapor Retarders ASTM E1745 – Standard Specification for Water Vapor Retarders Used in Contact with Soil or Granular Fill under Concrete Slabs ASTM E1745 Compliant
Water Vapor Permeance ASTM F1249 – Test Method for Water Vapor Transmission Rate Through Plastic Film and Sheeting Using a Modulated Infrared Sensor 0.0069 perms
Push-Through Puncture ASTM D4833 – Test Method for Index Puncture Resistance of Geotextiles, Geomembranes, and Related Products 183.9 Newtons
Tensile Strength ASTM D882 – Test Method for Tensile Properties of Thin Plastic Sheeting 53.5 lbf/in
Permeance After Conditioning ASTM E154 Section 8, F1249 – Permeance after wetting, drying, and soaking 0.0073 perms(ASTM E1745 ASTM E154 Section 11, F1249 – Permeance after heat conditioning 0.0070 permsSections 7.1.2 - 7.1.5) ASTM E154 Section 12, F1249 – Permeance after low temperature conditioning 0.0062 perms ASTM E154 Section 13, F1249 – Permeance after soil organism exposure 0.0081 perms
Hydrocarbon Attenuation Factors Contact Stego Industries’ Technical Department
Chlorinated Solvent Attenuation Factors Contact Stego Industries’ Technical Department
Methane Transmission Rate ASTM D1434 – Test Method for Determining Gas Permeability Characteristics of 7.0 GTR** Plastic Film and Sheeting (mL(STP)/m2*day)
Radon Diffusion Coefficient K124/02/95 9.8 x 10-14 m2/second
Thickness 20 mil
Roll Dimensions 14' x 105' or 1,470 ft2
Roll Weight 150 lb
Note: perm unit = grains/(ft2*hr*in-Hg) ** GTR = Gas Transmission Rate
USES: Drago Wrap is specifically engineered to attenuate volatile organic compounds (VOCs) and serve as a below-slab
moisture vapor barrier.
COMPOSITION: Drago Wrap is a multi-layered plastic extrusion that combines uniquely designed materials with only
high grade, prime, virgin resins.
ENVIRONMENTAL FACTORS: Drago Wrap can be used in systems for the control of various VOCs including hydrocarbons,
chlorinated solvents, radon, methane, soil poisons, and sulfates.
4. TECHNICAL DATA
Continued... Note – legal notice on page 2.
DRAGO® WRAPVAPOR INTRUSION BARRIER
A STEGO TECHNOLOGY, LLC INNOVATION | VAPOR RETARDERS 07 26 00, 03 30 00 | VERSION: 2/22/2019
DATA SHEETS ARE SUBJECT TO CHANGE. FOR MOST CURRENT VERSION, VISIT WWW.STEGOINDUSTRIES.COM
[phone] | www.stegoindustries.com
*Stego Industries, LLC (“Stego”) is the exclusive Representative for Drago Wrap and Pango Wrap. All designated trademarks are the intellectual property
of Stego or the entity for which it is acting as a Representative. Installation, Warranty, State Approval Information and Disclosure of Representative Status: www.stegoindustries.com/legal. ©2019 Stego Industries, LLC. All rights reserved.
5. INSTALLATION
UNDER SLAB: Unroll Drago Wrap over a tamped aggregate, sand, or earth base. Overlap all seams a minimum of 12
inches and tape using Drago® Tape. All penetrations must be sealed using a combination of Drago Wrap and Drago
Accessories.
Review Drago Wrap’s complete installation instructions prior to installation.
6. AVAILABILITY & COST
Drago Wrap is available nationally through our network of building supply distributors. For current cost information,
contact your local Drago distributor or Stego Industries’ Sales Representative.
7. WARRANTY
Stego Industries, LLC believes to the best of its knowledge, that specifications and recommendations herein are
accurate and reliable. However, since site conditions are not within its control, Stego Industries does not guarantee
results from the use of the information provided and disclaims all liability from any loss or damage. Stego Technology,
LLC does offer a limited warranty on Drago Wrap. Please see www.stegoindustries.com/legal.
8. MAINTENANCE
Store Drago Wrap in a dry and temperate area.
9. TECHNICAL SERVICES
Technical advice, custom CAD drawings, and additional information can be obtained by contacting Stego Industries or
by visiting the website.
Contact Number: [phone]
Website: www.stegoindustries.com
10. FILING SYSTEMS
• www.stegoindustries.com
P2 OF 2
INSTALLATIONINSTRUCTIONS
DRAGO® WRAP
VAPOR INTRUSION BARRIER
Engineered protection to create a healthy built environment.
2. Unroll Drago Wrap over the area where the slab is to be placed.
Drago Wrap should completely cover the concrete placement
area. All joints/seams should be overlapped a minimum of
12 inches and taped using Drago® Tape. (Fig. 1). If additional
protection is needed, install DragoTack™ Tape in between the
overlapped seam in combination with Drago Tape on top of the
seam.
NOTE: The area of adhesion should be free from dust, dirt, moisture,
and frost to allow maximum adhesion of the pressure-sensitive tape. Ensure that all seams are taped with applied pressure to allow for
maximum and continuous adhesion of the pressure-sensitive Drago Tape. Adhesives should be installed above 40°F. In temperatures
below 40°F, take extra care to remove moisture/frost from the area
of adhesion.
3. ASTM E1643 requires sealing the perimeter of the slab. Extend
vapor retarder over footings and seal to foundation wall or
grade beam at an elevation consistent with the top of the slab
or terminate at impediments such as waterstops or dowels.
Consult the structural and environmental engineer of record
before proceeding.
IMPORTANT: Please read these installation instructions completely, prior to beginning any Drago Wrap installation. The following installation
instructions are generally based on ASTM E1643 – Standard Practice for Selection, Design, Installation, and Inspection of Water Vapor Retarders
Used in Contact with Earth or Granular Fill Under Concrete Slabs. There are specific instructions in this document that go beyond what is stated in
ASTM E1643 to take into account vapor intrusion mitigation. If project specifications call for compliance with ASTM E1643, then be sure to review
the specific installation sections outlined in the standard along with the techniques referenced in these instructions.
DRAGO TAPE
Minimum 12” overlap
VAPOR INTRUSION BARRIER
Fig.1: UNDER-SLAB INSTALLATION
DRAGO® WRAP VAPOR INTRUSION BARRIERINSTALLATION INSTRUCTIONS
UNDER-SLAB INSTRUCTIONS:
FOOTING
DRAGOTACK TAPE
VAPOR INTRUSION BARRIER
Fig.2a: SEAL TO PERIMETER WALL Fig. 2b: SEAL TO FOOTING
FOOTING
DRAGOTACK TAPE
VAPOR INTRUSION BARRIER
SEAL TO PERIMETER WALL OR FOOTING WITH DRAGOTACK
TAPE: (Fig. 2a and 2b)
a. Make sure area of adhesion is free of dust,
dirt, debris, moisture, and frost to allow
maximum adhesion.
b. Remove release liner on one side and stick to
desired surface.
c. When ready to apply Drago Wrap, remove the
exposed release liner and press firmly against
DragoTack Tape to secure.
d. If a mechanical seal is needed, fasten a
termination bar over the top of the Drago Wrap
inline with the DragoTack Tape.
NOTE: If sealing to the footing, the footing should receive
a hand float finish to allow for maximum adhesion.
1. Drago Wrap has been engineered to be installed over a tamped aggregate, sand, or earth base. It is not typically necessary
to have a cushion layer or sand base, as Drago Wrap is tough enough to withstand rugged construction environments.
NOTE: Drago Wrap must be installed with the gray facing the subgrade.
P2 of 4
Continued ... Note - legal notice on last page.
DETAIL PATCH FOR PIPE PENETRATION SEALING: (Fig. 4b)a. Install Drago Wrap around pipe penetrations by slitting/cutting material as needed. Try to minimize void space
created.
b. If Drago Wrap is close to pipe and void space is minimized, proceed to step d.
c. If void space exists, then
i. Cut a detail patch to a size and shape that creates a 6-inch overlap on all edges around the void space at
the base of the pipe.
ii. Cut an “X” slightly smaller than the size of the pipe diameter in the center of the detail patch and slide
tightly over pipe.
iii. Tape the edges of the detail patch using Drago Tape.
d. Seal around the base of the pipe using Drago Tape and/or Drago Sealant and Drago Sealant Form.
i. If Drago Sealant is used to seal around pipe, make sure Drago Wrap is flush with the base of the
penetration prior to pouring Drago Sealant.
5. IMPORTANT: ALL PENETRATIONS MUST BE SEALED. All pipe, ducting, rebar, and block outs should be sealed using
Drago Wrap, Drago Tape, and/or Drago® Sealant and Drago® Sealant Form. (Fig. 4a). Drago accessories should be
sealed directly to the penetrations.
DRAGO TAPE
DAMAGED AREA
DRAGO TAPE DRAGO TAPE
SMALL HOLE
VAPOR INTRUSION BARRIER
VAPOR INTRUSION BARRIER VAPOR INTRUSION BARRIER VAPOR INTRUSION BARRIER
Fig. 3: SEALING DAMAGED AREAS
4. In the event that Drago Wrap is damaged during or after installation, repairs must be made. Cut a piece of Drago Wrap
to a size and shape that covers any damage by a minimum of 6 inches in all directions. Clean all adhesion areas of dust,
dirt, moisture, and frost. Tape down all edges using Drago Tape. (Fig. 3)
MINIMAL VOID SPACE CREATED
DRAGO SEALANTDRAGO TAPE
OR DRAGO SEALANT FORM
VAPOR INTRUSION BARRIER VAPOR INTRUSION BARRIER VAPOR INTRUSION BARRIER
Fig. 4a: PIPE PENETRATION SEALING
DRAGO TAPE
LARGE VOID SPACE CREATED
DRAGO SEALANTDRAGO TAPE
OR DRAGO SEALANT FORM
VAPOR INTRUSION BARRIERVAPOR INTRUSION BARRIERVAPOR INTRUSION BARRIER
VAPOR INTRUSION BARRIER
Fig. 4b: DETAIL PATCH FOR PIPE PENETRATION SEALING
Continued ... Note - legal notice on last page.
P3 of 4
DRAGO® WRAP VAPOR INTRUSION BARRIERINSTALLATION INSTRUCTIONS
STEGO INDUSTRIES, LLC • SAN CLEMENTE, CA • 949-257-4100 • 877-464-7834 • www.stegoindustries.com
*Stego Industries, LLC (“Stego”) is the exclusive Representative for Drago Wrap and Pango Wrap. All designated trademarks are the intellectual property of Stego or the entity for which it is acting as a Representative. Installation, Warranty, State Approval Information and Disclosure of Representative Status: www.stegoindustries.com/legal. ©2019 Stego Industries, LLC. All rights reserved. 11/2019
NOTE: While Drago Wrap installation instructions are based on ASTM E1643 - Standard Practice for Selection, Design, Installation, and Inspection of Water Vapor Retarders Used in Contact with Earth or Granular Fill Under Concrete Slabs, these instructions are meant to be used as a guide, and do not take into account specific job site situations. Consult local building codes and regulations along with the building owner or owner’s representative before proceeding. If you have any questions regarding the above-mentioned installation instructions or products, please call us at 877-464-7834 for technical assistance. While Stego Industries’ employees and representatives may provide technical assistance regarding the utility of a specific installation practice or Stego product, they are not authorized to make final design decisions.
MULTIPLE PIPE PENETRATION SEALING: (Fig. 5)
NOTE: Multiple pipe penetrations in close proximity may be most efficiently sealed using Drago Wrap, Drago
Sealant, and Drago Sealant Form for ease of installation.
a. Cut a hole in Drago Wrap such that the membrane fits over and around the base of the pipes as closely as
possible, ensuring that it is flush with the base of the penetrations.
b. Install Drago Sealant Form continuously around the entire perimeter of the group of penetrations and at least
1 inch beyond the terminating edge of Drago Wrap.
c. Pour Drago Sealant inside of Drago Sealant Form to create a seal around the penetrations.
d. If the void space between Drago Wrap and the penetrations is not minimized and/or the base course allows for
too much drainage of sealant, a second coat of Drago Sealant may need to be poured after the first application
has cured.
IMPORTANT: AN INSTALLATION COMPLETED PER THESE INSTRUCTIONS SHOULD CREATE A MONOLITHIC MEMBRANE
BETWEEN ALL INTERIOR INTRUSION PATHWAYS AND VAPOR SOURCES BELOW THE SLAB AS WELL AS AT THE SLAB
PERIMETER. THE UNDERLYING SUBBASE SHOULD NOT BE VISIBLE IN ANY AREA WHERE CONCRETE WILL BE PLACED. IF
REQUIRED BY THE DESIGN ENGINEER, ADDITIONAL INSTALLATION VALIDATION CAN BE DONE THROUGH SMOKE TESTING.
Stego Industries* recommends the use of BEAST vapor barrier-safe concrete accessories, to help eliminate the use of non-permanent penetrations in Drago Wrap installations.
MINIMAL VOID SPACE CREATED
DRAGO SEALANT
DRAGO SEALANT FORM DRAGO SEALANT FORM DRAGO SEALANT FORM
DRAGO SEALANT
VAPOR INTRUSION BARRIER VAPOR INTRUSION BARRIER VAPOR INTRUSION BARRIER VAPOR INTRUSION BARRIER
Fig. 5: MULTIPLE PIPE PENETRATION SEALING
BEAST® CONCRETE ACCESSORIES - VAPOR BARRIER SAFE
BEAST® SCREED BEAST® HOOK
P3 of 4
BEAST® FORM STAKE
Locate itand lock it down!Improve efficiency and maintain concrete floor levelness with the BEAST SCREED SYSTEM!
The Stego barrier-safe forming system that prevents punctures in the vapor barrier.
P1 OF 2
DRAGO® TAPE
A STEGO TECHNOLOGY, LLC INNOVATION | VAPOR RETARDERS 07 26 00, 03 30 00 | VERSION: 11/27/2019
1. PRODUCT NAME
DRAGO TAPE
2. MANUFACTURER
c/o Stego® Industries, LLC*
216 Avenida Fabricante, Suite 101
San Clemente, CA 92672
Sales, Technical Assistance
Ph: [phone]
Fx: [phone]
www.stegoindustries.com
3. PRODUCT DESCRIPTION
USES: Drago Tape is a low-permeance tape designed for protective sealing, seaming, splicing, and patching applications
where a highly conformable material is required. It has been engineered to bond specifically to Drago® Wrap Vapor
Intrusion Barrier, making it ideal for sealing Drago Wrap seams and penetrations.
COMPOSITION: Drago Tape is a multi-layered plastic extrusion that combines uniquely designed materials with only
high grade, prime, virgin resins, and an acrylic, pressure-sensitive adhesive.
SIZE: Drago Tape is 3.75" x 180'. Drago Tape ships 12 rolls in a case.
4. TECHNICAL DATA
APPLICABLE STANDARDS:
Pressure Sensitive Tape Council (PSTC)
• PSTC 101 – International Standard for Peel Adhesion of Pressure Sensitive Tape
• PSTC 107 – International Standard for Shear Adhesion of Pressure Sensitive Tape
American Society for Testing & Materials (ASTM)
• ASTM E1643 – Standard Practice for Selection, Design, Installation, and Inspection of Water Vapor Retarders
Used In Contact with Earth or Granular Fill under Concrete Slabs.
TABLE 4.1: PHYSICAL PROPERTIES OF DRAGO TAPE
PROPERTY TEST RESULTS
Total Thickness 8 mil
Permeance ASTM F1249 0.031 perms
Tensile Strength MD ASTM D882 20.5 lbf/in
Elongation (at break) MD ASTM D882 702%
180° Peel Adhesion PSTC 101 20-min dwell to Drago Wrap 50.1 oz/in
PSTC 101 24-hour dwell to Drago Wrap 92.9 oz/in
Shear Adhesion PSTC 107 24-hour dwell (1" x 1", 1kg/wt) to Drago Wrap 188 minutes
Note: perm unit = grains/(ft2*hr*in-Hg)
Continued... Note – legal notice on page 2.
DRAGO® TAPE
A STEGO TECHNOLOGY, LLC INNOVATION | VAPOR RETARDERS 07 26 00, 03 30 00 | VERSION: 11/27/2019
DATA SHEETS ARE SUBJECT TO CHANGE. FOR MOST CURRENT VERSION, VISIT WWW.STEGOINDUSTRIES.COM
[phone] | www.stegoindustries.com
*Stego Industries, LLC (“Stego”) is the exclusive Representative for Drago Wrap and Pango Wrap. All designated trademarks are the intellectual property
of Stego or the entity for which it is acting as a Representative. Installation, Warranty, State Approval Information and Disclosure of Representative Status: www.stegoindustries.com/legal. ©2019 Stego Industries, LLC. All rights reserved.
5. INSTALLATION
SEAMS: Overlap Drago Wrap a minimum 12 inches and seal with Drago Tape. Make sure the area of adhesion is free
from dust, moisture and frost to allow maximum adhesion of the pressure-sensitive tape.
PIPE PENETRATION SEALING:
• Install Drago Wrap around pipe by slitting/cutting material.
• If void space is minimal, seal around base of pipe with Drago Tape and/or Drago® Sealant and Drago® Sealant Form.
DETAIL PATCH FOR PIPE PENETRATION SEALING:
• Cut a piece of Drago Wrap that creates a 6 inch overlap around all edges of the void space.
• Cut an “X” slightly smaller than the size of the pipe diameter in the center of the detail patch.
• Slide detail patch over pipe, secure tightly.
• Tape down all sides of detail patch with Drago Tape.
• Seal around base of pipe with Drago Tape and/or Drago Sealant and Drago Sealant Form.
Drago Tape should be installed above 40°F. In temperatures below 40°F, take extra care to remove moisture or frost
from the area of adhesion. Ensure that the entirety of all seams are taped with applied pressure to allow for maximum
and continuous adhesion of the pressure-sensitive Drago Tape.
Review Drago Wrap’s complete installation instructions prior to installation.
6. AVAILABILITY & COST
Drago Tape is available nationally through our network of building supply distributors. For current cost information,
contact your local Drago distributor or Stego Industries’ Sales Representative.
7. WARRANTY
Stego Industries, LLC believes to the best of its knowledge, that specifications and recommendations herein are
accurate and reliable. However, since site conditions are not within its control, Stego Industries does not guarantee
results from the use of the information provided and disclaims all liability from any loss or damage. Stego Technology,
LLC does offer a limited warranty on Drago Wrap. Please see www.stegoindustries.com/legal.
8. MAINTENANCE
Store Drago Tape in a dry and temperate area.
9. TECHNICAL SERVICES
Technical advice, custom CAD drawings, and additional information can be obtained by contacting Stego Industries or
by visiting the website.
Contact Number: [phone]
Website: www.stegoindustries.com
10. FILING SYSTEMS
• www.stegoindustries.com
P2 OF 2
P1 OF 2
DRAGOTACK™ TAPE
A STEGO TECHNOLOGY, LLC INNOVATION | VAPOR RETARDERS 07 26 00, 03 30 00 | VERSION: 2/22/2019
1. PRODUCT NAME
DRAGOTACK TAPE
2. MANUFACTURER
c/o Stego® Industries, LLC*
216 Avenida Fabricante, Suite 101
San Clemente, CA 92672
Sales, Technical Assistance
Ph: [phone]
Fx: [phone]
www.stegoindustries.com
3. PRODUCT DESCRIPTION
TABLE 4.1: PHYSICAL PROPERTIES OF DRAGOTACK TAPE
PROPERTY TEST RESULTS
Dimensions 2" x 50'
Total Thickness 30 mil
Color Grey
Material Synthetic rubber blend
Permeance ASTM F1249 0.03 perms (30 mil) Adhesion to Steel ASTM D1000 12.5 lbs/in width
Chemical Resistance No significant change to(TCE, PCE, Toluene, Xylene) ASTM D471 / D543 mass or volume.
Installation Temperature 40°F / 110°
In Service Temperature Range -20°F / +140°F
VOC Content No VOCs, 100% solids
Note: perm unit = grains/(ft2*hr*in-Hg)
USES: DragoTack Tape is a solvent-resistant, double-sided adhesive strip used to bond and seal Drago® Wrap Vapor
Intrusion Barrier to concrete, masonry, wood, metal, and other surfaces. DragoTack Tape is a flexible and moldable
material to allow for a variety of applications and installations.
COMPOSITION: DragoTack Tape is made from a solvent-resistant blend of synthetic rubber and resins.
SIZE: DragoTack Tape is 2" x 50'. DragoTack Tape ships 12 rolls in a case.
4. TECHNICAL DATA
Continued... Note – legal notice on page 2.
DRAGOTACK™ TAPE
A STEGO TECHNOLOGY, LLC INNOVATION | VAPOR RETARDERS 07 26 00, 03 30 00 | VERSION: 2/22/2019
DATA SHEETS ARE SUBJECT TO CHANGE. FOR MOST CURRENT VERSION, VISIT WWW.STEGOINDUSTRIES.COM
[phone] | www.stegoindustries.com
*Stego Industries, LLC (“Stego”) is the exclusive Representative for Drago Wrap and Pango Wrap. All designated trademarks are the intellectual property
of Stego or the entity for which it is acting as a Representative. Installation, Warranty, State Approval Information and Disclosure of Representative Status: www.stegoindustries.com/legal. ©2019 Stego Industries, LLC. All rights reserved.
5. INSTALLATION
TO WALLS AND FOOTINGS: Make sure the area of adhesion is free of dust, dirt, debris, moisture, and frost to allow
maximum adhesion. Remove release liner on one side and stick to desired surface. When ready to apply Drago Wrap,
remove the exposed release liner and press Drago Wrap firmly against DragoTack Tape to secure.
Cut DragoTack Tape using a utility knife or scissors. Cut DragoTack Tape before removing the release liner for easier
cutting. Install DragoTack Tape between 40°F and 110°F.
Review Drago Wrap’s complete installation instructions prior to installation.
6. AVAILABILITY & COST
DragoTack Tape is available nationally through our network of building supply distributors. For current cost information,
contact your local Drago distributor or Stego Industries’ Sales Representative.
7. WARRANTY
Stego Industries, LLC believes to the best of its knowledge, that specifications and recommendations herein are
accurate and reliable. However, since site conditions are not within its control, Stego Industries does not guarantee
results from the use of the information provided and disclaims all liability from any loss or damage. Stego Technology,
LLC does offer a limited warranty on Drago Wrap. Please see www.stegoindustries.com/legal.
8. MAINTENANCE
Store DragoTack Tape in a dry and temperate area.
9. TECHNICAL SERVICES
Technical advice, custom CAD drawings, and additional information can be obtained by contacting Stego Industries or
by visiting the website.
Contact Number: [phone]
Website: www.stegoindustries.com
10. FILING SYSTEMS
• www.stegoindustries.com
P2 OF 2
P1 OF 2
DRAGO® SEALANT FORM
A STEGO TECHNOLOGY, LLC INNOVATION | VAPOR RETARDERS 07 26 00, 03 30 00 | VERSION: 2/22/2019
1. PRODUCT NAME
DRAGO SEALANT FORM
2. MANUFACTURER
c/o Stego® Industries, LLC*
216 Avenida Fabricante, Suite 101
San Clemente, CA 92672
Sales, Technical Assistance
Ph: [phone]
Fx: [phone]
www.stegoindustries.com
3. PRODUCT DESCRIPTION
USES: Drago Sealant Form is used in conjunction with Drago® Sealant to help create an efficient and effective seal
around pipe penetrations in Drago® Wrap Vapor Intrusion Barrier.
COMPOSITION: Drago Sealant Form is a low-density, cross-linked, closed-cell polyethylene foam with an acrylic,
pressure-sensitive adhesive.
SIZE: Drago Sealant Form is ½" x ½" x 24". Drago Sealant Form comes in 200 pieces per case (10 boxes of 20 pieces).
4. TECHNICAL DATA
TABLE 4.1: PHYSICAL PROPERTIES OF DRAGO SEALANT FORM
PROPERTY RESULTS
Dimensions ½” x ½” x 24”
Color White
Weight 0.11 oz (3.1 grams)
Continued... Note – legal notice on page 2.
5. INSTALLATION
PENETRATIONS: Make sure the area of adhesion is free of dust, debris, moisture, and frost to allow maximum adhesion.
When ready to apply to Drago Wrap, remove the release liner and press Drago Sealant Form firmly against Drago Wrap
to secure. Install Drago Sealant Form continuously around the entire perimeter of the penetration(s) and at least 1 inch
beyond the terminating edge of Drago Wrap. Install Drago Sealant Form between 40°F and 110°F. Pour Drago Sealant
inside of Drago Sealant Form to create a seal around the penetration(s).
Review Drago Wrap’s complete installation instructions prior to installation.
6. AVAILABILITY & COST
Drago Sealant Form is available nationally through our network of building supply distributors. For current cost
information, contact your local Drago distributor or Stego Industries’ Sales Representative.
DRAGO® SEALANT FORM
A STEGO TECHNOLOGY, LLC INNOVATION | VAPOR RETARDERS 07 26 00, 03 30 00 | VERSION: 2/22/2019
DATA SHEETS ARE SUBJECT TO CHANGE. FOR MOST CURRENT VERSION, VISIT WWW.STEGOINDUSTRIES.COM
[phone] | www.stegoindustries.com
*Stego Industries, LLC (“Stego”) is the exclusive Representative for Drago Wrap and Pango Wrap. All designated trademarks are the intellectual property
of Stego or the entity for which it is acting as a Representative. Installation, Warranty, State Approval Information and Disclosure of Representative Status: www.stegoindustries.com/legal. ©2019 Stego Industries, LLC. All rights reserved.
7. WARRANTY
Stego Industries, LLC believes to the best of its knowledge, that specifications and recommendations herein are
accurate and reliable. However, since site conditions are not within its control, Stego Industries does not guarantee
results from the use of the information provided and disclaims all liability from any loss or damage. Stego Technology,
LLC does offer a limited warranty on Drago Wrap. Please see www.stegoindustries.com/legal.
8. MAINTENANCE
Store Drago Sealant Form in a dry and temperate area.
9. TECHNICAL SERVICES
Technical advice, custom CAD drawings, and additional information can be obtained by contacting Stego Industries or
by visiting the website.
Contact Number: [phone]
Website: www.stegoindustries.com
10. FILING SYSTEMS
• www.stegoindustries.com
P2 OF 2
PRODUCT PART #
VAPORBLOCK 10 ........................................................................... VB10
VAPORBLOCK 15 ........................................................................... VB15
Vapor Barrier - Commercial
APPLICATIONS
• Underslab Vapor Retarder/Barrier
• Foundation Wall Vapor Retarder
• Radon Retarder
HIGH PERFORMANCE UNDERSLAB VAPOR BARRIER
© 2018 RAVEN INDUSTRIES INC. All rights reserved.
PRODUCT DESCRIPTION
VaporBlock® is a high performance underslab vapor barrier
designed to retard moisture migration through concrete slabs and
concrete walls to protect your structure from:
• MOLD: VaporBlock® reduces moisture condensation within a
structure, impeding the growth of molds, mildews, and fungi.
• MOISTURE: VaporBlock® protects flooring materials by
maintaining moisture levels well below the requirements of
ASTM E-1745-11.
• RADON: VaporBlock® is used as a component of radon
mitigation systems to protect indoor air quality and occupant
health. Raven also offers VaporBlock® Plus™, a highly
effective gas and moisture barrier.
VaporBlock® is one of the most effective underslab vapor barriers
on the market today! Benefits include:
• Ultra-low moisture vapor permeability
• Superior puncture resistance
• High tensile tear strength
• Resistance to decay and degradation
VaporBlock® is manufactured to strict conformance specifications
under our ISO 9001 Certified Management System to consistently
exceed ASTM standards and project expectations. Raven's
accredited lab ensures VaporBlock® meets the highest possible
quality standards across multiple industries. VaporBlock® is
supported with independent testing. Results are available upon
request, as required under ASTM E-1745-11. VaporBlock® is readily
available through nation-wide distribution:
• Available in 10 and 15 mil for optimal project flexibility
• Larger roll sizes equal lower installation costs
Raven Industries manufactures VaporBlock® and controls all
aspects from start to finish assuring the final product meets our high
performance standards. Raven is a publicly-traded company, with
over 60 years of stability and service excellence to stand behind our
products with a future of innovation and growth.
Note: All instructions on architectural or structural drawings should be
reviewed and followed. Detailed installation instructions accompany
each roll of VaporBlock and can also be located on our website.
ASTM E-1643 also provides general installation information for vapor
retarders. All VaporBlock series materials can be installed with print
or color facing up or down and will provide the same performance.
ASTM E-1745-11, "Plastic Water Vapor Retarders Used in Contact with
Soil or Granular Fill Under Concrete Slabs".
VAPORBLOCK®VB10 & VB15
HIGH PERFORMANCE UNDERSLAB VAPOR BARRIER
PRO-FORMA DATA SHEETFOR VAPORBLOCK® VB15**
VAPORBLOCK VB10 VAPORBLOCKVB15**ASTM E 1745-11Class A, B & C1
PROPERTIES TEST METHOD IMPERIAL IMPERIAL IMPERIAL
AppeArAnce Blue Blue -
Thickness, nominAl 10 mil 15 mil -
roll size 15 ft x 200 ft 12 ft x 200 ft -
WeighT 49 lbs/MSF 73 lbs/MSF -
clAssificATion ASTM E1745-11 CLASS A, B, & C CLASS A, B, & C Class A, B, or C
Tensile sTrengThAverAge mD & TD(neW mATeriAl)
(AfTer exposure)
ASTM E154Section 9, (D882)52 lbs/in
53 lbs/in
60 lbs/in
61 lbs/in
Class A = 45 lbs/in
Class B = 30 lbs/in
Class C = 13.6 lbs/in
Minimum
puncTure resisTAnce ASTM D1709Method B 2600 g 3000 g
Class A = 2200 g
Class B = 1700 g
Class C = 475 g
Minimum
permeAnce(neW mATeriAl)
(AfTer conDiTioning)
ASTM E154
Section 7
ASTM E96
Procedure B
ASTM E154
Section 8, E96
Section 11, E96
Section 12, E96
Section 13, E96
0.0146
Perms
grains/(ft²•hr•in Hg)
0.0153
0.0151
0.0160
0.0181
0.01
Perms
grains/(ft²•hr•in Hg)
0.01
0.01
0.01
0.01
Class A, B, & C
0.1
Permsgrains/(ft²•hr•in Hg) Maximum
WVTR ASTM E96Procedure B 0.0084grain/hr-ft²0.004grain/hr-ft²-
mAximum sTATic use Temp 180° F 180° F -
minimum sTATic use Temp -70° F -70° F -
VaporBlock® is a high performance underslab vapor barrier designed to retard
moisture migration through concrete slabs and concrete walls.
1 Referencing ASTM E1745-11, Standard Specification for Plastic Water Vapor
Retarders Used in Contact with Soil or Granular Fill under Concrete Slabs
© 2018 RAVEN INDUSTRIES INC. All rights reserved.
Note: To the best of our knowledge, unless otherwise stated, these are typical property values and are intended as guides only, not as specification limits. Chemical resistance, odor transmission, longevity as well as other performance criteria is not implied or given and actual testing must be performed for applicability in specific applications and/or conditions. RAVEN INDUSTRIES MAKES NO WARRANTIES AS TO THE FITNESS FOR A SPECIFIC USE OR MERCHANTABILITY OF PRODUCTS REFERRED TO, no guarantee of satisfactory results from reliance upon contained information or recommendations and disclaims all liability for resulting loss or damage. Limited Warranty available at www.RavenEFD.com
092818 EFD 1092
RAVEN ENGINEERED FILMSP.O. Box 5107 Sioux Falls, SD 57117-5107Ph: [phone] • TF: [phone] [e-mail]
VAPORBLOCK®VB10 & VB15
**PROFORMA Contents: Data listed for VaporBlock® VB15, under ASTM
E154, section 11, 12, and 13, is extrapolated from actual section 8 values and
is subject to change at any time as additonal test data becomes available.
Scan QR Code to download
current technical data sheets
via the Raven website.
DESCRIPTION
MEL-ROL waterproofing system is a flexible,
versatile, dependable, bituminous, roll-type
waterproofing membrane. It is a 60 mil-membrane
composed of a nominally 56 mil thick layer of
polymeric waterproofing membrane on a heavy duty,
four-mil thick, cross-laminated polyethylene carrier
film. The two components are laminated together
under strict quality-controlled production procedures.
A handy overlap guideline is printed 2 ½” (63.5 mm)
in from the material edge on each side to assure
proper overlap coverage and to assist in maintaining
a straight application. Special exposed polymeric
membrane strips are provided on both sides for
positive membrane-to-membrane adhesion in the
overlap area. The membrane strips are protected by
a pull-off release strip. All components of the MEL-
ROL waterproofing system work together to provide
a cost-effective, positive waterproofing system that’s
quick and easy to apply.
W. R. MEADOWS accessory products included in
the MEL-ROL waterproofing system are: BEM, MEL-
ROL LIQUID MEMBRANE, MEL-PRIME™ adhesive
(solvent-based and water-based), POINTING
MASTIC, DETAIL STRIP, CATALYTIC BONDING
ASPHALT, TERMINATION BAR, PROTECTION
COURSE and MEL-DRAIN™ drainage board.

USES
MEL-ROL waterproofing system provides a cost-
effective answer to properly waterproof foundations,
vertical walls, and below-grade floors in residential
and commercial construction. It is equally effective
for use as between-the-slab waterproofing on plaza
decks, parking decks, and structural slabs. Use it as
a waterproofing membrane to isolate mechanical
and electronic rooms, laboratories, kitchens, and
bathrooms. MEL-ROL offers positive protection
when “wrapped around” major rapid transit,
vehicular, utility, and pedestrian tunnel projects.
MEL-ROL can also be used on insulated concrete
MEL-ROL®
Rolled, Self-Adhering Waterproofing Membrane
NO. 711
Master Format: 07 13 26 FEBRUARY 2022
(Supersedes October 2013)
CONTINUED ON THE REVERSE SIDE…
HAMPSHIRE, IL / CARTERSVILLE, GA / YORK, PA
FORT WORTH, TX / BENICIA, CA / POMONA, CA
GOODYEAR, AZ / MILTON, ON / SHERWOOD PARK, AB
forms (ICF). MEL-ROL can be applied to concrete, masonry
surfaces, wood, insulated wall systems, and metal.
Installation of PROTECTION COURSE from W. R. MEADOWS is
recommended before backfilling. MEL-ROL can also be used with
drainage boards when specified.
FEATURES/BENEFITS
• Provides cost-effective, flexible, versatile, dependable, positive
waterproofing protection against damaging moisture migration
and the infiltration of free water.
• Offers a quick and easy-to-apply system for maximum
productivity.
• Special membrane-to-membrane adhesion provides additional
overlap security.
• Meets or exceeds the test requirements of all currently applicable
specifications.
• Components work together for positive waterproofing protection.
• Handles with ease on the jobsite.
• Available in a low temperature version for use when air and
surface temperatures are between 20° F (-7° C) and 60° F (16°
C). An extra-low temp version is also available, ideal for
application in extra-low temperatures down to 0º F (-18º C).
PACKAGING
38.5” (977.9 mm) wide x 62.5’ (19.1 m) long, one roll per carton.

COVERAGE
Provides 200 ft.2 (18.6 m2) per roll. Gross coverage is 200 ft.2 (18.6
m2). [Net coverage is 187.5 ft.2 (17.4 m2) with overlap of 2 ½” (63.5
mm).]

SPECIFICATIONS
ƒ A.R.E.M.A.® Specifications Chapter 29, Waterproofing
ƒ LARR Report 26022

APPLICATION
Surface Preparation … Concrete should be cured at least 72 hours,
be clean, dry, smooth, and free of voids. Repair spalled areas; fill all
voids and remove all sharp protrusions.

PAGE 2 … MEL-ROL #714 … FEBRUARY 2022
MEL-ROL COMBINES POSITIVE WATERPROOFING PROTECTION WITH EASE OF HANDLING
EXCLUSIVE FEATURES
A handy overlap guideline is printed 2 ½” (63.5 mm) in from the material edge on each side, assuring proper overlap
coverage and assisting in maintaining a straight application. The polymeric waterproofing membrane is protected by a
special, easy-to-remove release paper. The exposed membrane strips on the material edges are protected by a pull-off
release strip. Exposed polymeric membrane strips are provided on both sides of MEL-ROL for positive membrane-to-
membrane adhesion in the overlap area ... Note the detail, as shown in inset photo.
TECHNICAL DATA
PROPERTY TYPICAL VALUE TEST METHOD
COLOR … Carrier Film White
Polymeric Membrane Black
THICKNESS … Carrier Film 4 mils
Polymeric Membrane 56 mils
TENSILE STRENGTH ... Carrier Film 5900 psi min. (40.71 MPa) ASTM D 412
Membrane 460 psi (3230 KPa) (Die C)
ELONGATION 971.3% ASTM D 412
LOW TEMP CRACK BRIDGING
100 Cycle -25° F (-32° C) Pass ASTM C 836
PEEL ADHESION 11.8 lb./in. (2068 N/m) ASTM D 903
LAP ADHESION 8.62 lbf/in. (1508.5 N/m) ASTM D 1876
WATER VAPOR PERMEABILITY 0.036 Perms
ASTM E-96, B
WATER ABSORPTION 0.1%, 72 hrs. max. ASTM D570
HYDROSTATIC RESISTANCE Equiv. to 230.9’ (70.38 m) ASTM D 5385
of water
PUNCTURE RESISTANCE 50 lbf (222 N) ASTM E154
EXPOSURE TO FUNGI Pass, 16 weeks Soil Test
FLEXIBILITY @ -20° F (-29° C) Pass ASTM D 1970
MEL-ROL IS QUICK AND EASY TO APPLY
Temperature ... Apply in dry, fair weather when the air and
surface temperatures are above 40° F (4° C). Do not apply
to frozen concrete.
MEL-ROL LOW TEMP can be used when air and surface
temperatures are between 20° F (-7° C) and 60° F (16° C).
Surface Conditioning … Apply MEL-PRIME adhesive to
surfaces that will be covered within one working day. If left
exposed overnight, additional adhesive must be
applied. Follow all instructions and precautions on
containers. All substrates must be clean, dry, and free of
all surface irregularities.

Footing Details … Use DETAIL STRIP for impaction
sheet coverage. First, fold strips lengthwise and then cut
at the fold. Material is then ready to install as 4 ½” (114.3
mm) strips on either side of the rebar. Any excess can be
turned down on the face of the footing. Next, fill the voids
around rebars in the keyway with CATALYTIC BONDING
ASPHALT. Pour the walls. Install DETAIL STRIP
horizontally along the wall where it meets the footing,
placing half the material up the wall and the other half
onto the footing. Extend the material 4 ½” (114.3 mm)
beyond outside corners. Slit extended portion of DETAIL
STRIP lengthwise. Place the horizontal flap out onto the
footing and bend the vertical flap around the wall. (See
Diagram A.) Repeat this procedure in the opposite
direction as shown in Diagram B.
Horizontal Application … REMOVE release paper from
MEL-ROL from the top edge of the roll and firmly press
exposed area to the wall. Remove the release paper from
the rolls in a downward direction, pressing MEL-ROL into
place on the wall. Remove release paper on edge, then
position the MEL-ROL membrane. Pull balance of
release paper off, running the roll from low to high points,
so all laps will shed water. Stagger end laps and overlap
all seams at least 2 ½” (63.5 mm). Apply a double-
thickness of the MEL-ROL membrane over construction,
control, all expansion joints and over cracks greater than
1/16” (1.59 mm) wide.
Vertical Wall Application … Masonry walls may
require the application of a cementitious parge-coat.
Allow the parge-coat to dry before priming and applying
MEL-ROL. When applied, the parge-coat will produce
a smooth, uniform, and well-bonded surface. Remove
release paper, then apply vertically in lengths
approximately 8’ (2.44 m) long over the top of the
horizontal DETAIL STRIP at the footing. Overlap
seams at least 2 ½” (63.5 mm). Tightly butt edges of
membrane and apply POINTING MASTIC in corner
applications. (See Diagram C.)

To the top terminations, apply POINTING MASTIC at
least 1/8” (3.18 mm) thick and 1” (25.4 mm) wide. As an
option, TERMINATION BAR may be used to
mechanically fasten the membrane.
Hand-Rub and Roll Press … Once positioned,
immediately hand-rub the MEL-ROL membrane firmly
to the surface, removing any bubbles or wrinkles, then
pressure roll the complete surface to assure positive
adhesion.
Inside Corners ... Before MEL-ROL is applied, place a
vertical DETAIL STRIP on inside corners extending the
material 4 ½” (114.3 mm) beyond each side of the
corner. (See Diagram D.) Terminate at the footing and
finish the corner with POINTING MASTIC.

PAGE 3 … MEL-ROL #714 … FEBRUARY 2022
Inspect and Repair … A thorough inspection should be
made before covering and all necessary repairs made
immediately. Tears and inadequate overlaps should be
covered with MEL-ROL ... slit fish mouths and patch.
Seal edges of all patches with POINTING MASTIC.
Where applicable, horizontal applications can be flood-
tested for 24 hours. All leaks should be marked and
repaired when membrane dries.
Protect the Membrane … on all vertical and horizontal
installations with the immediate application of
PROTECTION COURSE if no drainage system is used,
or MEL-DRAIN. To secure PROTECTION COURSE,
use POINTING MASTIC as an adhesive, and/or
physically attach at the top edge using TERMINATION
BAR. Backfilling should be done immediately, using
care and caution to avoid damaging the waterproofing
application.
PRECAUTIONS
Avoid the use of products that contain tars, solvents,
pitches, polysulfide polymers, or flexible PVC and vinyl
materials that may come into contact with MEL-ROL. As
part of a complete waterproofing solution, W. R.
MEADOWS recommends proper site drainage, but due
to certain site conditions this sometimes cannot be done
effectively. Proper design and suitability of the use of
MEL-ROL should be at the discretion of the design
consultant.
Outside Corners … Bend DETAIL STRIP vertically
over the outside corner and extend 4 ½” (114.3 mm)
beyond each side of the corner. Terminate the material
at the footing. Finish the corner with POINTING
MASTIC. (See Diagram C.)

If MEL-ROL is proposed to be used in place of DETAIL
STRIP, contact W. R. MEADOWS Technical Services
to determine the suitability of the installation.
Drains and Protrusions … All protrusions should be
sealed with two layers of membrane applied at least 6”
(152.4 mm) in all directions. Seal all terminations with
POINTING MASTIC. Around drains, apply two layers of
MEL-ROL and put a bead of POINTING MASTIC
between the membrane and clamping rings and at all
terminations, drains, and protrusions. See ASTM D
5898.
ACCESSORIES
MEL-PRIME W/B … This water-based adhesive prepares
surfaces for MEL-ROL application. Applies easily with manual
sprayer or roller; VOC-compliant. MEL-PRIME W/B is for use
at temperatures of 40° F (4° C) and up.
COVERAGE: 150 - 200 ft.2/gal. (3.7 - 4.9 m2/L)
PACKAGING: 1 Gallon (3.79 Liter) Units (4 units per carton),
5 Gallon (18.93 Liter) Pails
MEL-PRIME … This solvent-based adhesive is for use at
temperatures of 25° F (-4° C) and above. Apply by roller.
COVERAGE: 250-350 ft.2/gal. (6.14 to 8.59 m2/L)
PACKAGING: 5 Gallon (18.93 Liter) Pails
MEL-PRIME N.E. … MEL-PRIME N.E. solvent-based VOC
adhesive is a ready-to-use adhesive specifically formulated to
meet the maximum VOC content limits of 200 g/L for quick dry
primers as required by VOC regulations in the northeastern
U.S.
COVERAGE: 150 - 250 ft.2/gal.
PACKAGING: 1 Gallon Can, 5 Gallon Pail
MEL-ROL LIQUID MEMBRANE … A two-component
material used as a flashing to form fillets at corners and at
protrusions. May be used as a substitute for POINTING
MASTIC. Product can also be used in between walls and
footings in lieu of DETAIL STRIP.
COVERAGE: As a fillet, approximately 135 lineal feet per
gallon (10.87 m per liter) PACKAGING: 1 Gallon (3.79 Liter)
Units, 4 Units per carton.
BEM … BEM can be used as a fillet to round out 90° angles,
such as the wall-footing connection, and can be used as a
substitute for MEL-ROL LIQUID MEMBRANE.
COVERAGE: As a fillet, approximately 135 lineal ft./gal. (10.9
m/L). PACKAGING: 28 Oz. (828 mL) Cartridges (12 per
Carton)
POINTING MASTIC … Used as an adhesive and for sealing
top edge terminations on DETAIL STRIP and membrane, and
to adhere PROTECTION COURSE.
COVERAGE: 1/8” x 1” x 200’/gal. (3.18 mm x 25.4 mm x 16.10
ml). PACKAGING: 5 Gallon (18.93 Liter) Pails, 29 Oz. (857.65
l) C t id 12/ t
PAGE 4 … MEL-ROL #714 … FEBRUARY 2022
CATALYTIC BONDING ASPHALT … Easy-to-apply,
one-component material for sealing around rebar.
COVERAGE: 5 gal./1000 ft.2/gal. (4.9 m2/L) PACKAGING:
5 Gallon (18.93 Liter) Pails. DETAIL STRIP … Convenient, easy-to-use DETAIL
STRIP provides an economical and effective method for
sealing vertical and horizontal butt joints, i.e. inside or
outside corners and where walls and footings meet.
PACKAGING: 9” x 50’ (.23 x 15.24 m) roll, 4 rolls per
carton.
PROTECTION COURSE … Use for vertical and
horizontal applications. Adhere with POINTING MASTIC
or use mechanical fasteners.
PACKAGING: 4’ x 8’ (1.22 x 2.44 m) panels.
MEL-DRAIN … is a dimple-raised molded polystyrene
fabric designed to provide high flow capacity to reduce
hydrostatic pressure buildup around waterproofing and
vaporproofing membranes. Choice of drain types are
available for vertical, horizontal, and site applications.
Use MEL-PRIME to condition surface prior to application
of MEL-DRAIN.
TERMINATION BAR ... is a high strength, pre-formed,
multi-purpose, plastic strip designed to support vertical
membrane systems and PROTECTION COURSE at their
termination point.
PACKAGING: 10' (Holes every 6" o/c, 2" from either end),
25 pieces per carton.
MAINTAIN ENERGY EFFICIENCY
Wet insulating materials lose much of their “R” factor
performance characteristics, reducing the energy
efficiency of the structure. W. R. MEADOWS thermal and
moisture protection products play a key role in maintaining
the structure’s energy efficiency and aiding in the integrity
of other structural systems, such as insulation. For CAD details, most recent data sheet, further LEED information, and SDS, visit www.wrmeadows.com.
02/22-2M
TURBINE VENTILATORS
CONSTRUCTION SPECIFICATIONS
“A”
THROAT SIZE
GUAGE NO. OF
BRACES
BRACE
MATERIALCROWN GALV.BLADE GALV.THROAT GALV.
4 24 28 26 3 ALUMINUM
6 24 28 26 3 ALUMINUM
8 24 28 26 3 ALUMINUM
10 24 28 26 3 ALUMINUM
12 24 28 24 3 ALUMINUM
14 22 26 24 3 ALUMINUM
16 22 26 24 3 STEEL
18 22 26 24 4 STEEL
20 20 26 24 4 STEEL
24 20 26 22 4 STEEL
DIMENSIONAL AND PERFORMACE DATA
“A”
THROAT SIZE
“B”
HEIGHT
“C”
OVERALL WIDTH
EXHAUSTED
CAPACITY*
APPROX.
SHIPPING WEIGHT
4 12 10 1/4 125 5
6 14 1/2 12 3/4 147 7
8 15 14 1/4 255 8
10 16 1/4 16 1/4 425 11
12 17 19 631 13
14 19 3/4 22 3/4 700 21
16 21 3/4 25 1/2 950 31
18 24 29 1200 38
20 25 1/4 31 5/8 1700 46
24 28 1/4 35 3/4 2350 58
*4 MPHWIND CFM

Appendix C Photographic Log
Photographs 1a and 1b: General view of installed gravel and sub-slab piping in the West
Building.
CA
M
-
0
1
0
2923 S. Tryon Street, Suite 100
Charlotte, NC 28203
704.586.0007(p) 704.586.0373(f)
CAHDBORN MILL AND THERON PROPERTIES
500 AND 508 CHARLES AVENUECHARLOTTE, NORTH CAROLINA
2923 S. Tryon Street, Suite 100
Charlotte, NC 28203
704.586.0007(p) 704.586.0373(f)
CAHDBORN MILL AND THERON PROPERTIES
500 AND 508 CHARLES AVENUECHARLOTTE, NORTH CAROLINA
Photograph 3: General view of installed vapor barrier used for installation at the
Ground/Basement level.
CA
M
-
0
1
0
Photograph 2: General view of installed vapor barrier sealed to penetrations and column.
2923 S. Tryon Street, Suite 100
Charlotte, NC 28203
704.586.0007(p) 704.586.0373(f)
CAHDBORN MILL AND THERON PROPERTIES
500 AND 508 CHARLES AVENUECHARLOTTE, NORTH CAROLINACA
M
-
0
1
0
Photographs 4a & 4b: General view of installed vapor barrier used for installation at Level 1 on West
Building.
2923 S. Tryon Street, Suite 100
Charlotte, NC 28203
704.586.0007(p) 704.586.0373(f)
CAHDBORN MILL AND THERON PROPERTIES
500 AND 508 CHARLES AVENUECHARLOTTE, NORTH CAROLINACA
M
-
0
1
0
Photographs 4c and 4d: General view of installed vapor barriers used for installation at Level 1 at the
West Building.
Photographs 5a & 5b: General view of installed vapor barrier used for installation at
retaining walls.
2923 S. Tryon Street, Suite 100
Charlotte, NC 28203
704.586.0007(p) 704.586.0373(f)
CAHDBORN MILL AND THERON PROPERTIES
500 AND 508 CHARLES AVENUECHARLOTTE, NORTH CAROLINACA
M
-
0
1
0
Photograph 7: Representative view of exhaust pipes and wind-driven turbine ventilators
installed on the roof.
2923 S. Tryon Street, Suite 100
Charlotte, NC 28203
704.586.0007(p) 704.586.0373(f)
Photographs 6a & 6b: Representative view of vertical riser piping with proper labeling,
slope, and pitch.
CAHDBORN MILL AND THERON PROPERTIES
500 AND 508 CHARLES AVENUECHARLOTTE, NORTH CAROLINACA
M
-
0
1
0
2923 S. Tryon Street, Suite 100
Charlotte, NC 28203
704.586.0007(p) 704.586.0373(f)
CAHDBORN MILL AND THERON PROPERTIES
500 AND 508 CHARLES AVENUECHARLOTTE, NORTH CAROLINACA
M
-
0
1
0
Photograph 9: Representative view of completed monitoring points finished in the floor, view of MP-8.
Photograph 9: Representative view of completed RavenBlock-15 in East Building – F-13 Area.
2923 S. Tryon Street, Suite 100
Charlotte, NC 28203
704.586.0007(p) 704.586.0373(f)
CAHDBORN MILL AND THERON PROPERTIES
500 AND 508 CHARLES AVENUECHARLOTTE, NORTH CAROLINACA
M
-
0
1
0
Photograph 10: Representative view of completed monitoring points in maintenance closets, view of MP-3.
Photograph 11: View of completed monitoring point, MP-4, inside of wall.

Appendix D VIMS Influence Testing Forms and Sampling Field Forms
Category Example Criteria
Proper base layer (i.e., gravel, aerated flooring) and thickness
Proper placement, type, and pitch of VIMS vent piping
Proper placement, type, and pitch of monitoring points
Correct vapor barrier type
Proper vapor barrier overlap and seals around penetrations per
manufacturer instructions
Proper vapor barrier installation along vertical walls (e.g. retaining walls,
elevators, etc.)
Good condition of vapor barrier
Riser pipe material and fitting connections
Proper pitch towards sub-slab (gravity drain)
Appropriate VIMS labels
Correct fan/ventilator
Fan/ventilator operation
Proper fittings and protection (varmint screens, electrical covers, etc.)
Appropriate VIMS labels
Proper distance from roof intakes and parapets
Pilot test completed
Monitoring points finished and accessible SMS
Pilot Test / Checkout
TCD
TCD
SMS
SMS
SMS
SMS
SMS
Fan/Ventilator
SMS
SMS
SMS
TCD
Sub-Slab
Vapor Barrier
Vent Riser Piping
TCD
TCD
TCD
TCD
TCD
Vapor Intrusion Mitigation System - Inspection Checklist
The Hart & Hickman Construction Manager assigned to each project should complete the checklist below
throughout the Vapor Intrusion Mitigation System (VIMS) construction process for North Carolina Department of
Environmental Quality (DEQ) Brownfield Sites. The checklist should document proper installation of VIMS in
general accordance with the Vapor Intrusion Mitigation Plan.
Building/Area ID:____West Building________ DEQ Brownfields IDs:_20086-16-060 and 23035-19-060___ H&H ID:_CAM-010_
Start Date:_1/18/2021____ End Date:_9/30/2022_______ Construction Manager(s): ___Shannon Switch___________
Proper Installation
(Initial below)
https://harthick.sharepoint.com/sites/MasterFiles-1/Shared Documents/AAA-Master Projects/Camden - CAM/CAM-010 Camden NoDa Redevelopment/VIMP/VIMS Install
Report - West Bldg/Inspection checklist_2022\West Building
Category Example Criteria
Proper base layer (i.e., gravel, aerated flooring) and thickness
Proper placement, type, and pitch of VIMS vent piping
Proper placement, type, and pitch of monitoring points
Correct vapor barrier type
Proper vapor barrier overlap and seals around penetrations per
manufacturer instructions
Proper vapor barrier installation along vertical walls (e.g. retaining walls,
elevators, etc.)
Good condition of vapor barrier
Riser pipe material and fitting connections
Proper pitch towards sub-slab (gravity drain)
Appropriate VIMS labels
Correct fan/ventilator
Fan/ventilator operation
Proper fittings and protection (varmint screens, electrical covers, etc.)
Appropriate VIMS labels
Proper distance from roof intakes and parapets
Pilot test completed
Monitoring points finished and accessible
Vent Riser Piping
SMS
SMS
SMS
Vapor Intrusion Mitigation System - Inspection Checklist
The Hart & Hickman Construction Manager assigned to each project should complete the checklist below
throughout the Vapor Intrusion Mitigation System (VIMS) construction process for North Carolina Department of
Environmental Quality (DEQ) Brownfield Sites. The checklist should document proper installation of VIMS in
general accordance with the Vapor Intrusion Mitigation Plan.
Building/Area ID:_East Building - F-13 area ____ DEQ Brownfields IDs:_20086-16-060 and 23035-19-060___ H&H ID:_CAM-010_
Start Date:_1/18/2021____ End Date:_9/30/2022_______ Construction Manager(s): ___Shannon Switch___________
Proper Installation
(Initial below)
Sub-Slab
TCD
TCD
TCD
Vapor Barrier
TCD
TCD
TCD
TCD
Pilot Test / Checkout
SMS
SMS
Fan/Ventilator
SMS
SMS
SMS
SMS
SMS
https://harthick.sharepoint.com/sites/MasterFiles-1/Shared Documents/AAA-Master Projects/Camden - CAM/CAM-010 Camden NoDa Redevelopment/VIMP/VIMS Install
Report - West Bldg/Inspection checklist_2022\East Building - F-13 area
Pilot Test Results ‐ West Building
Chadbourn Mill/Theron Properties
Charlotte, North Carolina
Brownfields Project No. 20086‐16‐060 & 23035‐19‐060
H&H Job No. Project CAM‐010
Baseline Initial 
reading
Follow‐up 
reading
RP‐265 F‐1 0.000 ‐1.895 ‐2.035
‐‐MP‐1 0.000 ‐1.199 ‐1.197
RP‐265 F‐2 0.000 ‐2.265 ‐2.002
AMG Legend F‐3 0.000 ‐2.008 ‐1.883
RP‐265 F‐4 0.000 ‐2.007 ‐1.853
AMG Legend F‐5 0.000 ‐1.845 ‐1.812
RP‐265 F‐6 0.000 ‐1.962 ‐2.187
‐‐MP‐2 0.000 ‐0.560 ‐0.559
‐‐MP‐3 0.000 ‐0.605 ‐0.608
‐‐MP‐4 0.000 ‐0.682 ‐0.683
‐‐MP‐5 0.000 ‐0.707 ‐0.704
‐‐MP‐6 0.000 ‐0.661 ‐0.664
‐‐MP‐7 0.000 ‐0.580 ‐0.579
RP‐265 F‐7 0.000 ‐2.260 ‐2.010
RP‐265 F‐8 0.000 ‐1.970 ‐2.000
RP‐265 F‐9 0.000 ‐2.135 ‐2.110
‐‐MP‐8 0.000 ‐0.560 ‐0.558
‐‐MP‐9 0.000 ‐0.651 ‐0.651
‐‐MP‐10 0.000 ‐0.626 ‐0.627
RP‐265 F‐13 0.000 ‐2.350 ‐2.439
‐‐MP‐29 0.007 ‐0.073 ‐0.072
‐‐MP‐30 0.000 ‐0.079 ‐0.074
Follow up readings were collected approximately 10 minutes following the intial reading.
12/14/2021 F‐13
Fan Type Point ID
Vacuum Measurements 
(in‐WC)
F‐1
5/27/2021
F‐2
F‐3
F‐4
F‐5
F‐6
F‐7 
F‐8
F‐9 
Date Section Tested
&Žƌŵ^sͲϭ
6XE6ODE6RLO*DV9DSRU,QVWDOODWLRQ)LHOG)RUP
3URMHFW1RBBBBBBBBBBBBBBBBBB6DPSOHUBBBBBBBBBBBBBBBBBBBBBB:HDWKHUBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
6XUIDFH
0DWHULDO
6ODE
7KLFNQHVVLI
DSSO
0DWHULDO%HORZ
6ODE
LIDSSO
'HSWKRI
6FUHHQ
LIDSSO
7\SH 'DWH 7LPH
$PELHQW
7HPS3XUJH0HWKRG 9ROXPH
3XUJHG
6KURXG
+HOLXP
&RQF
3XUJH
+HOLXP&RQF
/HDN7HVW
3DVV"
VHHQRWH
666*3HUP
7HPS
&RQFUHWHVRLO
JUDYHODVSKDOW ,QFKHV *UDYHOVDQG
FOD\HWFIWEJV )XOOVDPSOHWUDLQRU
SRLQWRQO\
PPGG\\
KU R)6\ULQJHSXPS
/LWHUV
VHHQRWHV
IRUFDOF

RUSSP
LQGLFDWHXQLWV
EHORZ
<HV1R
^͗
͗
Z͗
^͗
͗
Z͗
^͗
͗
Z͗
^͗
͗
Z͗
^͗
͗
Z͗
^͗
͗
Z͗
6 VDPSOH,'& FDQLVWHU,'5 UHJXODWRU,'66 VXEVODE6* VRLOJDV3HUP SHUPDQHQW7HPS WHPSRUDU\ 9ROXPH3XUJHG [SXUJHYROXPHV 
/
D /DVWXSGDWHG
+J LQFKHVRIPHUFXU\SSP SDUWVSHUPLOOLRQ
1RWHVBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
6DPSOH,'7\SH
9DSRU0RQLWRULQJ3RLQW&RQVWUXFWLRQ +HOLXP/HDN7HVW
EŽƚĞ͗>ĞĂŬdĞƐƚZĞƋƵŝƌĞŵĞŶƚƐ
WĞƌEYtDsĂƉŽƌ/ŶƚƌƵƐŝŽŶ'ƵŝĚĂŶĐĞ͕ůĞĂŬƚĞƐƚƉĂƐƐĞƐŝĨŚĞůŝƵŵ
ĐŽŶĐĞŶƚƌĂƚŝŽŶŝŶƉƵƌŐĞĂŝƌŝƐůĞƐƐƚŚĂŶϭϬйŽĨŚĞůŝƵŵĐŽŶĐĞŶƚƌĂƚŝŽŶŝŶ
ƐŚƌŽƵĚ͘
/ OHQJWKRIWXELQJSLSHIW
D IRUGLDPHWHU/IW
D IRUGLDPHWHU/IW
͗ͰhƐĞƌƐͰŵǀĂǁƚĞƌͰƌŽƉďŽdžͰLJKƚŚĞƌͰ&ŽƌŵĚŝƚƐͰ/YͲ^^sͰsĂƉŽƌ^ĂŵƉůŝŶŐ&ŽƌŵƐͺsϲ͘Ϭ
^ƵďͲ^ůĂďͬ^Žŝů'ĂƐ^ĂŵƉůŝŶŐsĂƉŽƌ/ŶƐƚĂůůĂƚŝŽŶ&ŝĞůĚ&Žƌŵ
,ĂƌƚΘ,ŝĐŬŵĂŶ͕W
CAM-010 TJS Cloudy, 80s
MP-29
1L3940 SS Perm. Concr. NA Gravel NA Full
7/21/22
9:25
79 Pump 15 L 12.8 0 ppm Yes
23347
MP-8
1L3011 SS Perm. Concr. NA Gravel NA Full
7/21/22
10:25 81 Pump 15 L 13.1 0 ppm Yes
23811
MP-7
1L3965 SS Perm. Concr. NA Gravel NA Full
7/21/22
11:05 83 Pump 15 L 10.8 0 ppm Yes
23464
MP-5/MP-DUP
1L3121/1L2728 SS Perm. Concr. NA Gravel NA Full
7/21/22
11:45 82 Pump 15 L 10.4 0 ppm Yes
23977
MP-3
1L2488 SS Perm. Concr. NA Gravel NA Full
7/21/22
12:20 82 Pump 15 L 11.3 0 ppm Yes
23436
MP-10
1L1680 SS Perm. Concr. NA Gravel NA Full
7/21/22
13:15 85 Pump 15 L 10.7 0 ppm Yes
24046
&Žƌŵ^sͲϭ
6XE6ODE6RLO*DV9DSRU,QVWDOODWLRQ)LHOG)RUP
3URMHFW1RBBBBBBBBBBBBBBBBBB6DPSOHUBBBBBBBBBBBBBBBBBBBBBB:HDWKHUBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
6XUIDFH
0DWHULDO
6ODE
7KLFNQHVVLI
DSSO
0DWHULDO%HORZ
6ODE
LIDSSO
'HSWKRI
6FUHHQ
LIDSSO
7\SH 'DWH 7LPH
$PELHQW
7HPS3XUJH0HWKRG 9ROXPH
3XUJHG
6KURXG
+HOLXP
&RQF
3XUJH
+HOLXP&RQF
/HDN7HVW
3DVV"
VHHQRWH
666*3HUP
7HPS
&RQFUHWHVRLO
JUDYHODVSKDOW ,QFKHV *UDYHOVDQG
FOD\HWFIWEJV )XOOVDPSOHWUDLQRU
SRLQWRQO\
PPGG\\
KU R)6\ULQJHSXPS
/LWHUV
VHHQRWHV
IRUFDOF

RUSSP
LQGLFDWHXQLWV
EHORZ
<HV1R
^͗
͗
Z͗
^͗
͗
Z͗
^͗
͗
Z͗
^͗
͗
Z͗
^͗
͗
Z͗
^͗
͗
Z͗
6 VDPSOH,'& FDQLVWHU,'5 UHJXODWRU,'66 VXEVODE6* VRLOJDV3HUP SHUPDQHQW7HPS WHPSRUDU\ 9ROXPH3XUJHG [SXUJHYROXPHV 
/
D /DVWXSGDWHG
+J LQFKHVRIPHUFXU\SSP SDUWVSHUPLOOLRQ
1RWHVBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
6DPSOH,'7\SH
9DSRU0RQLWRULQJ3RLQW&RQVWUXFWLRQ +HOLXP/HDN7HVW
EŽƚĞ͗>ĞĂŬdĞƐƚZĞƋƵŝƌĞŵĞŶƚƐ
WĞƌEYtDsĂƉŽƌ/ŶƚƌƵƐŝŽŶ'ƵŝĚĂŶĐĞ͕ůĞĂŬƚĞƐƚƉĂƐƐĞƐŝĨŚĞůŝƵŵ
ĐŽŶĐĞŶƚƌĂƚŝŽŶŝŶƉƵƌŐĞĂŝƌŝƐůĞƐƐƚŚĂŶϭϬйŽĨŚĞůŝƵŵĐŽŶĐĞŶƚƌĂƚŝŽŶŝŶ
ƐŚƌŽƵĚ͘
/ OHQJWKRIWXELQJSLSHIW
D IRUGLDPHWHU/IW
D IRUGLDPHWHU/IW
͗ͰhƐĞƌƐͰŵǀĂǁƚĞƌͰƌŽƉďŽdžͰLJKƚŚĞƌͰ&ŽƌŵĚŝƚƐͰ/YͲ^^sͰsĂƉŽƌ^ĂŵƉůŝŶŐ&ŽƌŵƐͺsϲ͘Ϭ
^ƵďͲ^ůĂďͬ^Žŝů'ĂƐ^ĂŵƉůŝŶŐsĂƉŽƌ/ŶƐƚĂůůĂƚŝŽŶ&ŝĞůĚ&Žƌŵ
,ĂƌƚΘ,ŝĐŬŵĂŶ͕W
CAM-010 TJS Cloudy, 80s
MP-9
1L2840 SS Perm. Concr. NA Gravel NA Full
7/21/22
14:50 89 Pump 15 L 11.7 0 ppm Yes
23586
MP-1
1L1900 SS Perm. Concr. NA Gravel NA Full
7/21/22
15:25 90 Pump 15 L 11.7 0 ppm Yes
24800
&Žƌŵ^sͲϮ
6XE6ODE6RLO*DV9DSRU6DPSOLQJ)LHOG)RUP
3URMHFW1RBBBBBBBBBBBBBBBBBBB 6DPSOHUBBBBBBBBBBBBBBBBBBBBBB :HDWKHUBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
'DWH
3URSRVHG
6DPSOLQJ
'XUDWLRQ
7LPH&DQLVWHU
3UHVVXUH
2XWGRRU
7HPSHUDWXUH
2XWGRRU
+XPLGLW\
,QGRRU
7HPSHUDWXUH
,QGRRU
+XPLGLW\
PPGG\\ 0LQXWHV KU +J
R)R)
^͗%HJLQQLQJ
͗0LGGOH
Z͗(QG
^͗%HJLQQLQJ
͗0LGGOH
Z͗(QG
^͗%HJLQQLQJ
͗0LGGOH
Z͗(QG
^͗%HJLQQLQJ
͗0LGGOH
Z͗(QG
^͗%HJLQQLQJ
͗0LGGOH
Z͗(QG
^͗%HJLQQLQJ
͗0LGGOH
Z͗(QG
6 VDPSOH,'& FDQLVWHU,'5 UHJXODWRU,'66 VXEVODE6* VRLOJDV3HUP SHUPDQHQW7HPS WHPSRUDU\/DVWXSGDWHG
+J LQFKHVRIPHUFXU\
1RWHVBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
^ŝnjĞ͗
&ůŽǁZĂƚĞ͗
^ŝnjĞ͗
&ůŽǁZĂƚĞ͗
6DPSOH,'
^ŝnjĞ͗
&ůŽǁZĂƚĞ͗
^ŝnjĞ͗
&ůŽǁZĂƚĞ͗
^ŝnjĞ͗
&ůŽǁZĂƚĞ͗
^ŝnjĞ͗
&ůŽǁZĂƚĞ͗
6DPSOLQJ,QIRUPDWLRQ ,QGRRU3DUDPHWHUV2XWGRRU3DUDPHWHUV
6DPSOLQJ
3HULRG
EŽƚĞ͗
WĞƌEYtDsĂƉŽƌ/ŶƚƌƵƐŝŽŶ'ƵŝĚĂŶĐĞ͕
ƐŚƵƚͲŝŶƚĞƐƚĂŶĚŚĞůŝƵŵůĞĂŬĐŚĞĐŬŵƵƐƚďĞ
ƉĂƐƐĞĚďĞĨŽƌĞƐĂŵƉůŝŶŐ͘
͗ͰhƐĞƌƐͰŵǀĂǁƚĞƌͰƌŽƉďŽdžͰLJKƚŚĞƌͰ&ŽƌŵĚŝƚƐͰ/YͲ^^sͰsĂƉŽƌ^ĂŵƉůŝŶŐ&ŽƌŵƐͺsϲ͘Ϭ
^ƵďͲ^ůĂďͬ^Žŝů'ĂƐ^ĂŵƉůŝŶŐsĂƉŽƌ^ĂŵƉůŝŶŐ&ŝĞůĚ&Žƌŵ
,ĂƌƚΘ,ŝĐŬŵĂŶ͕W
CAM-010 TJS Cloudy, 80s
MP-29 1L1L3940 7/21/22 10
100mL/min
9:40 -16
79 88 --
23347 9:45 -5
9:35 -27
--
MP-8 1L 10:35 -28
1L3011 7/21/22 10 10:40 -16
81 79 -- --
100mL/min23811 10:45 -5
MP-7 11:15 -261L1L39657/21/22 10 83 77 -- --
23464 100mL/min
11:20 -16
11:25 -6
MP-5/MP-DUP 11:50 -281L
1L3121/1L2728 7/21/22 10 12:00 -17 82 79 -- --
23977 100mL/min 12:15 -5
MP-3 12:35 -271L1L24887/21/22 10 12:40 -16 82 79 -- --
100mL/min23436 12:45 -5
MP-10 1L 13:25 -26
7/21/221L1680 10 13:30 -16
85 65 -- --
24046 100mL/min 13:35 -5
&Žƌŵ^sͲϮ
6XE6ODE6RLO*DV9DSRU6DPSOLQJ)LHOG)RUP
3URMHFW1RBBBBBBBBBBBBBBBBBBB 6DPSOHUBBBBBBBBBBBBBBBBBBBBBB :HDWKHUBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
'DWH
3URSRVHG
6DPSOLQJ
'XUDWLRQ
7LPH&DQLVWHU
3UHVVXUH
2XWGRRU
7HPSHUDWXUH
2XWGRRU
+XPLGLW\
,QGRRU
7HPSHUDWXUH
,QGRRU
+XPLGLW\
PPGG\\ 0LQXWHV KU +J
R)R)
^͗%HJLQQLQJ
͗0LGGOH
Z͗(QG
^͗%HJLQQLQJ
͗0LGGOH
Z͗(QG
^͗%HJLQQLQJ
͗0LGGOH
Z͗(QG
^͗%HJLQQLQJ
͗0LGGOH
Z͗(QG
^͗%HJLQQLQJ
͗0LGGOH
Z͗(QG
^͗%HJLQQLQJ
͗0LGGOH
Z͗(QG
6 VDPSOH,'& FDQLVWHU,'5 UHJXODWRU,'66 VXEVODE6* VRLOJDV3HUP SHUPDQHQW7HPS WHPSRUDU\/DVWXSGDWHG
+J LQFKHVRIPHUFXU\
1RWHVBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
^ŝnjĞ͗
&ůŽǁZĂƚĞ͗
^ŝnjĞ͗
&ůŽǁZĂƚĞ͗
6DPSOH,'
^ŝnjĞ͗
&ůŽǁZĂƚĞ͗
^ŝnjĞ͗
&ůŽǁZĂƚĞ͗
^ŝnjĞ͗
&ůŽǁZĂƚĞ͗
^ŝnjĞ͗
&ůŽǁZĂƚĞ͗
6DPSOLQJ,QIRUPDWLRQ ,QGRRU3DUDPHWHUV2XWGRRU3DUDPHWHUV
6DPSOLQJ
3HULRG
EŽƚĞ͗
WĞƌEYtDsĂƉŽƌ/ŶƚƌƵƐŝŽŶ'ƵŝĚĂŶĐĞ͕
ƐŚƵƚͲŝŶƚĞƐƚĂŶĚŚĞůŝƵŵůĞĂŬĐŚĞĐŬŵƵƐƚďĞ
ƉĂƐƐĞĚďĞĨŽƌĞƐĂŵƉůŝŶŐ͘
͗ͰhƐĞƌƐͰŵǀĂǁƚĞƌͰƌŽƉďŽdžͰLJKƚŚĞƌͰ&ŽƌŵĚŝƚƐͰ/YͲ^^sͰsĂƉŽƌ^ĂŵƉůŝŶŐ&ŽƌŵƐͺsϲ͘Ϭ
^ƵďͲ^ůĂďͬ^Žŝů'ĂƐ^ĂŵƉůŝŶŐsĂƉŽƌ^ĂŵƉůŝŶŐ&ŝĞůĚ&Žƌŵ
,ĂƌƚΘ,ŝĐŬŵĂŶ͕W
CAM-010 TJS Cloudy, 80s
MP-9 1 L1L2840 7/21/22 10
100 mL/min
15:00 -16
89 57 --
23586 15:05 -5
14:55 -27
--
MP-1 1 L 15:30 -27
1L1900 7/21/22 10 15:35 -16
90 55 -- --
100 mL/min24800 15:40 -5

Appendix E Laboratory Analytical Report
ANALYTICAL REPORT
Eurofins Savannah
5102 LaRoche Avenue
Savannah, GA 31404
Tel:[phone]
Laboratory Job ID: 680-218981-1
Client Project/Site: CAM-010
For:
Hart & Hickman, PC
2923 S Tryon Street
Suite 100
Charlotte, North Carolina 28203
Attn: Trinh DeSa
Authorized for release by:
8/2/2022 1:41:03 PM
David Fuller, Project Manager
[phone]
[e-mail]
The test results in this report meet all 2003 NELAC, 2009 TNI, and 2016 TNIrequirements for accredited parameters, exceptions are noted in this report. This
report may not be reproduced except in full, and with written approval from the
laboratory. For questions please contact the Project Manager at the e-mail address or
telephone number listed on this page.
This report has been electronically signed and authorized by the signatory. Electronic
signature is intended to be the legally binding equivalent of a traditionally handwritten
signature.
Results relate only to the items tested and the sample(s) as received by the laboratory.
1
2
3
4
5
6
Table of Contents
Client: Hart & Hickman, PC
Project/Site: CAM-010
Laboratory Job ID: 680-218981-1
Page 2 of 47 Eurofins Savannah8/2/2022
Cover Page . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1
Table of Contents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2
Case Narrative . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .3
Sample Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .4
Subcontract Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .5
Chain of Custody . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .47
1
2
3
4
5
6





 




 
!"



 







! "
#$%
&%'
()*!"+,%%$'%)'$%
&%
()-)
)+

!!#$
"$)#./#$%$)'
%%0


)102%!#3
%+#$%0




4
2
%)222$
2$
2

4%%0-$2
&+
102%
(

$Page 3 of 47 8/2/2022
1
2
3
4
5
6





 




 
!"


 

    
 " ! #$% #
 "& ! #%$ #
& "$ ! #$ #
% "# ! #$ #
$ " ! #%$ #
 " ! #$$ #
# " ! #&&$ #
 " ! #%$ #
 ' ! # #
()*+
,

-Page 4 of 47 8/2/2022
1
2
3
4
5
6
8/2/2022
Mr. David Fuller
Eurofins Test America
5102 LaRoche
Savannah GA 31404
Project Name: CAM-010
Project #: CAM.010
Dear Mr. David Fuller
The following report includes the data for the above referenced project for sample(s)
received on 7/26/2022 at Eurofins Air Toxics LLC.
The data and associated QC analyzed by TO-15 are compliant with the project
requirements or laboratory criteria with the exception of the deviations noted in the
attached case narrative.
Thank you for choosing Eurofins Air Toxics LLC. for your air analysis needs. Eurofins Air
Toxics Inc. is committed to providing accurate data of the highest quality. Please feel free
to contact the Project Manager: Brian Whittaker at 916-985-1000 if you have any
questions regarding the data in this report.
Regards,
Brian Whittaker
Project Manager
Workorder #: 2207680
Page 1 of 42Page 5 of 47 8/2/2022
1
2
3
4
5
6
Mr. David Fuller
Eurofins Environment Testing
5102 LaRoche
Savannah, GA 31404
WORK ORDER #: 2207680
CLIENT: BILL TO:
PHONE:
Accounts Payable
Eurofins Environment Testing
4104 Shuffel St NW
North Canton, OH 44720
912-354-7858
07/26/2022
DATE COMPLETED:08/02/2022
P.O. #
PROJECT #CAM.010 CAM-010
Work Order Summary
FAX:
DATE RECEIVED:CONTACT:Brian Whittaker
NAMEFRACTION #TEST VAC./PRES.
RECEIPT
PRESSURE
FINAL
01A MP-1 TO-15 6.9 "Hg 10 psi
02A MP-3 TO-15 7.1 "Hg 10 psi
03A MP-5 TO-15 6.7 "Hg 9.9 psi
04A MP-7 TO-15 7.8 "Hg 9.8 psi
05A MP-8 TO-15 6.1 "Hg 10.1 psi
06A MP-9 TO-15 6.9 "Hg 9.9 psi
07A MP-10 TO-15 5.9 "Hg 9.9 psi
08A MP-29 TO-15 6.9 "Hg 10 psi
09A DUP-01 TO-15 6.7 "Hg 9.9 psi
10A Lab Blank TO-15 NA NA
11A CCV TO-15 NA NA
12A LCS TO-15 NA NA
12AA LCSD TO-15 NA NA
CERTIFIED BY:
Technical Director
DATE: 08/02/22
Page 2 of 42
Certification numbers: AZ Licensure AZ0775, FL NELAP – E87680, LA NELAP – 02089, NH NELAP - 209221, NJ NELAP - CA016,
NY NELAP - 11291, TX NELAP - T104704434-21-17, UT NELAP – CA009332021-13, VA NELAP - 10615, WA NELAP - C935
Name of Accreditation Body: NELAP/ORELAP (Oregon Environmental Laboratory Accreditation Program)
Accreditation number: CA300005-015, Effective date: 10/18/2021, Expiration date: 10/17/2022.
Eurofins Air Toxics, LLC certifies that the test results contained in this report meet all requirements of the NELAC standards
This report shall not be reproduced, except in full, without the written approval of Eurofins Air Toxics, LLC.
180 BLUE RAVINE ROAD, SUITE B FOLSOM, CA - 95630
[phone] . [phone] . FAX [phone]
Page 6 of 47 8/2/2022
1
2
3
4
5
6
LABORATORY NARRATIVE
EPA Method TO-15Eurofins Test AmericaWorkorder# 2207680
Nine 1 Liter Summa Canister samples were received on July 28, 2022. The laboratory performed analysis
via EPA Method TO-15 using GC/MS in the full scan mode.
There were no receiving discrepancies.
Receiving Notes
As per client project requirements, the laboratory has reported estimated values for target compound hits
that are below the Reporting Limit but greater than the Method Detection Limit. Concentrations that are
below the level at which the canister was certified may be false positives.
Dilution was performed on sample MP-8 due to the presence of high level target species.
Analytical Notes
Ten qualifiers may have been used on the data analysis sheets and indicates as follows:
B - Compound present in laboratory blank greater than reporting limit (background subtraction not
performed).
J - Estimated value.
E - Exceeds instrument calibration range.
S - Saturated peak.
Q - Exceeds quality control limits.
U - Compound analyzed for but not detected above the reporting limit, LOD, or MDL value. See
data page for project specific U-flag definition.
UJ- Non-detected compound associated with low bias in the CCV
N - The identification is based on presumptive evidence.
M - Reported value may be biased due to apparent matrix interferences.
CN - See Case Narrative.
File extensions may have been used on the data analysis sheets and indicates
as follows:
a-File was requantified
b-File was quantified by a second column and detector
r1-File was requantified for the purpose of reissue
Definition of Data Qualifying Flags
Page 3 of 42Page 7 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

0
5
:
0
0

P
M
2.
1
8
ms
d
j
.
i

/

j
0
7
3
1
1
2
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
0
1
A
7/
2
1
/
2
2

0
3
:
4
0

P
M
1
L
i
t
e
r

S
u
m
m
a

C
a
n
i
s
t
e
r
CA
M
-
0
1
0
MP
-
1
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
(u
g
/
m
3
)
CA
S
#
LO
D
Co
m
p
o
u
n
d
(u
g
/
m
3
)
MD
L
Rp
t
.

L
i
m
i
t
(u
g
/
m
3
)
Am
o
u
n
t
(u
g
/
m
3
)
1,
1
,
1
-
T
r
i
c
h
l
o
r
o
e
t
h
a
n
e
71
-
5
5
-
6
5.
9
1.
5
No
t

D
e
t
e
c
t
e
d
3.
3
1,
1
,
2
,
2
-
T
e
t
r
a
c
h
l
o
r
o
e
t
h
a
n
e
79
-
3
4
-
5
7.
5
1.
9
No
t

D
e
t
e
c
t
e
d
5.
5
1,
1
,
2
-
T
r
i
c
h
l
o
r
o
e
t
h
a
n
e
79
-
0
0
-
5
5.
9
1.
3
No
t

D
e
t
e
c
t
e
d
4.
4
1,
1
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
75
-
3
4
-
3
4.
4
1.
5
No
t

D
e
t
e
c
t
e
d
2.
5
1,
1
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
75
-
3
5
-
4
4.
3
2.
3
No
t

D
e
t
e
c
t
e
d
3.
2
1,
2
,
4
-
T
r
i
c
h
l
o
r
o
b
e
n
z
e
n
e
12
0
-
8
2
-
1
32
13
No
t

D
e
t
e
c
t
e
d
28
1,
2
,
4
-
T
r
i
m
e
t
h
y
l
b
e
n
z
e
n
e
95
-
6
3
-
6
5.
4
2.
3
No
t

D
e
t
e
c
t
e
d
4.
0
1,
2
-
D
i
b
r
o
m
o
e
t
h
a
n
e

(
E
D
B
)
10
6
-
9
3
-
4
8.
4
1.
8
No
t

D
e
t
e
c
t
e
d
6.
2
1,
2
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
95
-
5
0
-
1
6.
6
1.
6
No
t

D
e
t
e
c
t
e
d
4.
8
1,
2
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
10
7
-
0
6
-
2
4.
4
1.
5
No
t

D
e
t
e
c
t
e
d
3.
3
1,
2
-
D
i
c
h
l
o
r
o
p
r
o
p
a
n
e
78
-
8
7
-
5
5.
0
1.
9
No
t

D
e
t
e
c
t
e
d
3.
7
1,
3
,
5
-
T
r
i
m
e
t
h
y
l
b
e
n
z
e
n
e
10
8
-
6
7
-
8
5.
4
1.
7
No
t

D
e
t
e
c
t
e
d
4.
0
1,
3
-
B
u
t
a
d
i
e
n
e
10
6
-
9
9
-
0
2.
4
2.
0
No
t

D
e
t
e
c
t
e
d
2.
2
1,
3
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
54
1
-
7
3
-
1
6.
6
1.
8
No
t

D
e
t
e
c
t
e
d
4.
8
1,
4
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
10
6
-
4
6
-
7
6.
6
1.
6
No
t

D
e
t
e
c
t
e
d
4.
8
1,
4
-
D
i
o
x
a
n
e
12
3
-
9
1
-
1
16
1.
7
No
t

D
e
t
e
c
t
e
d
5.
9
2,
2
,
4
-
T
r
i
m
e
t
h
y
l
p
e
n
t
a
n
e
54
0
-
8
4
-
1
5.
1
1.
2
No
t

D
e
t
e
c
t
e
d
3.
8
2-
B
u
t
a
n
o
n
e

(
M
e
t
h
y
l

E
t
h
y
l

K
e
t
o
n
e
)
78
-
9
3
-
3
13
4.
2
35
11
2-
H
e
x
a
n
o
n
e
59
1
-
7
8
-
6
18
8.
5
No
t

D
e
t
e
c
t
e
d
15
2-
P
r
o
p
a
n
o
l
67
-
6
3
-
0
11
3.
7
9.
3

J
7.
0
3-
C
h
l
o
r
o
p
r
o
p
e
n
e
10
7
-
0
5
-
1
14
3.
1
No
t

D
e
t
e
c
t
e
d
5.
1
4-
E
t
h
y
l
t
o
l
u
e
n
e
62
2
-
9
6
-
8
5.
4
1.
8
No
t

D
e
t
e
c
t
e
d
4.
0
4-
M
e
t
h
y
l
-
2
-
p
e
n
t
a
n
o
n
e
10
8
-
1
0
-
1
4.
5
1.
3
No
t

D
e
t
e
c
t
e
d
3.
3
Ac
e
t
o
n
e
67
-
6
4
-
1
26
5.
4
12
0
8.
8
Pa
g
e

4

o
f

4
2
Page 8 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

0
5
:
0
0

P
M
2.
1
8
ms
d
j
.
i

/

j
0
7
3
1
1
2
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
0
1
A
7/
2
1
/
2
2

0
3
:
4
0

P
M
1
L
i
t
e
r

S
u
m
m
a

C
a
n
i
s
t
e
r
CA
M
-
0
1
0
MP
-
1
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
(u
g
/
m
3
)
CA
S
#
LO
D
Co
m
p
o
u
n
d
(u
g
/
m
3
)
MD
L
Rp
t
.

L
i
m
i
t
(u
g
/
m
3
)
Am
o
u
n
t
(u
g
/
m
3
)
al
p
h
a
-
C
h
l
o
r
o
t
o
l
u
e
n
e
10
0
-
4
4
-
7
5.
6
1.
4
No
t

D
e
t
e
c
t
e
d
4.
2
Be
n
z
e
n
e
71
-
4
3
-
2
3.
5
1.
2
No
t

D
e
t
e
c
t
e
d
2.
6
Br
o
m
o
d
i
c
h
l
o
r
o
m
e
t
h
a
n
e
75
-
2
7
-
4
7.
3
2.
0
No
t

D
e
t
e
c
t
e
d
4.
1
Br
o
m
o
f
o
r
m
75
-
2
5
-
2
11
2.
0
No
t

D
e
t
e
c
t
e
d
8.
3
Br
o
m
o
m
e
t
h
a
n
e
74
-
8
3
-
9
42
7.
5
No
t

D
e
t
e
c
t
e
d
14
Ca
r
b
o
n

D
i
s
u
l
f
i
d
e
75
-
1
5
-
0
14
4.
9
No
t

D
e
t
e
c
t
e
d
12
Ca
r
b
o
n

T
e
t
r
a
c
h
l
o
r
i
d
e
56
-
2
3
-
5
6.
8
1.
4
No
t

D
e
t
e
c
t
e
d
5.
1
Ch
l
o
r
o
b
e
n
z
e
n
e
10
8
-
9
0
-
7
5.
0
0.
7
6
No
t

D
e
t
e
c
t
e
d
2.
8
Ch
l
o
r
o
e
t
h
a
n
e
75
-
0
0
-
3
12
3.
9
No
t

D
e
t
e
c
t
e
d
9.
8
Ch
l
o
r
o
f
o
r
m
67
-
6
6
-
3
5.
3
2.
0
19
3.
0
Ch
l
o
r
o
m
e
t
h
a
n
e
74
-
8
7
-
3
22
4.
9
No
t

D
e
t
e
c
t
e
d
7.
6
ci
s
-
1
,
2
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
15
6
-
5
9
-
2
4.
3
1.
8
No
t

D
e
t
e
c
t
e
d
3.
2
ci
s
-
1
,
3
-
D
i
c
h
l
o
r
o
p
r
o
p
e
n
e
10
0
6
1
-
0
1
-
5
4.
9
1.
5
No
t

D
e
t
e
c
t
e
d
3.
7
Cu
m
e
n
e
98
-
8
2
-
8
5.
4
1.
9
No
t

D
e
t
e
c
t
e
d
4.
0
Cy
c
l
o
h
e
x
a
n
e
11
0
-
8
2
-
7
3.
8
0.
6
6
2.
5

J
2.
8
Di
b
r
o
m
o
c
h
l
o
r
o
m
e
t
h
a
n
e
12
4
-
4
8
-
1
9.
3
1.
3
No
t

D
e
t
e
c
t
e
d
6.
9
Et
h
a
n
o
l
64
-
1
7
-
5
20
6.
5
20
7.
0
Et
h
y
l

B
e
n
z
e
n
e
10
0
-
4
1
-
4
4.
7
1.
3
No
t

D
e
t
e
c
t
e
d
3.
5
Fr
e
o
n

1
1
75
-
6
9
-
4
6.
1
1.
8
2.
3

J
4.
5
Fr
e
o
n

1
1
3
76
-
1
3
-
1
8.
4
1.
9
No
t

D
e
t
e
c
t
e
d
6.
2
Fr
e
o
n

1
1
4
76
-
1
4
-
2
7.
6
2.
6
No
t

D
e
t
e
c
t
e
d
5.
6
Fr
e
o
n

1
2
75
-
7
1
-
8
5.
4
2.
1
2.
5

J
4.
0
He
p
t
a
n
e
14
2
-
8
2
-
5
4.
5
1.
9
No
t

D
e
t
e
c
t
e
d
3.
3
He
x
a
c
h
l
o
r
o
b
u
t
a
d
i
e
n
e
87
-
6
8
-
3
46
14
No
t

D
e
t
e
c
t
e
d
40
Pa
g
e

5

o
f

4
2
Page 9 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

0
5
:
0
0

P
M
2.
1
8
ms
d
j
.
i

/

j
0
7
3
1
1
2
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
0
1
A
7/
2
1
/
2
2

0
3
:
4
0

P
M
1
L
i
t
e
r

S
u
m
m
a

C
a
n
i
s
t
e
r
CA
M
-
0
1
0
MP
-
1
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
(u
g
/
m
3
)
CA
S
#
LO
D
Co
m
p
o
u
n
d
(u
g
/
m
3
)
MD
L
Rp
t
.

L
i
m
i
t
(u
g
/
m
3
)
Am
o
u
n
t
(u
g
/
m
3
)
He
x
a
n
e
11
0
-
5
4
-
3
3.
8
1.
1
No
t

D
e
t
e
c
t
e
d
2.
8
m,
p
-
X
y
l
e
n
e
10
8
-
3
8
-
3
4.
7
1.
4
1.
6

J
3.
5
Me
t
h
y
l

t
e
r
t
-
b
u
t
y
l

e
t
h
e
r
16
3
4
-
0
4
-
4
16
2.
0
No
t

D
e
t
e
c
t
e
d
5.
9
Me
t
h
y
l
e
n
e

C
h
l
o
r
i
d
e
75
-
0
9
-
2
38
5.
7
No
t

D
e
t
e
c
t
e
d
13
o-
X
y
l
e
n
e
95
-
4
7
-
6
4.
7
1.
5
No
t

D
e
t
e
c
t
e
d
3.
5
Pr
o
p
y
l
b
e
n
z
e
n
e
10
3
-
6
5
-
1
5.
4
1.
3
No
t

D
e
t
e
c
t
e
d
4.
0
St
y
r
e
n
e
10
0
-
4
2
-
5
4.
6
1.
7
No
t

D
e
t
e
c
t
e
d
3.
4
Te
t
r
a
c
h
l
o
r
o
e
t
h
e
n
e
12
7
-
1
8
-
4
7.
4
1.
9
68
5.
5
Te
t
r
a
h
y
d
r
o
f
u
r
a
n
10
9
-
9
9
-
9
3.
2
1.
3
34
2.
4
To
l
u
e
n
e
10
8
-
8
8
-
3
4.
1
0.
7
3
10
3.
0
tr
a
n
s
-
1
,
2
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
15
6
-
6
0
-
5
4.
3
2.
1
No
t

D
e
t
e
c
t
e
d
3.
2
tr
a
n
s
-
1
,
3
-
D
i
c
h
l
o
r
o
p
r
o
p
e
n
e
10
0
6
1
-
0
2
-
6
4.
9
1.
2
No
t

D
e
t
e
c
t
e
d
3.
7
Tr
i
c
h
l
o
r
o
e
t
h
e
n
e
79
-
0
1
-
6
5.
8
2.
6
15
4.
3
Vi
n
y
l

C
h
l
o
r
i
d
e
75
-
0
1
-
4
2.
8
2.
0
No
t

D
e
t
e
c
t
e
d
2.
1
J
=

E
s
t
i
m
a
t
e
d

v
a
l
u
e
.
D:

A
n
a
l
y
t
e

n
o
t

w
i
t
h
i
n

t
h
e

D
o
D

s
c
o
p
e

o
f

a
c
c
r
e
d
i
t
a
t
i
o
n
.
CA
S
#
Su
r
r
o
g
a
t
e
s
Li
m
i
t
s

%
R
e
c
o
v
e
r
y
1,
2
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
-
d
4
17
0
6
0
-
0
7
-
0
70
-
1
3
0
10
1
4-
B
r
o
m
o
f
l
u
o
r
o
b
e
n
z
e
n
e
46
0
-
0
0
-
4
70
-
1
3
0
10
2
To
l
u
e
n
e
-
d
8
20
3
7
-
2
6
-
5
70
-
1
3
0
10
3
Pa
g
e

6

o
f

4
2
Page 10 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

0
5
:
3
3

P
M
2.
2
0
ms
d
j
.
i

/

j
0
7
3
1
1
3
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
0
2
A
7/
2
1
/
2
2

1
2
:
4
5

P
M
1
L
i
t
e
r

S
u
m
m
a

C
a
n
i
s
t
e
r
CA
M
-
0
1
0
MP
-
3
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
(u
g
/
m
3
)
CA
S
#
LO
D
Co
m
p
o
u
n
d
(u
g
/
m
3
)
MD
L
Rp
t
.

L
i
m
i
t
(u
g
/
m
3
)
Am
o
u
n
t
(u
g
/
m
3
)
1,
1
,
1
-
T
r
i
c
h
l
o
r
o
e
t
h
a
n
e
71
-
5
5
-
6
6.
0
1.
5
No
t

D
e
t
e
c
t
e
d
3.
4
1,
1
,
2
,
2
-
T
e
t
r
a
c
h
l
o
r
o
e
t
h
a
n
e
79
-
3
4
-
5
7.
6
2.
0
No
t

D
e
t
e
c
t
e
d
5.
6
1,
1
,
2
-
T
r
i
c
h
l
o
r
o
e
t
h
a
n
e
79
-
0
0
-
5
6.
0
1.
3
No
t

D
e
t
e
c
t
e
d
4.
4
1,
1
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
75
-
3
4
-
3
4.
4
1.
5
No
t

D
e
t
e
c
t
e
d
2.
5
1,
1
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
75
-
3
5
-
4
4.
4
2.
3
No
t

D
e
t
e
c
t
e
d
3.
2
1,
2
,
4
-
T
r
i
c
h
l
o
r
o
b
e
n
z
e
n
e
12
0
-
8
2
-
1
33
13
No
t

D
e
t
e
c
t
e
d
28
1,
2
,
4
-
T
r
i
m
e
t
h
y
l
b
e
n
z
e
n
e
95
-
6
3
-
6
5.
4
2.
3
No
t

D
e
t
e
c
t
e
d
4.
0
1,
2
-
D
i
b
r
o
m
o
e
t
h
a
n
e

(
E
D
B
)
10
6
-
9
3
-
4
8.
4
1.
8
No
t

D
e
t
e
c
t
e
d
6.
2
1,
2
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
95
-
5
0
-
1
6.
6
1.
6
No
t

D
e
t
e
c
t
e
d
4.
9
1,
2
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
10
7
-
0
6
-
2
4.
4
1.
5
No
t

D
e
t
e
c
t
e
d
3.
3
1,
2
-
D
i
c
h
l
o
r
o
p
r
o
p
a
n
e
78
-
8
7
-
5
5.
1
2.
0
No
t

D
e
t
e
c
t
e
d
3.
8
1,
3
,
5
-
T
r
i
m
e
t
h
y
l
b
e
n
z
e
n
e
10
8
-
6
7
-
8
5.
4
1.
7
No
t

D
e
t
e
c
t
e
d
4.
0
1,
3
-
B
u
t
a
d
i
e
n
e
10
6
-
9
9
-
0
2.
4
2.
0
No
t

D
e
t
e
c
t
e
d
2.
2
1,
3
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
54
1
-
7
3
-
1
6.
6
1.
8
No
t

D
e
t
e
c
t
e
d
4.
9
1,
4
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
10
6
-
4
6
-
7
6.
6
1.
6
No
t

D
e
t
e
c
t
e
d
4.
9
1,
4
-
D
i
o
x
a
n
e
12
3
-
9
1
-
1
16
1.
7
No
t

D
e
t
e
c
t
e
d
5.
9
2,
2
,
4
-
T
r
i
m
e
t
h
y
l
p
e
n
t
a
n
e
54
0
-
8
4
-
1
5.
1
1.
2
No
t

D
e
t
e
c
t
e
d
3.
8
2-
B
u
t
a
n
o
n
e

(
M
e
t
h
y
l

E
t
h
y
l

K
e
t
o
n
e
)
78
-
9
3
-
3
13
4.
2
No
t

D
e
t
e
c
t
e
d
11
2-
H
e
x
a
n
o
n
e
59
1
-
7
8
-
6
18
8.
6
No
t

D
e
t
e
c
t
e
d
15
2-
P
r
o
p
a
n
o
l
67
-
6
3
-
0
11
3.
7
13
7.
0
3-
C
h
l
o
r
o
p
r
o
p
e
n
e
10
7
-
0
5
-
1
14
3.
1
No
t

D
e
t
e
c
t
e
d
5.
2
4-
E
t
h
y
l
t
o
l
u
e
n
e
62
2
-
9
6
-
8
5.
4
1.
8
No
t

D
e
t
e
c
t
e
d
4.
0
4-
M
e
t
h
y
l
-
2
-
p
e
n
t
a
n
o
n
e
10
8
-
1
0
-
1
4.
5
1.
3
No
t

D
e
t
e
c
t
e
d
3.
3
Ac
e
t
o
n
e
67
-
6
4
-
1
26
5.
4
12
0
8.
9
Pa
g
e

7

o
f

4
2
Page 11 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

0
5
:
3
3

P
M
2.
2
0
ms
d
j
.
i

/

j
0
7
3
1
1
3
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
0
2
A
7/
2
1
/
2
2

1
2
:
4
5

P
M
1
L
i
t
e
r

S
u
m
m
a

C
a
n
i
s
t
e
r
CA
M
-
0
1
0
MP
-
3
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
(u
g
/
m
3
)
CA
S
#
LO
D
Co
m
p
o
u
n
d
(u
g
/
m
3
)
MD
L
Rp
t
.

L
i
m
i
t
(u
g
/
m
3
)
Am
o
u
n
t
(u
g
/
m
3
)
al
p
h
a
-
C
h
l
o
r
o
t
o
l
u
e
n
e
10
0
-
4
4
-
7
5.
7
1.
4
No
t

D
e
t
e
c
t
e
d
4.
2
Be
n
z
e
n
e
71
-
4
3
-
2
3.
5
1.
2
No
t

D
e
t
e
c
t
e
d
2.
6
Br
o
m
o
d
i
c
h
l
o
r
o
m
e
t
h
a
n
e
75
-
2
7
-
4
7.
4
2.
1
No
t

D
e
t
e
c
t
e
d
4.
1
Br
o
m
o
f
o
r
m
75
-
2
5
-
2
11
2.
1
No
t

D
e
t
e
c
t
e
d
8.
4
Br
o
m
o
m
e
t
h
a
n
e
74
-
8
3
-
9
43
7.
6
No
t

D
e
t
e
c
t
e
d
14
Ca
r
b
o
n

D
i
s
u
l
f
i
d
e
75
-
1
5
-
0
14
4.
9
No
t

D
e
t
e
c
t
e
d
12
Ca
r
b
o
n

T
e
t
r
a
c
h
l
o
r
i
d
e
56
-
2
3
-
5
6.
9
1.
4
No
t

D
e
t
e
c
t
e
d
5.
1
Ch
l
o
r
o
b
e
n
z
e
n
e
10
8
-
9
0
-
7
5.
1
0.
7
7
No
t

D
e
t
e
c
t
e
d
2.
8
Ch
l
o
r
o
e
t
h
a
n
e
75
-
0
0
-
3
12
4.
0
No
t

D
e
t
e
c
t
e
d
9.
9
Ch
l
o
r
o
f
o
r
m
67
-
6
6
-
3
5.
4
2.
0
No
t

D
e
t
e
c
t
e
d
3.
0
Ch
l
o
r
o
m
e
t
h
a
n
e
74
-
8
7
-
3
23
4.
9
No
t

D
e
t
e
c
t
e
d
7.
7
ci
s
-
1
,
2
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
15
6
-
5
9
-
2
4.
4
1.
8
No
t

D
e
t
e
c
t
e
d
3.
2
ci
s
-
1
,
3
-
D
i
c
h
l
o
r
o
p
r
o
p
e
n
e
10
0
6
1
-
0
1
-
5
5.
0
1.
5
No
t

D
e
t
e
c
t
e
d
3.
7
Cu
m
e
n
e
98
-
8
2
-
8
5.
4
1.
9
No
t

D
e
t
e
c
t
e
d
4.
0
Cy
c
l
o
h
e
x
a
n
e
11
0
-
8
2
-
7
3.
8
0.
6
7
1.
4

J
2.
8
Di
b
r
o
m
o
c
h
l
o
r
o
m
e
t
h
a
n
e
12
4
-
4
8
-
1
9.
4
1.
3
No
t

D
e
t
e
c
t
e
d
6.
9
Et
h
a
n
o
l
64
-
1
7
-
5
21
6.
6
12

J
7.
0
Et
h
y
l

B
e
n
z
e
n
e
10
0
-
4
1
-
4
4.
8
1.
3
No
t

D
e
t
e
c
t
e
d
3.
5
Fr
e
o
n

1
1
75
-
6
9
-
4
6.
2
1.
8
No
t

D
e
t
e
c
t
e
d
4.
6
Fr
e
o
n

1
1
3
76
-
1
3
-
1
8.
4
1.
9
No
t

D
e
t
e
c
t
e
d
6.
2
Fr
e
o
n

1
1
4
76
-
1
4
-
2
7.
7
2.
7
No
t

D
e
t
e
c
t
e
d
5.
7
Fr
e
o
n

1
2
75
-
7
1
-
8
5.
4
2.
1
2.
4

J
4.
0
He
p
t
a
n
e
14
2
-
8
2
-
5
4.
5
1.
9
No
t

D
e
t
e
c
t
e
d
3.
3
He
x
a
c
h
l
o
r
o
b
u
t
a
d
i
e
n
e
87
-
6
8
-
3
47
15
No
t

D
e
t
e
c
t
e
d
40
Pa
g
e

8

o
f

4
2
Page 12 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

0
5
:
3
3

P
M
2.
2
0
ms
d
j
.
i

/

j
0
7
3
1
1
3
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
0
2
A
7/
2
1
/
2
2

1
2
:
4
5

P
M
1
L
i
t
e
r

S
u
m
m
a

C
a
n
i
s
t
e
r
CA
M
-
0
1
0
MP
-
3
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
(u
g
/
m
3
)
CA
S
#
LO
D
Co
m
p
o
u
n
d
(u
g
/
m
3
)
MD
L
Rp
t
.

L
i
m
i
t
(u
g
/
m
3
)
Am
o
u
n
t
(u
g
/
m
3
)
He
x
a
n
e
11
0
-
5
4
-
3
3.
9
1.
1
No
t

D
e
t
e
c
t
e
d
2.
9
m,
p
-
X
y
l
e
n
e
10
8
-
3
8
-
3
4.
8
1.
4
No
t

D
e
t
e
c
t
e
d
3.
5
Me
t
h
y
l

t
e
r
t
-
b
u
t
y
l

e
t
h
e
r
16
3
4
-
0
4
-
4
16
2.
0
No
t

D
e
t
e
c
t
e
d
5.
9
Me
t
h
y
l
e
n
e

C
h
l
o
r
i
d
e
75
-
0
9
-
2
38
5.
8
No
t

D
e
t
e
c
t
e
d
13
o-
X
y
l
e
n
e
95
-
4
7
-
6
4.
8
1.
5
No
t

D
e
t
e
c
t
e
d
3.
5
Pr
o
p
y
l
b
e
n
z
e
n
e
10
3
-
6
5
-
1
5.
4
1.
3
No
t

D
e
t
e
c
t
e
d
4.
0
St
y
r
e
n
e
10
0
-
4
2
-
5
4.
7
1.
7
No
t

D
e
t
e
c
t
e
d
3.
5
Te
t
r
a
c
h
l
o
r
o
e
t
h
e
n
e
12
7
-
1
8
-
4
7.
5
1.
9
No
t

D
e
t
e
c
t
e
d
5.
5
Te
t
r
a
h
y
d
r
o
f
u
r
a
n
10
9
-
9
9
-
9
3.
2
1.
4
4.
4
2.
4
To
l
u
e
n
e
10
8
-
8
8
-
3
4.
1
0.
7
4
3.
2

J
3.
1
tr
a
n
s
-
1
,
2
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
15
6
-
6
0
-
5
4.
4
2.
1
No
t

D
e
t
e
c
t
e
d
3.
2
tr
a
n
s
-
1
,
3
-
D
i
c
h
l
o
r
o
p
r
o
p
e
n
e
10
0
6
1
-
0
2
-
6
5.
0
1.
2
No
t

D
e
t
e
c
t
e
d
3.
7
Tr
i
c
h
l
o
r
o
e
t
h
e
n
e
79
-
0
1
-
6
5.
9
2.
6
No
t

D
e
t
e
c
t
e
d
4.
4
Vi
n
y
l

C
h
l
o
r
i
d
e
75
-
0
1
-
4
2.
8
2.
0
No
t

D
e
t
e
c
t
e
d
2.
1
J
=

E
s
t
i
m
a
t
e
d

v
a
l
u
e
.
D:

A
n
a
l
y
t
e

n
o
t

w
i
t
h
i
n

t
h
e

D
o
D

s
c
o
p
e

o
f

a
c
c
r
e
d
i
t
a
t
i
o
n
.
CA
S
#
Su
r
r
o
g
a
t
e
s
Li
m
i
t
s

%
R
e
c
o
v
e
r
y
1,
2
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
-
d
4
17
0
6
0
-
0
7
-
0
70
-
1
3
0
10
1
4-
B
r
o
m
o
f
l
u
o
r
o
b
e
n
z
e
n
e
46
0
-
0
0
-
4
70
-
1
3
0
98
To
l
u
e
n
e
-
d
8
20
3
7
-
2
6
-
5
70
-
1
3
0
10
2
Pa
g
e

9

o
f

4
2
Page 13 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

0
6
:
0
6

P
M
2.
1
5
ms
d
j
.
i

/

j
0
7
3
1
1
4
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
0
3
A
7/
2
1
/
2
2

1
2
:
1
5

P
M
1
L
i
t
e
r

S
u
m
m
a

C
a
n
i
s
t
e
r
CA
M
-
0
1
0
MP
-
5
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
(u
g
/
m
3
)
CA
S
#
LO
D
Co
m
p
o
u
n
d
(u
g
/
m
3
)
MD
L
Rp
t
.

L
i
m
i
t
(u
g
/
m
3
)
Am
o
u
n
t
(u
g
/
m
3
)
1,
1
,
1
-
T
r
i
c
h
l
o
r
o
e
t
h
a
n
e
71
-
5
5
-
6
5.
9
1.
4
No
t

D
e
t
e
c
t
e
d
3.
3
1,
1
,
2
,
2
-
T
e
t
r
a
c
h
l
o
r
o
e
t
h
a
n
e
79
-
3
4
-
5
7.
4
1.
9
No
t

D
e
t
e
c
t
e
d
5.
5
1,
1
,
2
-
T
r
i
c
h
l
o
r
o
e
t
h
a
n
e
79
-
0
0
-
5
5.
9
1.
3
No
t

D
e
t
e
c
t
e
d
4.
3
1,
1
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
75
-
3
4
-
3
4.
4
1.
5
No
t

D
e
t
e
c
t
e
d
2.
4
1,
1
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
75
-
3
5
-
4
4.
3
2.
3
No
t

D
e
t
e
c
t
e
d
3.
2
1,
2
,
4
-
T
r
i
c
h
l
o
r
o
b
e
n
z
e
n
e
12
0
-
8
2
-
1
32
13
No
t

D
e
t
e
c
t
e
d
27
1,
2
,
4
-
T
r
i
m
e
t
h
y
l
b
e
n
z
e
n
e
95
-
6
3
-
6
5.
3
2.
3
No
t

D
e
t
e
c
t
e
d
3.
9
1,
2
-
D
i
b
r
o
m
o
e
t
h
a
n
e

(
E
D
B
)
10
6
-
9
3
-
4
8.
3
1.
7
No
t

D
e
t
e
c
t
e
d
6.
1
1,
2
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
95
-
5
0
-
1
6.
5
1.
6
No
t

D
e
t
e
c
t
e
d
4.
8
1,
2
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
10
7
-
0
6
-
2
4.
4
1.
4
No
t

D
e
t
e
c
t
e
d
3.
2
1,
2
-
D
i
c
h
l
o
r
o
p
r
o
p
a
n
e
78
-
8
7
-
5
5.
0
1.
9
No
t

D
e
t
e
c
t
e
d
3.
7
1,
3
,
5
-
T
r
i
m
e
t
h
y
l
b
e
n
z
e
n
e
10
8
-
6
7
-
8
5.
3
1.
7
No
t

D
e
t
e
c
t
e
d
3.
9
1,
3
-
B
u
t
a
d
i
e
n
e
10
6
-
9
9
-
0
2.
4
1.
9
No
t

D
e
t
e
c
t
e
d
2.
1
1,
3
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
54
1
-
7
3
-
1
6.
5
1.
8
No
t

D
e
t
e
c
t
e
d
4.
8
1,
4
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
10
6
-
4
6
-
7
6.
5
1.
6
No
t

D
e
t
e
c
t
e
d
4.
8
1,
4
-
D
i
o
x
a
n
e
12
3
-
9
1
-
1
15
1.
7
No
t

D
e
t
e
c
t
e
d
5.
8
2,
2
,
4
-
T
r
i
m
e
t
h
y
l
p
e
n
t
a
n
e
54
0
-
8
4
-
1
5.
0
1.
2
No
t

D
e
t
e
c
t
e
d
3.
7
2-
B
u
t
a
n
o
n
e

(
M
e
t
h
y
l

E
t
h
y
l

K
e
t
o
n
e
)
78
-
9
3
-
3
13
4.
1
No
t

D
e
t
e
c
t
e
d
11
2-
H
e
x
a
n
o
n
e
59
1
-
7
8
-
6
18
8.
4
No
t

D
e
t
e
c
t
e
d
15
2-
P
r
o
p
a
n
o
l
67
-
6
3
-
0
10
3.
6
6.
8

J
6.
9
3-
C
h
l
o
r
o
p
r
o
p
e
n
e
10
7
-
0
5
-
1
13
3.
0
No
t

D
e
t
e
c
t
e
d
5.
0
4-
E
t
h
y
l
t
o
l
u
e
n
e
62
2
-
9
6
-
8
5.
3
1.
7
No
t

D
e
t
e
c
t
e
d
3.
9
4-
M
e
t
h
y
l
-
2
-
p
e
n
t
a
n
o
n
e
10
8
-
1
0
-
1
4.
4
1.
3
No
t

D
e
t
e
c
t
e
d
3.
2
Ac
e
t
o
n
e
67
-
6
4
-
1
26
5.
3
35
8.
7
Pa
g
e

1
0

o
f

4
2
Page 14 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

0
6
:
0
6

P
M
2.
1
5
ms
d
j
.
i

/

j
0
7
3
1
1
4
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
0
3
A
7/
2
1
/
2
2

1
2
:
1
5

P
M
1
L
i
t
e
r

S
u
m
m
a

C
a
n
i
s
t
e
r
CA
M
-
0
1
0
MP
-
5
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
(u
g
/
m
3
)
CA
S
#
LO
D
Co
m
p
o
u
n
d
(u
g
/
m
3
)
MD
L
Rp
t
.

L
i
m
i
t
(u
g
/
m
3
)
Am
o
u
n
t
(u
g
/
m
3
)
al
p
h
a
-
C
h
l
o
r
o
t
o
l
u
e
n
e
10
0
-
4
4
-
7
5.
6
1.
4
No
t

D
e
t
e
c
t
e
d
4.
1
Be
n
z
e
n
e
71
-
4
3
-
2
3.
4
1.
2
No
t

D
e
t
e
c
t
e
d
2.
5
Br
o
m
o
d
i
c
h
l
o
r
o
m
e
t
h
a
n
e
75
-
2
7
-
4
7.
2
2.
0
No
t

D
e
t
e
c
t
e
d
4.
0
Br
o
m
o
f
o
r
m
75
-
2
5
-
2
11
2.
0
No
t

D
e
t
e
c
t
e
d
8.
2
Br
o
m
o
m
e
t
h
a
n
e
74
-
8
3
-
9
42
7.
4
No
t

D
e
t
e
c
t
e
d
14
Ca
r
b
o
n

D
i
s
u
l
f
i
d
e
75
-
1
5
-
0
13
4.
8
No
t

D
e
t
e
c
t
e
d
11
Ca
r
b
o
n

T
e
t
r
a
c
h
l
o
r
i
d
e
56
-
2
3
-
5
6.
8
1.
3
No
t

D
e
t
e
c
t
e
d
5.
0
Ch
l
o
r
o
b
e
n
z
e
n
e
10
8
-
9
0
-
7
4.
9
0.
7
5
No
t

D
e
t
e
c
t
e
d
2.
8
Ch
l
o
r
o
e
t
h
a
n
e
75
-
0
0
-
3
11
3.
9
No
t

D
e
t
e
c
t
e
d
9.
6
Ch
l
o
r
o
f
o
r
m
67
-
6
6
-
3
5.
2
2.
0
No
t

D
e
t
e
c
t
e
d
2.
9
Ch
l
o
r
o
m
e
t
h
a
n
e
74
-
8
7
-
3
22
4.
8
No
t

D
e
t
e
c
t
e
d
7.
5
ci
s
-
1
,
2
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
15
6
-
5
9
-
2
4.
3
1.
8
No
t

D
e
t
e
c
t
e
d
3.
2
ci
s
-
1
,
3
-
D
i
c
h
l
o
r
o
p
r
o
p
e
n
e
10
0
6
1
-
0
1
-
5
4.
9
1.
5
No
t

D
e
t
e
c
t
e
d
3.
6
Cu
m
e
n
e
98
-
8
2
-
8
5.
3
1.
9
No
t

D
e
t
e
c
t
e
d
3.
9
Cy
c
l
o
h
e
x
a
n
e
11
0
-
8
2
-
7
3.
7
0.
6
5
4.
4
2.
7
Di
b
r
o
m
o
c
h
l
o
r
o
m
e
t
h
a
n
e
12
4
-
4
8
-
1
9.
2
1.
3
No
t

D
e
t
e
c
t
e
d
6.
8
Et
h
a
n
o
l
64
-
1
7
-
5
20
6.
4
26
6.
9
Et
h
y
l

B
e
n
z
e
n
e
10
0
-
4
1
-
4
4.
7
1.
3
No
t

D
e
t
e
c
t
e
d
3.
4
Fr
e
o
n

1
1
75
-
6
9
-
4
6.
0
1.
8
No
t

D
e
t
e
c
t
e
d
4.
5
Fr
e
o
n

1
1
3
76
-
1
3
-
1
8.
2
1.
9
No
t

D
e
t
e
c
t
e
d
6.
1
Fr
e
o
n

1
1
4
76
-
1
4
-
2
7.
5
2.
6
No
t

D
e
t
e
c
t
e
d
5.
6
Fr
e
o
n

1
2
75
-
7
1
-
8
5.
3
2.
1
2.
4

J
3.
9
He
p
t
a
n
e
14
2
-
8
2
-
5
4.
4
1.
9
No
t

D
e
t
e
c
t
e
d
3.
3
He
x
a
c
h
l
o
r
o
b
u
t
a
d
i
e
n
e
87
-
6
8
-
3
46
14
No
t

D
e
t
e
c
t
e
d
39
Pa
g
e

1
1

o
f

4
2
Page 15 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

0
6
:
0
6

P
M
2.
1
5
ms
d
j
.
i

/

j
0
7
3
1
1
4
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
0
3
A
7/
2
1
/
2
2

1
2
:
1
5

P
M
1
L
i
t
e
r

S
u
m
m
a

C
a
n
i
s
t
e
r
CA
M
-
0
1
0
MP
-
5
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
(u
g
/
m
3
)
CA
S
#
LO
D
Co
m
p
o
u
n
d
(u
g
/
m
3
)
MD
L
Rp
t
.

L
i
m
i
t
(u
g
/
m
3
)
Am
o
u
n
t
(u
g
/
m
3
)
He
x
a
n
e
11
0
-
5
4
-
3
3.
8
1.
1
No
t

D
e
t
e
c
t
e
d
2.
8
m,
p
-
X
y
l
e
n
e
10
8
-
3
8
-
3
4.
7
1.
4
No
t

D
e
t
e
c
t
e
d
3.
4
Me
t
h
y
l

t
e
r
t
-
b
u
t
y
l

e
t
h
e
r
16
3
4
-
0
4
-
4
16
2.
0
No
t

D
e
t
e
c
t
e
d
5.
8
Me
t
h
y
l
e
n
e

C
h
l
o
r
i
d
e
75
-
0
9
-
2
37
5.
6
No
t

D
e
t
e
c
t
e
d
13
o-
X
y
l
e
n
e
95
-
4
7
-
6
4.
7
1.
4
No
t

D
e
t
e
c
t
e
d
3.
4
Pr
o
p
y
l
b
e
n
z
e
n
e
10
3
-
6
5
-
1
5.
3
1.
3
No
t

D
e
t
e
c
t
e
d
3.
9
St
y
r
e
n
e
10
0
-
4
2
-
5
4.
6
1.
7
No
t

D
e
t
e
c
t
e
d
3.
4
Te
t
r
a
c
h
l
o
r
o
e
t
h
e
n
e
12
7
-
1
8
-
4
7.
3
1.
8
No
t

D
e
t
e
c
t
e
d
5.
4
Te
t
r
a
h
y
d
r
o
f
u
r
a
n
10
9
-
9
9
-
9
3.
2
1.
3
10
2.
3
To
l
u
e
n
e
10
8
-
8
8
-
3
4.
0
0.
7
2
4.
9
3.
0
tr
a
n
s
-
1
,
2
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
15
6
-
6
0
-
5
4.
3
2.
0
No
t

D
e
t
e
c
t
e
d
3.
2
tr
a
n
s
-
1
,
3
-
D
i
c
h
l
o
r
o
p
r
o
p
e
n
e
10
0
6
1
-
0
2
-
6
4.
9
1.
2
No
t

D
e
t
e
c
t
e
d
3.
6
Tr
i
c
h
l
o
r
o
e
t
h
e
n
e
79
-
0
1
-
6
5.
8
2.
5
No
t

D
e
t
e
c
t
e
d
4.
3
Vi
n
y
l

C
h
l
o
r
i
d
e
75
-
0
1
-
4
2.
7
2.
0
No
t

D
e
t
e
c
t
e
d
2.
0
J
=

E
s
t
i
m
a
t
e
d

v
a
l
u
e
.
D:

A
n
a
l
y
t
e

n
o
t

w
i
t
h
i
n

t
h
e

D
o
D

s
c
o
p
e

o
f

a
c
c
r
e
d
i
t
a
t
i
o
n
.
CA
S
#
Su
r
r
o
g
a
t
e
s
Li
m
i
t
s

%
R
e
c
o
v
e
r
y
1,
2
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
-
d
4
17
0
6
0
-
0
7
-
0
70
-
1
3
0
10
1
4-
B
r
o
m
o
f
l
u
o
r
o
b
e
n
z
e
n
e
46
0
-
0
0
-
4
70
-
1
3
0
99
To
l
u
e
n
e
-
d
8
20
3
7
-
2
6
-
5
70
-
1
3
0
10
3
Pa
g
e

1
2

o
f

4
2
Page 16 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

0
6
:
4
0

P
M
2.
2
5
ms
d
j
.
i

/

j
0
7
3
1
1
5
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
0
4
A
7/
2
1
/
2
2

1
1
:
2
5

A
M
1
L
i
t
e
r

S
u
m
m
a

C
a
n
i
s
t
e
r
CA
M
-
0
1
0
MP
-
7
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
(u
g
/
m
3
)
CA
S
#
LO
D
Co
m
p
o
u
n
d
(u
g
/
m
3
)
MD
L
Rp
t
.

L
i
m
i
t
(u
g
/
m
3
)
Am
o
u
n
t
(u
g
/
m
3
)
1,
1
,
1
-
T
r
i
c
h
l
o
r
o
e
t
h
a
n
e
71
-
5
5
-
6
6.
1
1.
5
No
t

D
e
t
e
c
t
e
d
3.
4
1,
1
,
2
,
2
-
T
e
t
r
a
c
h
l
o
r
o
e
t
h
a
n
e
79
-
3
4
-
5
7.
7
2.
0
No
t

D
e
t
e
c
t
e
d
5.
7
1,
1
,
2
-
T
r
i
c
h
l
o
r
o
e
t
h
a
n
e
79
-
0
0
-
5
6.
1
1.
3
No
t

D
e
t
e
c
t
e
d
4.
5
1,
1
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
75
-
3
4
-
3
4.
6
1.
5
No
t

D
e
t
e
c
t
e
d
2.
6
1,
1
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
75
-
3
5
-
4
4.
5
2.
4
No
t

D
e
t
e
c
t
e
d
3.
3
1,
2
,
4
-
T
r
i
c
h
l
o
r
o
b
e
n
z
e
n
e
12
0
-
8
2
-
1
33
13
No
t

D
e
t
e
c
t
e
d
28
1,
2
,
4
-
T
r
i
m
e
t
h
y
l
b
e
n
z
e
n
e
95
-
6
3
-
6
5.
5
2.
4
No
t

D
e
t
e
c
t
e
d
4.
1
1,
2
-
D
i
b
r
o
m
o
e
t
h
a
n
e

(
E
D
B
)
10
6
-
9
3
-
4
8.
6
1.
8
No
t

D
e
t
e
c
t
e
d
6.
4
1,
2
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
95
-
5
0
-
1
6.
8
1.
6
No
t

D
e
t
e
c
t
e
d
5.
0
1,
2
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
10
7
-
0
6
-
2
4.
6
1.
5
No
t

D
e
t
e
c
t
e
d
3.
4
1,
2
-
D
i
c
h
l
o
r
o
p
r
o
p
a
n
e
78
-
8
7
-
5
5.
2
2.
0
No
t

D
e
t
e
c
t
e
d
3.
8
1,
3
,
5
-
T
r
i
m
e
t
h
y
l
b
e
n
z
e
n
e
10
8
-
6
7
-
8
5.
5
1.
8
No
t

D
e
t
e
c
t
e
d
4.
1
1,
3
-
B
u
t
a
d
i
e
n
e
10
6
-
9
9
-
0
2.
5
2.
0
No
t

D
e
t
e
c
t
e
d
2.
2
1,
3
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
54
1
-
7
3
-
1
6.
8
1.
9
No
t

D
e
t
e
c
t
e
d
5.
0
1,
4
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
10
6
-
4
6
-
7
6.
8
1.
6
No
t

D
e
t
e
c
t
e
d
5.
0
1,
4
-
D
i
o
x
a
n
e
12
3
-
9
1
-
1
16
1.
8
No
t

D
e
t
e
c
t
e
d
6.
1
2,
2
,
4
-
T
r
i
m
e
t
h
y
l
p
e
n
t
a
n
e
54
0
-
8
4
-
1
5.
2
1.
2
No
t

D
e
t
e
c
t
e
d
3.
9
2-
B
u
t
a
n
o
n
e

(
M
e
t
h
y
l

E
t
h
y
l

K
e
t
o
n
e
)
78
-
9
3
-
3
13
4.
3
4.
6

J
11
2-
H
e
x
a
n
o
n
e
59
1
-
7
8
-
6
18
8.
8
No
t

D
e
t
e
c
t
e
d
16
2-
P
r
o
p
a
n
o
l
67
-
6
3
-
0
11
3.
8
8.
7

J
7.
2
3-
C
h
l
o
r
o
p
r
o
p
e
n
e
10
7
-
0
5
-
1
14
3.
2
No
t

D
e
t
e
c
t
e
d
5.
3
4-
E
t
h
y
l
t
o
l
u
e
n
e
62
2
-
9
6
-
8
5.
5
1.
8
No
t

D
e
t
e
c
t
e
d
4.
1
4-
M
e
t
h
y
l
-
2
-
p
e
n
t
a
n
o
n
e
10
8
-
1
0
-
1
4.
6
1.
4
No
t

D
e
t
e
c
t
e
d
3.
4
Ac
e
t
o
n
e
67
-
6
4
-
1
27
5.
5
40
9.
1
Pa
g
e

1
3

o
f

4
2
Page 17 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

0
6
:
4
0

P
M
2.
2
5
ms
d
j
.
i

/

j
0
7
3
1
1
5
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
0
4
A
7/
2
1
/
2
2

1
1
:
2
5

A
M
1
L
i
t
e
r

S
u
m
m
a

C
a
n
i
s
t
e
r
CA
M
-
0
1
0
MP
-
7
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
(u
g
/
m
3
)
CA
S
#
LO
D
Co
m
p
o
u
n
d
(u
g
/
m
3
)
MD
L
Rp
t
.

L
i
m
i
t
(u
g
/
m
3
)
Am
o
u
n
t
(u
g
/
m
3
)
al
p
h
a
-
C
h
l
o
r
o
t
o
l
u
e
n
e
10
0
-
4
4
-
7
5.
8
1.
5
No
t

D
e
t
e
c
t
e
d
4.
3
Be
n
z
e
n
e
71
-
4
3
-
2
3.
6
1.
3
No
t

D
e
t
e
c
t
e
d
2.
6
Br
o
m
o
d
i
c
h
l
o
r
o
m
e
t
h
a
n
e
75
-
2
7
-
4
7.
5
2.
1
No
t

D
e
t
e
c
t
e
d
4.
2
Br
o
m
o
f
o
r
m
75
-
2
5
-
2
12
2.
1
No
t

D
e
t
e
c
t
e
d
8.
6
Br
o
m
o
m
e
t
h
a
n
e
74
-
8
3
-
9
44
7.
8
No
t

D
e
t
e
c
t
e
d
15
Ca
r
b
o
n

D
i
s
u
l
f
i
d
e
75
-
1
5
-
0
14
5.
0
No
t

D
e
t
e
c
t
e
d
12
Ca
r
b
o
n

T
e
t
r
a
c
h
l
o
r
i
d
e
56
-
2
3
-
5
7.
1
1.
4
No
t

D
e
t
e
c
t
e
d
5.
2
Ch
l
o
r
o
b
e
n
z
e
n
e
10
8
-
9
0
-
7
5.
2
0.
7
9
No
t

D
e
t
e
c
t
e
d
2.
9
Ch
l
o
r
o
e
t
h
a
n
e
75
-
0
0
-
3
12
4.
0
No
t

D
e
t
e
c
t
e
d
10
Ch
l
o
r
o
f
o
r
m
67
-
6
6
-
3
5.
5
2.
1
No
t

D
e
t
e
c
t
e
d
3.
1
Ch
l
o
r
o
m
e
t
h
a
n
e
74
-
8
7
-
3
23
5.
0
No
t

D
e
t
e
c
t
e
d
7.
9
ci
s
-
1
,
2
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
15
6
-
5
9
-
2
4.
5
1.
9
No
t

D
e
t
e
c
t
e
d
3.
3
ci
s
-
1
,
3
-
D
i
c
h
l
o
r
o
p
r
o
p
e
n
e
10
0
6
1
-
0
1
-
5
5.
1
1.
6
No
t

D
e
t
e
c
t
e
d
3.
8
Cu
m
e
n
e
98
-
8
2
-
8
5.
5
2.
0
No
t

D
e
t
e
c
t
e
d
4.
1
Cy
c
l
o
h
e
x
a
n
e
11
0
-
8
2
-
7
3.
9
0.
6
8
3.
3

J
2.
9
Di
b
r
o
m
o
c
h
l
o
r
o
m
e
t
h
a
n
e
12
4
-
4
8
-
1
9.
6
1.
4
No
t

D
e
t
e
c
t
e
d
7.
1
Et
h
a
n
o
l
64
-
1
7
-
5
21
6.
7
23
7.
2
Et
h
y
l

B
e
n
z
e
n
e
10
0
-
4
1
-
4
4.
9
1.
4
No
t

D
e
t
e
c
t
e
d
3.
6
Fr
e
o
n

1
1
75
-
6
9
-
4
6.
3
1.
8
No
t

D
e
t
e
c
t
e
d
4.
7
Fr
e
o
n

1
1
3
76
-
1
3
-
1
8.
6
2.
0
No
t

D
e
t
e
c
t
e
d
6.
4
Fr
e
o
n

1
1
4
76
-
1
4
-
2
7.
9
2.
7
No
t

D
e
t
e
c
t
e
d
5.
8
Fr
e
o
n

1
2
75
-
7
1
-
8
5.
6
2.
2
2.
4

J
4.
1
He
p
t
a
n
e
14
2
-
8
2
-
5
4.
6
2.
0
No
t

D
e
t
e
c
t
e
d
3.
4
He
x
a
c
h
l
o
r
o
b
u
t
a
d
i
e
n
e
87
-
6
8
-
3
48
15
No
t

D
e
t
e
c
t
e
d
41
Pa
g
e

1
4

o
f

4
2
Page 18 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

0
6
:
4
0

P
M
2.
2
5
ms
d
j
.
i

/

j
0
7
3
1
1
5
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
0
4
A
7/
2
1
/
2
2

1
1
:
2
5

A
M
1
L
i
t
e
r

S
u
m
m
a

C
a
n
i
s
t
e
r
CA
M
-
0
1
0
MP
-
7
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
(u
g
/
m
3
)
CA
S
#
LO
D
Co
m
p
o
u
n
d
(u
g
/
m
3
)
MD
L
Rp
t
.

L
i
m
i
t
(u
g
/
m
3
)
Am
o
u
n
t
(u
g
/
m
3
)
He
x
a
n
e
11
0
-
5
4
-
3
4.
0
1.
1
No
t

D
e
t
e
c
t
e
d
2.
9
m,
p
-
X
y
l
e
n
e
10
8
-
3
8
-
3
4.
9
1.
4
No
t

D
e
t
e
c
t
e
d
3.
6
Me
t
h
y
l

t
e
r
t
-
b
u
t
y
l

e
t
h
e
r
16
3
4
-
0
4
-
4
16
2.
1
No
t

D
e
t
e
c
t
e
d
6.
1
Me
t
h
y
l
e
n
e

C
h
l
o
r
i
d
e
75
-
0
9
-
2
39
5.
9
No
t

D
e
t
e
c
t
e
d
13
o-
X
y
l
e
n
e
95
-
4
7
-
6
4.
9
1.
5
No
t

D
e
t
e
c
t
e
d
3.
6
Pr
o
p
y
l
b
e
n
z
e
n
e
10
3
-
6
5
-
1
5.
5
1.
4
No
t

D
e
t
e
c
t
e
d
4.
1
St
y
r
e
n
e
10
0
-
4
2
-
5
4.
8
1.
7
No
t

D
e
t
e
c
t
e
d
3.
5
Te
t
r
a
c
h
l
o
r
o
e
t
h
e
n
e
12
7
-
1
8
-
4
7.
6
1.
9
No
t

D
e
t
e
c
t
e
d
5.
6
Te
t
r
a
h
y
d
r
o
f
u
r
a
n
10
9
-
9
9
-
9
3.
3
1.
4
12
2.
4
To
l
u
e
n
e
10
8
-
8
8
-
3
4.
2
0.
7
6
5.
4
3.
1
tr
a
n
s
-
1
,
2
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
15
6
-
6
0
-
5
4.
5
2.
1
No
t

D
e
t
e
c
t
e
d
3.
3
tr
a
n
s
-
1
,
3
-
D
i
c
h
l
o
r
o
p
r
o
p
e
n
e
10
0
6
1
-
0
2
-
6
5.
1
1.
2
No
t

D
e
t
e
c
t
e
d
3.
8
Tr
i
c
h
l
o
r
o
e
t
h
e
n
e
79
-
0
1
-
6
6.
0
2.
6
No
t

D
e
t
e
c
t
e
d
4.
5
Vi
n
y
l

C
h
l
o
r
i
d
e
75
-
0
1
-
4
2.
9
2.
1
No
t

D
e
t
e
c
t
e
d
2.
1
J
=

E
s
t
i
m
a
t
e
d

v
a
l
u
e
.
D:

A
n
a
l
y
t
e

n
o
t

w
i
t
h
i
n

t
h
e

D
o
D

s
c
o
p
e

o
f

a
c
c
r
e
d
i
t
a
t
i
o
n
.
CA
S
#
Su
r
r
o
g
a
t
e
s
Li
m
i
t
s

%
R
e
c
o
v
e
r
y
1,
2
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
-
d
4
17
0
6
0
-
0
7
-
0
70
-
1
3
0
10
3
4-
B
r
o
m
o
f
l
u
o
r
o
b
e
n
z
e
n
e
46
0
-
0
0
-
4
70
-
1
3
0
10
2
To
l
u
e
n
e
-
d
8
20
3
7
-
2
6
-
5
70
-
1
3
0
10
4
Pa
g
e

1
5

o
f

4
2
Page 19 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

1
1
:
1
8

P
M
23
.
5
ms
d
j
.
i

/

j
0
7
3
1
2
0
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
0
5
A
7/
2
1
/
2
2

1
0
:
4
5

A
M
1
L
i
t
e
r

S
u
m
m
a

C
a
n
i
s
t
e
r
CA
M
-
0
1
0
MP
-
8
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
(u
g
/
m
3
)
CA
S
#
LO
D
Co
m
p
o
u
n
d
(u
g
/
m
3
)
MD
L
Rp
t
.

L
i
m
i
t
(u
g
/
m
3
)
Am
o
u
n
t
(u
g
/
m
3
)
1,
1
,
1
-
T
r
i
c
h
l
o
r
o
e
t
h
a
n
e
71
-
5
5
-
6
64
16
No
t

D
e
t
e
c
t
e
d
36
1,
1
,
2
,
2
-
T
e
t
r
a
c
h
l
o
r
o
e
t
h
a
n
e
79
-
3
4
-
5
81
21
No
t

D
e
t
e
c
t
e
d
60
1,
1
,
2
-
T
r
i
c
h
l
o
r
o
e
t
h
a
n
e
79
-
0
0
-
5
64
14
No
t

D
e
t
e
c
t
e
d
47
1,
1
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
75
-
3
4
-
3
48
16
No
t

D
e
t
e
c
t
e
d
27
1,
1
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
75
-
3
5
-
4
46
25
No
t

D
e
t
e
c
t
e
d
34
1,
2
,
4
-
T
r
i
c
h
l
o
r
o
b
e
n
z
e
n
e
12
0
-
8
2
-
1
35
0
14
0
No
t

D
e
t
e
c
t
e
d
30
0
1,
2
,
4
-
T
r
i
m
e
t
h
y
l
b
e
n
z
e
n
e
95
-
6
3
-
6
58
25
No
t

D
e
t
e
c
t
e
d
43
1,
2
-
D
i
b
r
o
m
o
e
t
h
a
n
e

(
E
D
B
)
10
6
-
9
3
-
4
90
19
No
t

D
e
t
e
c
t
e
d
67
1,
2
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
95
-
5
0
-
1
71
17
No
t

D
e
t
e
c
t
e
d
52
1,
2
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
10
7
-
0
6
-
2
48
16
No
t

D
e
t
e
c
t
e
d
35
1,
2
-
D
i
c
h
l
o
r
o
p
r
o
p
a
n
e
78
-
8
7
-
5
54
21
No
t

D
e
t
e
c
t
e
d
40
1,
3
,
5
-
T
r
i
m
e
t
h
y
l
b
e
n
z
e
n
e
10
8
-
6
7
-
8
58
18
No
t

D
e
t
e
c
t
e
d
43
1,
3
-
B
u
t
a
d
i
e
n
e
10
6
-
9
9
-
0
26
21
No
t

D
e
t
e
c
t
e
d
23
1,
3
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
54
1
-
7
3
-
1
71
20
No
t

D
e
t
e
c
t
e
d
52
1,
4
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
10
6
-
4
6
-
7
71
17
No
t

D
e
t
e
c
t
e
d
52
1,
4
-
D
i
o
x
a
n
e
12
3
-
9
1
-
1
17
0
18
No
t

D
e
t
e
c
t
e
d
64
2,
2
,
4
-
T
r
i
m
e
t
h
y
l
p
e
n
t
a
n
e
54
0
-
8
4
-
1
55
13
No
t

D
e
t
e
c
t
e
d
41
2-
B
u
t
a
n
o
n
e

(
M
e
t
h
y
l

E
t
h
y
l

K
e
t
o
n
e
)
78
-
9
3
-
3
14
0
45
14
0
0
12
0
2-
H
e
x
a
n
o
n
e
59
1
-
7
8
-
6
19
0
92
No
t

D
e
t
e
c
t
e
d
16
0
2-
P
r
o
p
a
n
o
l
67
-
6
3
-
0
12
0
40
No
t

D
e
t
e
c
t
e
d
75
3-
C
h
l
o
r
o
p
r
o
p
e
n
e
10
7
-
0
5
-
1
15
0
33
No
t

D
e
t
e
c
t
e
d
55
4-
E
t
h
y
l
t
o
l
u
e
n
e
62
2
-
9
6
-
8
58
19
No
t

D
e
t
e
c
t
e
d
43
4-
M
e
t
h
y
l
-
2
-
p
e
n
t
a
n
o
n
e
10
8
-
1
0
-
1
48
14
No
t

D
e
t
e
c
t
e
d
36
Ac
e
t
o
n
e
67
-
6
4
-
1
28
0
58
80
0
95
Pa
g
e

1
6

o
f

4
2
Page 20 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

1
1
:
1
8

P
M
23
.
5
ms
d
j
.
i

/

j
0
7
3
1
2
0
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
0
5
A
7/
2
1
/
2
2

1
0
:
4
5

A
M
1
L
i
t
e
r

S
u
m
m
a

C
a
n
i
s
t
e
r
CA
M
-
0
1
0
MP
-
8
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
(u
g
/
m
3
)
CA
S
#
LO
D
Co
m
p
o
u
n
d
(u
g
/
m
3
)
MD
L
Rp
t
.

L
i
m
i
t
(u
g
/
m
3
)
Am
o
u
n
t
(u
g
/
m
3
)
al
p
h
a
-
C
h
l
o
r
o
t
o
l
u
e
n
e
10
0
-
4
4
-
7
61
15
No
t

D
e
t
e
c
t
e
d
45
Be
n
z
e
n
e
71
-
4
3
-
2
38
13
No
t

D
e
t
e
c
t
e
d
28
Br
o
m
o
d
i
c
h
l
o
r
o
m
e
t
h
a
n
e
75
-
2
7
-
4
79
22
No
t

D
e
t
e
c
t
e
d
44
Br
o
m
o
f
o
r
m
75
-
2
5
-
2
12
0
22
No
t

D
e
t
e
c
t
e
d
90
Br
o
m
o
m
e
t
h
a
n
e
74
-
8
3
-
9
46
0
81
No
t

D
e
t
e
c
t
e
d
16
0
Ca
r
b
o
n

D
i
s
u
l
f
i
d
e
75
-
1
5
-
0
15
0
53
No
t

D
e
t
e
c
t
e
d
12
0
Ca
r
b
o
n

T
e
t
r
a
c
h
l
o
r
i
d
e
56
-
2
3
-
5
74
15
No
t

D
e
t
e
c
t
e
d
55
Ch
l
o
r
o
b
e
n
z
e
n
e
10
8
-
9
0
-
7
54
8.
2
No
t

D
e
t
e
c
t
e
d
30
Ch
l
o
r
o
e
t
h
a
n
e
75
-
0
0
-
3
12
0
42
No
t

D
e
t
e
c
t
e
d
10
0
Ch
l
o
r
o
f
o
r
m
67
-
6
6
-
3
57
22
No
t

D
e
t
e
c
t
e
d
32
Ch
l
o
r
o
m
e
t
h
a
n
e
74
-
8
7
-
3
24
0
53
No
t

D
e
t
e
c
t
e
d
82
ci
s
-
1
,
2
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
15
6
-
5
9
-
2
46
20
No
t

D
e
t
e
c
t
e
d
34
ci
s
-
1
,
3
-
D
i
c
h
l
o
r
o
p
r
o
p
e
n
e
10
0
6
1
-
0
1
-
5
53
16
No
t

D
e
t
e
c
t
e
d
39
Cu
m
e
n
e
98
-
8
2
-
8
58
21
No
t

D
e
t
e
c
t
e
d
43
Cy
c
l
o
h
e
x
a
n
e
11
0
-
8
2
-
7
40
7.
1
No
t

D
e
t
e
c
t
e
d
30
Di
b
r
o
m
o
c
h
l
o
r
o
m
e
t
h
a
n
e
12
4
-
4
8
-
1
10
0
14
No
t

D
e
t
e
c
t
e
d
74
Et
h
a
n
o
l
64
-
1
7
-
5
22
0
70
12
0

J
75
Et
h
y
l

B
e
n
z
e
n
e
10
0
-
4
1
-
4
51
14
No
t

D
e
t
e
c
t
e
d
38
Fr
e
o
n

1
1
75
-
6
9
-
4
66
19
No
t

D
e
t
e
c
t
e
d
49
Fr
e
o
n

1
1
3
76
-
1
3
-
1
90
20
No
t

D
e
t
e
c
t
e
d
67
Fr
e
o
n

1
1
4
76
-
1
4
-
2
82
28
No
t

D
e
t
e
c
t
e
d
61
Fr
e
o
n

1
2
75
-
7
1
-
8
58
23
No
t

D
e
t
e
c
t
e
d
43
He
p
t
a
n
e
14
2
-
8
2
-
5
48
20
No
t

D
e
t
e
c
t
e
d
36
He
x
a
c
h
l
o
r
o
b
u
t
a
d
i
e
n
e
87
-
6
8
-
3
50
0
16
0
No
t

D
e
t
e
c
t
e
d
43
0
Pa
g
e

1
7

o
f

4
2
Page 21 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

1
1
:
1
8

P
M
23
.
5
ms
d
j
.
i

/

j
0
7
3
1
2
0
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
0
5
A
7/
2
1
/
2
2

1
0
:
4
5

A
M
1
L
i
t
e
r

S
u
m
m
a

C
a
n
i
s
t
e
r
CA
M
-
0
1
0
MP
-
8
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
(u
g
/
m
3
)
CA
S
#
LO
D
Co
m
p
o
u
n
d
(u
g
/
m
3
)
MD
L
Rp
t
.

L
i
m
i
t
(u
g
/
m
3
)
Am
o
u
n
t
(u
g
/
m
3
)
He
x
a
n
e
11
0
-
5
4
-
3
41
12
No
t

D
e
t
e
c
t
e
d
31
m,
p
-
X
y
l
e
n
e
10
8
-
3
8
-
3
51
15
20

J
38
Me
t
h
y
l

t
e
r
t
-
b
u
t
y
l

e
t
h
e
r
16
3
4
-
0
4
-
4
17
0
22
No
t

D
e
t
e
c
t
e
d
64
Me
t
h
y
l
e
n
e

C
h
l
o
r
i
d
e
75
-
0
9
-
2
41
0
62
No
t

D
e
t
e
c
t
e
d
14
0
o-
X
y
l
e
n
e
95
-
4
7
-
6
51
16
No
t

D
e
t
e
c
t
e
d
38
Pr
o
p
y
l
b
e
n
z
e
n
e
10
3
-
6
5
-
1
58
14
No
t

D
e
t
e
c
t
e
d
43
St
y
r
e
n
e
10
0
-
4
2
-
5
50
18
No
t

D
e
t
e
c
t
e
d
37
Te
t
r
a
c
h
l
o
r
o
e
t
h
e
n
e
12
7
-
1
8
-
4
80
20
No
t

D
e
t
e
c
t
e
d
59
Te
t
r
a
h
y
d
r
o
f
u
r
a
n
10
9
-
9
9
-
9
35
14
13
0
0
0
26
To
l
u
e
n
e
10
8
-
8
8
-
3
44
7.
9
44
33
tr
a
n
s
-
1
,
2
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
15
6
-
6
0
-
5
46
22
No
t

D
e
t
e
c
t
e
d
34
tr
a
n
s
-
1
,
3
-
D
i
c
h
l
o
r
o
p
r
o
p
e
n
e
10
0
6
1
-
0
2
-
6
53
13
No
t

D
e
t
e
c
t
e
d
39
Tr
i
c
h
l
o
r
o
e
t
h
e
n
e
79
-
0
1
-
6
63
27
No
t

D
e
t
e
c
t
e
d
47
Vi
n
y
l

C
h
l
o
r
i
d
e
75
-
0
1
-
4
30
22
No
t

D
e
t
e
c
t
e
d
22
J
=

E
s
t
i
m
a
t
e
d

v
a
l
u
e
.
D:

A
n
a
l
y
t
e

n
o
t

w
i
t
h
i
n

t
h
e

D
o
D

s
c
o
p
e

o
f

a
c
c
r
e
d
i
t
a
t
i
o
n
.
CA
S
#
Su
r
r
o
g
a
t
e
s
Li
m
i
t
s

%
R
e
c
o
v
e
r
y
1,
2
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
-
d
4
17
0
6
0
-
0
7
-
0
70
-
1
3
0
99
4-
B
r
o
m
o
f
l
u
o
r
o
b
e
n
z
e
n
e
46
0
-
0
0
-
4
70
-
1
3
0
10
4
To
l
u
e
n
e
-
d
8
20
3
7
-
2
6
-
5
70
-
1
3
0
10
1
Pa
g
e

1
8

o
f

4
2
Page 22 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

0
9
:
0
9

P
M
2.
1
7
ms
d
j
.
i

/

j
0
7
3
1
1
6
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
0
6
A
7/
2
1
/
2
2

0
3
:
0
5

P
M
1
L
i
t
e
r

S
u
m
m
a

C
a
n
i
s
t
e
r
CA
M
-
0
1
0
MP
-
9
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
(u
g
/
m
3
)
CA
S
#
LO
D
Co
m
p
o
u
n
d
(u
g
/
m
3
)
MD
L
Rp
t
.

L
i
m
i
t
(u
g
/
m
3
)
Am
o
u
n
t
(u
g
/
m
3
)
1,
1
,
1
-
T
r
i
c
h
l
o
r
o
e
t
h
a
n
e
71
-
5
5
-
6
5.
9
1.
5
No
t

D
e
t
e
c
t
e
d
3.
3
1,
1
,
2
,
2
-
T
e
t
r
a
c
h
l
o
r
o
e
t
h
a
n
e
79
-
3
4
-
5
7.
4
1.
9
No
t

D
e
t
e
c
t
e
d
5.
5
1,
1
,
2
-
T
r
i
c
h
l
o
r
o
e
t
h
a
n
e
79
-
0
0
-
5
5.
9
1.
3
No
t

D
e
t
e
c
t
e
d
4.
4
1,
1
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
75
-
3
4
-
3
4.
4
1.
5
No
t

D
e
t
e
c
t
e
d
2.
4
1,
1
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
75
-
3
5
-
4
4.
3
2.
3
No
t

D
e
t
e
c
t
e
d
3.
2
1,
2
,
4
-
T
r
i
c
h
l
o
r
o
b
e
n
z
e
n
e
12
0
-
8
2
-
1
32
13
No
t

D
e
t
e
c
t
e
d
27
1,
2
,
4
-
T
r
i
m
e
t
h
y
l
b
e
n
z
e
n
e
95
-
6
3
-
6
5.
3
2.
3
No
t

D
e
t
e
c
t
e
d
3.
9
1,
2
-
D
i
b
r
o
m
o
e
t
h
a
n
e

(
E
D
B
)
10
6
-
9
3
-
4
8.
3
1.
8
No
t

D
e
t
e
c
t
e
d
6.
2
1,
2
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
95
-
5
0
-
1
6.
5
1.
6
No
t

D
e
t
e
c
t
e
d
4.
8
1,
2
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
10
7
-
0
6
-
2
4.
4
1.
5
No
t

D
e
t
e
c
t
e
d
3.
2
1,
2
-
D
i
c
h
l
o
r
o
p
r
o
p
a
n
e
78
-
8
7
-
5
5.
0
1.
9
No
t

D
e
t
e
c
t
e
d
3.
7
1,
3
,
5
-
T
r
i
m
e
t
h
y
l
b
e
n
z
e
n
e
10
8
-
6
7
-
8
5.
3
1.
7
No
t

D
e
t
e
c
t
e
d
3.
9
1,
3
-
B
u
t
a
d
i
e
n
e
10
6
-
9
9
-
0
2.
4
1.
9
No
t

D
e
t
e
c
t
e
d
2.
2
1,
3
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
54
1
-
7
3
-
1
6.
5
1.
8
No
t

D
e
t
e
c
t
e
d
4.
8
1,
4
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
10
6
-
4
6
-
7
6.
5
1.
6
No
t

D
e
t
e
c
t
e
d
4.
8
1,
4
-
D
i
o
x
a
n
e
12
3
-
9
1
-
1
16
1.
7
No
t

D
e
t
e
c
t
e
d
5.
9
2,
2
,
4
-
T
r
i
m
e
t
h
y
l
p
e
n
t
a
n
e
54
0
-
8
4
-
1
5.
1
1.
2
No
t

D
e
t
e
c
t
e
d
3.
8
2-
B
u
t
a
n
o
n
e

(
M
e
t
h
y
l

E
t
h
y
l

K
e
t
o
n
e
)
78
-
9
3
-
3
13
4.
2
21
0
11
2-
H
e
x
a
n
o
n
e
59
1
-
7
8
-
6
18
8.
4
No
t

D
e
t
e
c
t
e
d
15
2-
P
r
o
p
a
n
o
l
67
-
6
3
-
0
11
3.
6
13
6.
9
3-
C
h
l
o
r
o
p
r
o
p
e
n
e
10
7
-
0
5
-
1
14
3.
1
No
t

D
e
t
e
c
t
e
d
5.
1
4-
E
t
h
y
l
t
o
l
u
e
n
e
62
2
-
9
6
-
8
5.
3
1.
8
No
t

D
e
t
e
c
t
e
d
3.
9
4-
M
e
t
h
y
l
-
2
-
p
e
n
t
a
n
o
n
e
10
8
-
1
0
-
1
4.
4
1.
3
1.
7

J
3.
3
Ac
e
t
o
n
e
67
-
6
4
-
1
26
5.
4
21
0
8.
8
Pa
g
e

1
9

o
f

4
2
Page 23 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

0
9
:
0
9

P
M
2.
1
7
ms
d
j
.
i

/

j
0
7
3
1
1
6
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
0
6
A
7/
2
1
/
2
2

0
3
:
0
5

P
M
1
L
i
t
e
r

S
u
m
m
a

C
a
n
i
s
t
e
r
CA
M
-
0
1
0
MP
-
9
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
(u
g
/
m
3
)
CA
S
#
LO
D
Co
m
p
o
u
n
d
(u
g
/
m
3
)
MD
L
Rp
t
.

L
i
m
i
t
(u
g
/
m
3
)
Am
o
u
n
t
(u
g
/
m
3
)
al
p
h
a
-
C
h
l
o
r
o
t
o
l
u
e
n
e
10
0
-
4
4
-
7
5.
6
1.
4
No
t

D
e
t
e
c
t
e
d
4.
2
Be
n
z
e
n
e
71
-
4
3
-
2
3.
5
1.
2
No
t

D
e
t
e
c
t
e
d
2.
6
Br
o
m
o
d
i
c
h
l
o
r
o
m
e
t
h
a
n
e
75
-
2
7
-
4
7.
3
2.
0
No
t

D
e
t
e
c
t
e
d
4.
1
Br
o
m
o
f
o
r
m
75
-
2
5
-
2
11
2.
0
No
t

D
e
t
e
c
t
e
d
8.
3
Br
o
m
o
m
e
t
h
a
n
e
74
-
8
3
-
9
42
7.
5
No
t

D
e
t
e
c
t
e
d
14
Ca
r
b
o
n

D
i
s
u
l
f
i
d
e
75
-
1
5
-
0
14
4.
9
No
t

D
e
t
e
c
t
e
d
11
Ca
r
b
o
n

T
e
t
r
a
c
h
l
o
r
i
d
e
56
-
2
3
-
5
6.
8
1.
3
No
t

D
e
t
e
c
t
e
d
5.
0
Ch
l
o
r
o
b
e
n
z
e
n
e
10
8
-
9
0
-
7
5.
0
0.
7
6
No
t

D
e
t
e
c
t
e
d
2.
8
Ch
l
o
r
o
e
t
h
a
n
e
75
-
0
0
-
3
11
3.
9
No
t

D
e
t
e
c
t
e
d
9.
7
Ch
l
o
r
o
f
o
r
m
67
-
6
6
-
3
5.
3
2.
0
No
t

D
e
t
e
c
t
e
d
3.
0
Ch
l
o
r
o
m
e
t
h
a
n
e
74
-
8
7
-
3
22
4.
9
No
t

D
e
t
e
c
t
e
d
7.
6
ci
s
-
1
,
2
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
15
6
-
5
9
-
2
4.
3
1.
8
No
t

D
e
t
e
c
t
e
d
3.
2
ci
s
-
1
,
3
-
D
i
c
h
l
o
r
o
p
r
o
p
e
n
e
10
0
6
1
-
0
1
-
5
4.
9
1.
5
No
t

D
e
t
e
c
t
e
d
3.
6
Cu
m
e
n
e
98
-
8
2
-
8
5.
3
1.
9
No
t

D
e
t
e
c
t
e
d
3.
9
Cy
c
l
o
h
e
x
a
n
e
11
0
-
8
2
-
7
3.
7
0.
6
6
4.
7
2.
8
Di
b
r
o
m
o
c
h
l
o
r
o
m
e
t
h
a
n
e
12
4
-
4
8
-
1
9.
2
1.
3
No
t

D
e
t
e
c
t
e
d
6.
8
Et
h
a
n
o
l
64
-
1
7
-
5
20
6.
5
21
7.
0
Et
h
y
l

B
e
n
z
e
n
e
10
0
-
4
1
-
4
4.
7
1.
3
1.
6

J
3.
5
Fr
e
o
n

1
1
75
-
6
9
-
4
6.
1
1.
8
No
t

D
e
t
e
c
t
e
d
4.
5
Fr
e
o
n

1
1
3
76
-
1
3
-
1
8.
3
1.
9
No
t

D
e
t
e
c
t
e
d
6.
2
Fr
e
o
n

1
1
4
76
-
1
4
-
2
7.
6
2.
6
No
t

D
e
t
e
c
t
e
d
5.
6
Fr
e
o
n

1
2
75
-
7
1
-
8
5.
4
2.
1
2.
7

J
4.
0
He
p
t
a
n
e
14
2
-
8
2
-
5
4.
4
1.
9
No
t

D
e
t
e
c
t
e
d
3.
3
He
x
a
c
h
l
o
r
o
b
u
t
a
d
i
e
n
e
87
-
6
8
-
3
46
14
No
t

D
e
t
e
c
t
e
d
39
Pa
g
e

2
0

o
f

4
2
Page 24 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

0
9
:
0
9

P
M
2.
1
7
ms
d
j
.
i

/

j
0
7
3
1
1
6
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
0
6
A
7/
2
1
/
2
2

0
3
:
0
5

P
M
1
L
i
t
e
r

S
u
m
m
a

C
a
n
i
s
t
e
r
CA
M
-
0
1
0
MP
-
9
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
(u
g
/
m
3
)
CA
S
#
LO
D
Co
m
p
o
u
n
d
(u
g
/
m
3
)
MD
L
Rp
t
.

L
i
m
i
t
(u
g
/
m
3
)
Am
o
u
n
t
(u
g
/
m
3
)
He
x
a
n
e
11
0
-
5
4
-
3
3.
8
1.
1
No
t

D
e
t
e
c
t
e
d
2.
8
m,
p
-
X
y
l
e
n
e
10
8
-
3
8
-
3
4.
7
1.
4
7.
0
3.
5
Me
t
h
y
l

t
e
r
t
-
b
u
t
y
l

e
t
h
e
r
16
3
4
-
0
4
-
4
16
2.
0
No
t

D
e
t
e
c
t
e
d
5.
9
Me
t
h
y
l
e
n
e

C
h
l
o
r
i
d
e
75
-
0
9
-
2
38
5.
7
No
t

D
e
t
e
c
t
e
d
13
o-
X
y
l
e
n
e
95
-
4
7
-
6
4.
7
1.
4
2.
9

J
3.
5
Pr
o
p
y
l
b
e
n
z
e
n
e
10
3
-
6
5
-
1
5.
3
1.
3
No
t

D
e
t
e
c
t
e
d
3.
9
St
y
r
e
n
e
10
0
-
4
2
-
5
4.
6
1.
7
No
t

D
e
t
e
c
t
e
d
3.
4
Te
t
r
a
c
h
l
o
r
o
e
t
h
e
n
e
12
7
-
1
8
-
4
7.
4
1.
9
No
t

D
e
t
e
c
t
e
d
5.
4
Te
t
r
a
h
y
d
r
o
f
u
r
a
n
10
9
-
9
9
-
9
3.
2
1.
3
15
0
0

E
2.
4
To
l
u
e
n
e
10
8
-
8
8
-
3
4.
1
0.
7
3
8.
5
3.
0
tr
a
n
s
-
1
,
2
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
15
6
-
6
0
-
5
4.
3
2.
0
No
t

D
e
t
e
c
t
e
d
3.
2
tr
a
n
s
-
1
,
3
-
D
i
c
h
l
o
r
o
p
r
o
p
e
n
e
10
0
6
1
-
0
2
-
6
4.
9
1.
2
No
t

D
e
t
e
c
t
e
d
3.
6
Tr
i
c
h
l
o
r
o
e
t
h
e
n
e
79
-
0
1
-
6
5.
8
2.
5
No
t

D
e
t
e
c
t
e
d
4.
3
Vi
n
y
l

C
h
l
o
r
i
d
e
75
-
0
1
-
4
2.
8
2.
0
No
t

D
e
t
e
c
t
e
d
2.
0
J
=

E
s
t
i
m
a
t
e
d

v
a
l
u
e
.
E
=

E
x
c
e
e
d
s

i
n
s
t
r
u
m
e
n
t

c
a
l
i
b
r
a
t
i
o
n

r
a
n
g
e
.
D:

A
n
a
l
y
t
e

n
o
t

w
i
t
h
i
n

t
h
e

D
o
D

s
c
o
p
e

o
f

a
c
c
r
e
d
i
t
a
t
i
o
n
.
CA
S
#
Su
r
r
o
g
a
t
e
s
Li
m
i
t
s

%
R
e
c
o
v
e
r
y
1,
2
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
-
d
4
17
0
6
0
-
0
7
-
0
70
-
1
3
0
10
2
4-
B
r
o
m
o
f
l
u
o
r
o
b
e
n
z
e
n
e
46
0
-
0
0
-
4
70
-
1
3
0
10
5
To
l
u
e
n
e
-
d
8
20
3
7
-
2
6
-
5
70
-
1
3
0
10
2
Pa
g
e

2
1

o
f

4
2
Page 25 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

0
9
:
4
2

P
M
2.
0
8
ms
d
j
.
i

/

j
0
7
3
1
1
7
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
0
7
A
7/
2
1
/
2
2

0
1
:
3
5

P
M
1
L
i
t
e
r

S
u
m
m
a

C
a
n
i
s
t
e
r
CA
M
-
0
1
0
MP
-
1
0
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
(u
g
/
m
3
)
CA
S
#
LO
D
Co
m
p
o
u
n
d
(u
g
/
m
3
)
MD
L
Rp
t
.

L
i
m
i
t
(u
g
/
m
3
)
Am
o
u
n
t
(u
g
/
m
3
)
1,
1
,
1
-
T
r
i
c
h
l
o
r
o
e
t
h
a
n
e
71
-
5
5
-
6
5.
7
1.
4
No
t

D
e
t
e
c
t
e
d
3.
2
1,
1
,
2
,
2
-
T
e
t
r
a
c
h
l
o
r
o
e
t
h
a
n
e
79
-
3
4
-
5
7.
1
1.
8
No
t

D
e
t
e
c
t
e
d
5.
3
1,
1
,
2
-
T
r
i
c
h
l
o
r
o
e
t
h
a
n
e
79
-
0
0
-
5
5.
7
1.
2
No
t

D
e
t
e
c
t
e
d
4.
2
1,
1
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
75
-
3
4
-
3
4.
2
1.
4
No
t

D
e
t
e
c
t
e
d
2.
4
1,
1
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
75
-
3
5
-
4
4.
1
2.
2
No
t

D
e
t
e
c
t
e
d
3.
0
1,
2
,
4
-
T
r
i
c
h
l
o
r
o
b
e
n
z
e
n
e
12
0
-
8
2
-
1
31
12
No
t

D
e
t
e
c
t
e
d
26
1,
2
,
4
-
T
r
i
m
e
t
h
y
l
b
e
n
z
e
n
e
95
-
6
3
-
6
5.
1
2.
2
No
t

D
e
t
e
c
t
e
d
3.
8
1,
2
-
D
i
b
r
o
m
o
e
t
h
a
n
e

(
E
D
B
)
10
6
-
9
3
-
4
8.
0
1.
7
No
t

D
e
t
e
c
t
e
d
5.
9
1,
2
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
95
-
5
0
-
1
6.
2
1.
5
No
t

D
e
t
e
c
t
e
d
4.
6
1,
2
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
10
7
-
0
6
-
2
4.
2
1.
4
No
t

D
e
t
e
c
t
e
d
3.
1
1,
2
-
D
i
c
h
l
o
r
o
p
r
o
p
a
n
e
78
-
8
7
-
5
4.
8
1.
8
No
t

D
e
t
e
c
t
e
d
3.
6
1,
3
,
5
-
T
r
i
m
e
t
h
y
l
b
e
n
z
e
n
e
10
8
-
6
7
-
8
5.
1
1.
6
No
t

D
e
t
e
c
t
e
d
3.
8
1,
3
-
B
u
t
a
d
i
e
n
e
10
6
-
9
9
-
0
2.
3
1.
9
No
t

D
e
t
e
c
t
e
d
2.
1
1,
3
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
54
1
-
7
3
-
1
6.
2
1.
7
No
t

D
e
t
e
c
t
e
d
4.
6
1,
4
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
10
6
-
4
6
-
7
6.
2
1.
5
No
t

D
e
t
e
c
t
e
d
4.
6
1,
4
-
D
i
o
x
a
n
e
12
3
-
9
1
-
1
15
1.
6
No
t

D
e
t
e
c
t
e
d
5.
6
2,
2
,
4
-
T
r
i
m
e
t
h
y
l
p
e
n
t
a
n
e
54
0
-
8
4
-
1
4.
8
1.
2
1.
6

J
3.
6
2-
B
u
t
a
n
o
n
e

(
M
e
t
h
y
l

E
t
h
y
l

K
e
t
o
n
e
)
78
-
9
3
-
3
12
4.
0
9.
0

J
10
2-
H
e
x
a
n
o
n
e
59
1
-
7
8
-
6
17
8.
1
No
t

D
e
t
e
c
t
e
d
14
2-
P
r
o
p
a
n
o
l
67
-
6
3
-
0
10
3.
5
18
6.
6
3-
C
h
l
o
r
o
p
r
o
p
e
n
e
10
7
-
0
5
-
1
13
2.
9
No
t

D
e
t
e
c
t
e
d
4.
9
4-
E
t
h
y
l
t
o
l
u
e
n
e
62
2
-
9
6
-
8
5.
1
1.
7
No
t

D
e
t
e
c
t
e
d
3.
8
4-
M
e
t
h
y
l
-
2
-
p
e
n
t
a
n
o
n
e
10
8
-
1
0
-
1
4.
3
1.
3
No
t

D
e
t
e
c
t
e
d
3.
2
Ac
e
t
o
n
e
67
-
6
4
-
1
25
5.
1
47
8.
4
Pa
g
e

2
2

o
f

4
2
Page 26 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

0
9
:
4
2

P
M
2.
0
8
ms
d
j
.
i

/

j
0
7
3
1
1
7
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
0
7
A
7/
2
1
/
2
2

0
1
:
3
5

P
M
1
L
i
t
e
r

S
u
m
m
a

C
a
n
i
s
t
e
r
CA
M
-
0
1
0
MP
-
1
0
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
(u
g
/
m
3
)
CA
S
#
LO
D
Co
m
p
o
u
n
d
(u
g
/
m
3
)
MD
L
Rp
t
.

L
i
m
i
t
(u
g
/
m
3
)
Am
o
u
n
t
(u
g
/
m
3
)
al
p
h
a
-
C
h
l
o
r
o
t
o
l
u
e
n
e
10
0
-
4
4
-
7
5.
4
1.
4
No
t

D
e
t
e
c
t
e
d
4.
0
Be
n
z
e
n
e
71
-
4
3
-
2
3.
3
1.
2
1.
3

J
2.
4
Br
o
m
o
d
i
c
h
l
o
r
o
m
e
t
h
a
n
e
75
-
2
7
-
4
7.
0
2.
0
No
t

D
e
t
e
c
t
e
d
3.
9
Br
o
m
o
f
o
r
m
75
-
2
5
-
2
11
1.
9
No
t

D
e
t
e
c
t
e
d
8.
0
Br
o
m
o
m
e
t
h
a
n
e
74
-
8
3
-
9
40
7.
2
No
t

D
e
t
e
c
t
e
d
14
Ca
r
b
o
n

D
i
s
u
l
f
i
d
e
75
-
1
5
-
0
13
4.
7
No
t

D
e
t
e
c
t
e
d
11
Ca
r
b
o
n

T
e
t
r
a
c
h
l
o
r
i
d
e
56
-
2
3
-
5
6.
5
1.
3
No
t

D
e
t
e
c
t
e
d
4.
8
Ch
l
o
r
o
b
e
n
z
e
n
e
10
8
-
9
0
-
7
4.
8
0.
7
3
No
t

D
e
t
e
c
t
e
d
2.
7
Ch
l
o
r
o
e
t
h
a
n
e
75
-
0
0
-
3
11
3.
7
No
t

D
e
t
e
c
t
e
d
9.
3
Ch
l
o
r
o
f
o
r
m
67
-
6
6
-
3
5.
1
1.
9
No
t

D
e
t
e
c
t
e
d
2.
8
Ch
l
o
r
o
m
e
t
h
a
n
e
74
-
8
7
-
3
21
4.
7
No
t

D
e
t
e
c
t
e
d
7.
3
ci
s
-
1
,
2
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
15
6
-
5
9
-
2
4.
1
1.
7
No
t

D
e
t
e
c
t
e
d
3.
0
ci
s
-
1
,
3
-
D
i
c
h
l
o
r
o
p
r
o
p
e
n
e
10
0
6
1
-
0
1
-
5
4.
7
1.
4
No
t

D
e
t
e
c
t
e
d
3.
5
Cu
m
e
n
e
98
-
8
2
-
8
5.
1
1.
8
No
t

D
e
t
e
c
t
e
d
3.
8
Cy
c
l
o
h
e
x
a
n
e
11
0
-
8
2
-
7
3.
6
0.
6
3
12
2.
6
Di
b
r
o
m
o
c
h
l
o
r
o
m
e
t
h
a
n
e
12
4
-
4
8
-
1
8.
8
1.
3
No
t

D
e
t
e
c
t
e
d
6.
6
Et
h
a
n
o
l
64
-
1
7
-
5
20
6.
2
43
6.
7
Et
h
y
l

B
e
n
z
e
n
e
10
0
-
4
1
-
4
4.
5
1.
2
1.
3

J
3.
3
Fr
e
o
n

1
1
75
-
6
9
-
4
5.
8
1.
7
No
t

D
e
t
e
c
t
e
d
4.
3
Fr
e
o
n

1
1
3
76
-
1
3
-
1
8.
0
1.
8
No
t

D
e
t
e
c
t
e
d
5.
9
Fr
e
o
n

1
1
4
76
-
1
4
-
2
7.
3
2.
5
No
t

D
e
t
e
c
t
e
d
5.
4
Fr
e
o
n

1
2
75
-
7
1
-
8
5.
1
2.
0
2.
4

J
3.
8
He
p
t
a
n
e
14
2
-
8
2
-
5
4.
3
1.
8
No
t

D
e
t
e
c
t
e
d
3.
2
He
x
a
c
h
l
o
r
o
b
u
t
a
d
i
e
n
e
87
-
6
8
-
3
44
14
No
t

D
e
t
e
c
t
e
d
38
Pa
g
e

2
3

o
f

4
2
Page 27 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

0
9
:
4
2

P
M
2.
0
8
ms
d
j
.
i

/

j
0
7
3
1
1
7
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
0
7
A
7/
2
1
/
2
2

0
1
:
3
5

P
M
1
L
i
t
e
r

S
u
m
m
a

C
a
n
i
s
t
e
r
CA
M
-
0
1
0
MP
-
1
0
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
(u
g
/
m
3
)
CA
S
#
LO
D
Co
m
p
o
u
n
d
(u
g
/
m
3
)
MD
L
Rp
t
.

L
i
m
i
t
(u
g
/
m
3
)
Am
o
u
n
t
(u
g
/
m
3
)
He
x
a
n
e
11
0
-
5
4
-
3
3.
7
1.
0
1.
4

J
2.
7
m,
p
-
X
y
l
e
n
e
10
8
-
3
8
-
3
4.
5
1.
3
5.
0
3.
3
Me
t
h
y
l

t
e
r
t
-
b
u
t
y
l

e
t
h
e
r
16
3
4
-
0
4
-
4
15
1.
9
No
t

D
e
t
e
c
t
e
d
5.
6
Me
t
h
y
l
e
n
e

C
h
l
o
r
i
d
e
75
-
0
9
-
2
36
5.
4
6.
9

J
12
o-
X
y
l
e
n
e
95
-
4
7
-
6
4.
5
1.
4
1.
9

J
3.
3
Pr
o
p
y
l
b
e
n
z
e
n
e
10
3
-
6
5
-
1
5.
1
1.
3
No
t

D
e
t
e
c
t
e
d
3.
8
St
y
r
e
n
e
10
0
-
4
2
-
5
4.
4
1.
6
No
t

D
e
t
e
c
t
e
d
3.
3
Te
t
r
a
c
h
l
o
r
o
e
t
h
e
n
e
12
7
-
1
8
-
4
7.
0
1.
8
No
t

D
e
t
e
c
t
e
d
5.
2
Te
t
r
a
h
y
d
r
o
f
u
r
a
n
10
9
-
9
9
-
9
3.
1
1.
3
6.
5
2.
3
To
l
u
e
n
e
10
8
-
8
8
-
3
3.
9
0.
7
0
39
2.
9
tr
a
n
s
-
1
,
2
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
15
6
-
6
0
-
5
4.
1
2.
0
No
t

D
e
t
e
c
t
e
d
3.
0
tr
a
n
s
-
1
,
3
-
D
i
c
h
l
o
r
o
p
r
o
p
e
n
e
10
0
6
1
-
0
2
-
6
4.
7
1.
1
No
t

D
e
t
e
c
t
e
d
3.
5
Tr
i
c
h
l
o
r
o
e
t
h
e
n
e
79
-
0
1
-
6
5.
6
2.
4
No
t

D
e
t
e
c
t
e
d
4.
1
Vi
n
y
l

C
h
l
o
r
i
d
e
75
-
0
1
-
4
2.
6
1.
9
No
t

D
e
t
e
c
t
e
d
2.
0
J
=

E
s
t
i
m
a
t
e
d

v
a
l
u
e
.
D:

A
n
a
l
y
t
e

n
o
t

w
i
t
h
i
n

t
h
e

D
o
D

s
c
o
p
e

o
f

a
c
c
r
e
d
i
t
a
t
i
o
n
.
CA
S
#
Su
r
r
o
g
a
t
e
s
Li
m
i
t
s

%
R
e
c
o
v
e
r
y
1,
2
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
-
d
4
17
0
6
0
-
0
7
-
0
70
-
1
3
0
10
2
4-
B
r
o
m
o
f
l
u
o
r
o
b
e
n
z
e
n
e
46
0
-
0
0
-
4
70
-
1
3
0
98
To
l
u
e
n
e
-
d
8
20
3
7
-
2
6
-
5
70
-
1
3
0
10
3
Pa
g
e

2
4

o
f

4
2
Page 28 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

1
0
:
1
5

P
M
2.
1
8
ms
d
j
.
i

/

j
0
7
3
1
1
8
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
0
8
A
7/
2
1
/
2
2

0
9
:
4
5

A
M
1
L
i
t
e
r

S
u
m
m
a

C
a
n
i
s
t
e
r
CA
M
-
0
1
0
MP
-
2
9
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
(u
g
/
m
3
)
CA
S
#
LO
D
Co
m
p
o
u
n
d
(u
g
/
m
3
)
MD
L
Rp
t
.

L
i
m
i
t
(u
g
/
m
3
)
Am
o
u
n
t
(u
g
/
m
3
)
1,
1
,
1
-
T
r
i
c
h
l
o
r
o
e
t
h
a
n
e
71
-
5
5
-
6
5.
9
1.
5
No
t

D
e
t
e
c
t
e
d
3.
3
1,
1
,
2
,
2
-
T
e
t
r
a
c
h
l
o
r
o
e
t
h
a
n
e
79
-
3
4
-
5
7.
5
1.
9
No
t

D
e
t
e
c
t
e
d
5.
5
1,
1
,
2
-
T
r
i
c
h
l
o
r
o
e
t
h
a
n
e
79
-
0
0
-
5
5.
9
1.
3
No
t

D
e
t
e
c
t
e
d
4.
4
1,
1
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
75
-
3
4
-
3
4.
4
1.
5
No
t

D
e
t
e
c
t
e
d
2.
5
1,
1
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
75
-
3
5
-
4
4.
3
2.
3
No
t

D
e
t
e
c
t
e
d
3.
2
1,
2
,
4
-
T
r
i
c
h
l
o
r
o
b
e
n
z
e
n
e
12
0
-
8
2
-
1
32
13
No
t

D
e
t
e
c
t
e
d
28
1,
2
,
4
-
T
r
i
m
e
t
h
y
l
b
e
n
z
e
n
e
95
-
6
3
-
6
5.
4
2.
3
No
t

D
e
t
e
c
t
e
d
4.
0
1,
2
-
D
i
b
r
o
m
o
e
t
h
a
n
e

(
E
D
B
)
10
6
-
9
3
-
4
8.
4
1.
8
No
t

D
e
t
e
c
t
e
d
6.
2
1,
2
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
95
-
5
0
-
1
6.
6
1.
6
No
t

D
e
t
e
c
t
e
d
4.
8
1,
2
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
10
7
-
0
6
-
2
4.
4
1.
5
No
t

D
e
t
e
c
t
e
d
3.
3
1,
2
-
D
i
c
h
l
o
r
o
p
r
o
p
a
n
e
78
-
8
7
-
5
5.
0
1.
9
No
t

D
e
t
e
c
t
e
d
3.
7
1,
3
,
5
-
T
r
i
m
e
t
h
y
l
b
e
n
z
e
n
e
10
8
-
6
7
-
8
5.
4
1.
7
No
t

D
e
t
e
c
t
e
d
4.
0
1,
3
-
B
u
t
a
d
i
e
n
e
10
6
-
9
9
-
0
2.
4
2.
0
No
t

D
e
t
e
c
t
e
d
2.
2
1,
3
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
54
1
-
7
3
-
1
6.
6
1.
8
No
t

D
e
t
e
c
t
e
d
4.
8
1,
4
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
10
6
-
4
6
-
7
6.
6
1.
6
No
t

D
e
t
e
c
t
e
d
4.
8
1,
4
-
D
i
o
x
a
n
e
12
3
-
9
1
-
1
16
1.
7
No
t

D
e
t
e
c
t
e
d
5.
9
2,
2
,
4
-
T
r
i
m
e
t
h
y
l
p
e
n
t
a
n
e
54
0
-
8
4
-
1
5.
1
1.
2
No
t

D
e
t
e
c
t
e
d
3.
8
2-
B
u
t
a
n
o
n
e

(
M
e
t
h
y
l

E
t
h
y
l

K
e
t
o
n
e
)
78
-
9
3
-
3
13
4.
2
5.
0

J
11
2-
H
e
x
a
n
o
n
e
59
1
-
7
8
-
6
18
8.
5
No
t

D
e
t
e
c
t
e
d
15
2-
P
r
o
p
a
n
o
l
67
-
6
3
-
0
11
3.
7
46
7.
0
3-
C
h
l
o
r
o
p
r
o
p
e
n
e
10
7
-
0
5
-
1
14
3.
1
No
t

D
e
t
e
c
t
e
d
5.
1
4-
E
t
h
y
l
t
o
l
u
e
n
e
62
2
-
9
6
-
8
5.
4
1.
8
No
t

D
e
t
e
c
t
e
d
4.
0
4-
M
e
t
h
y
l
-
2
-
p
e
n
t
a
n
o
n
e
10
8
-
1
0
-
1
4.
5
1.
3
No
t

D
e
t
e
c
t
e
d
3.
3
Ac
e
t
o
n
e
67
-
6
4
-
1
26
5.
4
24
0
8.
8
Pa
g
e

2
5

o
f

4
2
Page 29 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

1
0
:
1
5

P
M
2.
1
8
ms
d
j
.
i

/

j
0
7
3
1
1
8
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
0
8
A
7/
2
1
/
2
2

0
9
:
4
5

A
M
1
L
i
t
e
r

S
u
m
m
a

C
a
n
i
s
t
e
r
CA
M
-
0
1
0
MP
-
2
9
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
(u
g
/
m
3
)
CA
S
#
LO
D
Co
m
p
o
u
n
d
(u
g
/
m
3
)
MD
L
Rp
t
.

L
i
m
i
t
(u
g
/
m
3
)
Am
o
u
n
t
(u
g
/
m
3
)
al
p
h
a
-
C
h
l
o
r
o
t
o
l
u
e
n
e
10
0
-
4
4
-
7
5.
6
1.
4
No
t

D
e
t
e
c
t
e
d
4.
2
Be
n
z
e
n
e
71
-
4
3
-
2
3.
5
1.
2
No
t

D
e
t
e
c
t
e
d
2.
6
Br
o
m
o
d
i
c
h
l
o
r
o
m
e
t
h
a
n
e
75
-
2
7
-
4
7.
3
2.
0
No
t

D
e
t
e
c
t
e
d
4.
1
Br
o
m
o
f
o
r
m
75
-
2
5
-
2
11
2.
0
No
t

D
e
t
e
c
t
e
d
8.
3
Br
o
m
o
m
e
t
h
a
n
e
74
-
8
3
-
9
42
7.
5
No
t

D
e
t
e
c
t
e
d
14
Ca
r
b
o
n

D
i
s
u
l
f
i
d
e
75
-
1
5
-
0
14
4.
9
6.
5

J
12
Ca
r
b
o
n

T
e
t
r
a
c
h
l
o
r
i
d
e
56
-
2
3
-
5
6.
8
1.
4
No
t

D
e
t
e
c
t
e
d
5.
1
Ch
l
o
r
o
b
e
n
z
e
n
e
10
8
-
9
0
-
7
5.
0
0.
7
6
No
t

D
e
t
e
c
t
e
d
2.
8
Ch
l
o
r
o
e
t
h
a
n
e
75
-
0
0
-
3
12
3.
9
No
t

D
e
t
e
c
t
e
d
9.
8
Ch
l
o
r
o
f
o
r
m
67
-
6
6
-
3
5.
3
2.
0
No
t

D
e
t
e
c
t
e
d
3.
0
Ch
l
o
r
o
m
e
t
h
a
n
e
74
-
8
7
-
3
22
4.
9
No
t

D
e
t
e
c
t
e
d
7.
6
ci
s
-
1
,
2
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
15
6
-
5
9
-
2
4.
3
1.
8
No
t

D
e
t
e
c
t
e
d
3.
2
ci
s
-
1
,
3
-
D
i
c
h
l
o
r
o
p
r
o
p
e
n
e
10
0
6
1
-
0
1
-
5
4.
9
1.
5
No
t

D
e
t
e
c
t
e
d
3.
7
Cu
m
e
n
e
98
-
8
2
-
8
5.
4
1.
9
No
t

D
e
t
e
c
t
e
d
4.
0
Cy
c
l
o
h
e
x
a
n
e
11
0
-
8
2
-
7
3.
8
0.
6
6
1.
5

J
2.
8
Di
b
r
o
m
o
c
h
l
o
r
o
m
e
t
h
a
n
e
12
4
-
4
8
-
1
9.
3
1.
3
No
t

D
e
t
e
c
t
e
d
6.
9
Et
h
a
n
o
l
64
-
1
7
-
5
20
6.
5
46
7.
0
Et
h
y
l

B
e
n
z
e
n
e
10
0
-
4
1
-
4
4.
7
1.
3
No
t

D
e
t
e
c
t
e
d
3.
5
Fr
e
o
n

1
1
75
-
6
9
-
4
6.
1
1.
8
No
t

D
e
t
e
c
t
e
d
4.
5
Fr
e
o
n

1
1
3
76
-
1
3
-
1
8.
4
1.
9
2.
1

J
6.
2
Fr
e
o
n

1
1
4
76
-
1
4
-
2
7.
6
2.
6
No
t

D
e
t
e
c
t
e
d
5.
6
Fr
e
o
n

1
2
75
-
7
1
-
8
5.
4
2.
1
2.
8

J
4.
0
He
p
t
a
n
e
14
2
-
8
2
-
5
4.
5
1.
9
No
t

D
e
t
e
c
t
e
d
3.
3
He
x
a
c
h
l
o
r
o
b
u
t
a
d
i
e
n
e
87
-
6
8
-
3
46
14
No
t

D
e
t
e
c
t
e
d
40
Pa
g
e

2
6

o
f

4
2
Page 30 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

1
0
:
1
5

P
M
2.
1
8
ms
d
j
.
i

/

j
0
7
3
1
1
8
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
0
8
A
7/
2
1
/
2
2

0
9
:
4
5

A
M
1
L
i
t
e
r

S
u
m
m
a

C
a
n
i
s
t
e
r
CA
M
-
0
1
0
MP
-
2
9
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
(u
g
/
m
3
)
CA
S
#
LO
D
Co
m
p
o
u
n
d
(u
g
/
m
3
)
MD
L
Rp
t
.

L
i
m
i
t
(u
g
/
m
3
)
Am
o
u
n
t
(u
g
/
m
3
)
He
x
a
n
e
11
0
-
5
4
-
3
3.
8
1.
1
No
t

D
e
t
e
c
t
e
d
2.
8
m,
p
-
X
y
l
e
n
e
10
8
-
3
8
-
3
4.
7
1.
4
2.
3

J
3.
5
Me
t
h
y
l

t
e
r
t
-
b
u
t
y
l

e
t
h
e
r
16
3
4
-
0
4
-
4
16
2.
0
No
t

D
e
t
e
c
t
e
d
5.
9
Me
t
h
y
l
e
n
e

C
h
l
o
r
i
d
e
75
-
0
9
-
2
38
5.
7
No
t

D
e
t
e
c
t
e
d
13
o-
X
y
l
e
n
e
95
-
4
7
-
6
4.
7
1.
5
No
t

D
e
t
e
c
t
e
d
3.
5
Pr
o
p
y
l
b
e
n
z
e
n
e
10
3
-
6
5
-
1
5.
4
1.
3
No
t

D
e
t
e
c
t
e
d
4.
0
St
y
r
e
n
e
10
0
-
4
2
-
5
4.
6
1.
7
No
t

D
e
t
e
c
t
e
d
3.
4
Te
t
r
a
c
h
l
o
r
o
e
t
h
e
n
e
12
7
-
1
8
-
4
7.
4
1.
9
2.
0

J
5.
5
Te
t
r
a
h
y
d
r
o
f
u
r
a
n
10
9
-
9
9
-
9
3.
2
1.
3
No
t

D
e
t
e
c
t
e
d
2.
4
To
l
u
e
n
e
10
8
-
8
8
-
3
4.
1
0.
7
3
1.
4

J
3.
0
tr
a
n
s
-
1
,
2
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
15
6
-
6
0
-
5
4.
3
2.
1
No
t

D
e
t
e
c
t
e
d
3.
2
tr
a
n
s
-
1
,
3
-
D
i
c
h
l
o
r
o
p
r
o
p
e
n
e
10
0
6
1
-
0
2
-
6
4.
9
1.
2
No
t

D
e
t
e
c
t
e
d
3.
7
Tr
i
c
h
l
o
r
o
e
t
h
e
n
e
79
-
0
1
-
6
5.
8
2.
6
6.
1
4.
3
Vi
n
y
l

C
h
l
o
r
i
d
e
75
-
0
1
-
4
2.
8
2.
0
No
t

D
e
t
e
c
t
e
d
2.
1
J
=

E
s
t
i
m
a
t
e
d

v
a
l
u
e
.
D:

A
n
a
l
y
t
e

n
o
t

w
i
t
h
i
n

t
h
e

D
o
D

s
c
o
p
e

o
f

a
c
c
r
e
d
i
t
a
t
i
o
n
.
CA
S
#
Su
r
r
o
g
a
t
e
s
Li
m
i
t
s

%
R
e
c
o
v
e
r
y
1,
2
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
-
d
4
17
0
6
0
-
0
7
-
0
70
-
1
3
0
10
2
4-
B
r
o
m
o
f
l
u
o
r
o
b
e
n
z
e
n
e
46
0
-
0
0
-
4
70
-
1
3
0
97
To
l
u
e
n
e
-
d
8
20
3
7
-
2
6
-
5
70
-
1
3
0
10
3
Pa
g
e

2
7

o
f

4
2
Page 31 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

1
0
:
4
9

P
M
2.
1
5
ms
d
j
.
i

/

j
0
7
3
1
1
9
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
0
9
A
7/
2
1
/
2
2

1
2
:
0
0

A
M
1
L
i
t
e
r

S
u
m
m
a

C
a
n
i
s
t
e
r
CA
M
-
0
1
0
DU
P
-
0
1
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
(u
g
/
m
3
)
CA
S
#
LO
D
Co
m
p
o
u
n
d
(u
g
/
m
3
)
MD
L
Rp
t
.

L
i
m
i
t
(u
g
/
m
3
)
Am
o
u
n
t
(u
g
/
m
3
)
1,
1
,
1
-
T
r
i
c
h
l
o
r
o
e
t
h
a
n
e
71
-
5
5
-
6
5.
9
1.
4
No
t

D
e
t
e
c
t
e
d
3.
3
1,
1
,
2
,
2
-
T
e
t
r
a
c
h
l
o
r
o
e
t
h
a
n
e
79
-
3
4
-
5
7.
4
1.
9
No
t

D
e
t
e
c
t
e
d
5.
5
1,
1
,
2
-
T
r
i
c
h
l
o
r
o
e
t
h
a
n
e
79
-
0
0
-
5
5.
9
1.
3
No
t

D
e
t
e
c
t
e
d
4.
3
1,
1
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
75
-
3
4
-
3
4.
4
1.
5
No
t

D
e
t
e
c
t
e
d
2.
4
1,
1
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
75
-
3
5
-
4
4.
3
2.
3
No
t

D
e
t
e
c
t
e
d
3.
2
1,
2
,
4
-
T
r
i
c
h
l
o
r
o
b
e
n
z
e
n
e
12
0
-
8
2
-
1
32
13
No
t

D
e
t
e
c
t
e
d
27
1,
2
,
4
-
T
r
i
m
e
t
h
y
l
b
e
n
z
e
n
e
95
-
6
3
-
6
5.
3
2.
3
No
t

D
e
t
e
c
t
e
d
3.
9
1,
2
-
D
i
b
r
o
m
o
e
t
h
a
n
e

(
E
D
B
)
10
6
-
9
3
-
4
8.
3
1.
7
No
t

D
e
t
e
c
t
e
d
6.
1
1,
2
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
95
-
5
0
-
1
6.
5
1.
6
No
t

D
e
t
e
c
t
e
d
4.
8
1,
2
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
10
7
-
0
6
-
2
4.
4
1.
4
No
t

D
e
t
e
c
t
e
d
3.
2
1,
2
-
D
i
c
h
l
o
r
o
p
r
o
p
a
n
e
78
-
8
7
-
5
5.
0
1.
9
No
t

D
e
t
e
c
t
e
d
3.
7
1,
3
,
5
-
T
r
i
m
e
t
h
y
l
b
e
n
z
e
n
e
10
8
-
6
7
-
8
5.
3
1.
7
No
t

D
e
t
e
c
t
e
d
3.
9
1,
3
-
B
u
t
a
d
i
e
n
e
10
6
-
9
9
-
0
2.
4
1.
9
No
t

D
e
t
e
c
t
e
d
2.
1
1,
3
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
54
1
-
7
3
-
1
6.
5
1.
8
No
t

D
e
t
e
c
t
e
d
4.
8
1,
4
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
10
6
-
4
6
-
7
6.
5
1.
6
No
t

D
e
t
e
c
t
e
d
4.
8
1,
4
-
D
i
o
x
a
n
e
12
3
-
9
1
-
1
15
1.
7
No
t

D
e
t
e
c
t
e
d
5.
8
2,
2
,
4
-
T
r
i
m
e
t
h
y
l
p
e
n
t
a
n
e
54
0
-
8
4
-
1
5.
0
1.
2
No
t

D
e
t
e
c
t
e
d
3.
7
2-
B
u
t
a
n
o
n
e

(
M
e
t
h
y
l

E
t
h
y
l

K
e
t
o
n
e
)
78
-
9
3
-
3
13
4.
1
No
t

D
e
t
e
c
t
e
d
11
2-
H
e
x
a
n
o
n
e
59
1
-
7
8
-
6
18
8.
4
No
t

D
e
t
e
c
t
e
d
15
2-
P
r
o
p
a
n
o
l
67
-
6
3
-
0
10
3.
6
14
6.
9
3-
C
h
l
o
r
o
p
r
o
p
e
n
e
10
7
-
0
5
-
1
13
3.
0
No
t

D
e
t
e
c
t
e
d
5.
0
4-
E
t
h
y
l
t
o
l
u
e
n
e
62
2
-
9
6
-
8
5.
3
1.
7
No
t

D
e
t
e
c
t
e
d
3.
9
4-
M
e
t
h
y
l
-
2
-
p
e
n
t
a
n
o
n
e
10
8
-
1
0
-
1
4.
4
1.
3
No
t

D
e
t
e
c
t
e
d
3.
2
Ac
e
t
o
n
e
67
-
6
4
-
1
26
5.
3
42
8.
7
Pa
g
e

2
8

o
f

4
2
Page 32 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

1
0
:
4
9

P
M
2.
1
5
ms
d
j
.
i

/

j
0
7
3
1
1
9
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
0
9
A
7/
2
1
/
2
2

1
2
:
0
0

A
M
1
L
i
t
e
r

S
u
m
m
a

C
a
n
i
s
t
e
r
CA
M
-
0
1
0
DU
P
-
0
1
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
(u
g
/
m
3
)
CA
S
#
LO
D
Co
m
p
o
u
n
d
(u
g
/
m
3
)
MD
L
Rp
t
.

L
i
m
i
t
(u
g
/
m
3
)
Am
o
u
n
t
(u
g
/
m
3
)
al
p
h
a
-
C
h
l
o
r
o
t
o
l
u
e
n
e
10
0
-
4
4
-
7
5.
6
1.
4
No
t

D
e
t
e
c
t
e
d
4.
1
Be
n
z
e
n
e
71
-
4
3
-
2
3.
4
1.
2
No
t

D
e
t
e
c
t
e
d
2.
5
Br
o
m
o
d
i
c
h
l
o
r
o
m
e
t
h
a
n
e
75
-
2
7
-
4
7.
2
2.
0
No
t

D
e
t
e
c
t
e
d
4.
0
Br
o
m
o
f
o
r
m
75
-
2
5
-
2
11
2.
0
No
t

D
e
t
e
c
t
e
d
8.
2
Br
o
m
o
m
e
t
h
a
n
e
74
-
8
3
-
9
42
7.
4
No
t

D
e
t
e
c
t
e
d
14
Ca
r
b
o
n

D
i
s
u
l
f
i
d
e
75
-
1
5
-
0
13
4.
8
43
11
Ca
r
b
o
n

T
e
t
r
a
c
h
l
o
r
i
d
e
56
-
2
3
-
5
6.
8
1.
3
No
t

D
e
t
e
c
t
e
d
5.
0
Ch
l
o
r
o
b
e
n
z
e
n
e
10
8
-
9
0
-
7
4.
9
0.
7
5
No
t

D
e
t
e
c
t
e
d
2.
8
Ch
l
o
r
o
e
t
h
a
n
e
75
-
0
0
-
3
11
3.
9
No
t

D
e
t
e
c
t
e
d
9.
6
Ch
l
o
r
o
f
o
r
m
67
-
6
6
-
3
5.
2
2.
0
No
t

D
e
t
e
c
t
e
d
2.
9
Ch
l
o
r
o
m
e
t
h
a
n
e
74
-
8
7
-
3
22
4.
8
No
t

D
e
t
e
c
t
e
d
7.
5
ci
s
-
1
,
2
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
15
6
-
5
9
-
2
4.
3
1.
8
No
t

D
e
t
e
c
t
e
d
3.
2
ci
s
-
1
,
3
-
D
i
c
h
l
o
r
o
p
r
o
p
e
n
e
10
0
6
1
-
0
1
-
5
4.
9
1.
5
No
t

D
e
t
e
c
t
e
d
3.
6
Cu
m
e
n
e
98
-
8
2
-
8
5.
3
1.
9
No
t

D
e
t
e
c
t
e
d
3.
9
Cy
c
l
o
h
e
x
a
n
e
11
0
-
8
2
-
7
3.
7
0.
6
5
1.
4

J
2.
7
Di
b
r
o
m
o
c
h
l
o
r
o
m
e
t
h
a
n
e
12
4
-
4
8
-
1
9.
2
1.
3
No
t

D
e
t
e
c
t
e
d
6.
8
Et
h
a
n
o
l
64
-
1
7
-
5
20
6.
4
28
6.
9
Et
h
y
l

B
e
n
z
e
n
e
10
0
-
4
1
-
4
4.
7
1.
3
No
t

D
e
t
e
c
t
e
d
3.
4
Fr
e
o
n

1
1
75
-
6
9
-
4
6.
0
1.
8
No
t

D
e
t
e
c
t
e
d
4.
5
Fr
e
o
n

1
1
3
76
-
1
3
-
1
8.
2
1.
9
No
t

D
e
t
e
c
t
e
d
6.
1
Fr
e
o
n

1
1
4
76
-
1
4
-
2
7.
5
2.
6
No
t

D
e
t
e
c
t
e
d
5.
6
Fr
e
o
n

1
2
75
-
7
1
-
8
5.
3
2.
1
2.
6

J
3.
9
He
p
t
a
n
e
14
2
-
8
2
-
5
4.
4
1.
9
No
t

D
e
t
e
c
t
e
d
3.
3
He
x
a
c
h
l
o
r
o
b
u
t
a
d
i
e
n
e
87
-
6
8
-
3
46
14
No
t

D
e
t
e
c
t
e
d
39
Pa
g
e

2
9

o
f

4
2
Page 33 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

1
0
:
4
9

P
M
2.
1
5
ms
d
j
.
i

/

j
0
7
3
1
1
9
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
0
9
A
7/
2
1
/
2
2

1
2
:
0
0

A
M
1
L
i
t
e
r

S
u
m
m
a

C
a
n
i
s
t
e
r
CA
M
-
0
1
0
DU
P
-
0
1
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
(u
g
/
m
3
)
CA
S
#
LO
D
Co
m
p
o
u
n
d
(u
g
/
m
3
)
MD
L
Rp
t
.

L
i
m
i
t
(u
g
/
m
3
)
Am
o
u
n
t
(u
g
/
m
3
)
He
x
a
n
e
11
0
-
5
4
-
3
3.
8
1.
1
No
t

D
e
t
e
c
t
e
d
2.
8
m,
p
-
X
y
l
e
n
e
10
8
-
3
8
-
3
4.
7
1.
4
No
t

D
e
t
e
c
t
e
d
3.
4
Me
t
h
y
l

t
e
r
t
-
b
u
t
y
l

e
t
h
e
r
16
3
4
-
0
4
-
4
16
2.
0
No
t

D
e
t
e
c
t
e
d
5.
8
Me
t
h
y
l
e
n
e

C
h
l
o
r
i
d
e
75
-
0
9
-
2
37
5.
6
No
t

D
e
t
e
c
t
e
d
13
o-
X
y
l
e
n
e
95
-
4
7
-
6
4.
7
1.
4
No
t

D
e
t
e
c
t
e
d
3.
4
Pr
o
p
y
l
b
e
n
z
e
n
e
10
3
-
6
5
-
1
5.
3
1.
3
No
t

D
e
t
e
c
t
e
d
3.
9
St
y
r
e
n
e
10
0
-
4
2
-
5
4.
6
1.
7
No
t

D
e
t
e
c
t
e
d
3.
4
Te
t
r
a
c
h
l
o
r
o
e
t
h
e
n
e
12
7
-
1
8
-
4
7.
3
1.
8
No
t

D
e
t
e
c
t
e
d
5.
4
Te
t
r
a
h
y
d
r
o
f
u
r
a
n
10
9
-
9
9
-
9
3.
2
1.
3
11
2.
3
To
l
u
e
n
e
10
8
-
8
8
-
3
4.
0
0.
7
2
4.
0
3.
0
tr
a
n
s
-
1
,
2
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
15
6
-
6
0
-
5
4.
3
2.
0
No
t

D
e
t
e
c
t
e
d
3.
2
tr
a
n
s
-
1
,
3
-
D
i
c
h
l
o
r
o
p
r
o
p
e
n
e
10
0
6
1
-
0
2
-
6
4.
9
1.
2
No
t

D
e
t
e
c
t
e
d
3.
6
Tr
i
c
h
l
o
r
o
e
t
h
e
n
e
79
-
0
1
-
6
5.
8
2.
5
No
t

D
e
t
e
c
t
e
d
4.
3
Vi
n
y
l

C
h
l
o
r
i
d
e
75
-
0
1
-
4
2.
7
2.
0
No
t

D
e
t
e
c
t
e
d
2.
0
J
=

E
s
t
i
m
a
t
e
d

v
a
l
u
e
.
D:

A
n
a
l
y
t
e

n
o
t

w
i
t
h
i
n

t
h
e

D
o
D

s
c
o
p
e

o
f

a
c
c
r
e
d
i
t
a
t
i
o
n
.
CA
S
#
Su
r
r
o
g
a
t
e
s
Li
m
i
t
s

%
R
e
c
o
v
e
r
y
1,
2
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
-
d
4
17
0
6
0
-
0
7
-
0
70
-
1
3
0
10
1
4-
B
r
o
m
o
f
l
u
o
r
o
b
e
n
z
e
n
e
46
0
-
0
0
-
4
70
-
1
3
0
99
To
l
u
e
n
e
-
d
8
20
3
7
-
2
6
-
5
70
-
1
3
0
10
2
Pa
g
e

3
0

o
f

4
2
Page 34 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

1
2
:
0
1

P
M
1.
0
0
ms
d
j
.
i

/

j
0
7
3
1
0
5
c
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
1
0
A
NA

-

N
o
t

A
p
p
l
i
c
a
b
l
e
NA

-

N
o
t

A
p
p
l
i
c
a
b
l
e
CA
M
-
0
1
0
La
b

B
l
a
n
k
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
(u
g
/
m
3
)
CA
S
#
LO
D
Co
m
p
o
u
n
d
(u
g
/
m
3
)
MD
L
Rp
t
.

L
i
m
i
t
(u
g
/
m
3
)
Am
o
u
n
t
(u
g
/
m
3
)
1,
1
,
1
-
T
r
i
c
h
l
o
r
o
e
t
h
a
n
e
71
-
5
5
-
6
2.
7
0.
6
8
No
t

D
e
t
e
c
t
e
d
1.
5
1,
1
,
2
,
2
-
T
e
t
r
a
c
h
l
o
r
o
e
t
h
a
n
e
79
-
3
4
-
5
3.
4
0.
8
9
No
t

D
e
t
e
c
t
e
d
2.
5
1,
1
,
2
-
T
r
i
c
h
l
o
r
o
e
t
h
a
n
e
79
-
0
0
-
5
2.
7
0.
5
9
No
t

D
e
t
e
c
t
e
d
2.
0
1,
1
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
75
-
3
4
-
3
2.
0
0.
6
8
No
t

D
e
t
e
c
t
e
d
1.
1
1,
1
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
75
-
3
5
-
4
2.
0
1.
0
No
t

D
e
t
e
c
t
e
d
1.
5
1,
2
,
4
-
T
r
i
c
h
l
o
r
o
b
e
n
z
e
n
e
12
0
-
8
2
-
1
15
5.
9
No
t

D
e
t
e
c
t
e
d
13
1,
2
,
4
-
T
r
i
m
e
t
h
y
l
b
e
n
z
e
n
e
95
-
6
3
-
6
2.
4
1.
0
No
t

D
e
t
e
c
t
e
d
1.
8
1,
2
-
D
i
b
r
o
m
o
e
t
h
a
n
e

(
E
D
B
)
10
6
-
9
3
-
4
3.
8
0.
8
1
No
t

D
e
t
e
c
t
e
d
2.
8
1,
2
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
95
-
5
0
-
1
3.
0
0.
7
2
No
t

D
e
t
e
c
t
e
d
2.
2
1,
2
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
10
7
-
0
6
-
2
2.
0
0.
6
8
No
t

D
e
t
e
c
t
e
d
1.
5
1,
2
-
D
i
c
h
l
o
r
o
p
r
o
p
a
n
e
78
-
8
7
-
5
2.
3
0.
8
9
No
t

D
e
t
e
c
t
e
d
1.
7
1,
3
,
5
-
T
r
i
m
e
t
h
y
l
b
e
n
z
e
n
e
10
8
-
6
7
-
8
2.
4
0.
7
8
No
t

D
e
t
e
c
t
e
d
1.
8
1,
3
-
B
u
t
a
d
i
e
n
e
10
6
-
9
9
-
0
1.
1
0.
8
9
No
t

D
e
t
e
c
t
e
d
1.
0
1,
3
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
54
1
-
7
3
-
1
3.
0
0.
8
4
No
t

D
e
t
e
c
t
e
d
2.
2
1,
4
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
10
6
-
4
6
-
7
3.
0
0.
7
3
No
t

D
e
t
e
c
t
e
d
2.
2
1,
4
-
D
i
o
x
a
n
e
12
3
-
9
1
-
1
7.
2
0.
7
9
No
t

D
e
t
e
c
t
e
d
2.
7
2,
2
,
4
-
T
r
i
m
e
t
h
y
l
p
e
n
t
a
n
e
54
0
-
8
4
-
1
2.
3
0.
5
6
No
t

D
e
t
e
c
t
e
d
1.
7
2-
B
u
t
a
n
o
n
e

(
M
e
t
h
y
l

E
t
h
y
l

K
e
t
o
n
e
)
78
-
9
3
-
3
5.
9
1.
9
No
t

D
e
t
e
c
t
e
d
5.
0
2-
H
e
x
a
n
o
n
e
59
1
-
7
8
-
6
8.
2
3.
9
No
t

D
e
t
e
c
t
e
d
7.
0
2-
P
r
o
p
a
n
o
l
67
-
6
3
-
0
4.
9
1.
7
No
t

D
e
t
e
c
t
e
d
3.
2
3-
C
h
l
o
r
o
p
r
o
p
e
n
e
10
7
-
0
5
-
1
6.
3
1.
4
No
t

D
e
t
e
c
t
e
d
2.
3
4-
E
t
h
y
l
t
o
l
u
e
n
e
62
2
-
9
6
-
8
2.
4
0.
8
1
No
t

D
e
t
e
c
t
e
d
1.
8
4-
M
e
t
h
y
l
-
2
-
p
e
n
t
a
n
o
n
e
10
8
-
1
0
-
1
2.
0
0.
6
1
No
t

D
e
t
e
c
t
e
d
1.
5
Ac
e
t
o
n
e
67
-
6
4
-
1
12
2.
5
No
t

D
e
t
e
c
t
e
d
4.
0
Pa
g
e

3
1

o
f

4
2
Page 35 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

1
2
:
0
1

P
M
1.
0
0
ms
d
j
.
i

/

j
0
7
3
1
0
5
c
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
1
0
A
NA

-

N
o
t

A
p
p
l
i
c
a
b
l
e
NA

-

N
o
t

A
p
p
l
i
c
a
b
l
e
CA
M
-
0
1
0
La
b

B
l
a
n
k
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
(u
g
/
m
3
)
CA
S
#
LO
D
Co
m
p
o
u
n
d
(u
g
/
m
3
)
MD
L
Rp
t
.

L
i
m
i
t
(u
g
/
m
3
)
Am
o
u
n
t
(u
g
/
m
3
)
al
p
h
a
-
C
h
l
o
r
o
t
o
l
u
e
n
e
10
0
-
4
4
-
7
2.
6
0.
6
6
No
t

D
e
t
e
c
t
e
d
1.
9
Be
n
z
e
n
e
71
-
4
3
-
2
1.
6
0.
5
6
No
t

D
e
t
e
c
t
e
d
1.
2
Br
o
m
o
d
i
c
h
l
o
r
o
m
e
t
h
a
n
e
75
-
2
7
-
4
3.
4
0.
9
4
No
t

D
e
t
e
c
t
e
d
1.
9
Br
o
m
o
f
o
r
m
75
-
2
5
-
2
5.
2
0.
9
4
No
t

D
e
t
e
c
t
e
d
3.
8
Br
o
m
o
m
e
t
h
a
n
e
74
-
8
3
-
9
19
3.
4
No
t

D
e
t
e
c
t
e
d
6.
6
Ca
r
b
o
n

D
i
s
u
l
f
i
d
e
75
-
1
5
-
0
6.
2
2.
2
No
t

D
e
t
e
c
t
e
d
5.
3
Ca
r
b
o
n

T
e
t
r
a
c
h
l
o
r
i
d
e
56
-
2
3
-
5
3.
1
0.
6
2
No
t

D
e
t
e
c
t
e
d
2.
3
Ch
l
o
r
o
b
e
n
z
e
n
e
10
8
-
9
0
-
7
2.
3
0.
3
5
No
t

D
e
t
e
c
t
e
d
1.
3
Ch
l
o
r
o
e
t
h
a
n
e
75
-
0
0
-
3
5.
3
1.
8
No
t

D
e
t
e
c
t
e
d
4.
5
Ch
l
o
r
o
f
o
r
m
67
-
6
6
-
3
2.
4
0.
9
2
No
t

D
e
t
e
c
t
e
d
1.
4
Ch
l
o
r
o
m
e
t
h
a
n
e
74
-
8
7
-
3
10
2.
2
No
t

D
e
t
e
c
t
e
d
3.
5
ci
s
-
1
,
2
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
15
6
-
5
9
-
2
2.
0
0.
8
4
No
t

D
e
t
e
c
t
e
d
1.
5
ci
s
-
1
,
3
-
D
i
c
h
l
o
r
o
p
r
o
p
e
n
e
10
0
6
1
-
0
1
-
5
2.
3
0.
7
0
No
t

D
e
t
e
c
t
e
d
1.
7
Cu
m
e
n
e
98
-
8
2
-
8
2.
4
0.
8
9
No
t

D
e
t
e
c
t
e
d
1.
8
Cy
c
l
o
h
e
x
a
n
e
11
0
-
8
2
-
7
1.
7
0.
3
0
No
t

D
e
t
e
c
t
e
d
1.
3
Di
b
r
o
m
o
c
h
l
o
r
o
m
e
t
h
a
n
e
12
4
-
4
8
-
1
4.
2
0.
6
1
No
t

D
e
t
e
c
t
e
d
3.
2
Et
h
a
n
o
l
64
-
1
7
-
5
9.
4
3.
0
No
t

D
e
t
e
c
t
e
d
3.
2
Et
h
y
l

B
e
n
z
e
n
e
10
0
-
4
1
-
4
2.
2
0.
6
0
No
t

D
e
t
e
c
t
e
d
1.
6
Fr
e
o
n

1
1
75
-
6
9
-
4
2.
8
0.
8
2
No
t

D
e
t
e
c
t
e
d
2.
1
Fr
e
o
n

1
1
3
76
-
1
3
-
1
3.
8
0.
8
7
No
t

D
e
t
e
c
t
e
d
2.
8
Fr
e
o
n

1
1
4
76
-
1
4
-
2
3.
5
1.
2
No
t

D
e
t
e
c
t
e
d
2.
6
Fr
e
o
n

1
2
75
-
7
1
-
8
2.
5
0.
9
8
No
t

D
e
t
e
c
t
e
d
1.
8
He
p
t
a
n
e
14
2
-
8
2
-
5
2.
0
0.
8
7
No
t

D
e
t
e
c
t
e
d
1.
5
He
x
a
c
h
l
o
r
o
b
u
t
a
d
i
e
n
e
87
-
6
8
-
3
21
6.
7
No
t

D
e
t
e
c
t
e
d
18
Pa
g
e

3
2

o
f

4
2
Page 36 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

1
2
:
0
1

P
M
1.
0
0
ms
d
j
.
i

/

j
0
7
3
1
0
5
c
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
1
0
A
NA

-

N
o
t

A
p
p
l
i
c
a
b
l
e
NA

-

N
o
t

A
p
p
l
i
c
a
b
l
e
CA
M
-
0
1
0
La
b

B
l
a
n
k
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
(u
g
/
m
3
)
CA
S
#
LO
D
Co
m
p
o
u
n
d
(u
g
/
m
3
)
MD
L
Rp
t
.

L
i
m
i
t
(u
g
/
m
3
)
Am
o
u
n
t
(u
g
/
m
3
)
He
x
a
n
e
11
0
-
5
4
-
3
1.
8
0.
4
9
No
t

D
e
t
e
c
t
e
d
1.
3
m,
p
-
X
y
l
e
n
e
10
8
-
3
8
-
3
2.
2
0.
6
4
No
t

D
e
t
e
c
t
e
d
1.
6
Me
t
h
y
l

t
e
r
t
-
b
u
t
y
l

e
t
h
e
r
16
3
4
-
0
4
-
4
7.
2
0.
9
2
No
t

D
e
t
e
c
t
e
d
2.
7
Me
t
h
y
l
e
n
e

C
h
l
o
r
i
d
e
75
-
0
9
-
2
17
2.
6
No
t

D
e
t
e
c
t
e
d
5.
9
o-
X
y
l
e
n
e
95
-
4
7
-
6
2.
2
0.
6
7
No
t

D
e
t
e
c
t
e
d
1.
6
Pr
o
p
y
l
b
e
n
z
e
n
e
10
3
-
6
5
-
1
2.
4
0.
6
1
No
t

D
e
t
e
c
t
e
d
1.
8
St
y
r
e
n
e
10
0
-
4
2
-
5
2.
1
0.
7
7
No
t

D
e
t
e
c
t
e
d
1.
6
Te
t
r
a
c
h
l
o
r
o
e
t
h
e
n
e
12
7
-
1
8
-
4
3.
4
0.
8
6
No
t

D
e
t
e
c
t
e
d
2.
5
Te
t
r
a
h
y
d
r
o
f
u
r
a
n
10
9
-
9
9
-
9
1.
5
0.
6
2
No
t

D
e
t
e
c
t
e
d
1.
1
To
l
u
e
n
e
10
8
-
8
8
-
3
1.
9
0.
3
4
No
t

D
e
t
e
c
t
e
d
1.
4
tr
a
n
s
-
1
,
2
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
15
6
-
6
0
-
5
2.
0
0.
9
5
No
t

D
e
t
e
c
t
e
d
1.
5
tr
a
n
s
-
1
,
3
-
D
i
c
h
l
o
r
o
p
r
o
p
e
n
e
10
0
6
1
-
0
2
-
6
2.
3
0.
5
5
No
t

D
e
t
e
c
t
e
d
1.
7
Tr
i
c
h
l
o
r
o
e
t
h
e
n
e
79
-
0
1
-
6
2.
7
1.
2
No
t

D
e
t
e
c
t
e
d
2.
0
Vi
n
y
l

C
h
l
o
r
i
d
e
75
-
0
1
-
4
1.
3
0.
9
2
No
t

D
e
t
e
c
t
e
d
0.
9
4
D:

A
n
a
l
y
t
e

n
o
t

w
i
t
h
i
n

t
h
e

D
o
D

s
c
o
p
e

o
f

a
c
c
r
e
d
i
t
a
t
i
o
n
.
CA
S
#
Su
r
r
o
g
a
t
e
s
Li
m
i
t
s

%
R
e
c
o
v
e
r
y
1,
2
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
-
d
4
17
0
6
0
-
0
7
-
0
70
-
1
3
0
10
0
4-
B
r
o
m
o
f
l
u
o
r
o
b
e
n
z
e
n
e
46
0
-
0
0
-
4
70
-
1
3
0
96
To
l
u
e
n
e
-
d
8
20
3
7
-
2
6
-
5
70
-
1
3
0
98
Pa
g
e

3
3

o
f

4
2
Page 37 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

0
9
:
5
6

A
M
1.
0
0
ms
d
j
.
i

/

j
0
7
3
1
0
2
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
1
1
A
NA

-

N
o
t

A
p
p
l
i
c
a
b
l
e
NA

-

N
o
t

A
p
p
l
i
c
a
b
l
e
CA
M
-
0
1
0
CC
V
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
CA
S
#
Co
m
p
o
u
n
d
%R
e
c
o
v
e
r
y
1,
1
,
1
-
T
r
i
c
h
l
o
r
o
e
t
h
a
n
e
71
-
5
5
-
6
99
1,
1
,
2
,
2
-
T
e
t
r
a
c
h
l
o
r
o
e
t
h
a
n
e
79
-
3
4
-
5
10
0
1,
1
,
2
-
T
r
i
c
h
l
o
r
o
e
t
h
a
n
e
79
-
0
0
-
5
10
1
1,
1
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
75
-
3
4
-
3
99
1,
1
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
75
-
3
5
-
4
10
4
1,
2
,
4
-
T
r
i
c
h
l
o
r
o
b
e
n
z
e
n
e
12
0
-
8
2
-
1
11
7
1,
2
,
4
-
T
r
i
m
e
t
h
y
l
b
e
n
z
e
n
e
95
-
6
3
-
6
12
7
1,
2
-
D
i
b
r
o
m
o
e
t
h
a
n
e

(
E
D
B
)
10
6
-
9
3
-
4
10
3
1,
2
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
95
-
5
0
-
1
11
4
1,
2
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
10
7
-
0
6
-
2
98
1,
2
-
D
i
c
h
l
o
r
o
p
r
o
p
a
n
e
78
-
8
7
-
5
99
1,
3
,
5
-
T
r
i
m
e
t
h
y
l
b
e
n
z
e
n
e
10
8
-
6
7
-
8
11
9
1,
3
-
B
u
t
a
d
i
e
n
e
10
6
-
9
9
-
0
10
2
1,
3
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
54
1
-
7
3
-
1
11
4
1,
4
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
10
6
-
4
6
-
7
11
5
1,
4
-
D
i
o
x
a
n
e
12
3
-
9
1
-
1
11
0
2,
2
,
4
-
T
r
i
m
e
t
h
y
l
p
e
n
t
a
n
e
54
0
-
8
4
-
1
11
8
2-
B
u
t
a
n
o
n
e

(
M
e
t
h
y
l

E
t
h
y
l

K
e
t
o
n
e
)
78
-
9
3
-
3
10
2
2-
H
e
x
a
n
o
n
e
59
1
-
7
8
-
6
11
3
2-
P
r
o
p
a
n
o
l
67
-
6
3
-
0
10
0
3-
C
h
l
o
r
o
p
r
o
p
e
n
e
10
7
-
0
5
-
1
98
4-
E
t
h
y
l
t
o
l
u
e
n
e
62
2
-
9
6
-
8
12
2
4-
M
e
t
h
y
l
-
2
-
p
e
n
t
a
n
o
n
e
10
8
-
1
0
-
1
11
3
Ac
e
t
o
n
e
67
-
6
4
-
1
99
Pa
g
e

3
4

o
f

4
2
Page 38 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

0
9
:
5
6

A
M
1.
0
0
ms
d
j
.
i

/

j
0
7
3
1
0
2
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
1
1
A
NA

-

N
o
t

A
p
p
l
i
c
a
b
l
e
NA

-

N
o
t

A
p
p
l
i
c
a
b
l
e
CA
M
-
0
1
0
CC
V
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
CA
S
#
Co
m
p
o
u
n
d
%R
e
c
o
v
e
r
y
al
p
h
a
-
C
h
l
o
r
o
t
o
l
u
e
n
e
10
0
-
4
4
-
7
12
1
Be
n
z
e
n
e
71
-
4
3
-
2
10
0
Br
o
m
o
d
i
c
h
l
o
r
o
m
e
t
h
a
n
e
75
-
2
7
-
4
96
Br
o
m
o
f
o
r
m
75
-
2
5
-
2
10
7
Br
o
m
o
m
e
t
h
a
n
e
74
-
8
3
-
9
10
8
Ca
r
b
o
n

D
i
s
u
l
f
i
d
e
75
-
1
5
-
0
10
0
Ca
r
b
o
n

T
e
t
r
a
c
h
l
o
r
i
d
e
56
-
2
3
-
5
10
2
Ch
l
o
r
o
b
e
n
z
e
n
e
10
8
-
9
0
-
7
10
0
Ch
l
o
r
o
e
t
h
a
n
e
75
-
0
0
-
3
97
Ch
l
o
r
o
f
o
r
m
67
-
6
6
-
3
10
0
Ch
l
o
r
o
m
e
t
h
a
n
e
74
-
8
7
-
3
96
ci
s
-
1
,
2
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
15
6
-
5
9
-
2
11
1
ci
s
-
1
,
3
-
D
i
c
h
l
o
r
o
p
r
o
p
e
n
e
10
0
6
1
-
0
1
-
5
11
0
Cu
m
e
n
e
98
-
8
2
-
8
12
8
Cy
c
l
o
h
e
x
a
n
e
11
0
-
8
2
-
7
11
8
Di
b
r
o
m
o
c
h
l
o
r
o
m
e
t
h
a
n
e
12
4
-
4
8
-
1
10
4
Et
h
a
n
o
l
64
-
1
7
-
5
93
Et
h
y
l

B
e
n
z
e
n
e
10
0
-
4
1
-
4
11
3
Fr
e
o
n

1
1
75
-
6
9
-
4
98
Fr
e
o
n

1
1
3
76
-
1
3
-
1
10
0
Fr
e
o
n

1
1
4
76
-
1
4
-
2
98
Fr
e
o
n

1
2
75
-
7
1
-
8
10
0
He
p
t
a
n
e
14
2
-
8
2
-
5
11
8
He
x
a
c
h
l
o
r
o
b
u
t
a
d
i
e
n
e
87
-
6
8
-
3
11
2
Pa
g
e

3
5

o
f

4
2
Page 39 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

0
9
:
5
6

A
M
1.
0
0
ms
d
j
.
i

/

j
0
7
3
1
0
2
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
1
1
A
NA

-

N
o
t

A
p
p
l
i
c
a
b
l
e
NA

-

N
o
t

A
p
p
l
i
c
a
b
l
e
CA
M
-
0
1
0
CC
V
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
CA
S
#
Co
m
p
o
u
n
d
%R
e
c
o
v
e
r
y
He
x
a
n
e
11
0
-
5
4
-
3
10
6
m,
p
-
X
y
l
e
n
e
10
8
-
3
8
-
3
11
8
Me
t
h
y
l

t
e
r
t
-
b
u
t
y
l

e
t
h
e
r
16
3
4
-
0
4
-
4
10
7
Me
t
h
y
l
e
n
e

C
h
l
o
r
i
d
e
75
-
0
9
-
2
99
o-
X
y
l
e
n
e
95
-
4
7
-
6
12
4
Pr
o
p
y
l
b
e
n
z
e
n
e
10
3
-
6
5
-
1
11
7
St
y
r
e
n
e
10
0
-
4
2
-
5
12
5
Te
t
r
a
c
h
l
o
r
o
e
t
h
e
n
e
12
7
-
1
8
-
4
10
4
Te
t
r
a
h
y
d
r
o
f
u
r
a
n
10
9
-
9
9
-
9
10
9
To
l
u
e
n
e
10
8
-
8
8
-
3
10
2
tr
a
n
s
-
1
,
2
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
15
6
-
6
0
-
5
10
6
tr
a
n
s
-
1
,
3
-
D
i
c
h
l
o
r
o
p
r
o
p
e
n
e
10
0
6
1
-
0
2
-
6
10
9
Tr
i
c
h
l
o
r
o
e
t
h
e
n
e
79
-
0
1
-
6
10
0
Vi
n
y
l

C
h
l
o
r
i
d
e
75
-
0
1
-
4
10
2
D:

A
n
a
l
y
t
e

n
o
t

w
i
t
h
i
n

t
h
e

D
o
D

s
c
o
p
e

o
f

a
c
c
r
e
d
i
t
a
t
i
o
n
.
CA
S
#
Su
r
r
o
g
a
t
e
s
Li
m
i
t
s

%
R
e
c
o
v
e
r
y
1,
2
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
-
d
4
17
0
6
0
-
0
7
-
0
70
-
1
3
0
10
0
4-
B
r
o
m
o
f
l
u
o
r
o
b
e
n
z
e
n
e
46
0
-
0
0
-
4
70
-
1
3
0
10
2
To
l
u
e
n
e
-
d
8
20
3
7
-
2
6
-
5
70
-
1
3
0
99
Pa
g
e

3
6

o
f

4
2
Page 40 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

1
0
:
2
7

A
M
1.
0
0
ms
d
j
.
i

/

j
0
7
3
1
0
3
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
1
2
A
NA

-

N
o
t

A
p
p
l
i
c
a
b
l
e
NA

-

N
o
t

A
p
p
l
i
c
a
b
l
e
CA
M
-
0
1
0
LC
S
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
CA
S
#
Co
m
p
o
u
n
d
%R
e
c
o
v
e
r
y
1,
1
,
1
-
T
r
i
c
h
l
o
r
o
e
t
h
a
n
e
71
-
5
5
-
6
10
1
1,
1
,
2
,
2
-
T
e
t
r
a
c
h
l
o
r
o
e
t
h
a
n
e
79
-
3
4
-
5
10
2
1,
1
,
2
-
T
r
i
c
h
l
o
r
o
e
t
h
a
n
e
79
-
0
0
-
5
10
5
1,
1
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
75
-
3
4
-
3
10
0
1,
1
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
75
-
3
5
-
4
10
5
1,
2
,
4
-
T
r
i
c
h
l
o
r
o
b
e
n
z
e
n
e
12
0
-
8
2
-
1
12
1
1,
2
,
4
-
T
r
i
m
e
t
h
y
l
b
e
n
z
e
n
e
95
-
6
3
-
6
12
5
1,
2
-
D
i
b
r
o
m
o
e
t
h
a
n
e

(
E
D
B
)
10
6
-
9
3
-
4
10
5
1,
2
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
95
-
5
0
-
1
11
2
1,
2
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
10
7
-
0
6
-
2
95
1,
2
-
D
i
c
h
l
o
r
o
p
r
o
p
a
n
e
78
-
8
7
-
5
97
1,
3
,
5
-
T
r
i
m
e
t
h
y
l
b
e
n
z
e
n
e
10
8
-
6
7
-
8
11
6
1,
3
-
B
u
t
a
d
i
e
n
e
10
6
-
9
9
-
0
10
3
1,
3
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
54
1
-
7
3
-
1
11
0
1,
4
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
10
6
-
4
6
-
7
11
1
1,
4
-
D
i
o
x
a
n
e
12
3
-
9
1
-
1
11
0
2,
2
,
4
-
T
r
i
m
e
t
h
y
l
p
e
n
t
a
n
e
54
0
-
8
4
-
1
11
6
2-
B
u
t
a
n
o
n
e

(
M
e
t
h
y
l

E
t
h
y
l

K
e
t
o
n
e
)
78
-
9
3
-
3
10
6
2-
H
e
x
a
n
o
n
e
59
1
-
7
8
-
6
11
6
2-
P
r
o
p
a
n
o
l
67
-
6
3
-
0
11
0
3-
C
h
l
o
r
o
p
r
o
p
e
n
e
10
7
-
0
5
-
1
10
1
4-
E
t
h
y
l
t
o
l
u
e
n
e
62
2
-
9
6
-
8
12
1
4-
M
e
t
h
y
l
-
2
-
p
e
n
t
a
n
o
n
e
10
8
-
1
0
-
1
11
2
Ac
e
t
o
n
e
67
-
6
4
-
1
96
Pa
g
e

3
7

o
f

4
2
*
%

R
e
c
o
v
e
r
y

i
s

c
a
l
c
u
l
a
t
e
d

u
s
i
n
g

u
n
r
o
u
n
d
e
d

a
n
a
l
y
t
i
c
a
l

r
e
s
u
l
t
s
.
Page 41 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

1
0
:
2
7

A
M
1.
0
0
ms
d
j
.
i

/

j
0
7
3
1
0
3
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
1
2
A
NA

-

N
o
t

A
p
p
l
i
c
a
b
l
e
NA

-

N
o
t

A
p
p
l
i
c
a
b
l
e
CA
M
-
0
1
0
LC
S
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
CA
S
#
Co
m
p
o
u
n
d
%R
e
c
o
v
e
r
y
al
p
h
a
-
C
h
l
o
r
o
t
o
l
u
e
n
e
10
0
-
4
4
-
7
11
9
Be
n
z
e
n
e
71
-
4
3
-
2
98
Br
o
m
o
d
i
c
h
l
o
r
o
m
e
t
h
a
n
e
75
-
2
7
-
4
94
Br
o
m
o
f
o
r
m
75
-
2
5
-
2
10
6
Br
o
m
o
m
e
t
h
a
n
e
74
-
8
3
-
9
10
4
Ca
r
b
o
n

D
i
s
u
l
f
i
d
e
75
-
1
5
-
0
10
0
Ca
r
b
o
n

T
e
t
r
a
c
h
l
o
r
i
d
e
56
-
2
3
-
5
10
1
Ch
l
o
r
o
b
e
n
z
e
n
e
10
8
-
9
0
-
7
10
0
Ch
l
o
r
o
e
t
h
a
n
e
75
-
0
0
-
3
10
2
Ch
l
o
r
o
f
o
r
m
67
-
6
6
-
3
96
Ch
l
o
r
o
m
e
t
h
a
n
e
74
-
8
7
-
3
94
ci
s
-
1
,
2
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
15
6
-
5
9
-
2
10
8
ci
s
-
1
,
3
-
D
i
c
h
l
o
r
o
p
r
o
p
e
n
e
10
0
6
1
-
0
1
-
5
11
3
Cu
m
e
n
e
98
-
8
2
-
8
12
6
Cy
c
l
o
h
e
x
a
n
e
11
0
-
8
2
-
7
12
1
Di
b
r
o
m
o
c
h
l
o
r
o
m
e
t
h
a
n
e
12
4
-
4
8
-
1
10
4
Et
h
a
n
o
l
64
-
1
7
-
5
10
0
Et
h
y
l

B
e
n
z
e
n
e
10
0
-
4
1
-
4
11
4
Fr
e
o
n

1
1
75
-
6
9
-
4
98
Fr
e
o
n

1
1
3
76
-
1
3
-
1
99
Fr
e
o
n

1
1
4
76
-
1
4
-
2
98
Fr
e
o
n

1
2
75
-
7
1
-
8
10
0
He
p
t
a
n
e
14
2
-
8
2
-
5
11
9
He
x
a
c
h
l
o
r
o
b
u
t
a
d
i
e
n
e
87
-
6
8
-
3
11
3
Pa
g
e

3
8

o
f

4
2
*
%

R
e
c
o
v
e
r
y

i
s

c
a
l
c
u
l
a
t
e
d

u
s
i
n
g

u
n
r
o
u
n
d
e
d

a
n
a
l
y
t
i
c
a
l

r
e
s
u
l
t
s
.
Page 42 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

1
0
:
2
7

A
M
1.
0
0
ms
d
j
.
i

/

j
0
7
3
1
0
3
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
1
2
A
NA

-

N
o
t

A
p
p
l
i
c
a
b
l
e
NA

-

N
o
t

A
p
p
l
i
c
a
b
l
e
CA
M
-
0
1
0
LC
S
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
CA
S
#
Co
m
p
o
u
n
d
%R
e
c
o
v
e
r
y
He
x
a
n
e
11
0
-
5
4
-
3
10
9
m,
p
-
X
y
l
e
n
e
10
8
-
3
8
-
3
11
8
Me
t
h
y
l

t
e
r
t
-
b
u
t
y
l

e
t
h
e
r
16
3
4
-
0
4
-
4
10
9
Me
t
h
y
l
e
n
e

C
h
l
o
r
i
d
e
75
-
0
9
-
2
96
o-
X
y
l
e
n
e
95
-
4
7
-
6
12
1
Pr
o
p
y
l
b
e
n
z
e
n
e
10
3
-
6
5
-
1
11
6
St
y
r
e
n
e
10
0
-
4
2
-
5
12
5
Te
t
r
a
c
h
l
o
r
o
e
t
h
e
n
e
12
7
-
1
8
-
4
10
5
Te
t
r
a
h
y
d
r
o
f
u
r
a
n
10
9
-
9
9
-
9
10
8
To
l
u
e
n
e
10
8
-
8
8
-
3
10
0
tr
a
n
s
-
1
,
2
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
15
6
-
6
0
-
5
10
7
tr
a
n
s
-
1
,
3
-
D
i
c
h
l
o
r
o
p
r
o
p
e
n
e
10
0
6
1
-
0
2
-
6
11
0
Tr
i
c
h
l
o
r
o
e
t
h
e
n
e
79
-
0
1
-
6
99
Vi
n
y
l

C
h
l
o
r
i
d
e
75
-
0
1
-
4
10
2
D:

A
n
a
l
y
t
e

n
o
t

w
i
t
h
i
n

t
h
e

D
o
D

s
c
o
p
e

o
f

a
c
c
r
e
d
i
t
a
t
i
o
n
.
CA
S
#
Su
r
r
o
g
a
t
e
s
Li
m
i
t
s

%
R
e
c
o
v
e
r
y
1,
2
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
-
d
4
17
0
6
0
-
0
7
-
0
70
-
1
3
0
99
4-
B
r
o
m
o
f
l
u
o
r
o
b
e
n
z
e
n
e
46
0
-
0
0
-
4
70
-
1
3
0
10
0
To
l
u
e
n
e
-
d
8
20
3
7
-
2
6
-
5
70
-
1
3
0
99
Pa
g
e

3
9

o
f

4
2
*
%

R
e
c
o
v
e
r
y

i
s

c
a
l
c
u
l
a
t
e
d

u
s
i
n
g

u
n
r
o
u
n
d
e
d

a
n
a
l
y
t
i
c
a
l

r
e
s
u
l
t
s
.
Page 43 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

1
0
:
5
7

A
M
1.
0
0
ms
d
j
.
i

/

j
0
7
3
1
0
4
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
1
2
A
A
NA

-

N
o
t

A
p
p
l
i
c
a
b
l
e
NA

-

N
o
t

A
p
p
l
i
c
a
b
l
e
CA
M
-
0
1
0
LC
S
D
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
CA
S
#
Co
m
p
o
u
n
d
%R
e
c
o
v
e
r
y
1,
1
,
1
-
T
r
i
c
h
l
o
r
o
e
t
h
a
n
e
71
-
5
5
-
6
10
0
1,
1
,
2
,
2
-
T
e
t
r
a
c
h
l
o
r
o
e
t
h
a
n
e
79
-
3
4
-
5
10
1
1,
1
,
2
-
T
r
i
c
h
l
o
r
o
e
t
h
a
n
e
79
-
0
0
-
5
10
4
1,
1
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
75
-
3
4
-
3
98
1,
1
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
75
-
3
5
-
4
10
6
1,
2
,
4
-
T
r
i
c
h
l
o
r
o
b
e
n
z
e
n
e
12
0
-
8
2
-
1
12
3
1,
2
,
4
-
T
r
i
m
e
t
h
y
l
b
e
n
z
e
n
e
95
-
6
3
-
6
12
3
1,
2
-
D
i
b
r
o
m
o
e
t
h
a
n
e

(
E
D
B
)
10
6
-
9
3
-
4
10
5
1,
2
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
95
-
5
0
-
1
11
0
1,
2
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
10
7
-
0
6
-
2
96
1,
2
-
D
i
c
h
l
o
r
o
p
r
o
p
a
n
e
78
-
8
7
-
5
97
1,
3
,
5
-
T
r
i
m
e
t
h
y
l
b
e
n
z
e
n
e
10
8
-
6
7
-
8
11
4
1,
3
-
B
u
t
a
d
i
e
n
e
10
6
-
9
9
-
0
10
1
1,
3
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
54
1
-
7
3
-
1
10
9
1,
4
-
D
i
c
h
l
o
r
o
b
e
n
z
e
n
e
10
6
-
4
6
-
7
11
0
1,
4
-
D
i
o
x
a
n
e
12
3
-
9
1
-
1
11
1
2,
2
,
4
-
T
r
i
m
e
t
h
y
l
p
e
n
t
a
n
e
54
0
-
8
4
-
1
11
7
2-
B
u
t
a
n
o
n
e

(
M
e
t
h
y
l

E
t
h
y
l

K
e
t
o
n
e
)
78
-
9
3
-
3
10
5
2-
H
e
x
a
n
o
n
e
59
1
-
7
8
-
6
11
6
2-
P
r
o
p
a
n
o
l
67
-
6
3
-
0
11
1
3-
C
h
l
o
r
o
p
r
o
p
e
n
e
10
7
-
0
5
-
1
10
4
4-
E
t
h
y
l
t
o
l
u
e
n
e
62
2
-
9
6
-
8
11
8
4-
M
e
t
h
y
l
-
2
-
p
e
n
t
a
n
o
n
e
10
8
-
1
0
-
1
11
4
Ac
e
t
o
n
e
67
-
6
4
-
1
97
Pa
g
e

4
0

o
f

4
2
*
%

R
e
c
o
v
e
r
y

i
s

c
a
l
c
u
l
a
t
e
d

u
s
i
n
g

u
n
r
o
u
n
d
e
d

a
n
a
l
y
t
i
c
a
l

r
e
s
u
l
t
s
.
Page 44 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

1
0
:
5
7

A
M
1.
0
0
ms
d
j
.
i

/

j
0
7
3
1
0
4
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
1
2
A
A
NA

-

N
o
t

A
p
p
l
i
c
a
b
l
e
NA

-

N
o
t

A
p
p
l
i
c
a
b
l
e
CA
M
-
0
1
0
LC
S
D
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
CA
S
#
Co
m
p
o
u
n
d
%R
e
c
o
v
e
r
y
al
p
h
a
-
C
h
l
o
r
o
t
o
l
u
e
n
e
10
0
-
4
4
-
7
11
7
Be
n
z
e
n
e
71
-
4
3
-
2
99
Br
o
m
o
d
i
c
h
l
o
r
o
m
e
t
h
a
n
e
75
-
2
7
-
4
93
Br
o
m
o
f
o
r
m
75
-
2
5
-
2
10
6
Br
o
m
o
m
e
t
h
a
n
e
74
-
8
3
-
9
10
6
Ca
r
b
o
n

D
i
s
u
l
f
i
d
e
75
-
1
5
-
0
10
0
Ca
r
b
o
n

T
e
t
r
a
c
h
l
o
r
i
d
e
56
-
2
3
-
5
10
0
Ch
l
o
r
o
b
e
n
z
e
n
e
10
8
-
9
0
-
7
98
Ch
l
o
r
o
e
t
h
a
n
e
75
-
0
0
-
3
10
1
Ch
l
o
r
o
f
o
r
m
67
-
6
6
-
3
95
Ch
l
o
r
o
m
e
t
h
a
n
e
74
-
8
7
-
3
90
ci
s
-
1
,
2
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
15
6
-
5
9
-
2
10
8
ci
s
-
1
,
3
-
D
i
c
h
l
o
r
o
p
r
o
p
e
n
e
10
0
6
1
-
0
1
-
5
11
3
Cu
m
e
n
e
98
-
8
2
-
8
12
6
Cy
c
l
o
h
e
x
a
n
e
11
0
-
8
2
-
7
12
2
Di
b
r
o
m
o
c
h
l
o
r
o
m
e
t
h
a
n
e
12
4
-
4
8
-
1
10
3
Et
h
a
n
o
l
64
-
1
7
-
5
10
1
Et
h
y
l

B
e
n
z
e
n
e
10
0
-
4
1
-
4
11
4
Fr
e
o
n

1
1
75
-
6
9
-
4
97
Fr
e
o
n

1
1
3
76
-
1
3
-
1
98
Fr
e
o
n

1
1
4
76
-
1
4
-
2
95
Fr
e
o
n

1
2
75
-
7
1
-
8
98
He
p
t
a
n
e
14
2
-
8
2
-
5
12
0
He
x
a
c
h
l
o
r
o
b
u
t
a
d
i
e
n
e
87
-
6
8
-
3
11
3
Pa
g
e

4
1

o
f

4
2
*
%

R
e
c
o
v
e
r
y

i
s

c
a
l
c
u
l
a
t
e
d

u
s
i
n
g

u
n
r
o
u
n
d
e
d

a
n
a
l
y
t
i
c
a
l

r
e
s
u
l
t
s
.
Page 45 of 47 8/2/2022
1
2
3
4
5
6
Di
l
u
t
i
o
n

F
a
c
t
o
r
:
In
s
t
r
u
m
e
n
t
/
F
i
l
e
n
a
m
e
:
7/
3
1
/
2
2

1
0
:
5
7

A
M
1.
0
0
ms
d
j
.
i

/

j
0
7
3
1
0
4
EP
A

M
E
T
H
O
D

T
O
-
1
5

G
C
/
M
S

F
U
L
L

S
C
A
N
22
0
7
6
8
0
-
1
2
A
A
NA

-

N
o
t

A
p
p
l
i
c
a
b
l
e
NA

-

N
o
t

A
p
p
l
i
c
a
b
l
e
CA
M
-
0
1
0
LC
S
D
Da
t
e
/
T
i
m
e

A
n
a
l
y
z
e
d
:
Cl
i
e
n
t

I
D
:
La
b

I
D
:
Da
t
e
/
T
i
m
e

C
o
l
l
e
c
t
e
d
:
Me
d
i
a
:
CA
S
#
Co
m
p
o
u
n
d
%R
e
c
o
v
e
r
y
He
x
a
n
e
11
0
-
5
4
-
3
10
8
m,
p
-
X
y
l
e
n
e
10
8
-
3
8
-
3
11
7
Me
t
h
y
l

t
e
r
t
-
b
u
t
y
l

e
t
h
e
r
16
3
4
-
0
4
-
4
11
2
Me
t
h
y
l
e
n
e

C
h
l
o
r
i
d
e
75
-
0
9
-
2
95
o-
X
y
l
e
n
e
95
-
4
7
-
6
12
1
Pr
o
p
y
l
b
e
n
z
e
n
e
10
3
-
6
5
-
1
11
4
St
y
r
e
n
e
10
0
-
4
2
-
5
12
4
Te
t
r
a
c
h
l
o
r
o
e
t
h
e
n
e
12
7
-
1
8
-
4
10
4
Te
t
r
a
h
y
d
r
o
f
u
r
a
n
10
9
-
9
9
-
9
10
9
To
l
u
e
n
e
10
8
-
8
8
-
3
10
0
tr
a
n
s
-
1
,
2
-
D
i
c
h
l
o
r
o
e
t
h
e
n
e
15
6
-
6
0
-
5
10
6
tr
a
n
s
-
1
,
3
-
D
i
c
h
l
o
r
o
p
r
o
p
e
n
e
10
0
6
1
-
0
2
-
6
11
0
Tr
i
c
h
l
o
r
o
e
t
h
e
n
e
79
-
0
1
-
6
99
Vi
n
y
l

C
h
l
o
r
i
d
e
75
-
0
1
-
4
10
0
D:

A
n
a
l
y
t
e

n
o
t

w
i
t
h
i
n

t
h
e

D
o
D

s
c
o
p
e

o
f

a
c
c
r
e
d
i
t
a
t
i
o
n
.
CA
S
#
Su
r
r
o
g
a
t
e
s
Li
m
i
t
s

%
R
e
c
o
v
e
r
y
1,
2
-
D
i
c
h
l
o
r
o
e
t
h
a
n
e
-
d
4
17
0
6
0
-
0
7
-
0
70
-
1
3
0
99
4-
B
r
o
m
o
f
l
u
o
r
o
b
e
n
z
e
n
e
46
0
-
0
0
-
4
70
-
1
3
0
99
To
l
u
e
n
e
-
d
8
20
3
7
-
2
6
-
5
70
-
1
3
0
98
Pa
g
e

4
2

o
f

4
2
*
%

R
e
c
o
v
e
r
y

i
s

c
a
l
c
u
l
a
t
e
d

u
s
i
n
g

u
n
r
o
u
n
d
e
d

a
n
a
l
y
t
i
c
a
l

r
e
s
u
l
t
s
.
Page 46 of 47 8/2/2022
1
2
3
4
5
6
Page 47 of 47 8/2/2022
1
2
3
4
5
6

Appendix F PVC Primer and PVC Glue Material Safety Data Sheets
SAFETY DATA SHEET
1. Identification
Oatey Purple Primer- NSF Listed for PVC and CPVCProduct identifier
Other means of identification
1402CSDS number
Part Numbers: 30755(TV), 30756(TV), 30757(TV), 30758, 30759, 30927, 31480, 31481, 31482,
31483Synonyms
Joining PVC PipesRecommended use
None known.Recommended restrictions
Manufacturer/Importer/Supplier/Distributor information
Company Name Oatey Co.
Address 4700 West 160th St.
Cleveland, OH 44135
Telephone [phone]
E-mail [e-mail]
Transport Emergency Chemtrec 1-800-424-9300 (Outside the US 1-703-527-3887)
Emergency First Aid 1-877-740-5015
Contact person MSDS Coordinator
2. Hazard(s) identification
Category 2Flammable liquidsPhysical hazards
Category 1Physical hazards not otherwise classified
Category 4Acute toxicity, oralHealth hazards
Category 2Skin corrosion/irritation
Category 2ASerious eye damage/eye irritation
Category 3 respiratory tract irritationSpecific target organ toxicity, single exposure
Category 3 narcotic effectsSpecific target organ toxicity, single exposure
Category 1Aspiration hazard
Category 1Health hazards not otherwise classified
Not classified.Environmental hazards
Label elements
Signal word Danger
Hazard statement Highly flammable liquid and vapor. Harmful if swallowed. May be fatal if swallowed and enters
airways. Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation. May
cause drowsiness or dizziness.
Precautionary statement
Prevention Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking.
Keep container tightly closed. Ground/bond container and receiving equipment. Use
explosion-proof electrical/ventilating/lighting/equipment. Use non-sparking tools. Take action to
prevent static discharges. Avoid breathing mist or vapor. Wash thoroughly after handling. Do not
eat, drink or smoke when using this product. Use only outdoors or in a well-ventilated area. Wear
protective gloves/protective clothing/eye protection/face protection.
Oatey Purple Primer- NSF Listed for PVC and CPVC SDS Canada
926733 Version #: 01 Revision date: - Issue date: 21-December-2015 1 / 9
Response IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. IF ON SKIN (or hair):
Take off immediately all contaminated clothing. Rinse skin with water. IF INHALED: Remove
victim to fresh air and keep at rest in a position comfortable for breathing. IF IN EYES: Rinse
cautiously with water for several minutes. Remove contact lenses, if present and easy to do.
Continue rinsing. Call a POISON CENTER or doctor/physician if you feel unwell. Rinse mouth. Do
NOT induce vomiting. Take off contaminated clothing and wash it before reuse. In case of fire:
Use appropriate media to extinguish.
Storage Keep cool. Store in a well-ventilated place. Keep container tightly closed. Store locked up.
Disposal Dispose of contents/container in accordance with local/regional/national/international regulations.
Other hazards Frequent or prolonged contact may defat and dry the skin, leading to discomfort and dermatitis.
May form explosive peroxides.
Supplemental information Not applicable.
3. Composition/information on ingredients
Mixtures
67-64-1 25-40Acetone
CAS number %Chemical name
108-94-1 25-40Cyclohexanone
78-93-3 15-30Methyl ethyl ketone
All concentrations are in percent by weight unless ingredient is a gas. Gas concentrations are in percent by volume.
4. First-aid measures
Remove victim to fresh air and keep at rest in a position comfortable for breathing. Call a POISON
CENTER or doctor/physician if you feel unwell.
Inhalation
Take off immediately all contaminated clothing. Wash with plenty of soap and water. If skin
irritation occurs: Get medical advice/attention.
Skin contact
Immediately flush eyes with plenty of water for at least 15 minutes. Remove contact lenses, if
present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice/attention.
Eye contact
Call a physician or poison control center immediately. Do not induce vomiting. If vomiting occurs,
keep head low so that stomach content doesn't get into the lungs. Aspiration may cause
pulmonary edema and pneumonitis.
Ingestion
Irritation of nose and throat. Aspiration may cause pulmonary edema and pneumonitis. Severe eye
irritation. Symptoms may include stinging, tearing, redness, swelling, and blurred vision. May
cause respiratory irritation. Vapors have a narcotic effect and may cause headache, fatigue,
dizziness and nausea. Skin irritation. May cause redness and pain.
Most important
symptoms/effects, acute and
delayed
Provide general supportive measures and treat symptomatically. Thermal burns: Flush with water
immediately. While flushing, remove clothes which do not adhere to affected area. Call an
ambulance. Continue flushing during transport to hospital. In case of shortness of breath, give
oxygen. Keep victim warm. Keep victim under observation. Symptoms may be delayed.
Indication of immediate
medical attention and special
treatment needed
Take off all contaminated clothing immediately. IF exposed or concerned: Get medical
advice/attention. Ensure that medical personnel are aware of the material(s) involved, and take
precautions to protect themselves. Wash contaminated clothing before reuse.
General information
5. Fire-fighting measures
Alcohol resistant foam. Water fog. Dry chemical powder. Carbon dioxide (CO2).Suitable extinguishing media
Do not use water jet as an extinguisher, as this will spread the fire.Unsuitable extinguishing
media
Vapors may form explosive mixtures with air. Vapors may travel considerable distance to a source
of ignition and flash back. During fire, gases hazardous to health may be formed.
Specific hazards arising from
the chemical
Self-contained breathing apparatus and full protective clothing must be worn in case of fire.Special protective equipment
and precautions for firefighters
In case of fire and/or explosion do not breathe fumes. Move containers from fire area if you can do
so without risk.
Fire fighting
equipment/instructions
Use standard firefighting procedures and consider the hazards of other involved materials. Cool
containers exposed to flames with water until well after the fire is out.Specific methods
Highly flammable liquid and vapor. This product contains tetrahydrofuran that may form explosive
organic peroxide when exposed to air or light or with age.
General fire hazards
Oatey Purple Primer- NSF Listed for PVC and CPVC SDS Canada
926733 Version #: 01 Revision date: - Issue date: 21-December-2015 2 / 9
6. Accidental release measures
Keep unnecessary personnel away. Keep people away from and upwind of spill/leak. Keep out of
low areas. Eliminate all ignition sources (no smoking, flares, sparks, or flames in immediate area).
Wear appropriate protective equipment and clothing during clean-up. Avoid inhalation of vapors or
mists. Do not touch damaged containers or spilled material unless wearing appropriate protective
clothing. Ventilate closed spaces before entering them. Local authorities should be advised if
significant spillages cannot be contained. For personal protection, see section 8 of the SDS.
Personal precautions,
protective equipment and
emergency procedures
Eliminate all ignition sources (no smoking, flares, sparks, or flames in immediate area). Take
precautionary measures against static discharge. Use only non-sparking tools. Keep combustibles
(wood, paper, oil, etc.) away from spilled material.
Large Spills: Stop the flow of material, if this is without risk. Dike the spilled material, where this is
possible. Cover with plastic sheet to prevent spreading. Use a non-combustible material like
vermiculite, sand or earth to soak up the product and place into a container for later disposal. Use
water spray to reduce vapors or divert vapor cloud drift. Following product recovery, flush area with
water.
Small Spills: Wipe up with absorbent material (e.g. cloth, fleece). Clean surface thoroughly to
remove residual contamination.
Never return spills to original containers for re-use. This product is miscible in water. For waste
disposal, see section 13 of the SDS.
Methods and materials for
containment and cleaning up
Avoid discharge into drains, water courses or onto the ground.Environmental precautions
7. Handling and storage
Vapors may form explosive mixtures with air. Do not handle, store or open near an open flame,
sources of heat or sources of ignition. Protect material from direct sunlight. Take precautionary
measures against static discharges. All equipment used when handling the product must be
grounded. Use non-sparking tools and explosion-proof equipment. Do not taste or swallow. Avoid
breathing mist or vapor. Avoid contact with skin. Avoid contact with eyes. Avoid prolonged
exposure. Avoid contact with clothing. Provide adequate ventilation. Wear appropriate personal
protective equipment. Observe good industrial hygiene practices. When using, do not eat, drink or
smoke. Wash hands thoroughly after handling.
Precautions for safe handling
Store locked up. Keep away from heat, sparks and open flame. Prevent electrostatic charge
build-up by using common bonding and grounding techniques. Store in original tightly closed
container. Store in a cool, dry place out of direct sunlight. Store in a well-ventilated place. Store
away from incompatible materials (see Section 10 of the SDS). Keep in an area equipped with
sprinklers.
Conditions for safe storage,
including any incompatibilities
8. Exposure controls/personal protection
Occupational exposure limits
US. ACGIH Threshold Limit Values
ValueTypeComponents
STEL 500 ppmAcetone (CAS 67-64-1)
TWA 250 ppm
STEL 50 ppmCyclohexanone (CAS
108-94-1)
TWA 20 ppm
STEL 300 ppmMethyl ethyl ketone (CAS
78-93-3)
TWA 200 ppm
Canada. Alberta OELs (Occupational Health & Safety Code, Schedule 1, Table 2)
ValueTypeComponents
STEL 1800 mg/m3Acetone (CAS 67-64-1)
750 ppm
TWA 1200 mg/m3
500 ppm
STEL 200 mg/m3Cyclohexanone (CAS
108-94-1)
50 ppm
TWA 80 mg/m3
20 ppm
Oatey Purple Primer- NSF Listed for PVC and CPVC SDS Canada
926733 Version #: 01 Revision date: - Issue date: 21-December-2015 3 / 9
Canada. Alberta OELs (Occupational Health & Safety Code, Schedule 1, Table 2)
ValueTypeComponents
STEL 885 mg/m3Methyl ethyl ketone (CAS
78-93-3)
300 ppm
TWA 590 mg/m3
200 ppm
Canada. British Columbia OELs. (Occupational Exposure Limits for Chemical Substances, Occupational Health and
Safety Regulation 296/97, as amended)
ValueTypeComponents
STEL 500 ppmAcetone (CAS 67-64-1)
TWA 250 ppm
STEL 50 ppmCyclohexanone (CAS
108-94-1)
TWA 20 ppm
STEL 100 ppmMethyl ethyl ketone (CAS
78-93-3)
TWA 50 ppm
Canada. Manitoba OELs (Reg. 217/2006, The Workplace Safety And Health Act)
ValueTypeComponents
STEL 500 ppmAcetone (CAS 67-64-1)
TWA 250 ppm
STEL 50 ppmCyclohexanone (CAS
108-94-1)
TWA 20 ppm
STEL 300 ppmMethyl ethyl ketone (CAS
78-93-3)
TWA 200 ppm
Canada. Ontario OELs. (Control of Exposure to Biological or Chemical Agents)
ValueTypeComponents
STEL 750 ppmAcetone (CAS 67-64-1)
TWA 500 ppm
STEL 50 ppmCyclohexanone (CAS
108-94-1)
TWA 20 ppm
STEL 300 ppmMethyl ethyl ketone (CAS
78-93-3)
TWA 200 ppm
Canada. Quebec OELs. (Ministry of Labor - Regulation Respecting the Quality of the Work Environment)
ValueTypeComponents
STEL 2380 mg/m3Acetone (CAS 67-64-1)
1000 ppm
TWA 1190 mg/m3
500 ppm
TWA 100 mg/m3Cyclohexanone (CAS
108-94-1)
25 ppm
STEL 300 mg/m3Methyl ethyl ketone (CAS
78-93-3)
100 ppm
TWA 150 mg/m3
50 ppm
Oatey Purple Primer- NSF Listed for PVC and CPVC SDS Canada
926733 Version #: 01 Revision date: - Issue date: 21-December-2015 4 / 9
Biological limit values
ACGIH Biological Exposure Indices
Value Sampling TimeDeterminant SpecimenComponents
25 mg/l Acetone Urine *Acetone (CAS 67-64-1)
80 mg/l 1,2-Cyclohexan
ediol,with
hydrolysis
Urine *Cyclohexanone (CAS
108-94-1)
8 mg/l Cyclohexanol,
with hydrolysis
Urine *
2 mg/l MEK Urine *Methyl ethyl ketone (CAS
78-93-3)
* - For sampling details, please see the source document.
Exposure guidelines
Canada - Alberta OELs: Skin designation
Cyclohexanone (CAS 108-94-1) Can be absorbed through the skin.
Canada - British Columbia OELs: Skin designation
Cyclohexanone (CAS 108-94-1) Can be absorbed through the skin.
Canada - Manitoba OELs: Skin designation
Cyclohexanone (CAS 108-94-1) Can be absorbed through the skin.
Canada - Ontario OELs: Skin designation
Cyclohexanone (CAS 108-94-1) Can be absorbed through the skin.
Canada - Quebec OELs: Skin designation
Cyclohexanone (CAS 108-94-1) Can be absorbed through the skin.
Canada - Saskatchewan OELs: Skin designation
Cyclohexanone (CAS 108-94-1) Can be absorbed through the skin.
US ACGIH Threshold Limit Values: Skin designation
Cyclohexanone (CAS 108-94-1) Can be absorbed through the skin.
Explosion-proof general and local exhaust ventilation. Good general ventilation (typically 10 air
changes per hour) should be used. Ventilation rates should be matched to conditions. If
applicable, use process enclosures, local exhaust ventilation, or other engineering controls to
maintain airborne levels below recommended exposure limits. If exposure limits have not been
established, maintain airborne levels to an acceptable level. Eye wash facilities and emergency
shower must be available when handling this product.
Appropriate engineering
controls
Individual protection measures, such as personal protective equipment
Wear safety glasses with side shields (or goggles).Eye/face protection
Skin protection
Wear appropriate chemical resistant gloves.Hand protection
Wear appropriate chemical resistant clothing.Other
If engineering controls do not maintain airborne concentrations below recommended exposure
limits (where applicable) or to an acceptable level (in countries where exposure limits have not
been established), an approved respirator must be worn.
Respiratory protection
Wear appropriate thermal protective clothing, when necessary.Thermal hazards
When using, do not eat, drink or smoke. Always observe good personal hygiene measures, such
as washing after handling the material and before eating, drinking, and/or smoking. Routinely wash
work clothing and protective equipment to remove contaminants.
General hygiene
considerations
9. Physical and chemical properties
Appearance
Liquid.Physical state
Translucent liquid.Form
PurpleColor
Solvent.Odor
Odor threshold Not available.
pH Not available.
Melting point/freezing point Not available.
Initial boiling point and boiling
range
151 °F (66.11 °C)
Oatey Purple Primer- NSF Listed for PVC and CPVC SDS Canada
926733 Version #: 01 Revision date: - Issue date: 21-December-2015 5 / 9
Flash point 14.0 - 23.0 °F (-10.0 - -5.0 °C)
Evaporation rate 5.5 - 8
Not available.Flammability (solid, gas)
Upper/lower flammability or explosive limits
Flammability limit - lower
(%)
1.8
Flammability limit - upper
(%)
11.8
Explosive limit - lower (%)Not available.
Explosive limit - upper (%)Not available.
Vapor pressure 145 mm Hg @ 20 C
Vapor density 2.5
Relative density 0.84 +/- 0.02 @20°C
Solubility(ies)
Solubility (water)Negligible
Partition coefficient
(n-octanol/water)
Not available.
Auto-ignition temperature Not available.
Decomposition temperature Not available.
Viscosity Not available.
Other information
Bulk density 7 lb/gal
VOC (Weight %)505 g/l SQACMD Method 24
10. Stability and reactivity
The product is stable and non-reactive under normal conditions of use, storage and transport.Reactivity
Material is stable under normal conditions.Chemical stability
No dangerous reaction known under conditions of normal use.Possibility of hazardous
reactions
Avoid heat, sparks, open flames and other ignition sources. Avoid temperatures exceeding the
flash point. Contact with incompatible materials.
Conditions to avoid
Acids. Strong oxidizing agents. Ammonia. Amines. Isocyanates. Caustics.Incompatible materials
No hazardous decomposition products are known.Hazardous decomposition
products
11. Toxicological information
Information on likely routes of exposure
Inhalation May be fatal if swallowed and enters airways. May cause irritation to the respiratory system.
Vapors have a narcotic effect and may cause headache, fatigue, dizziness and nausea.
Prolonged inhalation may be harmful.
Skin contact Causes skin irritation.
Eye contact Causes serious eye irritation.
Ingestion May be fatal if swallowed and enters airways. Harmful if swallowed.
Symptoms related to the
physical, chemical and
toxicological characteristics
Irritation of nose and throat. Aspiration may cause pulmonary edema and pneumonitis. Severe
eye irritation. Symptoms may include stinging, tearing, redness, swelling, and blurred vision. Skin
irritation. May cause redness and pain. Symptoms of overexposure may be headache, dizziness,
tiredness, nausea and vomiting.
Information on toxicological effects
Acute toxicity May be fatal if swallowed and enters airways. Narcotic effects. May cause respiratory irritation.
Oatey Purple Primer- NSF Listed for PVC and CPVC SDS Canada
926733 Version #: 01 Revision date: - Issue date: 21-December-2015 6 / 9
Test ResultsComponents Species
Acetone (CAS 67-64-1)
LD50 Rabbit
Dermal
Acute
20 ml/kg
LC50 Rat
Inhalation
50 mg/l, 8 Hours
LD50 Rat
Oral
5800 mg/kg
Cyclohexanone (CAS 108-94-1)
LD50 Rabbit
Dermal
Acute
948 mg/kg
LC50 Rat
Inhalation
8000 ppm, 4 hours
LD50 Rat
Oral
800 mg/kg
* Estimates for product may be based on additional component data not shown.
Causes skin irritation.Skin corrosion/irritation
Causes serious eye irritation.Serious eye damage/eye
irritation
Respiratory or skin sensitization
Respiratory sensitization Not available.
This product is not expected to cause skin sensitization.Skin sensitization
No data available to indicate product or any components present at greater than 0.1% are
mutagenic or genotoxic.
Germ cell mutagenicity
Carcinogenicity In 2012 USEPA Integrated Risk Information System (IRIS) reviewed a two species inhalation
lifetime study on THF conducted by NTP (1998). Male rats developed renal tumors and female
mice developed liver tumors while neither the female rats nor the male mice showed similar
results. Because the carcinogenic mechanisms could not be identified clearly in either species for
either tumor, the EPA determined that the male rat and female mouse findings are relevant to the
assessment of carcinogenic potential in humans. Therefore, the IRIS review concludes that these
data in aggregate indicate that there is "suggestive evidence of carcinogenic potential" following
exposure to THF by all routes of exposure.
ACGIH Carcinogens
Acetone (CAS 67-64-1) A4 Not classifiable as a human carcinogen.
Cyclohexanone (CAS 108-94-1) A3 Confirmed animal carcinogen with unknown relevance to
humans.
Canada - Manitoba OELs: carcinogenicity
ACETONE (CAS 67-64-1) Not classifiable as a human carcinogen.
CYCLOHEXANONE (CAS 108-94-1) Confirmed animal carcinogen with unknown relevance to humans.
IARC Monographs. Overall Evaluation of Carcinogenicity
Cyclohexanone (CAS 108-94-1) 3 Not classifiable as to carcinogenicity to humans.
This product is not expected to cause reproductive or developmental effects.Reproductive toxicity
Specific target organ toxicity -
single exposure
Narcotic effects. Respiratory tract irritation.
Specific target organ toxicity -
repeated exposure
Not classified.
Aspiration hazard May be fatal if swallowed and enters airways.
Chronic effects Prolonged inhalation may be harmful.
12. Ecological information
The product is not classified as environmentally hazardous. However, this does not exclude the
possibility that large or frequent spills can have a harmful or damaging effect on the environment.
Ecotoxicity
Oatey Purple Primer- NSF Listed for PVC and CPVC SDS Canada
926733 Version #: 01 Revision date: - Issue date: 21-December-2015 7 / 9
Components Test ResultsSpecies
Acetone (CAS 67-64-1)
Aquatic
LC50Fish > 100 mg/l, 96 hoursFathead minnow (Pimephales promelas)
* Estimates for product may be based on additional component data not shown.
Cyclohexanone (CAS 108-94-1)
Aquatic
LC50Fish 481 - 578 mg/l, 96 hoursFathead minnow (Pimephales promelas)
No data is available on the degradability of this product.Persistence and degradability
No data available.Bioaccumulative potential
Partition coefficient n-octanol / water (log Kow)
Acetone (CAS 67-64-1) -0.24
Cyclohexanone (CAS 108-94-1) 0.81
Methyl ethyl ketone (CAS 78-93-3) 0.29
No data available.Mobility in soil
Other adverse effects No other adverse environmental effects (e.g. ozone depletion, photochemical ozone creation
potential, endocrine disruption, global warming potential) are expected from this component.
13. Disposal considerations
Collect and reclaim or dispose in sealed containers at licensed waste disposal site. This material
and its container must be disposed of as hazardous waste. Do not allow this material to drain into
sewers/water supplies. Do not contaminate ponds, waterways or ditches with chemical or used
container. Dispose of contents/container in accordance with local/regional/national/international
regulations.
Disposal instructions
Dispose in accordance with all applicable regulations.Local disposal regulations
The waste code should be assigned in discussion between the user, the producer and the waste
disposal company.
Hazardous waste code
Dispose of in accordance with local regulations. Empty containers or liners may retain some
product residues. This material and its container must be disposed of in a safe manner (see:
Disposal instructions).
Waste from residues / unused
products
Since emptied containers may retain product residue, follow label warnings even after container is
emptied. Empty containers should be taken to an approved waste handling site for recycling or
disposal.
Contaminated packaging
14. Transport information
TDG
UN1993UN number
FLAMMABLE LIQUID, N.O.S. (Methyl ethyl ketone, Acetone)UN proper shipping name
3Class
Transport hazard class(es)
-Subsidiary risk
IIPacking group
DEnvironmental hazards
Read safety instructions, SDS and emergency procedures before handling.Special precautions for user
IATA
UN1993UN number
Flammable liquid, n.o.s. (Methyl ethyl ketone, Acetone)UN proper shipping name
3Class
Transport hazard class(es)
-Subsidiary risk
IIPacking group
No.Environmental hazards
3HERG Code
Read safety instructions, SDS and emergency procedures before handling.Special precautions for user
IMDG
UN1993UN number
FLAMMABLE LIQUID, N.O.S. (Methyl ethyl ketone, Acetone)UN proper shipping name
Oatey Purple Primer- NSF Listed for PVC and CPVC SDS Canada
926733 Version #: 01 Revision date: - Issue date: 21-December-2015 8 / 9
3Class
Transport hazard class(es)
-Subsidiary risk
IIPacking group
No.Marine pollutant
Environmental hazards
F-E, S-EEmS
Read safety instructions, SDS and emergency procedures before handling.Special precautions for user
Not available.Transport in bulk according to
Annex II of MARPOL 73/78 and
the IBC Code
15. Regulatory information
This product has been classified in accordance with the hazard criteria of the HPR and the SDS
contains all the information required by the HPR.
Canadian regulations
Controlled Drugs and Substances Act
Not regulated.
Export Control List (CEPA 1999, Schedule 3)
Not listed.
Greenhouse Gases
Not listed.
Precursor Control Regulations
Acetone (CAS 67-64-1) Class B
Methyl ethyl ketone (CAS 78-93-3) Class B
International regulations
Stockholm Convention
Not applicable.
Rotterdam Convention
Not applicable.
Kyoto protocol
Not applicable.
Montreal Protocol
Not applicable.
Basel Convention
Not applicable.
International Inventories
Country(s) or region Inventory name On inventory (yes/no)*
Domestic Substances List (DSL) YesCanada
Non-Domestic Substances List (NDSL) NoCanada
*A "Yes" indicates this product complies with the inventory requirements administered by the governing country(s).
A "No" indicates that one or more components of the product are not listed or exempt from listing on the inventory administered by the governing
country(s).
Toxic Substances Control Act (TSCA) Inventory YesUnited States & Puerto Rico
16. Other Information
21-December-2015Issue date
-Revision date
Version #01
Oatey Co. cannot anticipate all conditions under which this information and its product, or the
products of other manufacturers in combination with its product, may be used. It is the user’s
responsibility to ensure safe conditions for handling, storage and disposal of the product, and to
assume liability for loss, injury, damage or expense due to improper use. The information in the
sheet was written based on the best knowledge and experience currently available.
Disclaimer
Oatey Purple Primer- NSF Listed for PVC and CPVC SDS Canada
926733 Version #: 01 Revision date: - Issue date: 21-December-2015 9 / 9
SAFETY DATA SHEET
1. Identification
PVC Regular Clear CementProduct identifier
Other means of identification
1100EProduct code
Part Numbers: 31012, 31013, 31014, 31015, 31016, 31958, 31959, 31960, 31961Synonyms
Joining PVC PipesRecommended use
None known.Recommended restrictions
Manufacturer/Importer/Supplier/Distributor information
Company Name Oatey Co.
Address 4700 West 160th St.
Cleveland, OH 44135
Telephone [phone]
E-mail [e-mail]
Transport Emergency Chemtrec 1-800-424-9300 (Outside the US 1-703-527-3887)
Emergency First Aid 1-877-740-5015
Contact person MSDS Coordinator
2. Hazard(s) identification
Category 2Flammable liquidsPhysical hazards
Category 4Acute toxicity, oralHealth hazards
Category 2Skin corrosion/irritation
Category 2ASerious eye damage/eye irritation
Category 3 respiratory tract irritationSpecific target organ toxicity, single exposure
Category 3 narcotic effectsSpecific target organ toxicity, single exposure
Category 1Aspiration hazard
Not classified.OSHA defined hazards
Label elements
Signal word Danger
Hazard statement Highly flammable liquid and vapor. Harmful if swallowed. May be fatal if swallowed and enters
airways. Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation. May
cause drowsiness or dizziness.
Precautionary statement
Prevention Keep away from heat/sparks/open flames/hot surfaces. - No smoking. Keep container tightly
closed. Ground/bond container and receiving equipment. Use explosion-proof
electrical/ventilating/lighting equipment. Use only non-sparking tools. Take precautionary
measures against static discharge. Avoid breathing mist or vapor. Wash thoroughly after
handling. Do not eat, drink or smoke when using this product. Use only outdoors or in a
well-ventilated area. Wear protective gloves/protective clothing/eye protection/face protection.
Response If swallowed: Immediately call a poison center/doctor. If on skin (or hair): Take off immediately all
contaminated clothing. Rinse skin with water/shower. If inhaled: Remove person to fresh air and
keep comfortable for breathing. If in eyes: Rinse cautiously with water for several minutes.
Remove contact lenses, if present and easy to do. Continue rinsing. Call a poison center/doctor if
you feel unwell. Rinse mouth. Do NOT induce vomiting. If skin irritation occurs: Get medical
advice/attention. If eye irritation persists: Get medical advice/attention. Take off contaminated
clothing and wash before reuse. In case of fire: Use appropriate media to extinguish.
SDS USPVC Regular Clear Cement
927170 Version #: 01 Revision date: 11-22-2017 Issue date: 05-27-2015 1 / 10
Storage Store in a well-ventilated place. Keep container tightly closed. Keep cool. Store locked up.
Disposal Dispose of contents/container in accordance with local/regional/national/international regulations.
Hazard(s) not otherwise
classified (HNOC)
Frequent or prolonged contact may defat and dry the skin, leading to discomfort and dermatitis.
May form explosive peroxides. Contains a chemical classified by the US EPA as a suspected
possible carcinogen.
Supplemental information
Not applicable.
3. Composition/information on ingredients
Mixtures
78-93-3 25-40Methyl ethyl ketone
CAS number %Chemical name
108-94-1 10-25Cyclohexanone
109-99-9 10-25Furan, Tetrahydro-
67-64-1 5-15Acetone
9002-86-2 5-15Polyvinyl chloride
*Designates that a specific chemical identity and/or percentage of composition has been withheld as a trade secret.
4. First-aid measures
Remove victim to fresh air and keep at rest in a position comfortable for breathing. Call a POISON
CENTER or doctor/physician if you feel unwell.Inhalation
Take off immediately all contaminated clothing. Wash with plenty of soap and water. If skin
irritation occurs: Get medical advice/attention.
Skin contact
Immediately flush eyes with plenty of water for at least 15 minutes. Remove contact lenses, if
present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice/attention.Eye contact
Call a physician or poison control center immediately. Do not induce vomiting. If vomiting occurs,
keep head low so that stomach content doesn't get into the lungs. Aspiration may cause
pulmonary edema and pneumonitis.
Ingestion
Irritation of nose and throat. Aspiration may cause pulmonary edema and pneumonitis. Severe eye
irritation. Symptoms may include stinging, tearing, redness, swelling, and blurred vision. May
cause respiratory irritation. Vapors have a narcotic effect and may cause headache, fatigue,
dizziness and nausea. Skin irritation. May cause redness and pain.
Most important
symptoms/effects, acute and
delayed
Provide general supportive measures and treat symptomatically. Thermal burns: Flush with water
immediately. While flushing, remove clothes which do not adhere to affected area. Call an
ambulance. Continue flushing during transport to hospital. In case of shortness of breath, give
oxygen. Keep victim warm. Keep victim under observation. Symptoms may be delayed.
Indication of immediate
medical attention and special
treatment needed
Take off all contaminated clothing immediately. Ensure that medical personnel are aware of the
material(s) involved, and take precautions to protect themselves. Wash contaminated clothing
before reuse.
General information
5. Fire-fighting measures
Alcohol resistant foam. Water fog. Dry chemical powder. Carbon dioxide (CO2).Suitable extinguishing media
Do not use water jet as an extinguisher, as this will spread the fire.Unsuitable extinguishing
media
Vapors may form explosive mixtures with air. Vapors may travel considerable distance to a source
of ignition and flash back. During fire, gases hazardous to health may be formed.
Specific hazards arising from
the chemical
Self-contained breathing apparatus and full protective clothing must be worn in case of fire.Special protective equipment
and precautions for firefighters
In case of fire and/or explosion do not breathe fumes. Move containers from fire area if you can do
so without risk.
Fire fighting
equipment/instructions
Use standard firefighting procedures and consider the hazards of other involved materials.Specific methods
Highly flammable liquid and vapor. This product contains tetrahydrofuran that may form explosive
organic peroxide when exposed to air or light or with age.General fire hazards
SDS USPVC Regular Clear Cement
927170 Version #: 01 Revision date: 11-22-2017 Issue date: 05-27-2015 2 / 10
6. Accidental release measures
Keep unnecessary personnel away. Keep people away from and upwind of spill/leak. Keep out of
low areas. Eliminate all ignition sources (no smoking, flares, sparks, or flames in immediate area).
Wear appropriate protective equipment and clothing during clean-up. Avoid breathing mist or
vapor. Do not touch damaged containers or spilled material unless wearing appropriate protective
clothing. Ventilate closed spaces before entering them. Local authorities should be advised if
significant spillages cannot be contained. For personal protection, see section 8 of the SDS.
Personal precautions,
protective equipment and
emergency procedures
Eliminate all ignition sources (no smoking, flares, sparks, or flames in immediate area). Take
precautionary measures against static discharge. Use only non-sparking tools. Keep combustibles
(wood, paper, oil, etc.) away from spilled material. This product is miscible in water.
Large Spills: Stop the flow of material, if this is without risk. Use water spray to reduce vapors or
divert vapor cloud drift. Dike the spilled material, where this is possible. Cover with plastic sheet to
prevent spreading. Use a non-combustible material like vermiculite, sand or earth to soak up the
product and place into a container for later disposal. Prevent entry into waterways, sewer,
basements or confined areas. Following product recovery, flush area with water.
Small Spills: Absorb with earth, sand or other non-combustible material and transfer to containers
for later disposal. Wipe up with absorbent material (e.g. cloth, fleece). Clean surface thoroughly to
remove residual contamination.
Never return spills to original containers for re-use. For waste disposal, see section 13 of the SDS.
Methods and materials for
containment and cleaning up
Avoid discharge into drains, water courses or onto the ground.Environmental precautions
7. Handling and storage
Vapors may form explosive mixtures with air. Do not handle, store or open near an open flame,
sources of heat or sources of ignition. Protect material from direct sunlight. Explosion-proof
general and local exhaust ventilation. Take precautionary measures against static discharges. All
equipment used when handling the product must be grounded. Use non-sparking tools and
explosion-proof equipment. Avoid breathing mist or vapor. Avoid contact with eyes, skin, and
clothing. Avoid prolonged exposure. Do not taste or swallow. When using, do not eat, drink or
smoke. Wear appropriate personal protective equipment. Wash hands thoroughly after handling.
Observe good industrial hygiene practices.
Precautions for safe handling
Store locked up. Keep away from heat, sparks and open flame. Prevent electrostatic charge
build-up by using common bonding and grounding techniques. Store in a cool, dry place out of
direct sunlight. Store in original tightly closed container. Store in a well-ventilated place. Store
away from incompatible materials (see Section 10 of the SDS).
Conditions for safe storage,
including any incompatibilities
8. Exposure controls/personal protection
Occupational exposure limits
US. OSHA Specifically Regulated Substances (29 CFR 1910.1001-1050)
ValueTypeComponents
STEL 5 ppmPolyvinyl chloride (CAS
9002-86-2)
TWA 1 ppm
US. OSHA Table Z-1 Limits for Air Contaminants (29 CFR 1910.1000)
ValueType FormComponents
PEL 2400 mg/m3Acetone (CAS 67-64-1)
1000 ppm
PEL 200 mg/m3Cyclohexanone (CAS
108-94-1)
50 ppm
PEL 590 mg/m3Furan, Tetrahydro- (CAS
109-99-9)
200 ppm
PEL 590 mg/m3Methyl ethyl ketone (CAS
78-93-3)
200 ppm
PEL 5 mg/m3 Respirable fraction.Polyvinyl chloride (CAS
9002-86-2)
15 mg/m3 Total dust.
PVC Regular Clear Cement SDS US
927170 Version #: 01 Revision date: 11-22-2017 Issue date: 05-27-2015 3 / 10
US. ACGIH Threshold Limit Values
ValueType FormComponents
STEL 750 ppmAcetone (CAS 67-64-1)
TWA 500 ppm
STEL 50 ppmCyclohexanone (CAS
108-94-1)
TWA 20 ppm
STEL 100 ppmFuran, Tetrahydro- (CAS
109-99-9)
TWA 50 ppm
STEL 300 ppmMethyl ethyl ketone (CAS
78-93-3)
TWA 200 ppm
TWA 1 mg/m3 Respirable fraction.Polyvinyl chloride (CAS
9002-86-2)
US. NIOSH: Pocket Guide to Chemical Hazards
ValueTypeComponents
TWA 590 mg/m3Acetone (CAS 67-64-1)
250 ppm
TWA 100 mg/m3Cyclohexanone (CAS
108-94-1)
25 ppm
STEL 735 mg/m3Furan, Tetrahydro- (CAS
109-99-9)
250 ppm
TWA 590 mg/m3
200 ppm
STEL 885 mg/m3Methyl ethyl ketone (CAS
78-93-3)
300 ppm
TWA 590 mg/m3
200 ppm
Biological limit values
ACGIH Biological Exposure Indices
Value Sampling TimeDeterminant SpecimenComponents
50 mg/l Acetone Urine *Acetone (CAS 67-64-1)
80 mg/l 1,2-Cyclohexanediol,with
hydrolysis
Urine *Cyclohexanone (CAS
108-94-1)
8 mg/l Cyclohexanol,
with hydrolysis
Urine *
2 mg/l Tetrahydrofura
n
Urine *Furan, Tetrahydro- (CAS
109-99-9)
2 mg/l MEK Urine *Methyl ethyl ketone (CAS
78-93-3)
* - For sampling details, please see the source document.
Exposure guidelines
US - California OELs: Skin designation
Cyclohexanone (CAS 108-94-1)Can be absorbed through the skin.
US - Minnesota Haz Subs: Skin designation applies
Cyclohexanone (CAS 108-94-1)Skin designation applies.
US - Tennessee OELs: Skin designation
Cyclohexanone (CAS 108-94-1)Can be absorbed through the skin.
US ACGIH Threshold Limit Values: Skin designation
Cyclohexanone (CAS 108-94-1)Can be absorbed through the skin.
Furan, Tetrahydro- (CAS 109-99-9)Can be absorbed through the skin.
US. NIOSH: Pocket Guide to Chemical Hazards
Cyclohexanone (CAS 108-94-1)Can be absorbed through the skin.
SDS USPVC Regular Clear Cement
927170 Version #: 01 Revision date: 11-22-2017 Issue date: 05-27-2015 4 / 10
Explosion-proof general and local exhaust ventilation. Good general ventilation (typically 10 air
changes per hour) should be used. Ventilation rates should be matched to conditions. If
applicable, use process enclosures, local exhaust ventilation, or other engineering controls to
maintain airborne levels below recommended exposure limits. If exposure limits have not been
established, maintain airborne levels to an acceptable level. Eye wash facilities and emergency
shower must be available when handling this product.
Appropriate engineering
controls
Individual protection measures, such as personal protective equipment
Face shield is recommended. Wear safety glasses with side shields (or goggles).Eye/face protection
Skin protection
Wear appropriate chemical resistant gloves.Hand protection
Wear appropriate chemical resistant clothing.Other
If engineering controls do not maintain airborne concentrations below recommended exposure
limits (where applicable) or to an acceptable level (in countries where exposure limits have not
been established), an approved respirator must be worn.
Respiratory protection
Wear appropriate thermal protective clothing, when necessary.Thermal hazards
When using, do not eat, drink or smoke. Always observe good personal hygiene measures, such
as washing after handling the material and before eating, drinking, and/or smoking. Routinely wash
work clothing and protective equipment to remove contaminants.
General hygiene
considerations
9. Physical and chemical properties
Appearance
Liquid.Physical state
Translucent liquid.Form
Clear.Color
Solvent.Odor
Odor threshold Not available.
pH Not available.
Melting point/freezing point Not available.
Initial boiling point and boiling
range
151 °F (66.11 °C)
Flash point -4.0 °F (-20.0 °C)
Evaporation rate 5.5 - 8
Not available.Flammability (solid, gas)
Upper/lower flammability or explosive limits
Flammability limit - lower
(%)
1.8
Flammability limit - upper
(%)
11.8
Explosive limit - lower (%)Not available.
Explosive limit - upper (%)Not available.
Vapor pressure 145 mm Hg @ 20 C
Vapor density 2.5
Relative density 0.9 +/- 0.02
Solubility(ies)
Solubility (water)Negligible
Partition coefficient
(n-octanol/water)
Not available.
Auto-ignition temperature Not available.
Decomposition temperature Not available.
Viscosity 80 - 500 cP
Other information
VOC (Weight %)<510 g/l SCAQMD 1168/M316A
10. Stability and reactivity
The product is stable and non-reactive under normal conditions of use, storage and transport.Reactivity
SDS USPVC Regular Clear Cement
927170 Version #: 01 Revision date: 11-22-2017 Issue date: 05-27-2015 5 / 10
Material is stable under normal conditions.Chemical stability
No dangerous reaction known under conditions of normal use.Possibility of hazardous
reactions
Avoid heat, sparks, open flames and other ignition sources. Avoid temperatures exceeding the
flash point. Contact with incompatible materials.Conditions to avoid
Acids. Strong oxidizing agents. Ammonia. Amines. Isocyanates. Caustics.Incompatible materials
No hazardous decomposition products are known.Hazardous decomposition
products
11. Toxicological information
Information on likely routes of exposure
Inhalation May be fatal if swallowed and enters airways. Headache. Nausea, vomiting. May cause irritation
to the respiratory system. Vapors have a narcotic effect and may cause headache, fatigue,
dizziness and nausea. Prolonged inhalation may be harmful.
Skin contact Causes skin irritation.
Eye contact Causes serious eye irritation.
Ingestion May be fatal if swallowed and enters airways. Harmful if swallowed. Harmful if swallowed. Droplets
of the product aspirated into the lungs through ingestion or vomiting may cause a serious
chemical pneumonia.
Symptoms related to the
physical, chemical and
toxicological characteristics
Irritation of nose and throat. Aspiration may cause pulmonary edema and pneumonitis. Severe
eye irritation. Symptoms may include stinging, tearing, redness, swelling, and blurred vision. May
cause respiratory irritation. Skin irritation. May cause redness and pain. Symptoms of
overexposure may be headache, dizziness, tiredness, nausea and vomiting.
Information on toxicological effects
Acute toxicity May be fatal if swallowed and enters airways. Narcotic effects. May cause respiratory irritation.
Test ResultsComponentsSpecies
Acetone (CAS 67-64-1)
LD50 Rabbit
Dermal
Acute
20 ml/kg
LC50 Rat
Inhalation
50 mg/l, 8 Hours
LD50 Rat
Oral
5800 mg/kg
Cyclohexanone (CAS 108-94-1)
LD50 Rabbit
Dermal
Acute
948 mg/kg
LC50 Rat
Inhalation
8000 ppm, 4 hours
LD50 Rat
Oral
1540 mg/kg
* Estimates for product may be based on additional component data not shown.
Causes skin irritation.Skin corrosion/irritation
Causes serious eye irritation.Serious eye damage/eye
irritation
Respiratory or skin sensitization
Respiratory sensitization Not available.
This product is not expected to cause skin sensitization.Skin sensitization
No data available to indicate product or any components present at greater than 0.1% are
mutagenic or genotoxic.Germ cell mutagenicity
SDS USPVC Regular Clear Cement
927170 Version #: 01 Revision date: 11-22-2017 Issue date: 05-27-2015 6 / 10
Carcinogenicity In 2012 USEPA Integrated Risk Information System (IRIS) reviewed a two species inhalation
lifetime study on THF conducted by NTP (1998). Male rats developed renal tumors and female
mice developed liver tumors while neither the female rats nor the male mice showed similar
results. Because the carcinogenic mechanisms could not be identified clearly in either species for
either tumor, the EPA determined that the male rat and female mouse findings are relevant to the
assessment of carcinogenic potential in humans. Therefore, the IRIS review concludes that these
data in aggregate indicate that there is "suggestive evidence of carcinogenic potential" following
exposure to THF by all routes of exposure.
IARC Monographs. Overall Evaluation of Carcinogenicity
Cyclohexanone (CAS 108-94-1) 3 Not classifiable as to carcinogenicity to humans.
Polyvinyl chloride (CAS 9002-86-2) 3 Not classifiable as to carcinogenicity to humans.
OSHA Specifically Regulated Substances (29 CFR 1910.1001-1050)
Polyvinyl chloride (CAS 9002-86-2) Cancer
This product is not expected to cause reproductive or developmental effects.Reproductive toxicity
Specific target organ toxicity -
single exposure
Narcotic effects. May cause drowsiness and dizziness. Respiratory tract irritation.
Specific target organ toxicity -
repeated exposure
Not classified.
Aspiration hazard May be fatal if swallowed and enters airways.
Chronic effects Prolonged inhalation may be harmful.
12. Ecological information
The product is not classified as environmentally hazardous. However, this does not exclude the
possibility that large or frequent spills can have a harmful or damaging effect on the environment.
Ecotoxicity
Components Test ResultsSpecies
Acetone (CAS 67-64-1)
Aquatic
LC50Fish > 100 mg/l, 96 hoursFathead minnow (Pimephales promelas)
* Estimates for product may be based on additional component data not shown.
Cyclohexanone (CAS 108-94-1)
Aquatic
LC50Fish 481 - 578 mg/l, 96 hoursFathead minnow (Pimephales promelas)
No data is available on the degradability of this product.Persistence and degradability
No data available.Bioaccumulative potential
Partition coefficient n-octanol / water (log Kow)
Acetone (CAS 67-64-1)-0.24
Cyclohexanone (CAS 108-94-1)0.81
Furan, Tetrahydro- (CAS 109-99-9)0.46
Methyl ethyl ketone (CAS 78-93-3)0.29
No data available.Mobility in soil
Other adverse effects No other adverse environmental effects (e.g. ozone depletion, photochemical ozone creation
potential, endocrine disruption, global warming potential) are expected from this component.
13. Disposal considerations
Collect and reclaim or dispose in sealed containers at licensed waste disposal site. This material
and its container must be disposed of as hazardous waste. Do not allow this material to drain into
sewers/water supplies. Do not contaminate ponds, waterways or ditches with chemical or used
container. Dispose of contents/container in accordance with local/regional/national/international
regulations.
Disposal instructions
Dispose in accordance with all applicable regulations.Local disposal regulations
The waste code should be assigned in discussion between the user, the producer and the waste
disposal company.
Hazardous waste code
Dispose of in accordance with local regulations. Empty containers or liners may retain some
product residues. This material and its container must be disposed of in a safe manner (see:
Disposal instructions).
Waste from residues / unused
products
Empty containers should be taken to an approved waste handling site for recycling or disposal.
Since emptied containers may retain product residue, follow label warnings even after container is
emptied.
Contaminated packaging
SDS USPVC Regular Clear Cement
927170 Version #: 01 Revision date: 11-22-2017 Issue date: 05-27-2015 7 / 10
14. Transport information
DOT
UN1133UN number
AdhesivesUN proper shipping name
3Class
Transport hazard class(es)
-Subsidiary risk
3Label(s)
IIPacking group
Read safety instructions, SDS and emergency procedures before handling.Special precautions for user
T11, TP1, TP8, TP27Special provisions
Packaging exceptions
Packaging non bulk
150
201
243Packaging bulk
IATA
UN1133UN number
AdhesivesUN proper shipping name
3Class
Transport hazard class(es)
-Subsidiary risk
IIPacking group
No.Environmental hazards
3LERG Code
Read safety instructions, SDS and emergency procedures before handling.Special precautions for user
IMDG
UN number UN1133
ADHESIVESUN proper shipping name
3Class
Transport hazard class(es)
-Subsidiary risk
IIPacking group
Environmental hazards
Marine pollutant No.
EmS F-E, S-D
Special precautions for user Read safety instructions, SDS and emergency procedures before handling.
Not available.Transport in bulk according to
Annex II of MARPOL 73/78 and
the IBC Code
15. Regulatory information
This product is a "Hazardous Chemical" as defined by the OSHA Hazard Communication
Standard, 29 CFR 1910.1200.
All components are on the U.S. EPA TSCA Inventory List.
US federal regulations
TSCA Section 12(b) Export Notification (40 CFR 707, Subpt. D)
Not regulated.
OSHA Specifically Regulated Substances (29 CFR 1910.1001-1050)
Polyvinyl chloride (CAS 9002-86-2)Cancer
Central nervous system
Liver
Blood
Flammability
CERCLA Hazardous Substance List (40 CFR 302.4)
Acetone (CAS 67-64-1)LISTED
Cyclohexanone (CAS 108-94-1)LISTED
Furan, Tetrahydro- (CAS 109-99-9)LISTED
Methyl ethyl ketone (CAS 78-93-3)LISTED
SDS USPVC Regular Clear Cement
927170 Version #: 01 Revision date: 11-22-2017 Issue date: 05-27-2015 8 / 10
Superfund Amendments and Reauthorization Act of 1986 (SARA)
Immediate Hazard - Yes
Delayed Hazard - No
Fire Hazard - Yes
Pressure Hazard - No
Reactivity Hazard - No
Hazard categories
SARA 302 Extremely hazardous substance
Not listed.
NoSARA 311/312 Hazardous
chemical
SARA 313 (TRI reporting)
Not regulated.
Other federal regulations
Clean Air Act (CAA) Section 112 Hazardous Air Pollutants (HAPs) List
Not regulated.
Clean Air Act (CAA) Section 112(r) Accidental Release Prevention (40 CFR 68.130)
Not regulated.
Not regulated.Safe Drinking Water Act
(SDWA)
Drug Enforcement Administration (DEA). List 2, Essential Chemicals (21 CFR 1310.02(b) and 1310.04(f)(2) and
Chemical Code Number
Acetone (CAS 67-64-1)6532
Methyl ethyl ketone (CAS 78-93-3)6714
Drug Enforcement Administration (DEA). List 1 & 2 Exempt Chemical Mixtures (21 CFR 1310.12(c))
Acetone (CAS 67-64-1)35 %WV
Methyl ethyl ketone (CAS 78-93-3)35 %WV
DEA Exempt Chemical Mixtures Code Number
Acetone (CAS 67-64-1)6532
Methyl ethyl ketone (CAS 78-93-3)6714
US state regulations
US. Massachusetts RTK - Substance List
Acetone (CAS 67-64-1)
Cyclohexanone (CAS 108-94-1)
Furan, Tetrahydro- (CAS 109-99-9)
Methyl ethyl ketone (CAS 78-93-3)
US. New Jersey Worker and Community Right-to-Know Act
Acetone (CAS 67-64-1)
Cyclohexanone (CAS 108-94-1)
Furan, Tetrahydro- (CAS 109-99-9)
Methyl ethyl ketone (CAS 78-93-3)
Polyvinyl chloride (CAS 9002-86-2)
US. Pennsylvania Worker and Community Right-to-Know Law
Acetone (CAS 67-64-1)
Cyclohexanone (CAS 108-94-1)
Furan, Tetrahydro- (CAS 109-99-9)
Methyl ethyl ketone (CAS 78-93-3)
US. Rhode Island RTK
Acetone (CAS 67-64-1)
Cyclohexanone (CAS 108-94-1)
Furan, Tetrahydro- (CAS 109-99-9)
Methyl ethyl ketone (CAS 78-93-3)
US. California Proposition 65
California Safe Drinking Water and Toxic Enforcement Act of 1986 (Proposition 65): This material is not known to contain
any chemicals currently listed as carcinogens or reproductive toxins.
International Inventories
Country(s) or region Inventory name On inventory (yes/no)*
Domestic Substances List (DSL)YesCanada
SDS USPVC Regular Clear Cement
927170 Version #: 01 Revision date: 11-22-2017 Issue date: 05-27-2015 9 / 10
Country(s) or region Inventory name On inventory (yes/no)*
*A "Yes" indicates this product complies with the inventory requirements administered by the governing country(s).
A "No" indicates that one or more components of the product are not listed or exempt from listing on the inventory administered by the governing
country(s).
Toxic Substances Control Act (TSCA) Inventory NoUnited States & Puerto Rico
16. Other information, including date of preparation or last revision
05-27-2015Issue date
-Revision date
Version #01
Health: 2
Flammability: 3
Physical hazard: 0
HMIS® ratings
NFPA ratings
02
3
The information in the sheet was written based on the best knowledge and experience currently
available. Oatey Co. cannot anticipate all conditions under which this information and its product,
or the products of other manufacturers in combination with its product, may be used. It is the
user’s responsibility to ensure safe conditions for handling, storage and disposal of the product,
and to assume liability for loss, injury, damage or expense due to improper use.
Disclaimer
SDS USPVC Regular Clear Cement
927170 Version #: 01 Revision date: 11-22-2017 Issue date: 05-27-2015 10 / 10

Appendix G DEQ Risk Calculators (July 2022)
Version Date:
Basis:
Site Name:
Site Address:
DEQ Section:
Site ID:
Exposure Unit ID:
Submittal Date:
Reviewed By:
Sub-Slab Worst-Case
North Carolina Department of Environmental Quality
Risk Calculator
Chadbourn Mill/Theron Properties
431, 500, and 508 Charles Avenue
DEQ DWM Brownfields
23035-19-060
July 2022
May 2022 EPA RSL Table
Prepared By:Hart & Hickman
North Carolina DEQ Risk Calculator
Table of Contents
Version Date: July 2022
Basis: May 2022 EPA RSL Table
Site ID: 23035-19-060
Exposure Unit ID: Worst-Case
Form No.
Input Form 1A Complete Exposure Pathways
Input Form 1B Exposure Factors and Target Risks
Input Form 1C Contaminant Migration Parameters
Input Form 1D Sample Statistics
Input Form 2A Soil Exposure Point Concentration Table
Input Form 2B Groundwater Exposure Point Concentration Table
Input Form 2C Surface Water Exposure Point Concentration Table
Input Form 2D Soil Gas Exposure Point Concentration Table
Input Form 2E Indoor Air Exposure Point Concentration Table
Output Form 1A Risk for Individual Pathways
Output Form 1B Sitewide Risk
Output Form 2A Resident Soil
Output Form 2B Resident Groundwater Use
Output Form 2C Non-Residential Worker Soil
Output Form 2D Non-Residential Worker Groundwater Use
Output Form 2E Construction Worker Soil
Output Form 2F Recreator/Trespasser Soil
Output Form 2G Recreator/Trespasser Surface Water
Output Form 3A Resident Groundwater to Indoor Air
Output Form 3B Resident Soil Gas to Indoor Air
Output Form 3C Resident Indoor Air
Output Form 3D Non-Residential Worker Groundwater to Indoor Air
Output Form 3E Non-Residential Worker Soil Gas to Indoor Air
Output Form 3F Non-Residential Worker Indoor Air
Output Form 4A Soil to Groundwater - Forward Mode
Output Form 4B Groundwater to Groundwater - Forward Mode
Output Form 4C Soil to Surface Water - Forward Mode
Output Form 4D Groundwater to Surface Water - Forward Mode
Output Form 4E Soil to Groundwater - Backward Mode
Output Form 4F Groundwater to Groundwater - Backward Mode
Output Form 4G Soil to Surface Water - Backward Mode
Output Form 4H Groundwater to Surface Water - Backward Mode
Output Section 4 - Contaminant Migration Worksheets
Output Section 3 - Vapor Intrusion Calculators
TOC
Description
DATA INPUT SHEETS
Check box
if included
Input Section 1 - Exposure Pathways & Parameters
Input Section 2 - Exposure Point Concentrations
DATA OUTPUT SHEETS
Output Section 1 - Summary Output for All Calculators
Output Section 2 - Direct Contact Soil and Groundwater Calculators
North Carolina DEQ Risk Calculator
Complete Exposure Pathways
Version Date: July 2022
Basis: May 2022 EPA RSL Table
Site ID: 23035-19-060
Exposure Unit ID: Worst-Case
Note: Risk output will only be calculated for complete exposure pathways.
Receptor Pathway
Check box if
pathway
complete
Soil
Groundwater Use
Soil
Groundwater Use
Construction Worker Soil
Soil
Surface Water
Groundwater to Indoor Air
Soil Gas to Indoor Air
Indoor Air
Groundwater to Indoor Air
Soil Gas to Indoor Air
Indoor Air
Source Soil
Source Groundwater
Source Soil
Source Groundwater
Resident
Non-Residential Worker
CONTAMINANT MIGRATION PATHWAYS
Groundwater
Surface Water
Input Form 1A
VAPOR INTRUSION PATHWAYS
DIRECT CONTACT SOIL AND WATER PATHWAYS
Resident
Non-Residential Worker
Recreator/Trespasser
North Carolina DEQ Risk Calculator
Exposure Point ConcentrationsVersion Date: July 2022
Basis: May 2022 EPA RSL Table
Site ID: 23035-19-060
Exposure Unit ID: Worst-Case
Description of Exposure Point Concentration Selection:
Exposure Point
Concentration
(ug/m3)
Notes:CAS Number Chemical Minimum
Concentration
(Qualifier)
Maximum
Concentration
(Qualifier)
Units Location of
Maximum
Concentration
Detection
Frequency
Range of
Detection
Limits
Concentration
Used for
Screening
Background
Value
Screening Toxicity Value
(Screening Level) (n/c)
Potential
ARAR/TBC
Value
Potential
ARAR/TBC
Source
COPC Flag
(Y/N)
Rationale for
Selection or
Deletion
800 67-64-1 Acetone ug/m3
1.3 71-43-2 Benzene ug/m3
43 75-15-0 Carbon Disulfide ug/m3
19 67-66-3 Chloroform ug/m3
12 110-82-7 Cyclohexane ug/m3
2.8 75-71-8 Dichlorodifluoromethane ug/m3
1.6 100-41-4 Ethylbenzene ug/m3
13000 109-99-9 ~Tetrahydrofuran ug/m3
1.4 110-54-3 Hexane, N-ug/m3
46 67-63-0 Isopropanol ug/m3
1400 78-93-3 Methyl Ethyl Ketone (2-Butanone)ug/m3
1.7 108-10-1 Methyl Isobutyl Ketone (4-methyl-2-pentanone)ug/m3
6.9 75-09-2 Methylene Chloride ug/m3
68 127-18-4 Tetrachloroethylene ug/m3
44 108-88-3 Toluene ug/m3
2.1 76-13-1 Trichloro-1,2,2-trifluoroethane, 1,1,2-ug/m3
15 79-01-6 Trichloroethylene ug/m3
2.3 75-69-4 Trichlorofluoromethane ug/m3
20 108-38-3 Xylene, m-ug/m3
2.9 95-47-6 Xylene, o-ug/m3
Input Form 2D
Soil Gas Exposure Point Concentration Table
Note: Chemicals highlighted in orange are non-volatile chemicals. Since these chemicals do not pose a vapor intrusion risk, no risk values are calculated for these chemicals.If the chemical list is changed from a prior calculator run, remember to select "See All Chemicals" on the data output sheet or newly added chemicals will not be included in risk calculations
North Carolina DEQ Risk Calculator
DEQ Risk Calculator - Vapor Intrusion - Resident Soil Gas to Indoor Air
Version Date: July 2022
Basis: May 2022 EPA RSL Table
Site ID: 23035-19-060
Exposure Unit ID: Worst-Case
CAS #Chemical Name:
Soil Gas
Concentration
(ug/m3)
Calculated
Indoor Air
Concentration
(ug/m3)
Target Indoor Air Conc. for Carcinogens @ TCR = 1E-06
Target Indoor Air Conc. for Non-Carcinogens @ THQ = 0.2
Calculated
Carcinogenic
Risk
Calculated
Non-
Carcinogenic
Hazard
Quotient
67-64-1 Acetone 800 24 --
71-43-2 Benzene 1.3 0.039 3.6E-01 6.3E+00 1.1E-07 1.2E-03
75-15-0 Carbon Disulfide 43 1.29 -1.5E+02 1.8E-0367-66-3 Chloroform 19 0.57 1.2E-01 2.0E+01 4.7E-06 5.6E-03110-82-7 Cyclohexane 12 0.36 -1.3E+03 5.8E-0575-71-8 Dichlorodifluoromethane 2.8 0.084 -2.1E+01 8.1E-04
100-41-4 Ethylbenzene 1.6 0.048 1.1E+00 2.1E+02 4.3E-08 4.6E-05
109-99-9 ~Tetrahydrofuran 13000 390 -4.2E+02 1.9E-01
110-54-3 Hexane, N-1.4 0.042 -1.5E+02 5.8E-05
67-63-0 Isopropanol 46 1.38 -4.2E+01 6.6E-03
78-93-3 Methyl Ethyl Ketone (2-Butanone)1400 42 -1.0E+03 8.1E-03108-10-1 Methyl Isobutyl Ketone (4-methyl-2-pentanone)1.7 0.051 -6.3E+02 1.6E-0575-09-2 Methylene Chloride 6.9 0.207 1.0E+02 1.3E+02 2.0E-09 3.3E-04
127-18-4 Tetrachloroethylene 68 2.04 1.1E+01 8.3E+00 1.9E-07 4.9E-02
108-88-3 Toluene 44 1.32 -1.0E+03 2.5E-04
76-13-1 Trichloro-1,2,2-trifluoroethane, 1,1,2-2.1 0.063 -1.0E+03 1.2E-05
79-01-6 Trichloroethylene 15 0.45 4.8E-01 4.2E-01 9.4E-07 2.2E-0175-69-4 Trichlorofluoromethane 2.3 0.069 --108-38-3 Xylene, m-20 0.6 -2.1E+01 5.8E-0395-47-6 Xylene, o-2.9 0.087 -2.1E+01 8.3E-04
Cumulative:6.0E-06 4.8E-01
All concentrations are in ug/m3
Output Form 3B
Carcinogenic risk and hazard quotient cells highlighted in orange are associated with non-volatile chemicals. Since these chemicals do not pose a vapor intrusion risk, no risk values are calculated for these chemicals.
North Carolina DEQ Risk Calculator
Risk for Individual Pathways Output Form 1A
Version Date: July 2022
Basis: May 2022 EPA RSL Table
Site ID: 23035-19-060
Exposure Unit ID: Worst-Case
Receptor Pathway Carcinogenic
Risk Hazard Index Risk exceeded?
Soil NC NC NC
Groundwater Use*NC NC NC
Soil NC NC NC
Groundwater Use*NC NC NC
Construction Worker Soil NC NC NC
Soil NC NC NC
Surface Water*NC NC NC
Receptor Pathway Carcinogenic Risk Hazard Index Risk exceeded?
Groundwater to Indoor Air NC NC NC
Soil Gas to Indoor Air 6.0E-06 4.8E-01 NO
Indoor Air NC NC NC
Groundwater to Indoor Air NC NC NC
Soil Gas to Indoor Air NC NC NC
Indoor Air NC NC NC
Pathway Source
Source Soil NC
Source Groundwater NC
Source Soil NC
Source Groundwater NC
3. NM = Not Modeled
4. NC = Pathway not calculated
2. * = If concentrations in groundwater exceed the NC 2L Standards or IMAC, or concentrations in surface water exceed the
NC 2B Standards, appropriate remediation and/or institutional control measures will be necessary to be eligible for a risk-based
closure.
Surface Water Exceedence of 2B at Receptor?
Exceedence of 2B at Receptor?
VAPOR INTRUSION CALCULATORS
Resident
Non-Residential Worker
CONTAMINANT MIGRATION CALCULATORS
Target Receptor Concentrations Exceeded?
Groundwater Exceedence of 2L at Receptor?
Exceedence of 2L at Receptor?
1. If lead concentrations were entered in the exposure point concentration tables, see the individual calculator sheets for lead
concentrations in comparison to screening levels. Note that lead is not included in cumulative risk calculations.
Notes:
DIRECT CONTACT SOIL AND WATER CALCULATORS
Resident
Non-Residential Worker
Recreator/Trespasser
North Carolina DEQ Risk Calculator

November 2, 2022 Sent Via E-mail
Trinh ‘Ching’ DeSa, PE, Hart & Hickman, PC 2923 S Tryon Street, Suite 100 Charlotte, NC 28203 [e-mail]

Subject: Vapor Intrusion Mitigation System Installation Report Conditional Compliance Review – West Building Chadbourn Mills East and Theron Properties 500 & 508 Charles Avenue
Charlotte, Mecklenburg County Brownfields Project Nos. 20086-16-060 and 23035-19-060 Dear Mr. DeSa:
The North Carolina Department of Environmental Quality (DEQ) Brownfields Program received the Vapor Intrusion Mitigation System (VIMS) Installation Report- West Building Rev 1 dated November 1, 2022 (Report). ). DEQ Brownfields comments to previous version dated October 13, 2022 of this Report have been addressed.

DEQ Brownfields reviewed the analytical data for the West Building provided in the Report and evaluated this data using the DEQ Risk Calculator (July 2022 Version). The results of this risk evaluation using the DEQ Risk Calculator for West Building was below the DEQ thresholds for residential use.

As such, DEQ Brownfields will grant conditional compliance with Land Use Restriction
Number 11 of the subject site Notice of Brownfields Property. However, in granting
conditional compliance, the DEQ Brownfields Program requires the following conditions be
met:

(1) Re-sample monitoring point MP-8 due to the elevated laboratory MDLs. Once data is
received, update the worst-case risk calculator and submit the data for review. Submit
revised report with additional sampling data.

Mr. DeSa November 2, 2022
Page 2
(2) Pending a review of the future revisions to the Reports, additional sampling and/or
mitigation may be requested by DEQ Brownfields. All DEQ Brownfields sample and
mitigation requests must be addressed to DEQ Brownfields satisfaction and in a timely
manner as defined by DEQ Brownfields.

Please be advised that this approval from DEQ Brownfields does not waive any applicable requirement to obtain any necessary permits, licenses or certifications which may be required from other state or local entities. If you have any questions, please feel free to contact me at 704-661-0330, or via e-mail at [e-mail].
Sincerely,
Carolyn Minnich
Brownfields Project Manager ec: Andrew Besu [e-mail] Shannon Switch [e-mail];
Canter, Duane [e-mail]
[e-mail]

From:Trinh DeSa
To:Minnich, Carolyn; Ralph McGee
Cc:Andrew Besu; Shannon Switch; Canter, Duane; [e-mail]
Subject:RE: [External] Chadbourn Mill & Theron Properties - Camden NoDa - VIMS Installation Report - West Building
Date:Tuesday, November 1, 2022 5:34:42 PM
Attachments:VIMS Installation Report - West Building - Rev 1.pdf
CAUTION: External email. Do not click links or open attachments unless you verify. Send all suspicious email as an
attachment to Report Spam.
Carolyn,
Attached is the VIMS Installation Report – West Building – Revision 1 with responses to your
comments. The builder is looking to turn-over the building to leasing staff in the coming days.
Please note the following during review of this revised report and let me know if you require any
further information for the conditional compliance review approval:

Per our discussion, we will re-sample location MP-8 due to the elevated laboratory MDLs. The
sampling is scheduled for next week. Once data is received, we’ll recalculate worst-case risks,
and submit the data to you. This is indicated in the revised report.
In regards to the question about the previous laboratory data, the elevated MDLs were due to
the elevated presence of a building material, tetrahydrofuran, in the sample. On the lab
report, the “final pressure” reading in psi is a internal laboratory note regarding the pressure
needed to run the sample through the analyzer. The “received” vacuum in in-Hg is the
vacuum in the summa upon laboratory receipt.
Additional information regarding the elevator and installed waterproofing membrane is
included in Section 2.1.
A minor edit was made to Sheet VM-1, on the as-builts, to indicate vapor barrier below the
Elevator 1 lobby slabs located in the parking deck as it was inadvertently left off.

I appreciate your assistance with this project.

Thanks,

Trinh ‘Ching’ DeSa, PE, Engineering Manager
Hart & Hickman, PC
2923 S Tryon Street, Suite 100 · Charlotte, NC 28203
Direct: 704-887-4631· Mobile: [phone]

From: Minnich, Carolyn <[e-mail]>
Sent: Thursday, October 27, 2022 11:17 AM
To: Ralph McGee <[e-mail]>; Trinh DeSa <[e-mail]>
Cc: Andrew Besu <[e-mail]>; Shannon Switch <[e-mail]>;
Canter, Duane <[e-mail]>; [e-mail]
Subject: RE: [External] Chadbourn Mill & Theron Properties - Camden NoDa - VIMS Installation
Report - West Building

My error, attached is the correct document.

From: Ralph McGee <[e-mail]>
Sent: Thursday, October 27, 2022 11:14 AM
To: Minnich, Carolyn <[e-mail]>; Trinh DeSa <[e-mail]>
Cc: Andrew Besu <[e-mail]>; Shannon Switch <[e-mail]>;
Canter, Duane <[e-mail]>; [e-mail]
Subject: RE: [External] Chadbourn Mill & Theron Properties - Camden NoDa - VIMS Installation
Report - West Building

CAUTION: External email. Do not click links or open attachments unless you verify. Send all suspicious email as an
attachment to Report Spam.

Carolyn,

I may be mistaken but it appears that you attached a copy of the DEQ-approved VIMS Plan to your
email, not a copy of the installation completion report with DEQ comments. Please let us know if
I’ve missed something.

Thanks,
Ralph
Ralph McGee, PG, Project Manager
Hart & Hickman, PC
2923 S Tryon Street, Suite 100 · Charlotte, NC 28203
Direct: 704-887-4621 · Mobile: [phone]
www.harthickman.com

From: Minnich, Carolyn <[e-mail]>
Sent: Thursday, October 27, 2022 10:31 AM
To: Trinh DeSa <[e-mail]>
Cc: Ralph McGee <[e-mail]>; Andrew Besu <[e-mail]>;
Shannon Switch <[e-mail]>; Canter, Duane <[e-mail]>;
[e-mail]
Subject: RE: [External] Chadbourn Mill & Theron Properties - Camden NoDa - VIMS Installation
Report - West Building

Trinh,

Attached are comments to your VIMS installation and occupancy request. The comments are minor,
we can get it turned around quickly and meet your deadline for occupancy next month. Call or
message me if you have questions.

CFM

From: Trinh DeSa <[e-mail]>
Sent: Thursday, October 13, 2022 10:47 AM
To: Minnich, Carolyn <[e-mail]>
Cc: Ralph McGee <[e-mail]>; Andrew Besu <[e-mail]>;
Shannon Switch <[e-mail]>; Canter, Duane <[e-mail]>;
[e-mail]
Subject: [External] Chadbourn Mill & Theron Properties - Camden NoDa - VIMS Installation Report -
West Building

CAUTION: External email. Do not click links or open attachments unless you verify. Send all suspicious email as an
attachment to Report Spam.

Hi Carolyn,
Please find the VIMS Installation Report – West Building, dated October 13, 2022, attached for your
review for the Chadbourn Mill & Theron Properties Brownfields properties. This report documents
installation of the vapor intrusion mitigation system (VIMS) for the West Building and a portion of
the East Building. The developer is anticipating to turn-over these portions of the building to leasing
staff in early November. Please let us know if you have any questions or would like to discuss the
report upon your review.

Thanks,
-Trinh

Trinh ‘Ching’ DeSa, PE, Engineering Manager
Hart & Hickman, PC2923 S Tryon Street, Suite 100 · Charlotte, NC 28203Direct: 704-887-4631· Mobile: [phone]